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“Most people are mirrors, reflecting the moods and emotions of the times; few are
windows, bringing light to bear on the dark corners where troubles fester. The whole
purpose of education is to turn mirrors into windows.”
― Sydney Harris

This quote, attributed to journalist Sydney Harris, inspired the title of this thesis. For this
thesis, “Turning mirrors into windows” reflects the transition achieved through the
participatory model development approach. Participants work collaboratively to ensure
their combined knowledge and expertise is reflected in the structure and logic of the model
developed (the mirror). The learning achieved both through the collaborative process, and
by using the resulting dynamic simulation models provides beneficial insights and forecasts
the impact of intervention options to inform decision making for complex and contested
issues (the window).
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Abstract
Introduction:
Achieving evidence-based public health policy is challenging. There is increasing
recognition that more sophisticated, system-science, analytic methods, such as dynamic
simulation modelling (DSM), are needed to better understand the dynamic, interacting
and interrelated elements within complex public health systems. This thesis explored the
implementation, feasibility and value of a novel participatory DSM approach as a tool for
knowledge mobilisation and decision support in Australian health policy settings. An indepth case study of participatory modelling of Diabetes in Pregnancy (DIP) in the
Australian Capital Territory (2016-2018) was conducted. Two additional modelling case
studies focusing on prevention of childhood overweight and obesity and alcohol-related
harms in New South Wales provided supplementary data across different settings.

Methods:
A multidisciplinary stakeholder group, including researchers, clinicians, public health
practitioners, policy makers, and simulation modelling experts, was convened to coproduce a pioneering, multi-method DSM to inform DIP health service policy and planning.
Using participatory action research methods, interviews with participants, recordings from
model development workshops and meetings, participatory research field notes and other
documents were analysed to determine the feasibiliy and value of the participatory model
development process. The analysis explored the deliberations, challenges, opportunities
and decisions involved. Interviews with end-user participants for the primary and
additional case studies explored their perceptions of the utility and value of this approach
in applied settings.

Results:
Participatory DSM builds on elements of best practice in knowledge mobilisation, including
embedding deliberative methods to build shared understanding. The methods enabled a
collaborative, co-production approach to evidence-informed practice that moved beyond
evidence synthesis to provide dynamic decision support. The participatory process was
iterative, with key decisions re-visited and refined throughout the process. It facilitated a
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significant, interdisciplinary knowledge base, built understanding of the modelling process,
and established trust in the model to inform policy decisions. Key insights relating to the
prevention and management of DIP were gained. The importance of implementing and
maintaining population interventions promoting healthy weight for children and young
adults was demonstrated. The unique benefits of simulation modelling most valued by
health sector decision makers were its capacity to explore risk factor interactions,
compare the outcomes of alternative intervention combinations, and consider the impacts
of scaling-up. Participants also valued simulating new interventions prior to
implementation, and mapping evidence gaps to prioritise future research.

Discussion:
Using a participatory approach to DSM for health policy is feasible and enhances the value
of models as knowledge mobilisation and health policy decision support tools. The
detailed analysis in this thesis revealed the socio-technical opportunities and challenges of
implementing these interdisciplinary methods at the intersection of systems science,
knowledge mobilisation and public health policy, and the key elements required for
successful implementation in applied health policy settings.
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List of special terms and abbreviations
ACT Health: Australian Capital Territory Government, Health Directorate.
ADIPS: Australian Diabetes In Pregnancy Society.
Ageing chain: A stock and flow structure used in system dynamics to represent the ageing
of the population.
Agent: Agents in agent-based modelling represent an individual object. Agents can
represent virtually any individual object, for example, they may represent people, vehicles,
projects, products or countries [1].
Agent-based modelling (ABM): A computer modelling method that simulates the actions
and interactions of agents (i.e. individuals or collective entities such as organisations or
groups) to assess their impacts on the system as a whole [2]. This method is useful for
capturing heterogeneity in risk and in impacts of interventions and capturing social
network influences.
Agent journey: This term was used to refer to the changes and events that occur to an
agent throughout the simulation. For example, an agent will transition between states. In
the model developed for the primary case study an agent will experience increases and
decreases in weight status, insulin sensitivity, glycemia and diabetes status. These changes
are tracked within the model and can be analysed.
Antenatal: The period covering conception up to the time of birth.
Birthweight: The first weight of the baby (stillborn or live born) obtained after birth
(usually measured to the nearest 5 grams, and obtained within 1 hour of birth) [3].
Budding: Budding is a technique used in hybrid modelling where agents of particular
interest are “budded” or created from the system dynamics components and become
individuals in the agent-based modelling components.
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Calibration: A process for tuning some parameters of the model so that the model’s
behaviour matches a known (historical) pattern (https://help.anylogic.com/index.jsp).
Diabetes mellitus (diabetes): A chronic condition in which the body cannot properly use its
main energy source, carbohydrates. This is due to a relative or absolute deficiency in
insulin, a hormone that is produced by the pancreas and helps glucose enter the body’s
cells from the bloodstream and then be processed by them. Diabetes is marked by an
abnormal build-up of glucose in the blood, and it can have serious short- and long-term
effects [3]. The three main types of diabetes are type 1 diabetes, type 2 diabetes and
gestational diabetes.
Diabetes in pregnancy (DIP): Diabetes in pregnancy (DIP) is a complication of pregnancy
that is defined as carbohydrate intolerance resulting in hyperglycaemia (abnormally high
blood sugar) [4]. Diabetes in pregnancy includes both gestational diabetes and pre-existing
Type 1 or Type 2 diabetes.
Discrete event modelling: A modelling method that analyses processes and optimisation of
resource allocation for service delivery (e.g. patient flows through an emergency
department) [1].
Dynamic simulation modelling (DSM): Dynamic simulation modelling is a systems science
method that can be used to explore and understand problems that appear in the real-world
using computer simulations [1, 5-7]. Common methods include system dynamics modelling,
agent-based modelling, and discrete event simulation.
Flows: Flows are components used in system dynamics modelling. Flows are the rates at
which the stocks (or system states) change. Flows are typically measurements of quantities
in a given time period such as clients per month, dollars per year or incidence of disease
during a defined period [2].
Gestational age: Duration of pregnancy in completed weeks, calculated from the date of
the first day of a woman’s last menstrual period and her baby’s date of birth, or calculated
via ultrasound, or derived from clinical assessment during pregnancy or from examination
of the baby after birth [3].
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Gestational diabetes mellitus (GDM): A complication of pregnancy that is defined as
carbohydrate intolerance resulting in hyperglycaemia (abnormally high blood sugar) [4].
GDM occurs when the disease is first detected and diagnosed during pregnancy (gestation).
It might resolve after pregnancy but signals a high risk of diabetes occurring later on [3].
Incidence: The number of new cases (of an illness or event, and so on) occurring during a
given period.
Initialisation: The set of parameter values used at the start of the simulation.
Insulin: A hormone produced in the pancreas that helps glucose to enter body cells for
energy metabolism.
Model structure: The manner in which the elements of a system are represented in the
model; the building blocks of the model, including statecharts, stock and flow diagrams and
process diagrams.
NHMRC: National Health and Medical Research Council
NSW Health: New South Wales Government, Ministry of Health
Parameter: Parameters are used for quantifying characteristics of the modelled objects and
relationships between them. A parameter is normally a constant in a single simulation and
is changed only when the model behaviour needs to be adjusted
(https://help.anylogic.com/index.jsp).
Parameterisation: The implementation of parameters to quantify the model structure.
Sensitivity analysis: Sensitivity analysis is used to explore how sensitive the simulation
results are to changes of the model parameters. The analysis runs the model multiple times
varying one of the parameters and shows how the simulation output is impacted by the
variation (https://help.anylogic.com/index.jsp).
State: Represents the “state” of the agent e.g. the agent is either in a pregnant state or not
pregnant state. States are mutually exclusive and agents transition between states
according to the statechart rules [1].

17

Statechart: A visual construct that allows the modeller to define the behaviour of agents
using rules [1].
Stocks: Stocks are components used in system dynamics modelling. They are
accumulations and characterise the system state. Stocks are usually expressed in quantities
such as people, inventory levels, money, or knowledge [2].
System dynamics: System dynamics is a method for understanding how systems change. It
models the relationships between elements in a system and how these relationships
influence the behaviour of the system over time [1, 5, 8, 9]. Important elements of system
dynamic models include feedback loops (the circular causality in the system), stocks and
flows.
TAPPC: The Australian Prevention Partnership Centre.
Transition: Transitions determine agent movements between states in a statechart.
Transitions have triggers, such as a message, a condition, or a timeout that determine the
agent state will change [1].
Type 1 diabetes: A form of diabetes mostly arising among children or younger adults,
marked by a complete lack of insulin and needing insulin replacement to survive [3].
Type 2 diabetes: The most common form of diabetes, occurring mostly in people aged 40
and over, related to lifestyle risk factors, and marked by reduced or less effective insulin
[3].
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Chapter 1: Introduction

This thesis explored the novel use of participatory DSM as an integrated decision support
and knowledge mobilisation tool in Australian health policy settings. A participatory action
research framework [1, 2] was utilised to study and evaluate the implementation of a
participatory approach to DSM in a case study focused on prevention and management of
diabetes in pregnancy in the Australian Capital Territory (ACT). Diabetes in pregnancy
(DIP) was identified as a priority focus topic as incidence is increasing significantly in the
ACT, nationally and internationally, resulting in increasing pressure on services to meet
demand [3]. DIP impacted on 16% of pregnancies in the ACT in 2016 (increasing from 5%
in 2006) and decision makers require tools to support effective decision making. DSM
provided an opportunity to explore and compare the implications of health intervention
options for diabetes in pregnancy services in the ACT and inform policy and program
decision making (Chapter 3). Key findings related to the participatory modelling approach
from the DIP case study were triangulated with supplementary data drawn from two
additional case studies based in the neighbouring state of New South Wales (NSW). One
applied participatory DSM to explore strategies to reduce alcohol related harm, and the
other to examine the type and scale of interventions necessary to achieve the NSW
Premier’s target to reduce childhood overweight and obesity by 5% by 2025. The three
case studies are described in detail in Chapters 4 and 6.

1.1.

Origin of the thesis

My interest in decision support methods and knowledge mobilisation stemmed from over
20 years working in the health sector in a range of roles including clinical psychology and
health service planning, but predominantly in maternal and child epidemiology working
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with clinicians and policy makers to facilitate the use of evidence to inform policy and
program decisions. Over this time, I observed that, despite an abundance of information
and data being available for many priority topics, it was not available in a form that
addressed the most frequent question in policy advice “What should we do about this?”
The reliance in health services research on traditional statistical analytic techniques, such
as regression analysis and aetiological fractions, has provided substantial knowledge about
diseases and their aetiology, however these methods can provide only limited
understanding of the complex adaptive systems within which public health policy decisions
are made [4, 5]. Complex adaptive systems are characterised by feedbacks, interrelations
among components, self-organisation and adaptation, and time delays between cause and
effects [4]. I was interested in exploring the potential value of more sophisticated analytical
tools that could accommodate the dynamics of complex systems e.g. temporal dynamics,
and the interrelationships between elements of the system such as feedback, and system
responses to interventions for health policy settings. Tools, such as DSM, used in other
sectors such as environmental sciences, manufacturing and business to synthesise,
integrate information and forecast likely outcomes of policy and guide decisions [6-8] were
not often considered as a method to support health policy decision making [9, 10]. I was
interested to explore and assess the feasibility and value of using a participatory approach
with this method for a priority public health issue, in this case gestational diabetes mellitus,
in our local health service, ACT Health, in the Australian Capital Territory.
I focused on the participatory approach because I valued the expertise of my clinical and
policy colleagues and wanted to collaborate closely with them to integrate their significant
knowledge and other forms of evidence to develop a DSM for this priority health issue. My
initial reviews of the literature indicated that the research on stakeholder participation in
model development had primarily occurred in the environmental modelling field, with a
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rich history of community-based model development, for example the work of Peter
Hovmand, Peter Senge and Alexey Voinov [7, 11, 12]. There had been limited exploration of
participatory modelling in the health sector and when DSM projects had been undertaken
for health topics, they rarely involved end-user decision makers in the model development
[13]. However, end-user involvement is a key factor in increasing trust in model outputs
and facilitating their use to support decision making [10]. There were no studies of enduser experiences and perceptions of the participatory process and DSM as a health policy
decision support tool.
My research interests aligned well with the principles of The Australian Prevention
Partnership Centre (TAPPC), who funded my PhD research. TAPPC is a partnership centre in
which research is co-produced by academic researchers, systems practitioners and policy
makers across Australia. TAPPC aims to identify systems, strategies and structures to
inform better decisions for improving the prevention of lifestyle-related chronic disease in
Australia [14]. My employer, ACT Health, was a founding funding partner of TAPPC along
with the National Health and Medical Research Council, NSW Health, the Australian
Department of Health and a private health insurance funder. The study setting is described
further in Chapter 3.

1.2.

Rationale for the thesis

Achieving evidence-based policy for complex public health issues is challenging [15-17]. The
challenges include misalignment of research activities and policy questions in terms of
focus topic, timing and knowledge dissemination methods [18-20]. The knowledge
mobilisation field has evolved in response to these challenges and encompasses a diverse
range of activities and frameworks which aim to address the evidence policy gap [21].
Systems thinking and systems science approaches are increasingly being utilised to
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understand and mobilise knowledge for complex issues such as those encountered in
public health [22]. Dynamic simulation modelling is a systems science approach that can be
used to develop understanding about complex problems using computer simulation [23,
24]. By involving end-user stakeholders in the model development, participatory DSM can
facilitate the adoption and use of the models to inform decision making [10, 25]. The
detailed literature analysis underlying this rationale is described in Chapter 2.
Important gaps in knowledge remain regarding: the feasibility of using participatory
approaches in DSM to facilitate evidence informed decision making in Australian public
health settings; how the involvement of stakeholders as participants in DSM projects
impacts on the quality, trustworthiness and ultimately the use of model outputs for
decision making; and the perceived value of participatory simulation modelling as an
evidence synthesis and decision support method. These gaps in knowledge are explored in
detail in the research protocol presented in Chapter 3.
This thesis contributes new knowledge by exploring the novel use of participatory
simulation modelling as an integrated decision support and knowledge mobilisation tool in
Australian health policy settings. The thesis explores the processes involved in, and the
feasibility and value of, the participatory modelling approach. It describes the experiences
of end-user decision makers engaged in the case study processes, and their perceptions of
the value and utility of DSM and the likely impacts on policy and program decision making.

1.3.

Overarching theoretical framework and research approach

A Participatory Action Research (PAR) methodology was chosen as it encapsulates the
theoretical framework for this research to address the identified gaps in knowledge
described above. The PAR framework was chosen as it closely aligns with the active,
collaborative, iterative process of participatory DSM development and the involvement of
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researchers as participants in the process. The framework also aligns well with the
principles of partnership and co-production underpinning TAPPC and their remit to develop
the information, tools and actions needed for effective systems-level prevention of chronic
disease [14]. I completed the research for this thesis as the project lead for the primary DIP
modelling case-study, and as an embedded researcher with TAPPC and ACT Health
responsible for facilitating and studying the participatory modelling process.
There are many definitions of PAR that reflect wide ranging views, however most
definitions agree that PAR is inquiry that is done by or with insiders to an organisation or
community [26]. It is a reflective process that is deliberately and systematically undertaken,
and requires that conclusions and recommendations be supported by evidence produced
from the research [1, 26]. PAR is oriented to actions or cycles of actions that address a
particular problematic situation [1, 26]. PAR embeds the research in the context. The
research is planned and implemented, the effects observed and reflected on to determine
next steps all within the context of the organisation or community of focus [1, 27].
The key features of action research include its collaborative nature and its emphasis on
taking unified action on an issue [28]. It involves genuine partnership between researchers
and decision makers, who work directly with the identified issue, across each stage of the
research project, from identifying the problem to disseminating the results [2, 28]. This
partnership involves shared control of the research agenda and commitment to mutual
learning in the research process to improve researchers’ and research partners’
understanding of one another’s positions and contributions [28]. The case studies in this
thesis were highly collaborative. The modelling teams and key policy partners worked
collaboratively to negotiate the focus topics for the case studies, co-produced the DSMs
and prioritised interventions to be tested.
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An important qualitative element of PAR is how people are drawn into the processes of
inquiry and action and how they participate and collaborate [27]. The goal of PAR is to
make action more effective while simultaneously building up a body of scientific knowledge
[2, 27, 28]. The goal of PAR in the context of this thesis was the co-production of
knowledge that was useful, valid, descriptive, and informative of how practice and policy
interventions may have a positive impact on public health issues.
PAR comprises iterative cycles of gathering data, analysing the data, planning action, taking
action and evaluating, leading to further data gathering and so on. The PAR spiral [2] is
presented in Figure 1 and shows the main steps of planning, acting, observing and
reflecting.
Figure 1: Participatory Action Research Spiral

From: Kemmis S, McTaggart R, Nixon R. The action research planner: Doing critical participatory action
research. Springer Science & Business Media [2]
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1.4.

Application of the participatory action research framework to the
research objectives

In participatory action research projects, there are two action research cycles operating in
parallel [27, 29]. One is the action research spiral of plan, act, observe and reflect,
described above, in relation to the applied research project. This is referred to as the core
action research cycle [29]. In this research the development of three DSMs using a
participatory process is the core action research cycle. This cycle relates to Research
objective 1 (below).
The second is a reflection cycle which is an action research cycle that is undertaken
alongside the core action research cycle. At the same time as the researcher is engaging in
the project or core action research cycles, they are diagnosing, planning, taking action and
evaluating about how the action research project itself is working and what is being
learned [27, 29]. This secondary process of reflection has also been referred to as the
‘thesis’ action research cycle [29]. However, I haven’t adopted this term here to avoid
confusion with my PhD thesis; which comprises of both the ‘core action research’ and
‘reflection action research’ cycles (Figure 2).
In this research, the reflection cycle involves the examination of the participatory process
itself, investigating what worked well, what could be improved, how the participatory
process contributed to the development of the models and what the experience was like
for participants. This cycle relates to Research objective 2.
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Figure 2: Research objectives and action research cycles

The action research cycles and their relationship to the research objectives are represented
diagrammatically in Figure 2. The overall research objectives for this thesis were:
1. To pilot DSM to optimise the use of evidence to inform policy and program decisionmaking by synthesising and integrating diverse evidence sources into a decision
support tool for diabetes in pregnancy using a participatory modelling approach. (Core
action research cycle)
2. Investigate the perceived value and efficacy of participatory simulation modelling
methods as an evidence synthesis and decision support method in an applied health
sector context. (Reflection action research cycle)
These research objectives were investigated using a case study approach with three applied
health policy and program examples. The primary focus and core case study for this
research was the modelling project to inform prevention and management of diabetes in
pregnancy in the ACT (Case Study 1). Two other case study modelling projects were used
as sources of supplementary data to triangulate the findings for Research Objective 2, and
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as comparison to see whether and how the findings from Case Study 1 are reflected in
other settings. The research objectives and research questions are described further in the
published research protocol included in Chapter 3.

1.5.

Overview of thesis structure

This thesis is organised into eight chapters, five of which include peer-reviewed journal
articles (four have been published, and one is undergoing review). All papers were
prepared during my doctoral candidature with the University of Notre Dame. These papers,
as well as each chapter, contain their own reference lists. Supplementary material related
to ethics approval, study methods, and accompanying the published papers is included in
the relevant chapters and in the Appendices.

Chapter 2: Literature Review
This chapter provides an in-depth analysis of the various literatures that are relevant to
this thesis, including the broader challenges of achieving evidence informed decision
making in the health sector. It explores the synergies between system science and
knowledge mobilisation methods and outlines how these approaches were combined in
the thesis. DSM is introduced as a system science approach that can be applied to complex
public health issues to facilitate the use of evidence to inform policies and programs. Also
included is an explanation of the key DSM concepts, and the main methods, their history
and application are described. The motivations for using DSM over traditional statistical
techniques is explained and the application of participatory processes in DSM is outlined.
Chapter 2 also identifies the gaps in knowledge that are explored in more detail in Chapter
3.
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Chapter 3: Study methods
Chapter 3 includes the published protocol for this research. This paper describes and
discusses in further detail the current gaps in knowledge, which include the feasibility of
using DSM in “real world” health policy settings, and the value and effectiveness of using
participatory methods in model development. This paper also presents a detailed rationale
and research protocol for the primary case study investigating diabetes in pregnancy in the
Australian Capital Territory (ACT). The second part of the chapter outlines how the
research methods evolved following the publication, in 2016, of the research protocol and
explains my role in the research.

Chapter 4: Results Part 1: Mobilising Knowledge for Policy Development:
implementing systems approaches through participatory dynamic simulation
modelling
The published paper included in this chapter reviews knowledge mobilisation best practice
and describes how the participatory DSM examined in this research built on these
elements. It reports on the participatory modelling workshops from three policy settings,
including the primary case study in the Australian Capital Territory (ACT), and two
additional case studies from New South Wales (NSW), which were used as supplementary
data sources to explore and compare the feasibility and value of participatory DSM in
different settings. The reported findings from across the three case studies are reviewed
and presented with reflections on the lessons learned from the participatory simulation
modelling experience across policy settings, together with discussion of the benefits and
challenges of this approach.
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Chapter 5: Results Part 2: Turning conceptual systems maps into dynamic simulation
models: revealing the analytical deliberations and decisions of participatory dynamic
simulation modelling
The published paper in this chapter focuses on the processes, decisions, interactions and
activities that were required to convert the qualitative, conceptual map developed by
participants in the participatory workshops (described in Chapter 4) into a quantitative
DSM. This paper presents a qualitative, empirical analysis of the core processes,
stakeholder interactions and decisions, and practical strategies to develop a rigorous and
policy relevant model, which occurred outside the formal participatory workshops at the
interface between end-user participants and modellers. The implications for future
participatory modelling research and practice are considered.

Chapter 6: Results Part 3: Decision makers’ experience of participatory dynamic
simulation modelling methods for public health policy
The published paper included in this chapter reports on a qualitative analysis of the
perspectives of end-user decision makers from the three case studies. It examines their
views on the value of participatory simulation modelling to inform health policy and
program decision making, and their experiences of engaging in the participatory process.
The paper discusses interviewees’ motivations for contributing to the modelling projects,
and their perceptions about the key elements of the participatory process. The unique
benefits of participatory DSM for policy decision making processes are discussed. Also
included are a list of recommended implementation strategies based on reflections from
the three case study settings.
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Chapter 7: Results Part 4: ‘Turning the tide’ on diabetes in pregnancy: Insights from
advanced dynamic simulation modelling
The paper included in this chapter presents the DIP model that was developed in case
study 1, presented here in the final draft format that is undergoing wider clinical review
prior to journal submission. It describes the current challenges for the prevention and
management of diabetes in pregnancy, provides an overview of the DIP model structure,
logic, parameter inputs, assumptions and model outputs. The implications for DIP
prevention and management are also discussed. Associated communication products
prepared to facilitate knowledge dissemination to a non-technical audience and model
documentation to accompany the manuscript are included in this chapter.

Chapter 8: Discussion and conclusions
The overall key findings of the research and their implications are presented in Chapter 8.
These are discussed as a body of work in the context of participatory action research,
knowledge mobilisation and the policy and practice implications of using DSM. The
importance of using participatory methods to engage key stakeholders to co-produce
models for policy decision support and the benefits and challenges of interdisciplinary
research are reviewed and discussed. A framework proposed for reporting participatory
DSM projects in the environmental sciences field is applied to the primary case study and
extended based on the findings from this thesis. This chapter reflects on the strengths and
limitations of this real-world research and makes recommendations for the implementation
of future participatory modelling projects and for future research.

Appendices
Additional relevant information is provided in a series of appendices. Each appendix is
referenced in the text of the Thesis.
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Chapter 2: Literature review

This chapter includes a detailed analysis of the literature underlying the rationale for this
thesis. It is divided into seven sections describing: the challenges of evidence-informed
decision making; how the knowledge mobilisation field has developed to facilitate
evidence-informed policy; how systems science methods can be applied to public health
issues; the limitations of traditional statistical methods to analyse complex public health
problems; the core concepts and methods of dynamic simulation modelling (DSM); how
participatory methods can be applied to DSM and the important gaps in knowledge to be
addressed.

2.1

Challenges of evidence-informed decision making

Government and public policies have profound impact on the lives and health status of
populations, and therefore it is important to ensure that policies are cost effective and
mitigate the likelihood of negative outcomes [1, 2]. Ensuring that policies align with
research evidence is likely to result in higher quality and effectiveness [3]. However,
challenges in the use of evidence to inform policy remain [1, 3-7] and these are explored
below.

Evidence-informed decision making is defined as the process of distilling and disseminating
the best available evidence from research, context, and experience (political,
organisational) and using that evidence to inform and improve public health practice and
policy [2]. The barriers to evidence-informed policy include issues relating to the relevance
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and reliability of research findings, policy makers’ skills in interpreting research evidence,
costs of conducting research and poor alignment between the focus and timing of research
results and the answers required for policy [7-9]. Key questions chosen by researchers may
not align with the information priorities of decision makers, nor are the findings always
presented in a form that is useful for or relevant to the decisions at hand [5]. A traditional
investigator-driven approach to research that fails to adequately engage key stakeholders
within health care systems is a known barrier to translating research into real-world
settings [10]. Institutional characteristics, including the perceived importance and priority
placed on research evidence, the availability and access to research, and the training of
policy officers to engage with, assess and use research evidence have also been identified
as important barriers to the use of evidence [2, 7, 8, 11, 12]

A frequently identified facilitator for the use of evidence in policy is the quality of
relationships and collaborations between researchers and policymakers [7, 13]. Interaction
and exchange between researchers and policy makers can facilitate the use of evidence in
policy, however mechanisms and processes to promote these interactions are needed to
extend the exchanges beyond familiar networks and existing relationships [9].

Consideration of research evidence within the context in which it will be used is also
essential for effective policymaking and practice. The social and political context and the
many forces at work in the policy environment provide challenges to integrating research
evidence into policy and practice [9, 14]. The decision-making processes for researchers
and policymakers are significantly different, both in terms of the “real-world” steps in
decision making and also the factors that drive decisions [1]. Researchers rely on
experimental and observational scientific studies to test specific hypotheses in a systematic
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way and their influence is based on their specialised knowledge. On the other hand,
policymaking is built on a complex combination of competing priorities including the
political environment, history of related policies, demands from advocates and
stakeholders, resource constraints and public perceptions of the value of the policy
alternatives [1, 9, 14-16]. Decisions are often the result of compromise [1]. Even when
based on sound scientific data, some decisions may not be considered ready for policy
action due to lack of public support or competing policy issues [1].

Evidence provided to decision makers is often not in a form that is most useful for them
[13]. Policymakers are looking for evidence that is timely, synthesised, contextualised for
their local environment, demonstrates priority for an issue over many others, illustrates the
policy implications of research findings, contrasts policy options and personalises the issue
[1, 2, 11-13, 17]. Evidence dissemination preferences also vary between researchers and
policymakers, with researchers ranking publication in peer review journals as their first
preference for dissemination, whereas policymakers ranked seminars, webinars and
workshops as their most preferred way of learning about research evidence [2].

2.2

Knowledge mobilisation to facilitate evidence-informed policy

A range of terms, including evidence-based policy/practice, knowledge translation,
knowledge exchange, knowledge to action and knowledge mobilisation have been used to
describe activities associated with facilitating the creation and sharing of researchinformed knowledge to guide policy development [3]. Many of these terms are overlapping
and are used interchangeably [18]. Some have been used as nouns to describe the process
as a whole that results in the use of knowledge by decision makers whereas others are
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used as verbs to represent actions or specific strategies taken to facilitate the uptake of
research evidence [18]. The term knowledge mobilisation has been identified as
encompassing the broadest range of activities and reflecting the non-linear, complexity of
the process [3] and has been adopted for this research.

Best and Holmes have described three generations of knowledge mobilisation models:
linear, relationship, and systems models [19]. The linear model involves a one-way process
in which researchers produce new knowledge, which is disseminated to end users, and
then incorporated into practice and policy [4]. In this model, knowledge is seen as a
product that is supplied to users, can be generalised across contexts, and whose use is
dependent on effective communication of results [19]. The relationship model incorporates
the flow of information using principles from the linear model, however focuses on linkages
and exchanges between the researchers and users of the information [3]. In the
relationship model, knowledge generation is seen as a social and situational process arising
from multiple sources (research, theory, policy, and practice), and not solely from the
researcher [19]. In this model the use of evidence is seen to be dependent on effective
relationships and processes [19].

The third-generation systems model builds on the linear and relational models and
acknowledges that public health issues are often best understood as complex systems.
They are dynamic and constantly changing, involve interdependent systems (e.g. individual,
organisation, and community), have feedback effects and intervening in one part of the
system can have unexpected ripple effect on other parts of the system [19-21]. Complex
adaptive systems self-organise and adapt based on experience, meaning that from the
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same starting point, an intervention can potentially have several different outcomes [22,
23].

Many models, theories and frameworks have been developed for knowledge mobilisation
[24]. Twenty five key frameworks were identified in a recent comprehensive review of
knowledge mobilisation in the United Kingdom [3], however previous reviews identified up
to 60 frameworks in use [18]. There is overlap among the frameworks and common aims,
phases or domains can be identified [3, 18, 24]. These phases vary from project to project
but frequently include: clarifying the issue that needs to be addressed; negotiating the
purpose and goals for the knowledge mobilisation activity; identifying, reviewing and
selecting the knowledge that is relevant to the problem (e.g. new research findings,
knowledge synthesis or knowledge tools such as practice guidelines); considering the
connections and relationships that need to be established; identifying the people and
positions who should be involved; developing action plans and resources needed to
operationalise the knowledge mobilisation; and considering the potentially facilitating or
inhibiting effects of the local context on knowledge mobilisation efforts [3, 18].

Systems approaches are well suited to address current, complex public health issues and
systems [2, 25] and can be used to analyse both complex health issues as well as the
context within which they emerge. Systems approaches, such as participatory DSM, can
extend and build upon key elements of knowledge mobilisation including the synthesis of
diverse knowledge and evidence, investigation of dynamic and non-linear relationships
within systems and exploration of adaptive, emergent behaviour of the system in response
to policy interventions. The details of the synergies between systems approaches and
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knowledge mobilisation are explored further in Chapters 3 and 4 and therefore not
repeated here.

2.3

Systems science methods and public health

Public health issues are complex, with individual heterogeneity embedded in multilevel
social and environmental contexts [26]. There are intricate networks of factors, including
the physical, biological, ecological, technical, economic, social, and political, that impact on
public health [22, 23]. This complexity can hinder both the generation of knowledge and
the implementation of evidence-based health policies [23]. For most public health
problems there are many interacting risk factors that need to be considered as important
contributors to the issue [27]. However, the interactions between these risk factors and
delays between exposure and outcome make it difficult to identify which risk factors are
most important to target and to forecast the likely impact of policy interventions [23, 27].
Changes in behaviour also occur naturally, and continuously, as people within the system
acquire new information that alters their understanding. Planned change in such a system
is difficult because of these dynamic characteristics: nothing stands still while the
intervention is being implemented [4].

“Systems science” is a broad term referring to a family of analytic approaches that aim to
uncover the behaviour of complex systems and inform policy and program interventions
[26]. Complex systems are made up of interconnected and interdependent parts. The
behaviour and characteristics of a whole system cannot be anticipated, and often differs
from, the behaviour and characteristics of any one element in that system when these are
considered separately [22, 26, 28, 29]. Characteristics that distinguish complex systems
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from more simple ones include: the presence of many interrelated components of the
system, bidirectional relationships between components (also known as feedback loops),
non-linear relationships among components, self-organisation or adaptation of the system
in response to interventions (policy resistance), delayed effects from exposure to outcome
within the system, and changes in the system behaviour over time (temporal dynamics)
[22, 23, 26, 30].

In public health, such complexity is common and can be a significant challenge for the
design of public health policies and interventions. The interconnected dynamics of complex
systems can result in potential synergies, which may be overlooked in traditional methods
of policy design [23, 31]. Tipping points, where small actions can lead to large change, are
important levers that can be identified and utilised in policy decision making [32]. However,
policy responses should also consider that successful interventions in one part of the
system may be counteracted by negative responses elsewhere [23, 31]. Sophisticated
methodological and analytic tools, such as DSM, are useful to explore policy and program
scenarios, such as whether an intervention works as intended, for whom, under what
conditions, at what cost, how soon, and for how long [22, 23, 26, 27, 33].

2.4

Limitations of traditional statistical methods to analyse complex public

health issues

Traditional epidemiological statistical techniques have contributed substantial knowledge
in health research, however their inherent assumptions and characteristics result in
important limitations when applied to complex systems, like those in public health policy.
These limitations include reductionism, assumptions of independent associations between
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attributes and effects, reliance on methods that assume linear relationships and an inability
to accommodate time related dynamics of the system. These limitations and their impact
on the policy decision making discourse are discussed in detail below.

Complexities within disease prevention science have commonly been dealt with by
employing reductionist analytic approaches that focus on reliably estimating each
component of a system [26] and reducing the system to a series of isolated and
independent associational effects from which causal processes are inferred [22, 34].
Invaluable knowledge has been gained with these reductionist empirical approaches,
including the discovery of the link between smoking tobacco and lung cancer and asbestos
exposure and mesothelioma [22]. However, sole reliance on them may result in failure to
achieve adequate understanding of broader system behaviour shaping some of the most
pressing public health and disease prevention problems [22, 26, 33].

Traditional research methods such as randomised control trials may be viewed as the most
rigorous scientific design for evaluating intervention effectiveness, however they also have
limitations for real-world, policy-relevant research, when the exposure (i.e. policy issue)
cannot be randomised, may be subject to time delays or may emerge over time as the
system adapts and changes [1, 26]. For example, obesity is an important public health issue
which is impacted by multiple interdependent systems eg. biological, behavioural, social
and environmental [33]. Exposure to risk factors for obesity, such as family history or built
environment, cannot be randomised and may occur many years before the onset of the
condition e.g. dietary habits established in infancy and early childhood may result in the
onset of obesity in adolescence or early adulthood. Reliance on reductionist methods, that
attempt to isolate causal relationships between risk exposure and development of disease,
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may hinder insights about these complex systems that could be important for effective
intervention design or management of systems within which interventions are delivered
[26].

Multilevel statistical analyses are often used to summarise data and estimate
‘‘independent’’ associations with individual-level outcomes to test hypotheses [35]. These
techniques apply statistical controls for individual attributes, e.g. age or education status,
believed to be simultaneously related to a health outcome of interest, e.g. development of
diabetes mellitus, to isolate and investigate the impact of an independent variable e.g.
obesity. However, these regression-based approaches necessarily simplify complex
interrelations [36]. The focus is on decomposition of variability and estimating
‘‘independent’’ effects and this necessarily isolates elements from each other and ignores
feedback loops e.g. the reinforcing feedback loop that results in increases in bodyweight
associated with increasing age [35, 37].

Regression approaches are, therefore, not equipped to investigate the processes
embedded in complex systems characterised by dynamic interactions between
heterogeneous individuals and between individuals and their environment with multiple
feedback loops and adaptation [27, 35]. By attempting to isolate the effect of changing a
single factor while holding all the other features of the system constant, the context of
dynamic interactions and feedback loops is excluded. This results in findings that may not
be generalisable to other contexts, i.e. the effects of changing a single factor may be
contingent on, or influenced by, dynamic relationships within the context of the system
[35].
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Another frequently used statistical approach is the attributable fraction, that estimates the
comparative burden each risk factor contributes in a given population and the proportion
of that condition that could be averted by targeting specific prioritised risk factors [38].
Attributable fractions are often used as a static measure that considers a fixed scenario, for
a specific point of time, and assumes a risk distribution that remains unchanged over time
[39]. The assumptions underpinning the attributable fraction are that exposure variables
are independent, and relationships between exposures and outcomes are unidirectional,
linear and constant through time [36, 38]. This can result in overestimation of the potential
effect of an intervention, for example Page et. al. compared an attributable fraction
approach with system dynamics modelling to assess the impact of suicide prevention
interventions [36]. The authors demonstrated that, by artificially assuming that the
population prevalence and incidence of suicidal ideation remained constant over time, the
use of attributable fractions inflated the estimated effectiveness of the suicide prevention
programs. In contrast, the system dynamics modelling approach allowed for dynamic
movement of people in and out of states of suicidal ideation over time and this impacted
on the assessment of intervention effectiveness [36].

Effective policy decision making requires approaches that combine mechanisms and
explore their interactions, as no one relationship or mechanism is independently able to
completely explain all important aspects of the issue [31, 33]. Disease systems involve
complex relationships between causes and outcomes [23, 34]. Adaptivity means that
individual and population behaviour can evolve based on past history and feedback loops
and causal effects can be magnified (i.e., positive feedback) or dampened (i.e., negative
feedback) as disease processes progress or social systems adapt [31, 40]. Contextual effects
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mean that health outcomes are shaped by specific social, economic, and political contexts
and have a high degree of sensitivity to initial conditions of the system [34].

These traditional analytic methods yield few insights into both the dynamic processes of
systems, particularly when they involve feedback loops and adaptation, and the strength of
associations between risk factors [22, 27]. Temporal dynamics are also important but not
captured well using traditional epidemiological approaches [22, 26]. For example, time
from an exposure to disease, and time from a given intervention to its impact on disease,
are not considered in standard statistical techniques, such as attributable fraction
estimates [36]. Understanding these complex processes and temporal dynamics is
important for predicting the effects of the intervention under other scenarios and for
identifying alternate interventions that may achieve the desired effect [22, 33, 35, 36, 41].

The limitations of these statistical techniques are often acknowledged in epidemiological
papers, however may not be made explicit in the communication of results, and in
managing expectations of intervention effectiveness, among stakeholders and policy
planners [36]. This is important from a policy planning and resourcing perspective, as policy
makers need to have confidence in the statistics intended to inform policy decisions [1, 27].
They also need guidance regarding the length of time that an intervention will take to have
an effect, how long the effect might last, the impact of behavioural aspects of uptake and
participation in the intervention, potential intervention implementation issues and impact
of scaling up interventions - and this information is not commonly provided by traditional
statistical techniques [36, 42].

These methodological challenges also limit the ability to explore complex causal factors and
evaluate “up-stream” policies that target social determinants of health [22]. This can result

44

in the development of multi-sectoral, comprehensive strategies to tackle complex public
health problems in the hope that if more risk factors are targeted in strategies for
prevention, they are more likely to be effective [27]. However, comprehensive strategies
may not represent the most efficient or effective approach to reducing disease burden at
the population level. Rather, they may spread finite resources less intensively over a
greater number of programs and initiatives, resulting in a reduced “dose” effect and
diluting the potential impact of the investment [27]. For example, “Get Healthy Philly” was
introduced in Philadelphia as a multisectoral initiative targeting healthy food access and
affordability, tobacco control, built environment facilitators of physical activity, in multiple
settings including workplaces, schools and other childcare settings [33]. It involved a range
of approaches including partnerships with business, public health messaging and increasing
walkability and rideability [33]. Using traditional methods of evaluation, it was not possible
to determine which interventions included in the initiative were producing significant
effects and which were having minimal or no effect [33] . Yet this would be important
information to guide future intervention planning.

Failure to recognise the dynamics and feedbacks of the system, and the way the system
adapts and responds, can lead to or exacerbate policy resistance as policy makers
persistently react to the problem situation, intervening at low leverage points and
triggering delayed and distant, but powerful feedbacks [32, 43]. As a problem intensifies,
pulling the same policy levers can trigger a vicious cycle moving the system response
further from rather than closer to our goals [43].

Systems science methods seek to “put the pieces back together” so as to understand
characteristic system behaviour, not only at the level of the smallest components, but to
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also provide insight into the system as a whole [26], helping decision makers understand
how multiple variables, factors and interventions interact [44]. Dynamic simulation
modelling methods can be used to explore the dynamic complexity that characterises many
public health issues and provide guidance on when and how to intervene and likely
unanticipated consequences of policy decisions [22, 44, 45].

The ability to test the potential impact of programs and policies in the “safety” of a virtual
environment before they are implemented, saves time, effort, costs and resources [44, 46].
Systems science methods can capture “emergent behaviours” of the system, that is,
system-wide behaviour that is observed but cannot be attributed to the behaviour of any
individual component [22, 26].

2.5

Dynamic simulation modelling

Dynamic simulation modelling is a systems science method that can be used to explore and
understand problems that appear in the real world using computer simulations [23, 30, 46,
47]. Dynamic simulation modelling can provide a mechanism to represent a complex
system in a simpler form that is more accessible for direct study and experimentation [48].
Complex systems are often counterintuitive, with causes and effects separated in both time
and space, and modelling allows experiments to be conducted to see how a system
behaves under different conditions and scenarios [23, 47]. DSMs can account for temporal
dynamics in estimating the likely population-level impacts of interventions over time [22,
36].
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Once the model is built or even during the process of building, it can be used to explore and
test our understanding of the behaviour of the system [23, 26, 32, 43, 47, 49, 50]. In many
situations we are unable to use real-world experimentation to compare alternative
solutions to problems because it would be unethical, too expensive, dangerous or
impossible, and in these situations, models of the real system can be used to facilitate
understanding [23, 30, 46, 47].

Models should not be viewed as “crystal balls” that can precisely predict the future but as
tools that can enhance learning about complex issues and forecast likely outcomes for
defined scenarios [20, 47, 50]. Dynamic models can help us more quickly identify
inconsistencies between our understanding of the issue and the empirical evidence [50].
Models can also guide future data collection, raise new questions and hypotheses, facilitate
the identification of important leverage points in a system and bring scientific rigour to
thinking about an issue [23, 32, 43, 47, 51].

Methods in dynamic simulation modelling

The models that were developed in the participatory simulation modelling case studies
examined in this thesis applied three commonly used methods in DSM: System Dynamics
(SD), Agent-Based Modelling (ABM) and Discrete Event Simulation (DES). Each method was
chosen as the most appropriate tool to capture the mechanism being modelled. With
advances in modelling software the methods can be used in combination within a single
model and this opportunity was leveraged in this research with “hybrid” models utilising
multiple modelling methods being developed. These methods, their history and application
are outlined below.
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System Dynamics

System dynamics is a method for understanding how systems change. It models the
relationships between elements in a system and how these relationships influence the
behaviour of the system over time [23, 29, 30, 51]. Important elements of system dynamic
models include feedback loops, stocks and flows. Feedback loops represent the circular
causality in a system i.e. how elements in the system have positive or negative reinforcing
effects on other elements [23, 30, 52]. Causal loop diagrams are used to conceptualise the
system, identify key variables and important feedback loops [52].

System dynamics is considered a strategic modelling method where the system is modelled
at an aggregate level [30, 52]. In this modelling method individuals, for example, people or
products, do not appear in the model as individuals, they are represented in “stocks” or
accumulations. Individual events, such as decisions or recovery from a disease, are similarly
not considered, they are aggregated in “flows” [23, 30, 52].

Jay Forrester created the system dynamics method in the 1950’s. His first dynamic model
explained the large fluctuations in production, inventories, headcount and profit in the
appliance division of General Electric. Towards the end of the 1960s, his work increasingly
turned to public policy issues and the more general term “System Dynamics” replaced
“Industrial Dynamics” [53].

The combination of the field’s three defining elements, namely feedback, computer
simulation, and engagement with mental models, facilitated the adoption of system
dynamics across a wide range of applications [53]. For the first element, feedback,
Forrester placed prime importance on patterns of behaviour of feedback systems and the
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policies that produced them. He identified that decisions in different parts of an
organisation created repercussions elsewhere and that those repercussions eventually fed
back to impact on the originator [53].

The second element, computer simulation, brought Forrester’s theory to practical
realisation [43, 53]. The “what if ” analysis capability of computer simulation brought
scientific rigour to policy makers and managers considering the effects of decisions and
facilitated the identification of leverage points [32, 43]. As mentioned previously, leverage
points are those places in the system where a small shift in one element can produce large
changes in other parts of the system [32]. System dynamics practitioners have argued that
many policies debated in corporations or government are low leverage and unlikely to
result in significant impact or, where leverage points have been intuitively identified,
without a systems approach, then actions taken may in fact impact on the leverage point in
the opposite direction to that required [32, 43, 53].

Forrester also valued the importance of engaging with the mental models of managers and
decision-makers. Mental models are our cognitive understanding of a system [52]; people
rely on mental models to understand and manage situations ranging from simple every day
decisions, like what to cook for dinner, to developing a high level strategy for a complex
policy issue [20, 52]. The purpose of computer simulation is not to provide “the answer”
but to create a process through which stakeholders interact with a model to learn about
the complex dynamics of the systems in which they were embedded, improve their
intuition and create a new mental model which can then become the shared basis for
action [20, 52, 53].
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The system dynamics approach has two main advantages relative to other policy
informatics approaches. First, by emphasising feedback, system dynamics can identify and
highlight potential areas of policy resistance [43]. Models illustrate how policy actions can
trigger reactions, which can be delayed and unanticipated, that feed back to undermine
original policy objectives and even exacerbate original problems [23, 32, 43]. An
understanding of the sources of policy resistance is essential for the design of improved
public policies.

Second, the feedback approach enables system dynamics models to capture complex
dynamics with minimum detail. In contrast to other modelling techniques that generate
complexity from detailed depictions of individual agents, the system dynamics approach
allows modelers to isolate those dynamics generated by the broader feedback structure of
systems [23, 32]. This approach can produce models that are small enough to easily
communicate core insights to policy makers, yet sophisticated enough to replicate
counterintuitive behaviours [54] .

Discrete Event Simulation

Discrete Event Simulation (or Discrete Event Modelling) models systems as processes and
can be used to explore the impact of policy and program decisions for constrained and nonconstrained resource systems [55]. The core concepts of discrete event simulation (DES)
are entities, attributes, events, resources, queues, and time.

Entities are objects that have attributes, experience events, consume resources, and enter
queues over time as they move through the model [30, 55]. In health care applications,
entities are often people with a disease or patients in a service.

50

Attributes are features specific to each entity that allow it to carry information and, in a
health context, could include age, sex, ethnicity, health status, past events, and
accumulated costs [55]. These values may be used to determine how an entity responds to
a given set of circumstances, for example, the timing and type of past events may influence
the likelihood and timing of subsequent events [55]. Attribute values may be modified at
any time during the simulation, aggregated with those of other entities, or analysed further
outside the simulation (e.g., to estimate mean cost and effect) [30, 55].

Events are generally defined as things that can happen to an entity or the environment. An
event can be the occurrence of clinical conditions such as onset of a condition, a diagnostic
test result, or progression of a disease to a new stage; resource use (e.g., outpatient clinic
visit or admission to hospital); clinical decision (e.g., change in dose); or even experiences
outside of health care (e.g., failure to show up at work) [55]. Events can occur, and recur, in
any logical sequence.

A resource is an object that provides a service to an entity. DES represents resource
availability at relevant points in time (e.g., an emergency department with resourcing for
six beds can treat people more quickly than one with resourcing for two beds). In
representing resources, DES can capture spatial factors, such as the number of available
consulting rooms or distance between a ward and an operating theatre [30]. Queues are an
important concept in DES and occur when several entities compete for a specific resource
for which there is a constraint [41]. When a resource is “occupied” it cannot be accessed by
an entity and the entity must wait, forming a queue [30, 55]. The simulation can be used to
identify the utilisation of resources, the time spent in the system or part of the system,
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waiting times, queue lengths, system throughputs, bottlenecks and costs of entity
processing [30, 55].

Time is also an important component of DES. An explicit simulation clock (initiated at the
start of the model run) keeps track of time making it possible to track periods between
events (e.g., hospital length of stay, time spent with symptoms, survival) [55]. In health
care, events occurring to an individual and how that individual interacts with others, the
health care system, and the general environment can be modelled in DES simultaneously
[55]. The term “discrete” refers to the fact that DES moves forward in time at discrete
intervals (i.e., the model jumps from the time of one event to the time of the next) and that
the events are discrete (mutually exclusive) [55]. DES operations can include delays,
services provided by different resources, and choices between process branches [30, 41].

The level of abstraction for DES is much lower than for system dynamics. The process
diagrams reflect the physical steps that happen in the real-world system. Entities and
resources are passive in DES, that is, they have no behaviour of their own, they just carry
data. Anything that happens to them is defined by the process flowchart [30, 55].

DES was first used in the 1950’s in manufacturing companies to assist in the improvement
of production processes [56]. In 1961, IBM engineer Geoffrey Gordon developed the GPSS
(General Purpose Simulation System) which is considered the first software
implementation of discrete event simulation [30]. A time-consuming feature of early DES
was designing, writing and de-bugging the model's code [56]. From the earliest days of
simulation, there has been interest in creating the means to make this more rapid and
more reliable and with advances in technology this has been realised [30, 56].
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DES is widely used in business, logistics and manufacturing. It is one of the more common
modelling methods used in healthcare to model health services. A recent umbrella review
of systematic reviews found 586 papers published for health care applications of DES
compared with 103 for system dynamics, 47 for agent-based modelling and 1 for hybrid
modelling [57]. DES has been used to model biologic processes [58], emergency
department flows [40, 59], health system performance [60], and economic impact of
changes to population health screening methods [61].

Agent-based modelling

Agent-based modelling (ABM) is the most recently developed of the three modelling
methods. In ABM, system-level phenomena are observed through explicit modelling of an
individual, their behaviours and their interactions with each other and with the
environment [62]. The models can be used to uncover complex causal effects, identify
underlying mechanisms behind complex systems, and make sense of large amounts of
existing evidence and data [63]. The adoption of ABM by simulation practitioners increased
from the early 2000’s, triggered by computer science led advances in modelling technology,
rapid growth in computing power and memory and a motivation to gain deeper insights
into systems that could not be well captured by other modelling methods [30].

In an ABM, actors in a system are represented as autonomous individuals. They are given a
starting configuration and rules that govern their behaviour, including adaptation, and
interaction with each other and with their environment through time [62, 64]. The ABM
then simulates both individual trajectories and population-level patterns or outcomes,
which are generated from the bottom up by the actions and interactions of the agents. This
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modelling method provides mechanistic mapping from individual-level assumptions to
evolving population-level dynamics [62]. Assumptions can be informed by data or theory,
and outcomes at both the individual and population levels can be compared statistically.
ABM allows enormous flexibility in assumptions, and agents can be modelled at any level
(or multiple levels) of scale. [64]

Agents can represent virtually anything in agent-based modelling [30]. For example, agents
can be people, vehicles, equipment, health services, projects, investments or products.
Agents may or may not interact in a social context and they may be active or passive within
the model. Agents may be positioned in a spatial context (or not), may or may not interact
with each other and may be very many or very few [30, 63]. The characteristics of agents
may be defined in the model or they may emerge from the model dynamics and stochastics
[62-64].

By modelling populations of individuals, ABM can also capture the interaction of actors
with each other and with their evolving environments. This type of interaction and
feedback between individual and social levels of scale is important for the study of such
phenomena as interacting social influence and social selection processes, strategic social
marketing, and the bidirectional influence of social norms and individual behaviour [30, 62,
64].

The level of abstraction in an ABM is also flexible and is determined by the level of
abstraction of the “agents”. If agents are individuals, then the ABM will be more detailed,
however if the agents are developed at a high level of abstraction e.g. Projects, companies
or concepts, then the model will also be at a high level of abstraction [30]. ABM allows for
multiple levels of aggregation to coexist within a given model or to be modified easily if
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necessary. ABM can be useful when the appropriate level of complexity or abstraction is
not known ahead of time and requires exploration during model development [62].

An important benefit of ABM is that it can be used to explore emergent phenomena which
results from the interactions of individual entities [62]. Stochasticity can be applied to the
agents’ behaviour with sources of randomness incorporated where appropriate, as
opposed to a noise term added more or less arbitrarily to an aggregate equation in other
modelling methods [62].

ABM is of use when describing the system from the bottom up, that is, from the
perspective of the individual agents’ activities. It is useful when the behaviour of individuals
is complex and cannot be clearly defined in an aggregated form and when activities rather
than processes are a natural way of describing the system [62]. Experts can easily ‘connect’
to the model facilitating the crucial process of validating and calibrating the model through
expert judgement [62]. ABMs strive to represent detailed reality by including individual
behaviour, social networks and interactions, geographies, environmental variations, and
evolution. Thus, the computational model underlying a “realistic” ABM might contain
thousands of rules and model parameters [65].

ABMs allow us to generate hypotheses that articulate complex causal pathways which may
include latent variables. Therefore, the ways variables are instantiated (represented) differ
from those of other statistical approaches [65]. Good modelling practices suggest
instantiating the model parameters with empirical data whenever possible. When such
data are not available, models may be parameterised based on values derived from subject
matter experts. As a last resort, the parameters for which there are no data or even expert
opinion may be derived through calibration [65]. The relative importance of quantifying
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unspecified parameters can be assessed using sensitivity analysis of simulation data, which
demonstrates the magnitude of the impact the missing information is likely to have on the
model outcomes of interest [62, 65]. Moreover, ABM and other systems science
methodologies are capable of handling bidirectional relationships and feedback loops; nonlinear, networked relationships; and heterogeneity, which are difficult to handle using
statistical methods [65].

An early example of ABM was the Schelling model of segregation [66]. This was an abstract
study of the interactive dynamics of discriminatory individual choices. Schelling
demonstrated, using models of racial dynamics in neighbourhoods, that individual
members of two recognisable groups distributing themselves in accordance with a
preference that one’s neighbours be members of the same group as themselves or even a
preference for a mixture, but “only to some limit”, led to complete segregation. Once the
minority share (or number of people in the opposite group) in a neighbourhood reached
the “tipping point”, then the existing residents moved away, and more minority group
members moved into the neighbourhood. This model demonstrated that the behaviour at
an individual level (micro-behaviour) was different to the population level (macrobehaviour). For example, even when individuals had only a 60% preference to have
neighbours who were like them the resulting segregation at the population level was 100%.

Other early applications of ABM included the study of evacuation, traffic and customer
flows; market behaviour including stock markets, internet service provider business
models, and shopbots (online price comparison software); operational risk management
and organisational design; and how individuals are influenced by their social context [62].
More recent examples of health applications in ABM include models of obesity [31],
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tobacco use [64], diabetes [63], cardiovascular disease [61] and for the reduction of alcohol
related harms [67, 68].

Multimethod modelling

Advances in simulation modelling software now allow the modelling methods described
above to be combined into multi-scale hybrid models. This means that different
components of the system can be modelled at the appropriate level of abstraction [30]. For
example, in the model developed for diabetes in pregnancy in this thesis, agents have
individual differences, including age, weight status and ethnicity. They can interact with
health services represented by process (DES) components and system dynamics occur
within an agent to represent the physiological dynamics underlying the development of
impaired glucose regulation.

This flexibility is advantageous for several reasons: it allows each of the methods to be
chosen and implemented when they are best suited in terms of level of abstraction [30]; it
facilitates stakeholder understanding and learning [50, 69] and it can maximise
computational efficiency [50].

The involvement of stakeholders in the model development process can facilitate the
mobilisation of model-based learning into policy and program decision making. Policy
modelling is likely to be of limited value if done without strong and iterative engagement
with the users of the model outputs, i.e. decision makers [46, 69, 70]. Modellers must
engage with users in a meaningful, ethically informed and iterative way. This is introduced
briefly below and explored in detail in Chapters 3 to 6.
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2.6

Participatory simulation modelling

The process of participatory simulation modelling involves engaging multidisciplinary
stakeholders in a group model-building process and can be used in conjunction with
multiple modelling methods including system dynamics, discrete event simulation and
agent-based modelling [49, 52, 71, 72]. Various terms have been used to describe these
activities including: participatory modelling, group model building, companion modelling
(ComMod), and participatory simulation [72]. The tools and methods used in these
different approaches may differ, however the underlying principles are in essence very
similar, and subscribe to the same basic aim, to engage end-users and other stakeholders
actively in model development to increase the robustness, validity, utility of and trust in the
models and facilitate their use to support decision-making processes [50, 52, 69, 71-73].
The term participatory modelling has been adopted in this research. Participatory
modelling has been an important method in system dynamics modelling almost since its
inception [71] and has been widely adopted in environmental modelling projects [52, 7378].

Osgood (2017) describes the history of stakeholder engagement in modelling projects as
being divided into two eras, with a third era just starting to emerge [50]. In the first era
“Bring us your problem, and we’ll tell you what decision is best”, modelling projects were
mostly conducted inside academic or specialist organisations, with the primary outcome
delivered to stakeholders being findings from model explorations conducted in isolation by
such specialists. This was replaced by a second era in which models were often delivered to
the stakeholder team for use, but generally as a “black box” [50]. Stakeholders were able to
interact with the model (for example, through a web-based or desktop interface), but only
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for pre-defined scenarios and with constrained outputs. Within this second era of
modelling, the internals of the model, including the assumptions made, typically remained
invisible to end users, and were unable to be modified by them [50]. Even in those cases in
which the modeller was embedded within the end user team, requests to evolve the
model, even for modest changes to the assumptions, or to add certain outputs or new
types of scenarios, had to be referred to the modeller for action [50].

Advances in modelling technologies allow more transparency and a third era of
participatory modelling is developing which is increasingly being undertaken within
interdisciplinary teams [49, 50]. Although modelling experts are still required, modelling is
no longer restricted to computer science experts, and models are being designed to be
broadly accessible across team members [63]. Team members are able to proactively
inspect and critique the assumptions of a model, locally modify those assumptions, run the
model, and increasingly to supplement previously defined model outputs with those that
they develop themselves [50]. Such broader access to models can support faster model
evolution and learning, particularly in identifying discrepancies between model results and
empirical observations or knowledge concerning the world, and in helping to refine mental
models across the team [20, 23, 43, 52].

It is difficult to understand and forecast in advance the impact of policy decisions on system
behaviour as a whole [23, 32]; however, an unambiguous model specified on a computer
can play out the logical implications of the assumptions captured within that model [50].
From this perspective, the discovery of an inconsistency between what the model suggests
in simulation results and empirical knowledge is not a failure of the model, but a success of
the modelling process to facilitate learning, in that the process helps refine that
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understanding, making it more robust [49, 50, 77]. Within this third era of modelling,
embedded transparent models within teams helps harness the knowledge across the
breadth of the team and can enhance their ability to identify areas where their knowledge
falls short, and contribute to making it more robust [50].

Principles and functions of participatory modelling

Many frameworks, guidelines and principles for participatory modelling have been
developed within the environmental sciences field where it has been widely acknowledged
that sustainability issues involve social processes and stakeholder engagement is necessary
to support effective action [69, 70, 72, 79, 80]. Frameworks and guidelines for
participatory modelling have ranged from highly prescriptive scripts used for Group Model
Building associated with system dynamics modelling [52, 71, 73, 81-83] to more general
guidelines and considerations [20, 49, 69, 72, 84].

Participatory modelling projects are diverse and flexible principles guiding the conduct of
participatory processes that are also easily modifiable and applicable across sectors have
been proposed as a practical approach to inform existing and future practice [69, 72]. The
following principles have been emphasised:

Planning stakeholder engagement - There should be careful consideration of the selection
of stakeholders to include as participants, what their level of involvement and function will
be in the participatory model development and at what phases of the project they will be
involved [69, 84]. The specific skills, knowledge and domains of influence that each
stakeholder or group of stakeholders bring to the process also need to be taken into
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account, including the skills and knowledge of the modelling team, to ensure the right mix
is available to guide model development [85].

Being aware of social and group dynamics, special interests, power and hierarchies - A
participatory modelling process should always consider the reasons and intentions of
stakeholders in becoming involved as well as the reasons and intentions of modellers (and
other professionals) in proposing the involvement of stakeholders [49]. The social dynamics
within the participant group need to be considered, including, for example, how powerful
stakeholders might permit, facilitate, or encourage other actors to participate, or
alternatively, how they might prevent them from participating [49].

Flexibility - Participants are involved in the process from the very beginning, having a say in
the goals of the study, and also in the choice of methods, models and scenarios, and the
scope of the study [49, 72]. In many cases the participation in the study becomes the most
important and productive part of the project. Unexpected changes in goals and priorities
(particularly those that arise from learning from the model) should be expected and
accommodated within the process [49, 72]. Stakeholder motivation is important for the
success of projects, and stakeholders may be demotivated if they are forced into a
predefined protocol or procedure [72].

Openness and transparency – being open both scientifically and socially. Learning to work
with stakeholders throughout the whole project, and providing tools that they require, they
choose, and they are willing to use is necessary to encourage stakeholders to use the
models to inform decision making [72]. It may not be possible to identify which tools will be
needed at the start of a project, the decision-making process itself needs to be
collaborative, and that in this process a range of models and modelling methods may be
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needed [72]. Existing models need to be tested, documented, and archived in such a way
that would make them available if stakeholders require them, and the models should be
kept open so that they can be easily modified if such modifications are needed [72].

Iterating and refining - participatory modelling needs to be collaborative, iterative and
agile [46, 49, 72]. This approach facilitates a sense of ownership of the model and
encourages commitment from users about what they may come to see as ‘their’ model,
rather than some black box that someone else is imposing on them [46]. Participant input
also helps to prevent modellers making naive assumptions about the focus topic for the
model, which is easy to do if one is not a domain expert [46].

Accepting uncertainty and encouraging learning - In participatory modelling, the model is
always evolving, and uncertainty is an important consideration and discussion point [49,
72]. Through collaboration, the modellers are educated about the complexities of the
system they are trying to represent, but equally, the users are educated about the
capabilities, limitations and uncertainty in the model that they are helping to develop [46].
Active engagement of stakeholders can help parameterise and check the logical
consistency of models, even where ‘hard’ data is sparse [46]. Lack of data should not be
used to justify a decision not to model, but the approach needs moderation [46]. An
iterative, participative approach to modelling allows data needs to be identified and ways
of addressing these developed [46, 49, 72]. Rather than being viewed as “crystal balls” that
are assessed as either being accurate and successful or flawed and a failure, models have
significant potential to assist learning through the participatory process by bringing
together best evidence, data and knowledge and consolidating and testing a shared
hypothesis [20, 50].
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A recent review of participatory modelling projects identified a number of functions
enabled by the engagement of stakeholders in model development processes [69]. The
most frequently reported function was gaining access to specific domain knowledge,
followed by facilitating group processes and social learning, and yielding socially robust
solutions (i.e., those that are accepted by decision makers and the general public) [69].
Joint problem framing so that real-world problems are addressed, developing scenarios and
indicators to capture the relevant concepts from both science and practice perspectives,
gaining access to and informing decision makers about state-of-the-art science; presenting
results and facilitating use of the model results to inform decisions were also identified as
important functions of participatory model development processes [69].

2.7

Important gaps in knowledge

The advances in technology described in the preceding sections are leading to increased
adoption of tools and methods capable of integrating diverse evidence sources and
exploring the dynamics of complex systems to inform policy decision making [83, 86].
However, most participatory modelling projects do not explicitly reflect on the
participatory process component of the project [69]. Therefore, many of the challenges in
aligning these technological advances with real-life policy making had not been examined
in detail and were unresolved [69]. Questions also remained regarding how to facilitate
participatory processes effectively and encourage the acceptance of participatory
modelling processes [46, 72]. Exploration of different participatory modelling methods
have been needed to produce more detailed understanding of what motivates stakeholder
participation, in both the short and long term, with particular emphasis applied to
understanding the value (or lack thereof) participants obtain from participation, and how
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participatory model building and model-based reasoning can result in improvements to
decision making [87]. No standard template for participatory modelling processes has
emerged [69] and the literature is mostly theoretical [88]. It has been argued that lessons
to improve participatory modelling approaches will likely come from “craft knowledge”,
gained from experience [46].

Many participatory simulation modelling projects have been conducted in the
environmental science field. Therefore rigorous evaluation of the acceptability, perceived
value and utility of these methods and tools in the health sector has been required if their
adoption to support evidence-informed policy and planning is to be achieved [41, 89]. To
date, while DSM has been applied to health sector issues, the potential of participatory
DSM in the health sector has not been adequately explored. In particular, stakeholder
engagement and involvement of end-users in health-related simulation model
development has been lacking [86, 90] or, when engagement has occurred, the
participatory process has not been analysed and reported [91].

These gaps in knowledge and resulting research questions are described in more detail in
the research protocol presented in Chapter 3.
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Chapter 3: Research methods
Section 3.1 in this chapter presents the published research protocol. This paper also explored
the challenges associated with achieving evidence-based health policy making, and how
system science applications to knowledge mobilisation, such as participatory DSM, have
potential to overcome these challenges. Important gaps in knowledge are identified,
including firstly, whether it is feasible to use a participatory approach to dynamic simulation
modelling as a method for evidence synthesis and decision support in “real-world” public
health settings. Secondly, what are the perceived value and efficacy of participatory
simulation modelling methods from the perspective of end users.

Section 3.2 describes how the research methods evolved following publication of the
research protocol. Section 3.3 describes my role in the primary DIP case study and the two
supplementary case studies to examine the participatory DSM approach. Also included in
Section 3.3 is a summary of the research questions, and their relationship to the study
objectives, data sources, and the other chapters in thesis. Section 3.4 provides the relevant
information about the ethics approvals for this research.

3.1

Paper 1: Simulation modelling as a tool for knowledge mobilisation in
health policy settings: a case study protocol

Freebairn L, Atkinson J, Kelly P, McDonnell G, Rychetnik L. Simulation modelling as a tool for
knowledge mobilisation in health policy settings: a case study protocol. Health Res Policy Syst
2016;14:71 doi: 10.1186/s12961-016-0143-y https://health-policysystems.biomedcentral.com/articles/10.1186/s12961-016-0143-y
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Abstract
Background: Evidence-informed decision-making is essential to ensure that health programs and services are effective
and offer value for money; however, barriers to the use of evidence persist. Emerging systems science approaches and
advances in technology are providing new methods and tools to facilitate evidence-based decision-making. Simulation
modelling offers a unique tool for synthesising and leveraging existing evidence, data and expert local knowledge to
examine, in a robust, low risk and low cost way, the likely impact of alternative policy and service provision
scenarios. This case study will evaluate participatory simulation modelling to inform the prevention and management
of gestational diabetes mellitus (GDM). The risks associated with GDM are well recognised; however, debate remains
regarding diagnostic thresholds and whether screening and treatment to reduce maternal glucose levels reduce the
associated risks. A diagnosis of GDM may provide a leverage point for multidisciplinary lifestyle modification
interventions. This research will apply and evaluate a simulation modelling approach to understand the complex interrelation
of factors that drive GDM rates, test options for screening and interventions, and optimise the use of evidence to inform
policy and program decision-making.
Methods/Design: The study design will use mixed methods to achieve the objectives. Policy, clinical practice and research
experts will work collaboratively to develop, test and validate a simulation model of GDM in the Australian Capital Territory
(ACT). The model will be applied to support evidence-informed policy dialogues with diverse stakeholders for the
management of GDM in the ACT. Qualitative methods will be used to evaluate simulation modelling as an evidence
synthesis tool to support evidence-based decision-making. Interviews and analysis of workshop recordings will focus
on the participants’ engagement in the modelling process; perceived value of the participatory process, perceived
commitment, influence and confidence of stakeholders in implementing policy and program decisions identified in
the modelling process; and the impact of the process in terms of policy and program change.
Discussion: The study will generate empirical evidence on the feasibility and potential value of simulation modelling
to support knowledge mobilisation and consensus building in health settings.
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Background
Health systems are under continual pressure to provide
accessible and effective health services within limited
slow growing or reducing budgets. In this context, decisions regarding the best investment of health funds need
to be well informed, reviewed regularly and aimed at
achieving the greatest health gain for the investment.
The divide between research and health system actions
has been frequently recognised [1–3]. Knowledge derived
from research and experience will be of little benefit unless
it is utilised and its success monitored [1]. There is a need
to bridge the gap between the increasingly sophisticated
research on using evidence and practitioner knowledge to
inform practice and policy and the pragmatic nature of
agency decision-making for strategies and actions [2].
Advances in technology have led to increased adoption
of tools and methods aimed at integrating diverse evidence
sources to inform decision-making [4, 5]. However, rigorous assessment of the value and utility of these methods
and tools is required prior to them being more generally
adopted for evidence-based decision support. The application of systems science and simulation modelling to the
decision-making process is an innovative area with great
potential value for those responsible for allocating scarce
resources [6].

Even when research evidence is considered, as in public
health policy development for the prevention of chronic
disease [2], this evidence often points to a large range of
risk factors that contribute to the problem, including
broader social determinants of health. Our lack of understanding about how these risk factors interact, and which
are the most important, have resulted in the development
of more comprehensive, cross-sectoral strategies to tackle
complex or ‘wicked’ problems [5]. However, this approach
may not represent the most efficient or effective approach
to reducing disease burden at the population level. Rather,
it may act to spread finite resources less intensively over a
greater number of programs and initiatives, diluting the
potential impact of investment [5].
Knowledge mobilisation to support evidence-based
decision-making

The term knowledge mobilisation (KM) is used to refer
to a range of active approaches deployed to encourage
the creation and sharing of research-informed knowledge [2]. The number of terms used to describe KM
activities is large [16] and have been widely debated.
These terms include knowledge translation, knowledge
transfer, knowledge to action, knowledge exchange,
knowledge interaction, etc. [2]. This multiplicity of terms
can be a barrier to clear communication in this field [2].
In this research, the term KM is preferred as it reflects
that the process of producing and applying knowledge in
the health sector is non-linear and iterative. KM can involve a number of activities, including capacity building,
advocacy, implementation, research and evaluation [17].
Not all of these activities are applied in every KM project
[17] and they can be applied in different orders; however,
they share the common function of generating and sharing research-informed knowledge [2].
KM strategies have been applied to a range of issues,
including the quality and effectiveness of health services,
addressing policy questions (for example, mapping health
inequity and healthcare disparities), and addressing managerial and organisational issues such as the composition of
multidisciplinary teams and the costs and consequences of
different service models [2, 18]. A key strategy of KM is the
production of good quality, synthesised evidence [9] such
as scoping reviews, systematic reviews, meta analyses and
research summaries highlighting key findings for decisionmakers [9, 10].
Traditional methods of KM via evidence synthesis have
made a valuable contribution; however, they have a number
of characteristics that limit their utility as decision support
methods for complex policy questions. Firstly, systematic
reviews and meta-analyses focus on clear and specific questions and therefore have a narrow focus of investigation
and limited potential to examine complex questions
[11, 19]. Secondly, these methods frequently exclude

What are the challenges of evidence-informed
policymaking?

Evidence-informed policy decisions are essential to ensure
that health intervention programs and service plans are
likely to be effective and offer value for money. However,
barriers to the use of evidence to inform decision-making
remain [7] and the use of published research to inform
policy development is often limited [8]. Descriptive evidence and analytical studies are used to describe issues and
inform priorities; however, evidence on the implementation
and impact of interventions is less commonly used to inform program planning decisions and strategic actions [7].
In some cases, program decision-making can be driven by
“informed guesswork, expert hunches, political and other
imperatives” [9].
To address this, evidence provided to policymakers needs
to be in a form that is useful to them [10–12]. Policymakers
require synthesised and localised data that contrasts and
prioritises policy options, demonstrates effectiveness of interventions, demonstrates the need for a policy response,
demonstrates cost effectiveness of actions, reflects the level
of public support for a particular issue and personalises the
problem [12, 13]. In addition, policy and program decisionmaking processes are rarely linear. They are frequently
iterative processes and are influenced by a range of inputs
such as political environment, budget constraints, resources, values, available expertise and ethics [7, 12, 14, 15].
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systems [6, 25]. However, this approach can result in a
failure to achieve understanding of the broader system
behaviour influencing prevention problems and can
hinder insights that may be critical for effective policy
and program decision-making [25]. Traditional statistical
methods have difficulty accounting for delays between
cause and effect, non-linear relationships and unanticipated consequences of interventions [23].
Applying a systems approach through dynamic simulation modelling can provide a method to map, visualise and
quantify a complex system, to promote discussion among
stakeholders [26], and to identify points of high leverage for
intervening. Leverage points are those places in a system
where a small shift can create a large impact [27]. Leverage
points are difficult to identify in complex systems using
traditional reductionist research methods which examine
relationships between specific elements of the system in
isolation [28–30]. It is also difficult to identify the direction
of shift required to obtain the desired outcome without
comprehensive analysis and understanding of the system
and its behaviour [27, 31]. Unanticipated consequences of
interventions can have profound and negative impacts
[31, 32], and can lead to policy resistance in which the
intended positive impact of the intervention is counteracted by system responses to the intervention itself [32].
Dynamic simulation models allow for rapid integration
and use of new evidence for policy analysis, make tradeoffs of policy options explicit, and act as a vehicle for advancing controversial, contested and value-laden debates
[5, 31, 33]. Their use to explore the implications of policy
options can give rise to policy scenarios that have not previously been considered [5].
System dynamics modelling has been used as a tool to
represent disease prevalence, risk factors and local context
and to simulate the health outcomes of interventions, thus
facilitating the alignment of prevention efforts by a range
of community stakeholders [34]. For example, Loyo et al.
[35] used a stakeholder engagement process to develop a
system dynamics model to simulate the impact of various
interventions in chronic disease outcomes. The model was
used to illustrate which interventions were most effective
leverage points in the local context/system and therefore
to align and mobilise prevention efforts of community
stakeholders [35].
Participatory modelling processes, such as the one described by Loyo et al. [35], provide an opportunity to
understand and develop efficient solutions in the health
sector [36, 37]. Participatory modelling, firstly, helps community stakeholders understand how multiple variables,
factors and interventions interact. Secondly, simulation
modelling can test the potential impact of programs and
policies in the ‘safety’ of a virtual environment before they
are implemented, saving time, effort, costs and resources.
Thirdly, modelling demonstrates potential secondary and

qualitative evidence, and when qualitative evidence is
included it is not used to answer the primary research
question but only to answer supportive questions such
as whether an intervention was acceptable to consumers
[19]. Thirdly, these methods produce static overviews of
the evidence and policy options that are passively provided
to decision-makers, leaving them to interpret that evidence in their localised context and to navigate complexity
and uncertainty as they weigh up options for responding
to the problem [20].
While there are many KM approaches and techniques,
the evaluation of their use is still in its infancy [2, 21].
The limited focus on evaluation of the effectiveness of
KM methods, including systems-based ones, has been
attributed to the challenges associated with the evaluation task [2], including the methodological challenges
of conducting rigorous evaluations. It can be difficult to
measure impact, to attribute impact to different strands
of the activity in a complex environment, and to minimise
the evaluation reporting burden on stakeholders [2].
Systems approaches to knowledge mobilisation

There are acknowledged synergies between KM and systems science [21]. Systems science methods have emerged
as an effective analytical approach with the capacity to
examine both complex health problems and the context
in which they are embedded [6, 22, 23]. Systems science
can be used to map health system components and their
interactions; synthesise evidence, examine and compare
the potential outcomes of interventions; and guide more
efficient investment and conscientious disinvestment of
resources [5]. As practical systems-based KM tools and
strategies emerge, their efficacy needs to be evaluated and
this knowledge to be shared [2, 21].
Systems approaches recognise the highly contextualised
nature of health services and communities and, therefore,
evidence to inform decision-makers is unlikely to be in the
form of prescriptive statements of ‘what works’ [24].
Rather, evidence from a systems-thinking perspective
will suggest the range of strategies that will have different types of effects for different groups under certain
conditions. Building this type of evidence base will involve undertaking diverse methodologies, including the
use of case studies investigating the efficacy of using
systems techniques to inform decision-making [24].
Research methods in prevention science have traditionally employed a reductionist approach focusing on the detail of each component of the system. For example, many
studies focus on the design, measurement and analysis of
specific interventions for specific target groups. These
studies have contributed and will continue to contribute
significantly to understanding the effectiveness of prevention interventions, gaining knowledge about direct causal
relationships and understanding components of complex
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tool. Participatory modelling approaches aim to combine
multidisciplinary stakeholder perspectives to tackle the
social complexity of problems and recognise that different types of knowledge contribute alternative and valuable perspectives to the problem discourse [33].
Evaluation of the participatory simulation modelling
process in the health sector has been lacking [5, 41] despite assessment of its efficacy being essential to inform
decision-making [5, 37]. Understanding the intricacies of
the participatory process [33] and evaluating methods
and tools to facilitate participatory modelling is necessary to improve modelling outcomes [4, 31, 37] and further research is required to develop and refine rigorous
evaluation methods [39]. The Challenge and Reconstruct
Learning (CHaRL) Framework has been proposed by
Smajgl and Ward [46] to evaluate participatory modelling processes. This framework can be used for deliberative approaches [47] and involves assessing formalised
and facilitated learning among decision-makers and decision influencers at varied policy levels. The key component
of the CHaRL framework is the change in perception or
belief about assumed causality within the system. In other
words, participants’ mental models are challenged by the
presentation of different perspectives, scientific evidence
and system interactions through the modelling process.
The change in mental model can be measured using individual value and attitude/belief orientations recorded by
participants pre- and post- the modelling process [46].

tertiary effects (and even unintended consequences) of
intervention strategies. Fourthly, modelling can guide and
prioritise data collection and facilitate dialogue among
stakeholders [36].
The process of participatory simulation modelling involves engaging multidisciplinary stakeholders in a
group model-building process and can be used in conjunction with a number of modelling methods [31, 37, 38]. The
value of this engagement is the development of a shared
mental model of the causal pathways and potential intervention points in the system [39]. A participatory modelling
approach enhances stakeholder knowledge and understanding of the system and its dynamics in varying conditions. It
identifies and clarifies complex and contested real world
problems [33] and the impact of solutions, therefore facilitating the development of action statements based on the
evidence [39, 40]. The involvement of key decision-makers
in the model development and validation increases their
sense of ownership and confidence that the model is valid
for their local context. They are therefore more likely to
draw on the outputs to inform decisions about priority interventions and policies [23, 37, 39, 41].
Important gaps in knowledge

The application of systems thinking to health improvement is acknowledged as an ongoing challenge [42, 43].
Stakeholder engagement and involvement in the modelling process has been particularly lacking, resulting in
unsuccessful projects [42] and a reluctance from ‘nonresearchers’ to use models as a decision support tool
[33]. A systematic review of the use of simulation modelling to inform surgical patient flow processes found
that only half of publications stated that they had produced
a model to inform policymakers and health service
managers and only 26% actually included policymakers
and health service managers in the simulation modelling process [44]. Where policymakers have been included in the simulation modelling process there
remains an absence of rigorous analysis of their perspectives on the utility of the model, their learning relating to
the development and use of the model, and their commitment to implement the findings of the model [5, 37].
Relationships and collaborations are routinely identified as a key factor in systems approaches [45] and this
is particularly true for participatory modelling processes.
Important elements for implementing successful systems
thinking to address complex issues include the formation of networks and teams, distributed leadership, and
strong and effective communication and feedback mechanisms [17]. Understanding the role of participants
within the system as well as in the participatory modelling process and bridging professional cultures [45] is
key to understanding the factors that will impact on the
uptake of simulation modelling as an evidence synthesis

Study objectives

The objectives of the research are to apply and evaluate
a simulation modelling approach, using gestational diabetes
as a case study to:
1. Pilot simulation modelling to optimise the use of
evidence to inform policy and program decision-making
by synthesising and integrating diverse evidence sources
into a dynamic simulation model of gestational diabetes
using a participatory modelling approach. The model
will be used to understand the complex interrelation of
factors that drive gestational diabetes mellitus (GDM)
rates and test options for interventions.
2. Investigate the perceived value and efficacy of
participatory simulation modelling methods as an
evidence synthesis and decision support method in
an applied health sector context.
Using GDM as a case study

GDM is a complication of pregnancy that is defined as
carbohydrate intolerance resulting in hyperglycaemia (abnormally high blood sugar) of variable severity with onset
or first recognition during pregnancy [48]. GDM defined in
this way includes women with undiagnosed pre-existing
diabetes, as well as those for whom the first onset is during
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for the health of their baby and themselves [67]. Enablers
identified by women to implement lifestyle change during
pregnancy include family support [66, 67], physical access
to programs, knowledge (about diet, exercise and GDM),
and motivation levels [67].
Previous models of GDM developed to investigate the
cost effectiveness of screening and treatment regimens
[64, 65, 68, 69] have provided valuable evidence to inform decision-making. However, these models focussed
on an economic evaluation of specific treatments and
did not analyse the wider outcomes of policy and program decisions, including the intended and unintended
consequences and resource implications of interventions
delivered in the health system [70]. Dynamic simulation
modelling has been used to investigate the intergenerational impact of GDM on the development of Type 2
diabetes mellitus among First Nations and other population groups in Canada [71]. This model included representations of factors contributing to the development of
diabetes mellitus, including changes in behaviour regarding diet and physical activity over time and found that
GDM disproportionately contributed to the development of Type 2 diabetes mellitus in First Nations populations compared with other population groups [71].
Dynamic simulation modelling provides an opportunity to explore and compare the implications of health
intervention options for GDM services in the Australian
Capital Territory (ACT) and to inform policy and program decision-making. The simulations derived from the
model can be used to explore the dynamic interaction of
risk factors such as maternal weight and weight gain
(pre and during pregnancy); the impact of screening
earlier or later in pregnancy; the impact of universal or
selective screening; the impact of lowering the diagnosis
threshold on the number of women diagnosed, health
outcomes and health system impacts; the implications of
intervention options for prevention and treatment of
GDM with different target groups and with different
timings (e.g. at the start of pregnancy, during pregnancies, between pregnancies); GDM diagnosis and risk of
later development of Type 2 diabetes in the ACT; and
the short- and long-term outcomes for mother and baby
following treatment for GDM.
The current research project will contribute to knowledge on the application of systems thinking to a localised
health system case study by undertaking, validating and
evaluating a participatory simulation modelling process
focusing on GDM.

pregnancy (especially during the third trimester of pregnancy). The prevalence of GDM is increasing both in
Australia and internationally [49].
Identified risk factors for GDM include maternal body
mass index of at least 30 kg/m2 [50–52], increasing
maternal age [52], physical inactivity [50, 52], increasing
parity, and ethnicity [53]. Women are also at increased
risk if they have a history of GDM [52], previously had a
macrosomic baby (birthweight greater than 4000 g), a
family history of diabetes [52], polycystic ovary syndrome
[52], or a diet low in fibre [54, 55].
Perinatal risks associated with GDM include macrosomia, shoulder dystocia, other birth injuries, hypoglycaemia
and perinatal mortality [53, 56]. Long-term risks for the
infant from GDM include sustained impairment of glucose tolerance [57], subsequent obesity [58] (although not
when adjusted for size) [59], and impaired intellectual
achievement [60]. For women, gestational diabetes is a
strong risk factor for the development of diabetes later in
life [61, 62].
Although the risks associated with gestational diabetes
are well recognised, debate remains as to whether
screening and treatment to reduce maternal glucose
levels reduce these risks [53, 63]. Given this uncertainty,
professional groups disagree on whether to recommend
routine screening, selective screening based on risk factors for gestational diabetes, or no screening [53]. There
is also debate over the efficacy of using a single raised
blood glucose result to diagnose GDM [63].
The Australian diagnostic threshold for GDM was changed to be consistent with WHO criteria from January 1,
2015. The WHO report from which the criteria were obtained acknowledges that the evidence for the threshold
chosen is weak. However, they argue that the benefits of
treatment, i.e. reduction of risk for macrosomia, shoulder
dystocia and pre-eclampsia is sufficient justification. Treatment of gestational diabetes once diagnosed is generally
medicalised (insulin treatment) and involves intense use of
health services, mostly in the third trimester. Investigations
of the cost implications of using the lowered diagnostic
threshold concluded that cost effectiveness will only be
achieved if treatment reduces the risk of caesarean section
birth and developing Type 2 diabetes mellitus [64, 65].
Pregnancy has been identified as a point in the life
cycle where individuals have increased motivation to
commit to health improving behaviours, for example, in
smoking cessation [66]. A diagnosis of GDM (or even a
glucose tolerance test result that approaches the diagnostic cut-off ) may provide a powerful leverage point for
multidisciplinary health interventions promoting lifestyle
change to reduce the risk of developing diabetes later in
life. Almost all women (95%) with a diagnosis of borderline GDM in an Australian study identified that managing
their borderline GDM was important or very important

Methods/Design
Design overview

The study design will use mixed methods to achieve the
research objectives. A participatory simulation modelling
approach will be used to synthesise evidence and explore
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strategies for GDM diagnosis, early intervention and management (Objective 1). Evaluation of the modelling process
as a systems-based knowledge synthesis tool will incorporate both qualitative and quantitative methods (Objective 2).

maternity services are provided by Canberra Hospital at the
Centenary Hospital for Women. There are two publicly
funded hospitals and one private hospital in the ACT,
providing maternity services.
The number of women giving birth in the ACT is over
6000 per year. Approximately 15% of these women are
not ACT residents but access services in the ACT for high
risk pregnancy complications (i.e. requiring tertiary level
care). There a number of models of antenatal maternity
care provided in the ACT including hospital-based outpatient care, tertiary level care, private midwifery care, and
shared care (which is integrated with primary healthcare
providers).
A specialist gestational diabetes service with satellite
clinics in community health centres works with generalist maternity services to provide education and health
services for women with gestational diabetes.

Research questions

Simulation modelling will be used to answer the following
research questions about GDM interventions in the ACT.
Model simulations will explore:
 The dynamic interaction between risk factors such







as pre-pregnancy maternal weight, maternal weight
gain during pregnancy, GDM diagnosis and life-time
risk of developing of Type 2 diabetes for mothers
and babies in the ACT
The short- and long-term outcomes for mother and
baby following treatment for GDM in the ACT
The impact of changing the diagnosis threshold on
the number of women diagnosed, health outcomes
and the health system impacts (including health
economic analysis)
Health outcomes achieved from priority interventions
identified by participants
Cost effectiveness of priority interventions identified
by participants

Participants

Purposive sampling will be used to recruit participants
with a range of expertise such as endocrinology, obstetrics,
neonatology, diabetes education, nursing, midwifery, policy,
health economics, exercise physiology, pathology, public
health, research, allied health, health service management,
consumers (healthcare recipients) and the simulation modelling expert team. The anticipated number of participants
is 10 to 15 to allow for wide engagement with influential
leaders while maintaining a manageable dialogue with
meaningful contributions from all members.
The inclusion criteria for participants is that they are
recognised experts in providing care, planning services,
undertaking research or developing policy for the diagnosis and management of GDM. Participants must also
be willing to attend model development and application
sessions and participate in the evaluation.
Participants in the group model building and model
validation processes will be asked to provide written
consent prior to participating.

This research will also explore the effectiveness of
participatory simulation modelling methods to optimise
the use of evidence to inform policy and program decisionmaking through qualitative and quantitative methods investigating the participatory modelling process and evidence of
impact on decision-making (detailed further below). The
specific questions to be answered by this research include:
 Whether simulation modelling is an effective tool to

facilitate evidence-informed decision-making in an
applied health setting
 The efficacy of applying a participatory approach to
model development
 The benefits and limitations of using simulation
modelling to explore potential outcomes from a
range of policy and intervention options to inform
decision-making

Procedure
Objective 1 – Participatory model development

Model development This research will employ a participatory simulation modelling process, which will involve
the following steps [4, 26, 31, 36]:

Study setting

The study is being conducted as part of an ongoing initiative of The Australian Prevention Partnership Centre
to apply systems approaches to the prevention of chronic
disease. The research will be carried out at the ACT
Government Health Directorate, which provides publicly
funded health services for a population of approximately
390,000 in the ACT and is the major health referral centre
for the Greater Southern Region of NSW. The total catchment area population is over 600,000 people. Tertiary level

 Forming an expert sub-group of the participants

listed above who will define the boundaries of the
model. A model is not able to include in detail every
possible factor, relationship and intervention, and
therefore only those that are relevant to the policy
and practice questions to be answered by the model
should be included in the first instance. Engaging
with the literature and collaborating with stakeholders
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dynamics such as ‘If–Then’ statements and mechanistic
interactions among agents. When the program is run,
agents interact with one another and their environment, often resulting in counterintuitive insights about
behaviour of agents and the system [23]. Incorporating
ABM components allows flexibility to incorporate the
dynamics of people making decisions affecting population
health outcomes, and thus efficient planning of healthcare
interventions [70].
Discrete event modelling methods represent the system
as a process, namely, as a sequence of operations or events
performed across entities [72]. For example, discrete event
methods are frequently used to represent and improve efficiency of health services such as emergency departments.
This modelling method represents complex systems at a
low level of abstraction. The core concepts in discrete
event simulation (DES) are events, entities, attributes and
resources. An event happens at a certain time point in the
environment and can affect resources and/or entities.
Entities have attributes and consume resources while experiencing events, but consumption is not affected by
individual-level behaviour. Attributes are features or characteristics unique to an entity. They can change over time
or not. Resources are objects that provide a service to an
entity. Queues are another important concept in DES and
occur when several entities compete for a specific resource for which there is a constraint [70]. DES modelling is useful to analyse resource utilisation, throughput
of services and the impact of varying policy decisions [70].
Advances in modelling software technology now enable multiple modelling methods to be integrated [72].
This allows for modellers to represent the many interacting components of a system and the complex interplay between individual behaviour and social connections across
populations [6].

and researchers to understand the risk factors for
GDM, options for GDM diagnosis and intervention,
and reach agreement on the priority health and
economic outcome indicators to be included in the
model structure
Identifying data sources and populating the model
with data (parameterising the model)
Deciding which local and/or national data on current
practices and behaviours should be incorporated into
the model
Identifying potential intervention leverage points
and mapping the mechanism by which interventions
have their effect in the model
Validating the model using accepted validation
methods such as assessment of face validity, system
behaviour reproduction, parameter estimation,
sensitivity analysis and statistical testing [41]
As the model develops into a functioning simulation
tool, exploring possible scenarios and prediction of
outcomes
Ensuring the purpose, assumptions and limitations
of the model are clearly stated
Using the final model to explore the timing,
frequency and combination of interventions that
deliver optimal impact

The participatory model development process will
identify the factors to be represented in the model. It is
anticipated that a combination of high level aggregated,
individual characteristics and interactions and eventbased factors (e.g. service utilisation), will be identified.
Therefore, a more flexible hybrid modelling approach
will be adopted incorporating system dynamics, agentbased and discrete event modelling methods.
System dynamics modelling methods were created in
the 1950s by Jay Forrester in the field of engineering.
System dynamics modelling utilises feedback loops (causal
loop diagrams) and stock (accumulations) and flow diagrams to represent complex systems [6, 23, 72]. This modelling method represents the dynamics of the system at a
high level of abstraction [6], making them an efficient form
of modelling in terms of computing resources. System
dynamics simulates patterns and trends in system behaviour. Simulation experiments can be used to compare and contrast intervention alternatives to inform
decision-making [70].
Agent-based modelling (ABM) methods have been
developed more recently and allow for representation
of individuals or agents within the system. The model
can be built from the ground up by defining agents,
their behaviours and their interactions [6, 72]. ABM is
a computational method used to examine the actions of
agents (e.g. individuals) situated in an environment (e.g.
neighbourhood). ABMs specify decision rules controlling

Model application Once the model develops into a
functioning simulation tool it will be used to explore
possible scenarios and prediction of outcomes. During
this phase, a broader stakeholder group will be formed
and engaged in policy/strategy dialogues facilitated by
interaction with the model and explore the costs and
benefits for a range of intervention options. The composition of the stakeholder group will include the full
scope of disciplines and consumers outlined in the Participants section. The model application process aims to
refine the model as well as to demonstrate the utility of
the model to key decision-makers so as to inform policy
action and program decisions.
The transdisciplinary simulation modelling process
provides an opportunity to establish network relationships
and analyse policy and program options based on outcomes
simulated. An action statement regarding GDM diagnosis
and treatment in the ACT based on the simulation
81

Freebairn et al. Health Research Policy and Systems (2016) 14:71

Page 8 of 12

and statistical testing [41]. Expert participants in the model
development process will be asked to assess whether the
model and its behaviour and outputs are reasonable given
their knowledge of the system [73]. The model behaviour
will also be tested against historical data and model
simulations over time will be assessed. Available data
will be partitioned with a subset used to build the
model and the remaining data used to determine (or
test) whether the model replicates the historical system
behaviour [73]. Parameter variability and sensitivity
analyses will also be conducted to test model behaviour
and to determine which parameters the model is most
sensitive too. Those parameters that are sensitive, that
is they cause significant changes in the model’s behaviour
or output, should be made sufficiently accurate prior to
using the model [73].

modelling work and synthesised evidence will be developed with the expert group.
Data analysis The model will be built using AnyLogic®
7.2, St Petersburg, Russian Federation. AnyLogic® software allows for multiple modelling methods to be integrated into a single hybrid model providing participants
both flexibility and transparency in model design.
Model parameterisation involves populating the model
with data and will evolve in accordance with the participatory modelling process. This will make use of the following:
 Secondary analysis of de-identified administrative








data to inform transitions (hazard rates/probabilities/
relationships between risk factors) within the model
structure. For example, regression analyses may be
conducted to determine the contribution of gestational
diabetes in relation to other risk factors to perinatal
outcomes such as birthweight
Published demographic information such as age
and gender characteristics, age-specific fertility
rates, population estimates of weight status categories
Published results from research on intervention
effects such as the impact of targeted pregnancy
weight management programs focused on nutrition
or physical activity on the development of GDM
Local expert knowledge to supplement available data
Partitioned administrative and/or available survey
data to calibrate the model

Objective 2 – Evaluation of a participatory approach to
dynamic simulation model building

Procedure The case study methodology allows for investigation of the strengths, weaknesses and evaluation
of participatory simulation modelling as a mechanism to
influence policy and program decision-making and develop
action statements [2]. Little is known about the value,
strengths and limitations of simulation modelling as applied
to ‘real world’ health policy decision-making. The key
research questions addressed in this study include those relating to engagement of experts in the process; perceived
commitment, influence and confidence of stakeholders in
implementing policy and program decisions identified in
the modelling process; and measuring the impact of the
process in terms of policy and program change.
The evaluation of the participatory modelling process is
informed by the CHaRL Framework proposed by Smajgl
and Ward [46]. The CHaRL framework can be used for deliberative approaches and involves assessing formalised and
facilitated learning among decision-makers and decision
influencers at varied policy levels. The key component of
the CHaRL framework is the change in perception or belief
about assumed causality within the system. In other words,
participants’ mental models are challenged by the presentation of different perspectives, scientific evidence and system
interactions through the modelling process. The change in
mental model can be measured using individual value and
attitude/belief orientations recorded by participants before
and after the modelling process [46].
Therefore, the evaluation methods to determine the
effectiveness and impact of systems dynamic modelling
will include investigating the:

Statistical analysis of administrative data will be conducted using IBM SPSS Statistics version 22, United States.
Data availability is a potential limitation to this study.
It is proposed that, where data is not of high quality or
is not available, placeholder values will be used and
tested using the following methods. Firstly, the model
simulations will be analysed against trends and patterns
observed in historical data and, secondly, sensitivity testing will be conducted around the missing values to determine if the model outputs depend significantly on them.
When parameters are identified that the model is sensitive
too, this can be used to guide and prioritise future research activities to obtain these important pieces of data.
Assumptions surrounding the use of placeholder values
will be made explicit in descriptions of the methods used
to develop the model.
Validation of the model is necessary to assess the logic,
soundness and utility of the model outputs [41]. Validation of the model can be conducted as part of the model
development process by conducting tests and involving
the model users in assessing the validity of the model [73].
The model will be validated using accepted validation
methods such as assessment of face validity, system behaviour reproduction, parameter estimation, sensitivity analysis

 Participation in the process, e.g. response rate to

invitations, attendance and retention at modelling
sessions and subsequent deliberative forums
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 Participants’ perceptions of the key factors that

The main domains to be covered will include participant’s perceptions or ‘mental model’ of GDM through
the modelling process, value of simulation modelling as
an evidence synthesis methodology to inform decisionmaking, and intention to use this method in the future.
The proposed interview questions are contained in Box 1.

contribute to GDM and the best use of resources to
diagnose and manage GDM through survey responses
 Group interactions, contributions and engagement with
the process by qualitative analysis of audio recordings of
the model building and engagement sessions
 Informant views via semi-structured interview on the:
 value of simulation modelling as an evidence
synthesis tool
 strengths and limitations and intention to use
simulation modelling in the future
 perceived enablers and barriers to the use of
simulation modelling
 personal response to the participatory modelling
process
 Follow-up environment scan to determine policy
and program decisions that were informed by the
modelling process and the model outputs

Box 1 Semi-structured interview questions to obtain
key informant views
Prior to workshops
Based on your experience, what are the current challenges that
GDM services are facing? What do you think is driving these
challenges? What changes do you think GDM services need to
make to cope with these challenges? Which interventions would
you prioritise to prevent and manage GDM?
Could you talk a little about your thoughts on evidencebased decision-making in the health policy context? To what extent do you think evidence is used to inform health policy and

Data analysis Quantitative analyses will include measuring and reporting the number of sessions attended, and
analysing the responses recorded on the before and after
forum surveys.
Participants will be asked to record their views on the
main contributing factors to GDM, the optimal time for
screening for GDM and how they would allocate resources
to a hypothetical new service for women with GDM. They
will also be asked to provide self-reported evaluation feedback reflecting on their learning and ways to improve the
modelling sessions.
Qualitative analyses will include analysing the data collected during:

program decisions? What factors have you found to be
useful to support its use? What are the main challenges?
Have you had experience using results of evidence synthesis
methods such as systematic reviews, meta-analyses? Did they meet
your needs for evidence to inform your decision-making? From your
experience, what are the strengths and limitations of these methods?
What other forms of evidence do you use in decision-making?
Have you participated in any form of simulation modelling process
before? (If reply yes) Could you tell me about the modelling process
and your experience of it? In your opinion, what are the benefits and
limitations of simulation modelling as an evidence synthesis tool?
Post workshops

1. Model development sessions
2. Model application sessions
3. Semi-structured interviews (pre- and post-modelling
workshops)
4. Notes and memos based on meetings and de-identified
conversations with participants and the modelling team

Could you tell me about your experience of participating in the
simulation modelling process? What are the strengths and
weaknesses of simulation modelling as an evidence synthesis tool?
Has/How has the modelling process influenced your opinion
of the key factors that contribute to GDM? Has/How has the
modelling process influenced your opinion of the best use of

The model development and application sessions will
be audio recorded, primarily to allow the investigators to
review content information and expert advice provided
by participants relating to model development. The recordings, participant observations and field notes will be
kept to highlight particularly valuable comments and
analyse behaviours or interactions between participants.
The analysis of field notes will be triangulated against
the audio recordings and interview transcripts.
Semi-structured interviews will be conducted with
participants of the model development and model application sessions. Participants will be purposively selected
for interviews to provide a range of perspectives and interviews will be conducted face-to-face where possible.

resources to screen for and treat GDM?
Will you use the outcomes of the gestational diabetes modelling
process to guide your future decision-making? Why or why not?
Based on your experience would you say simulation modelling is
worthwhile for health sector policy/practice settings? Why/why not?
Do you intend to use the outputs of this model or participate in
other simulation modelling projects in the future? Why or why not?
In your opinion, what would you say are facilitators and
barriers to the use of simulation modelling to synthesise
evidence for decision-making?
Do you have any recommendations to improve the process
for using simulation modelling as an evidence synthesis tool?
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Field notes relating to meetings and informal discussions will be maintained by the researcher in a journal
format and will be included in the qualitative data analysis.
>Audio recordings will be transcribed and integrated
with field notes and reflections. Transcriptions will be
de-identified, collated and coded so that only general
themes emerge.
Interview data will be independently coded by two investigators. Initial codes will be derived from the research aims and subsequently refined over two coding
cycles. The two coders will compare and agree upon
codes and emerging themes at the end of each cycle, resolving disagreement by consensus opinion or by the
creation of new, mutually agreeable, codes/themes.
Data analysis will be iterative and begin with identifying central organising concepts, patterns and themes
from the coded data. Thematic analysis will be reflective
and revised by revisiting the coded and collated data to
ensure that identified themes and subthemes are coherent,
distinctive and relevant to the research question [74].
Common and repeated themes identified from the modelling sessions will be investigated through interviews to
better understand informant views in relation to specific
topics, and to assess the strength and importance of various
themes. A comparative analysis will be conducted to understand the range of participant views in relation to their role
perspective and level of power within their organisation,
e.g. clinician, researcher, manager and policymaker views.
This research involves investigators who currently work
within the local health sector. This provides some advantage
as these investigators have good knowledge of the system and
context; however, it also presents challenges and limitations.
For example, the investigators’ willingness to identify and report on system limitations may be impacted by their professional affiliation with the organisation. The involvement of
external co-investigators and the use of independent reporting
mechanisms through The Australian Prevention Partnership
Centre are mitigation strategies to be employed for this challenge. The use of voluntary recruitment processes and confidentialised analyses of individual input and participation will
be employed to address perceptions of coercion or concerns
of repercussion from either participating or declining to participate in this research.
A follow-up environment scan to determine policy
and program decisions that were informed by the modelling process and the model outputs will be conducted
three to 3–6 months after the model engagement workshops. This will involve interviews with end users and
document analyses to determine the use of model outputs to inform decision-making.

using codes instead of names and removing any potentially
identifying text from transcripts. Data will be stored
securely on password protected computers or ACT
Health secure servers and will only be accessible to the
researchers.
Paper surveys will be anonymised and scanned to create an
electronic file to be stored in secure folders on a secure server
only accessible to the researchers. The paper surveys will then
be securely destroyed. Clinical and administrative data to be
used for the project will be de-identified prior to analysis.

Discussion
This project will apply systems science and simulation
modelling to GDM in the ACT as a case study.
The outcomes will include, firstly, producing a model
that will be a functioning simulation tool to explore possible scenarios and the impact of those scenarios on health
outcomes for the mother and baby as well as service impacts for the health system; secondly, developing a joint
commitment for policy action and program decisions
through engagement with the stakeholder group and,
thirdly, evaluating the use of simulation modelling to
inform decision-making.
The participatory model-building process will be informed by a multidisciplinary expert stakeholder group.
This provides an opportunity to ensure the model reflects the shared understanding of the causal pathways
and potential intervention points in the system.
Simulation modelling methods will be used to explore
and compare strategies for GDM diagnosis, early intervention and management. The modelling will include interaction between risk factors, the short- and long-term
outcomes for mother and baby, and potential modes and
timing of intervention.
Importantly, involving key decision-makers and experts
in the model development and validation process increases the acceptability of the model for the local context.
The model is therefore more likely to be useful to inform
decisions about priority interventions and policies.
Systems science is emerging as an effective way to examine both complex health problems and their context. It can
be used to synthesise evidence, examine and compare potential outcomes of policy options, and guide the best use
of limited resources through methods such as simulation
modelling. This research will contribute to existing knowledge, firstly, by applying a participatory process to simulation modelling in a local health setting; the participatory
process will engage expert stakeholders in the development
of a functioning model to inform decision-making. Secondly, by developing and incorporating evaluation methods
to investigate the efficacy of simulation modelling as an evidence synthesis tool. Thirdly, by using quantitative data to
develop a simulation model to inform health policy and
program decisions.

Data storage and management

All audio-recorded data from the model development
and model application sessions will be de-identified by
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Chapter 3: Research methods
Section 3.1 in this chapter presents the published research protocol. This paper also explored
the challenges associated with achieving evidence-based health policy making, and how
system science applications to knowledge mobilisation, such as participatory DSM, have
potential to overcome these challenges. Important gaps in knowledge are identified,
including firstly, whether it is feasible to use a participatory approach to dynamic simulation
modelling as a method for evidence synthesis and decision support in “real-world” public
health settings. Secondly, what are the perceived value and efficacy of participatory
simulation modelling methods from the perspective of end users.

Section 3.2 describes how the research methods evolved following publication of the
research protocol. Section 3.3 describes my role in the primary DIP case study and the two
supplementary case studies to examine the participatory DSM approach. Also included in
Section 3.3 is a summary of the research questions, and their relationship to the study
objectives, data sources, and the other chapters in thesis. Section 3.4 provides the relevant
information about the ethics approvals for this research.

3.1

Paper 1: Simulation modelling as a tool for knowledge mobilisation in
health policy settings: a case study protocol

Freebairn L, Atkinson J, Kelly P, McDonnell G, Rychetnik L. Simulation modelling as a tool for
knowledge mobilisation in health policy settings: a case study protocol. Health Res Policy Syst
2016;14:71 doi: 10.1186/s12961-016-0143-y https://health-policysystems.biomedcentral.com/articles/10.1186/s12961-016-0143-y
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3.2

Evolution of research methods following publication of the protocol

My overall study objectives, from the protocol paper above, were to:

1. Pilot simulation modelling to optimise the use of evidence to inform policy and
program decision-making by synthesising and integrating diverse evidence sources
into a DSM of gestational diabetes using a participatory modelling approach.
2. Investigate the perceived value and efficacy of participatory simulation modelling
methods as an evidence synthesis and decision support method in an applied health
sector context.

As the study progressed following the publication of the protocol paper, further
developments to the study methods were implemented. These developments included
modifications to the scope of the DIP case study model, and triangulation of data compiled
about the value of PSM in this case study with additional data from two other modelling
projects conducted under the auspices of the Australian Prevention Partnership Centre.
These developments are described below.

3.2.1 Revised model scope for DIP case study (study objective 1)

The case study scope was expanded during the model development process from initially
including only gestational diabetes mellitus to including all forms of diabetes in pregnancy.
Diabetes in pregnancy includes both diabetes diagnosed during pregnancy, i.e. gestational
diabetes mellitus (GDM), and pre-existing diabetes. While most women who experience
diabetes in pregnancy have GDM, participants identified during the first model development
workshop that the number of pregnant women presenting to services with pre-existing Type
2 diabetes is increasing, and that these women have more complex care needs. Therefore, as
the model development progressed, the participants identified pre-existing Type 2 diabetes
as a priority for inclusion in the model. Type 2 diabetes was also identified as being of
interest from a broader public heath perspective as many of the risk factors are amenable to
lifestyle interventions.
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3.2.2 Expanded perspective on the value of participatory dynamic simulation
modelling - triangulation of data from other modelling projects (study objective
2)

The investigation into the value of participatory simulation modelling in health policy and
program decision making (objective 2) was expanded to include the perspectives of
participants from two other modelling projects (Table 1). These additional simulation
modelling case-studies used the same participatory processes to develop DSMs for use in
applied health policy settings under the auspices of The Australian Prevention Partnership
Centre. However, only the primary DIP case-study was accompanied by a concurrent
program of research to study the participatory modelling process – as reported in this thesis.

Triangulation is defined as the collection of information using more than one method,
including more than one perspective and more than one sample [1]. Triangulation is used to
increase the probability that alternative explanations for the phenomena being investigated
are uncovered through the use multiple data collection methods, settings and participants [1,
2]. When the data converges, or triangulates, it produces more reliable insights than could be
generated from a single method [2]. The decision to draw on participants’ experience from
the two other modelling projects strengthened the research by allowing the triangulation of
data collected in other Australian public health policy settings, and at different stages of
model maturity.

My data collection methods for all three case studies included modelling workshop
observations, field notes and interviews with the participants of the model development
workshops. End-user participants from the three DSM projects (Table 1) were invited to
participate in semi-structured interviews to discuss their experiences of the modelling
workshops, and their perspectives on the application and impact of participatory simulation
modelling on health policy and program decision making. My role in each project is described
below in Section 3.3 and summarised in Table 2.
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Table 1: Description of dynamic simulation modelling case studies and context. (modified from Chapter 4: Decision makers experience of participatory dynamic
simulation modelling methods for public health policy paper)
Topic area

Type of model

Model
development
period

Context

Application to decision making

Prevention and
management of
Diabetes in
Pregnancy (DIP)

Tripartite model
(system
dynamics, agent
based modelling
and discrete
event simulation)

2016 - 2018

Diabetes in pregnancy (DIP) is increasing in Australia, and
diabetes services are having difficulty meeting demand
with existing resources. This DSM focused on DIP from a
local perspective. It considered the short, intermediate,
and long-term implications of the increasing prevalence of
risk factors for DIP. Prevention of risk factors was
prioritised in the model as small delays in the development
of diabetes will have implications for the longer-term
burden of disease and costs to the health system.

The model informs the investments for
intervention in DIP, including both clinical
and population health interventions.

Reduction of alcoholrelated harms
(Alcohol)

Agent based
model

2015 - 2016

This project was implemented as a collaboration between
The Australian Prevention Partnership Centre, a state
department of health, local and national alcohol
researchers, clinicians and program planners to inform
strategies for reducing alcohol-related harms.

The model captures the heterogeneity of
drinking behaviours across the state
population, the dynamics of those drinking
behaviours across the life course, the acute
and chronic harms that arise and the
differential effects of interventions across
subgroups in the population.

Reduction of
childhood
overweight and
obesity (Obesity)

System dynamics
model

2016

In September 2015, an Australian State Premier unveiled
an ambitious target to reduce childhood overweight and
obesity in children by five per cent over 10 years. Based on
population projections and the anticipated impact of
enhancing the existing suite of interventions delivered, it
was estimated that additional strategies, or combinations
of strategies, would be required to achieve the Premier’s
target. However, the complexity of the problem and
uncertainty about where best to target resources and
efforts presented a challenge to decision makers.

The model tests the likely impacts of a
range of policies and programs and informs
the combination of interventions that might
achieve the Premier’s target.
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Workload and resource use have been
incorporated into the model to enable it to
act as a resource allocation decision support
tool

3.3

Candidate’s role in research activities

Participatory action research is highly collaborative [2]. It involves extensive teamwork
between researchers and partners throughout the research process; from identifying the
problem to disseminating the results [3]. The modelling case studies included in this thesis
involved the contribution of many people, however all of the research reported in the
published papers that form the basis of this thesis was led by me. This section aims to
distinguish and clarify my role in the implementation of the participatory process for each
case study, the model development for the primary case study, and the qualitative data
collection and analysis. My role in the case-study development, implementation, and
associated research activities for the primary case study (DIP model), and in additional case
studies, is summarised in Table 2. In summary, I led all of the work for the DIP case study,
as well as the supplementary data collection and analysis of participants’ experiences in the
two additional case studies focusing on childhood overweight and obesity and reducing
alcohol related harms. A detailed overview of my study objectives, research questions and
data sources is provided in Section 3.3.1. The details of my roles in the model development
for diabetes in pregnancy, and the qualitative data collection and analysis are described
below in Sections 3.3.3 and 3.3.4 respectively.

For the primary case study of DIP, I was the project lead and led all activities including:
project conceptualisation and design, initial engagement with the lead domain experts;
recruiting participants to the expert modelling consortium; planning, organising and
facilitating workshops and meetings; managing stakeholder relationships; managing the
core model development team (excluding technical supervision of the model
programming). I also led the analysing of evidence and providing of relevant data to inform
the model (Table 2). The core deliberative and analytical processes involved in the
participatory approach are described in detail in Chapters 4 to 6 and are not repeated here.
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Table 2: Candidate role in case study implementation and related research activities involved in the participatory modelling process for each of the case
studies
Case study implementation and research activity led by me

Prevention and management of
Diabetes in Pregnancy (DIP)

Project conception, design and planning (paper 1)

✔

Workshop planning, organisation and facilitation

✔

Engaging / collaborating with lead domain expert (a)

✔

Observational data collection, and advice on workshop
implementation
Stakeholder coordination and management for expert
modelling consortium (b)

✔

Core model development team (c) management

✔

Data provision (including statistical analysis) to guide model
development

✔

Participant observations, analysis of recordings and field
notes from participatory modelling workshops (papers 2
and 3)

✔

Qualitative data collection and analysis of deliberations and
decisions in model development process (paper 3)

✔

Interviews with end-user participants - data collection and
analysis (paper 4)

✔

Translating outcomes of participatory model development
process for technical programming of DIP model (paper 5)

✔

Notes:

(a)
(b)
(c)

Reduction of alcohol-related
harms (Alcohol)

Reduction of childhood
overweight and obesity
(Obesity)

Planning advice

Planning advice

✔

✔

✔

✔

✔

✔

Domain expert – well-respected authority on the focus issue who can play a lead role in the project planning and workshop facilitation.
Modelling consortium – the broader group of expert participants who participated in the model development process. These were people with a range of expertise, including providing or planning health services, undertaking
research or developing policy for the issue in focus.
Core model development team or group – a smaller core group of computer scientists, computer science students, research officers, public health practitioners, and medical specialists who met frequently with the project lead
to progress the model.
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3.3.1 Expanded summary of research questions and data sources

The overall objectives of this research were to examine the utility and feasibility of using
participatory DSM in applied health sector contexts; and to investigate the perceived value
and efficacy of the approach as an evidence synthesis and decision support method. I
conducted an in-depth examination of the primary case study (DIP) and two additional case
studies (alcohol and obesity) to determine the elements and strategies involved in
successful implementation, the overall challenges and opportunities arising from the
participatory approach, the nature of the analytic deliberations and decision-making
processes, and the end user perspectives of its value and utility. The research questions
that were examined to achieve the study objectives are outlined below and aligned with
the reported findings in Chapters 4 to 7.

The primary research questions addressed in Chapter 4 were: “how does participatory DSM
build on current knowledge mobilisation best practice?” and “How can participants be
engaged actively to successfully contribute their expert knowledge to the participatory
process?”. In this chapter, I examined and described the participatory activities and
stakeholder engagement strategies utilised across the three case studies and related them
to knowledge mobilisation principles and practice.

Chapter 5 focused on the primary case study (DIP) and explored the overall research
questions: “what were the analytical processes involved in converting the qualitative
conceptual map, developed collaboratively with participants, into a quantified DSM?”; and
“what were the decision-making processes involved in developing a rigorous DSM to
answer current policy and program questions for diabetes in pregnancy prevention and
management?”. I analysed the workshop and meeting recordings, and triangulated this
data with field notes and other documentation to uncover the deliberative methods and
decisions involved.

I explored the value of participatory DSM from the perspectives of end-user decision-maker
participants in Chapter 6. The paper in this chapter focused on the following research
questions: “What was the experience of participating in the interactive model building
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activities like for end-user participants?”, “What were the benefits and challenges of the
approach from their perspective?”, “What did participants learn from engaging in the
participatory model development process?” and “How were they using the DSMs to inform
policy and program decisions?”. I interviewed participants from the DIP case study before
and after the participatory modelling process, and the participants from the two additional
case studies after their participatory process to gain their perspectives on the efficacy and
value of the approach to inform decision making.

The DIP model and outputs are described in Chapter 7. This chapter addressed the research
questions in relation to DIP as outlined in the protocol paper, and provides information
about the many data sources used to inform the model. The research questions addressed
by the model included: “How does the dynamic interaction between risk factors impact on
DIP development”; “What are the short- and long-term outcomes for mother and baby
following diabetes in pregnancy?”, and “What is the impact of prevention interventions
prioritised by participants on incidence of DIP and individual health outcomes?”.

An overview of the research questions explored, the data sources used to answer them,
and their relationship to each of the two study objectives is provided in Table 3. Further
detail about the data collection and analyses is provided in Sections 3.3.3 to 3.3.5.
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Table 3: Overview of research questions and data sources used to investigate the objectives
Research questions and associated papers within this thesis:

Relates to
objective:

Data
sources:
Interviews
with
participants

Thesis
Chapter
Recordings from
modelling
workshops and
meetings

Participatory
field notes and
other
documentation

Model outputs
and associated
communication
products

How does participatory DSM build on knowledge mobilisation best
practice? (paper 2)

1, 2

✔

✔

4

How can participants be engaged to facilitate their expert knowledge
contribution to the process? (paper 2)

1, 2

✔

✔

4

What were the analytical processes involved in converting conceptual
systems maps to quantified simulation models? (paper 3)

1, 2

✔

✔

What were the decision-making processes involved in producing a
rigorous DSM to answer health service and policy questions relating to
diabetes in pregnancy? (paper 3)

1

✔

✔

What was the experience of participating in the interactive model
building activities like for end-user participants? (paper 4)

1, 2

✔

✔

6

What were the benefits and challenges of the approach from their
perspective? (paper 4)

1, 2

✔

✔

6

What did end-user participants learn from being involved? (paper 4)

1, 2

✔

✔

6

How were the case study models being used to inform policy and
program decisions? (paper 4)

1, 2

✔

✔

How does the dynamic interaction between risk factors impact on
development of DIP? (paper 5)

5
✔

5, 7

✔

6

1

✔

7

What are the short- and long-term outcomes for mothers and babies
following DIP? (paper 5)

1

✔

7

What is the impact of prioritised prevention interventions on DIP
incidence and individual health outcomes? (paper 5)

1

✔

7
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3.3.2 Search strategy and literature compilation

In addition to the comprehensive literature review presented in Chapter 2, each paper in
this thesis includes a literature review section to provide an overview of current knowledge
and to situate the research. A range of search terms were used to identify relevant
research. These were utilised regularly to search PubMed, Google Scholar and Medline
(OVID) databases. The list of terms here is not exhaustive and is included to provide an
overview of the literature domains that informed this research. The main search terms
included: “knowledge mobilis(z)ation”, “knowledge translation”, “knowledge transfer”,
“participatory action research health”, “dynamic simulation”, “agent-based model”,
“system dynamics”, “hybrid modelling”, “participatory modelling”, “group model building”,
“co-production health”, “interdisciplinary research health”, “participatory research”,
“diabetes and pregnancy”, “gestational diabetes”, “prevent* diabetes and pregnancy”,
“collaborative research”, “population health modelling”, “health policy decision support”,
“social policy decision support”, “epidemiologic methods”, “policy modelling”, “modelling
guidelines”, “selecting modelling methods”, “systems science (thinking) and population
health” and “evidence based policy health”. Notifications were set up in Google Scholar and
ResearchGate to alert me to new published research on topics of interest using the search
terms listed above. The identified literature was stored and categorised in Endnote version
9. Additional research was identified and recommended by my supervisors, other
collaborators and colleagues, and from reference lists of the papers identified during
database searches. The literature was reviewed and synthesised under “questions”, or
topics, that were refined iteratively throughout this PhD research and eventually formed
the literature review in Chapter 2.

3.3.3 Diabetes in pregnancy model development

The technical computer programming for the DIP model development process was
undertaken in collaboration with the Computational Epidemiology and Public Health
Informatics Laboratory (CEPHIL), Department of Computer Science, University of
Saskatchewan. Under the supervision of Professor Nathaniel Osgood, three post graduate
students took responsibility for implementing the technical development of the DIP model.
I was the primary conduit between the technical modellers and the participatory modelling
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consortium (the participant stakeholders). In addition to all communication with
participants, I facilitated regular model development meetings and frequent
communication with the technical modellers to contribute to and guide the model
development. This often involved translating the technical modellers’ questions into the
language of the DIP expert stakeholders, and in return translating the input from our expert
stakeholder group back to the modellers. The model development was informed by the
decisions of the core model development group (led by me), and incorporated the input of
the wider stakeholder engagement process with the modelling consortium that I also
facilitated. I summarised the outcomes of the participatory process activities for input into
the model by the technical modellers. Over the course of the projects, two of the postgraduate students were outposted from CEPHIL to The Australian Prevention Partnership
Centre to work on the model and another student worked on the model while based at
CEPHIL. This collaboration enabled the development of a sophisticated multi-method model
which leveraged the knowledge gained from previous diabetes modelling projects
undertaken at CEPHIL [4-7], while being developed to meet the decision requirements of
local stakeholders within ACT Health.

Dynamic simulation models require significant data and evidence, and the compilation and
synthesis of this evidence was an important additional analytical role I undertook in the
model development process. I searched for and reviewed evidence from published meta
analyses, systematic reviews, individual studies, population surveys, census and
administrative health service data. All of the statistical analysis of survey, census and
administrative data to inform and/or validate the model was also carried out by me. More
information about the data analysis and evidence synthesis processes involved in informing
DSMs is provided in Chapter 6. The data sources used in the DIP model are described in
detail in the model documentation in Chapter 7.

3.3.4 Model development for the two additional case studies

The two additional modelling case study projects were undertaken by The Australian
Prevention Partnership Centre, in collaboration with the Centre for Population Health, NSW
Ministry of Health. These projects were undertaken to inform policy and strategy dialogues
in NSW for the prevention of alcohol-related harm and for the reduction and prevention of
childhood overweight and obesity. The technical programming for the additional case
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studies was undertaken by members of the Decision Analytics team and was led by
Associate Professor Jo-An Atkinson, Dr Geoff McDonnell and Mr Mark Heffernan. Further
information about these projects is available here:
https://preventioncentre.org.au/resources/dynamic_simulation_modelling/.

3.3.5 Qualitative data collection and analysis

A qualitative approach was chosen for this research as it provides flexible and useful
research methods, which combine effectively with a participatory action research
framework [2, 3, 8]. As outlined in Chapter 2, the core principles of participatory modelling
include planning stakeholder engagement; being aware of social dynamics, power, and
special interests within the participatory group; flexibility in the process; openness and
transparency; and encouraging learning through the process. Qualitative analysis can
provide rich and detailed, yet complex, meaning from data collected using a variety of
methods including interviews, recordings, observations and document analysis [9, 10]. The
participatory process involved interactive stakeholder workshops, small group meetings
and written communications (mostly by email). The observations and recordings of
workshops and meetings, together with email communications and written documents
were important data sources arising from the participatory research process that provided
insights into the core principles outlined above. Further data were collected via semistructured interviews to provide individual perspectives from participants, both about their
expectations prior to participation and reflecting on their experience of the process and the
core principles post-participation. The methods used to collect and analyse data for this
thesis are described below.

Participant observations, recordings and analysis of participatory model development process

The participatory model development workshops for the three case study projects were
held during 2015 to 2017 (details reported in Chapters 4 to 6). Further model development
meetings for the primary case study (DIP model) were held during 2018. For the primary
DIP case study, the participatory workshops, web-based meetings with participants and
some core model development group meetings were recorded with participants’ consent to
facilitate the in-depth analysis of the model development process (Chapter 5).
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For the two supplementary case studies, I also documented participatory field notes based
on observations of the workshops, and subsequent debriefing discussions between myself,
my supervisors and the project officers working on those case studies (Eloise O’Donnell,
Nick Roberts, Jacqueline Davison and Christine Whittall - see acknowledgements).
Debriefing discussions occurred either immediately following or within one week of the
participatory workshops, and the field notes were compiled at this time. I also prepared
further follow up summaries of all our discussions. The primary role for the above-named
project officers from The Australian Prevention Partnership Centre was to provide
administrative and logistic support for the NSW participatory modelling workshops. One
project officer (NR) also played an active role in facilitating the workshops for the obesity
project. Those project officers with particular areas of content expertise also joined as
participants some of the small group model development activities.

In the debriefing sessions I led the discussions to focus on reviewing the participatory
activities, and identifying what had worked well, and what hadn’t worked well. The possible
reasons were explored based on observations of group dynamics, level of engagement from
participants, and conversations with participants during and after the workshops. Strategies
to address any issues or concerns about participation, engagement or representation in the
workshops were discussed and actioned where appropriate. For example, observers
identified that some participants had not been contributing to a discussion when another
expert was perceived to have greater authority. This observation was used to modify the
facilitation of subsequent workshops to ensure that all participants were provided with a
range of opportunities to contribute e.g. in small and large group activities, and through
individual discussions.

All of the workshop and meeting recordings and field notes were reviewed, coded and
analysed by me. The data coding and analysis for the workshops and meetings used
thematic analysis that was guided by the “theoretical” approach to thematic analysis
described by Braun and Clarke [9]. The focus research questions (Table 3) for this thematic
analysis (reported in Chapter 5) were: What were the key elements and features of the
participatory approach that were required to successfully develop a policy relevant DSM
from a qualitative systems map? What types of questions were asked by the stakeholders,
what concerns and issues were raised, and what was the feedback from participants during
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the process? What challenges and tensions arose in the process and how were they
managed?

After I had listened to and coded each recording, I reviewed the coding notes and used
coloured highlighting to identify themes. An analytic memo was written for each coded
recording to highlight important themes and concepts identified from the coding process. I
used worksheets in Microsoft Excel to compare data collected from each workshop or
meeting and to collate the data into important themes and categories. The progressive
analysis involved an iterative process of coding and analytical memos to develop themes
and conceptual categories and explore their inter-relationships. The analysis was iteratively
reviewed and refined as new data became available and themes and insights identified
were triangulated across the different data types and sources. The analyses were iteratively
discussed with and reviewed by my supervisors, Jo-An Atkinson and Lucie Rychetnik, and
my analytic memos were also shared with them to facilitate the analysis review process.

Interviews with participant stakeholders pre- and post-participatory process

I conducted pre-process interviews with participants in the DIP case-study in April and May
2016 and post-process interviews with participants across all three case studies in
September and October 2017. Two pre-process interviews were unable to be conducted by
me, and Ms Eloise O’Donnell (project officer within the Australian Prevention Partnership
Centre) conducted these two interviews using my interview schedule. All other interviews
and all of the data analysis were conducted by me. The interviews took place in the
participant’s workplace, or if that was not possible, via telephone or web-conferencing.
Each interview lasted between 30 and 60 minutes. Face-to-face and telephone interviews
were of comparable quality and length and telephone interviews were particularly useful in
enabling me to speak with experts in distant locations throughout Australia and overseas.

I used a semi-structured interview format, with questions and prompts designed to elicit
the interviewee’s views (indicative questions are shown in Box 1 in the published research
protocol, included above in this Chapter). I began each interview with the consent process
(either written or verbal), and an introduction broadly outlining the topics for the interview
questions. A common occurrence in the pre-process interviews was interviewees
expressing a concern that they had little or no experience with DSM, and thus they were
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uncertain as to what they could contribute to the project. Therefore, I provided those
participants with a preliminary explanation of what participatory DSM involved, and
explained the rationale for their role in the model development process as expert
participant stakeholders.

For the post-process interviews with end-users I explained that I was interested in hearing
about their experience of participating in a modelling project; and that I was collecting
information from end-user participants on the value and impact of this type of modelling
from three different settings and at different stages of model maturity. I also emphasised
that I was interested in hearing their honest perceptions of the pros and cons of the
participatory modelling methods. Although the broad topic areas were the same across all
interviews, I tailored some of the questions to the local project-specific experience of the
interviewees. Indicative questions are shown in the supplementary material for the paper
presented in Chapter 6. As my data collection and analysis progressed, I adapted my
question prompts to elicit further information that I had identified from previous interviews
as being interesting or important. I continued recruiting end-user participants until I found
that no new concepts or ideas were being raised during the interviews.

All interviews were recorded and professionally transcribed as soon as practicable. After
each interview I wrote a short memo which included some brief information about the
participant, their role in the modelling projects, my initial impressions from our discussion
and any new information and ideas that had emerged from the interview. Once each
interview transcript was available, I checked and corrected the transcription while listening
to the recording. I then deleted any identifying information.

The interview data analysis process was guided by methods of grounded theory [10, 11].
Using Microsoft Word, I formatted the transcripts into three columns with the first
indicating the speaker (i.e. interviewer or interviewee), the second column contained the
transcription and my analysis codes were entered in the third column. After each
transcription was checked for accuracy, I read them again, highlighting phrases and
concepts that seemed important and entering codes in the third column. Initially I used
line-by-line coding to become familiar with the data and to ensure that I did not miss any
important concepts. I made use of gerunds to focus my analysis on actions and processes
and to make explicit the connections between the data, concepts and themes [11]. As
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common themes and core concepts emerged from the data, I used colour coded
highlighting to easily identify these within my codes. I also applied the colour coding to
highlight sections of text from the transcripts that were enlightening for a particular theme
or category, and potentially useful for direct quote examples. After each transcript had
been coded, I reviewed the interview memos and added additional information based on
my analysis. After all the interviews had been analysed, I returned to the first transcripts to
review the coding and memos for alignment with my later analysis and added further
insights to my analytical memos.

Following the detailed coding process, I transitioned to focused coding to categorise the
data into the common and important conceptual groupings that had emerged from the
analysis [10, 11]. This process involved reviewing the line-by-line coding, reviewing the
transcript text and comparing across interviews to identify the dominant and most
important thematic and conceptual categories in the data. I used worksheets in Microsoft
Excel to collate the focused codes and to analyse the data across interviews. Where I had
highlighted transcripts as particularly important or insightful, I transferred these direct
quotes into the worksheets. For Chapter 6, the findings from the interview data were then
triangulated with further analysis of other data collected from the three case-studies
including: analysis of group process, email exchanges, participant observations I had
recorded, notes from workshop debriefing meetings, field notes and memos based on
meetings and de-identified discussions with participants and the modelling team. Analytical
memos for each key theme were further developed and integrated across the sources of
data.

3.4

Ethics approvals

I obtained ethics approval for my research from the University of Notre Dame, Australia
Human Research Ethics Committee (015119S) and the ACT Health Human Research Ethics
Committee (ETHLR.15.150). The committees specifically approved my participant
information sheet and consent form. The documentation is included in Appendices 2 and 3.
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An amendment was submitted to and approved by both committees in July 2017 to
interview participants from additional modelling projects to explore their experience and
perceived value of participatory DSM.

All participants gave individual consent. Those who were interviewed in person were given
the consent form to read, and all signed it. Those who were interviewed over the telephone
were sent the consent form and returned it prior to the interview being conducted.
Participants were informed that they were free to withdraw from the study at any stage,
but none have withdrawn. All the participants were assured confidentiality, and because of
the relatively small pool of participants, steps were taken to preserve anonymity in the
findings. For example, when providing information on the professional roles of quoted
experts in my published papers I did not provide sub-specialty information, preferring to
use more general descriptors such as “clinician” or “public health professional”.
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Appendices for Chapter 3
1.

Freebairn L and Kelly P. Harnessing new technologies to inform health decision
making: Dynamic simulation modelling as a decision support tool for diabetes in
pregnancy. ACT Population Health Bulletin. Volume 6, Issue 2, May 2017, p, 31-32

2.

Ethics approval letters from:


ACT Health Human Research Ethics Committee; and



University of Notre Dame Australia Human Research Ethics Committee.

3.

Participant Information Sheets and Consent Forms

4.

Participatory workshop one report – Diabetes in Pregnancy in the ACT

5.

The Australian Prevention Partnership Centre news article: Workshop unpicks
causes of gestational diabetes as part of simulation modelling project.
http://preventioncentre.org.au/news-and-events/prevention-centrenews/workshop-unpicks-causes-of-gestational-diabetes-as-part-of-simulationmodelling-project/

6.

Participatory workshop two report – Diabetes in Pregnancy in the ACT

7.

The Australian Prevention Partnership Centre news article: Project expanded to
tackle all forms of diabetes in pregnancy. http://preventioncentre.org.au/newsand-events/prevention-centre-news/project-expanded-to-tackle-all-forms-ofdiabetes-in-pregnancy/
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Chapter 4: Results part 1: Knowledge mobilisation for policy
development: implementing systems approaches through
participatory dynamic simulation modelling

The paper presented in this chapter describes the implementation of participatory dynamic
simulation modelling as a knowledge mobilisation tool in Australian health policy settings.
This paper reviews best practice knowledge mobilisation strategies and describes how
participatory dynamic simulation modelling builds on these elements. The participatory
activities and stakeholder engagement strategies utilised in the case studies are described.
The strategies used to actively engage participants and to address the technical and sociopolitical issues that arose during the participatory processes are explained. The paper
compiles the experiential lessons derived from workshop observations and field notes
across the three case-studies.

Paper 2:
L. Freebairn, L. Rychetnik, J. Atkinson, P. Kelly, G. McDonnell, N. Roberts, C. Whittall, and S
Redman. Knowledge mobilisation for policy development: implementing systems
approaches through participatory dynamic simulation modelling. Health Res Policy Syst
2017; 15:83 https://doi.org/10.1186/s12961-017-0245-1
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Key messages

suggests locally co-created knowledge, derived from researcher and end-user partnerships, preferably on the
location where it is to be applied, is particularly useful
for addressing policy and practice questions [13, 14].
This is akin to Senge’s description of the art and practice of collective learning [15].
The conceptual and empirical developments of contemporary strategies to support evidence-informed action are reflected in the evolving terminology. While
knowledge translation focuses on the transfer of
investigator-driven research to policy and practice settings [6, 11, 16], knowledge exchange has emphasised
the relational two-way communication required for research uptake to be effective and useful [17, 18]. The
most recent adoption of knowledge mobilisation further
highlights organisational structures and system design
requirements, and more explicitly values the ‘co-creation’ of knowledge [19, 20]. It is also the broadest term
to encompass all activities that involve generating, sharing and using research [19]. Best et al. [21, 22] described
these developments as the three generations of translation, namely linear, relational and systems-based
approaches. Whichever terminology one may prefer,
however, it is widely acknowledged that mobilising
knowledge for policy and practice is an emergent
process, and one that is highly relational, often messy
and profoundly context dependent [23–27].
Systems thinking and systems science have growing influence on many aspects of public health discourse and
research [28, 29]. Important elements of systems thinking include more conscious attention to how new forms
of knowledge are “gained, managed, exchanged, interpreted, integrated and disseminated”, and an emphasis
on “transdisciplinary, translational and network-centric”
science [28]. There are natural synergies between knowledge mobilisation methods and systems science
methods. Knowledge mobilisation refers to a range of
active approaches deployed to encourage the creation
and sharing of research-informed knowledge [30]. Systems science methods encompass a family of approaches
that can be used to elucidate the behaviour of complex
systems, inform efforts to address one or more system
problems [31], and have the capacity to examine both
complex health problems and the context in which they
are embedded [29, 32, 33]. Key elements of a systems
science approach include synthesising diverse knowledge
and evidence, exploring the potential for non-linear
relationships between contributing factors and unanticipated emergent behaviour of the complex systems
(including policy resistance) [31, 34, 35]. The value of
systems thinking for conducting reviews of evidence and
integrating other forms of knowledge are well described
[26, 36]. However, applying systems thinking to knowledge mobilisation is conceptually challenging and

 Participatory dynamic simulation modelling is being

implemented as a knowledge mobilisation strategy in
Australian health policy settings.
 Key elements of this knowledge mobilisation
approach has included:
– Moving beyond evidence synthesis to providing
dynamic decision support tool to compare policy
options.
– Embedding deliberative methods to build shared
understanding of complex issues and intervention
outcomes.
– Emphasising stakeholder participation in the
co-production of knowledge.
 Operationalising participatory simulation modelling
relied on:
– Effective and equal partnerships.
– Active participation of all stakeholders in the
modelling process.
– Transparency and trust in model outputs to
facilitate consensus for action.

Background
The utilisation of evidence has come a long way since
the advent of evidence-based medicine – a term coined
in the early 1990’s [1–3] when the leading proponents
were described as radicals [4]. Evidence-based healthcare
captured the zeitgeist and coalesced into a mainstream
movement built on decades of population-based research, clinical epidemiology, critical appraisal and systematic review methods [5]. Interventions aimed at
supporting the use of evidence in policy and practice
have spawned new theories and frameworks, translation
research, and an evolving lexicon [6]. A recent scoping
review identified 51 different taxonomies to categorise
research translation interventions [7].
Yet, despite great progress and mainstream acceptance of evidence-informed decision-making there
remain many operational challenges. Researchers who
understand the scientific evidence are often not
engaged, or unheard, when important policy decisions
are made [8, 9]. Similarly, practitioners familiar with
the local context and those who are considered the ‘end
users’ of the research are often not engaged in the
research process [10]. A common dilemma is the apparent mismatch between the information priorities of policy decision-makers and programme or service funders,
and the research priorities of investigators and research
funders [11]. To be policy relevant, research must reflect an understanding of decision-making environments, be responsive to end-user needs, and be
supported with stakeholder engagement and strategic
communication [11, 12]. Contemporary thinking also
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decision-makers to choose between, each course of action potentially resulting in complex and unintended
consequences [40, 44].
However, to date, the potential of participatory simulation modelling as a knowledge mobilisation tool in the
health sector has not been adequately explored. In particular, stakeholder engagement and involvement of endusers in health-related simulation model development
has been lacking [41]. This has limited the use of simulation modelling across the range of potential applications,
hindered the implementation of model findings [45, 46]
and led to a reluctance among ‘non-researchers’ to use
models as decision support tools [46, 47]. A systematic
review of the use of simulation modelling to inform surgical patient flow processes found that only half of publications stated that the goal of the model was to inform
policymakers and health service managers, and only 26%
actually included these end-users in the simulation modelling process [10].
Below, we discuss how participatory simulation modelling can build on contemporary knowledge mobilisation
approaches to offer a tool for timely and dynamic policy
decision support, both by embedding deliberative
methods and emphasising the co-production of knowledge in the modelling process. We then reflect on the
experience and learnings drawn from three Australian
case studies of participatory dynamic simulation modelling conducted in collaboration with jurisdictional health
departments [38, 39].

difficult to operationalise [37]. A recent multi-method
review of knowledge mobilisation across health and
other sectors concludes that the most fruitful lessons
about the future role of systems thinking will come from
natural experiments and case studies [19].
In this paper, we describe our experience of implementing a systems-based approach of participatory dynamic simulation modelling as a knowledge mobilisation
strategy in Australian real-world policy settings. We describe how this approach combined both systems science
methodology and some of the core elements of knowledge mobilisation best practice using three case studies
(two published [38, 39] and one as yet unpublished). We
describe the strategies adopted to address both technical
issues (e.g. synthesising diverse evidence into a quantifiable model) and socio-political issues (e.g. user engagement and trust), and compile the experiential lessons
derived. Finally, we consider the implications of these
knowledge mobilisation case-studies and provide
evidence for the feasibility of this approach in policy
development settings.

Participatory dynamic simulation modelling draws
on many elements of knowledge mobilisation
best practice
Dynamic simulation modelling is a systems science
method that recreates complex systems and human behaviours in a virtual world. These models can answer
‘what if’ questions about the likely impacts over time of
different policy and intervention options and combinations so that they can then be deliberated and considered more broadly before implementation in the real
world [40, 41]. Dynamic simulation modelling has been
used to map health system components and their interactions, synthesise evidence, examine and compare the
potential outcomes of interventions, and guide more efficient investment and conscientious disinvestment of
resources [41]. This is important for preventive health
policy and practice, where decision support tools must
have the capacity to steer a course through the complexity of interactions that give rise to real-world public
health problems such as the global epidemic of chronic
disease [40–42].
The concept of ‘evidence-informed decisions’ is challenging in population health policy and practice interventions that require engagement and partnership with
sectors outside of health. Many factors, including types
of information, opinion and experience, timing, the political cycle, local norms, the influence of external
players, and the availability of funds, all influence
decision-making [9, 43]. Many of the current ‘big questions’ in public health are complex and not easy to address. These problems have multiple interacting causal
factors with competing possible courses of action for

Moving from evidence synthesis to timely and dynamic
decision support

Evidence-informed policy and practice has traditionally
relied on systematic reviews, evidence summaries and
policy briefs to provide decision-makers with rigorous,
timely and concise information [48–50]. While their
inherent value is acknowledged, there are limitations
in their use and utility for health policy decisionmaking [12].
Systematic reviews and meta-analyses synthesise the
available evidence to answer the question ‘what do we
know about this issue?’ They focus on clear and specific
questions and usually have a narrow scope of investigation with limited potential to examine complex questions [51, 52]. These methods produce static reports that
rely on decision-makers to navigate the complexity and
uncertainty of translating the evidence for their local
context and weigh up the options for responding to their
problem [53]. Many systematic reviews fail to address
the policy implications of their findings [12] in a timely
way to inform decision-making [54].
More recently, there has been a shift towards rapid
reviews investigating policy questions. Here, the focus is
on providing immediate value to addressing the problem
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at hand. For example, rapid reviews like Evidence Check
from the Sax Institute [55, 56] commence with a collaborative process where policymakers and a knowledge
broker develop a structured review proposal that
describes the policy issue or decision for which the
evidence review is required, and articulate the review
questions and scope. The process aims to ensure the review will provide policymakers with information specific
to their decision and context in a timely way. This collaborative approach has been shown to be well suited for
assisting in planned policymaking processes and choosing between specific policy options [55, 57]. The use of
knowledge brokers is integral to organising the interactive process between researchers and policymakers so
that they can co-produce feasible and research-informed
policy options [56].
Policy briefs begin with a policy issue and present
evidence to answer the question ‘What should we do?’
A policy brief provides a rationale for choosing a policy
alternative or course of action based on the synthesised
research findings. They are more practical, flexible and
timely in supporting evidence-informed decisionmaking [49] and can also consider how the evidence
fits with prevailing values, beliefs and political context
[49]. However, the final product is still a static assessment that is unable to adequately account for changes
over time or test the prevailing real-world hypotheses
and assumptions [53, 58].
However, participatory dynamic simulation modelling
processes go further, providing a platform for explicit
synthesis of empirical evidence, local data, expert- and
practice-based knowledge, conceptual models and theory
to construct, quantify and test a detailed representation
of causal factors and the mechanisms of intervention effects [40, 41, 58, 59]. The resulting dynamic model becomes a decision support tool that can step beyond
comprehensive approaches, for example, in the prevention of chronic disease, to be used as a ‘what if’ tool to
simulate various policy and practice scenarios, and systematically explore the trade-offs of a range of intervention options [41, 58].

Processes such as deliberative dialogues involve
group interactions that integrate and interpret multiple
forms of evidence to inform policy development [61].
Key elements of a deliberative dialogue process include
a meeting environment that is conducive to open deliberation about a policy issue, bringing together a mix
of participants that ensures fair representation of all
relevant interests, and fostering a more equal knowledge base among participants through the presentation of research evidence [60].
Deliberative approaches tend to emphasise the rigour
and fairness of the process and try not to anticipate or
pre-determine the outcomes of the deliberation. They
rely on skilled and neutral facilitation and, while consensus building may be achieved, it is not the primary
aim [62]. This requires flexibility and acceptance that
the boundaries and scope may be changed as people
reflect and discuss the problem, and sometimes modify
the questions they want to address.
Thus, translation of research has progressed from
managed and controlled dissemination initiatives with
pre-defined targets [63]. For knowledge mobilisation,
the social, relational and contested nature of true deliberative dialogue or ‘exchange’ relies on negotiated
meanings and less predictable outcomes [62, 64, 65].
Participatory dynamic simulation modelling incorporates a deliberative process where stakeholders articulate and develop their understanding of how multiple
variables, factors and interventions interact [66, 67],
and provides a neutral platform for engaging stakeholders with conflicting views [59]. The participatory
model development necessitates in depth deliberation
to map a shared mental model of the causal pathways
for the focus issue, and the mechanisms by which interventions have an effect on outcomes [68]. The map
is then quantified, drawing on research evidence and
other data sources through an iterative process of theory testing and building in collaboration with participants. Model outputs are compared with real-world
historic data patterns across a range of indicators to
establish the validity of the model as an accurate representation of the real-world system. The resulting
model becomes a decision support tool that can be
used to consider and compare alternative policy
options [66, 67]. The model can be refined, updated
and customised through ongoing dialogue. Both the
process of model development and the results
produced by the model enhance stakeholder knowledge and understanding of the system and its dynamics in varying conditions. The process identifies and
clarifies complex and contested real world problems
[47] and the impact of solutions, and facilitates the
implementation of actions based on the available
evidence [68, 69].

Embedding deliberative methods

An important strategy in knowledge mobilisation theory
and practice is the incorporation of deliberative
methods. The value of the deliberative process is that it
increases understanding of the evidence, and of the
competing issues and values, through the engagement
and contribution of participants with different perspectives [60]. By deliberating on a problem and its potential
solutions, participants strengthen their capacity to address a policy issue and gain confidence in influencing
the policy agenda [60].
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Reflections on process and early learning from
participatory dynamic simulation modelling as a
knowledge mobilisation approach
The Australian Prevention Partnership Centre (http://preventioncentre.org.au/), in collaboration with jurisdictional
governments, has pioneered the co-production of sophisticated, multiscale dynamic simulation models to support
policy and practice. In developing these models,
researchers partnered with health departments, clinicians
and regional planners in collaboration with a multidisciplinary group of stakeholders using a participatory process
[38, 39]. The case studies are described in Box 1.

Emphasising co-production of knowledge

Co-creation and co-production are two terms used to
refer to the process of individuals from different sectors
working together to produce an output or outcome such
as goods, services or research [70]. Co-production of evidence aims to overcome the often described disconnect
between researchers and research end-users, such as
health policymakers and programme planners [14]. This
concept has been applied to social service design and
delivery [71] and increasingly to health research [72–74].
Research translation is embedded in the coproduction and partnership approach as the end users
are active participants in, and in some cases the drivers
for, all phases of the research project [14]. The key elements of co-creation include involving participants as
active and equal partners from beginning to end, encouraging reciprocity and sharing of resources and
knowledge, and aiming for a ‘transformative’ outcome,
i.e. where the research builds capacity and/or has a
practical impact on decision-making [14, 71]. The establishment of effective co-production partnerships is
an iterative journey, where structures, boundaries and
even the purpose of the project are re-negotiated
throughout the project dialogue [75].
Relationships and collaborations are routinely identified as key factors in systems approaches [76]. Participatory dynamic modelling provides a structure to
facilitate multidisciplinary partnerships, co-learning
and co-production. The participatory approach adopts
co-production as its driving principle and places the
end-user decision-makers at the centre of the process.
The decision-makers define the model scope and
purpose, and engage multidisciplinary expert
stakeholders in the model design and parameterisation
(and contribute the identification of data to be used in
the model).
Participatory dynamic simulation modelling involves
engaging multidisciplinary stakeholders in a deliberative group model-building process where participants
discuss evidence and share knowledge about the causal
mechanism of the issue being modelled and where and
how interventions have their effect within the
articulated mechanism. Participatory modelling
approaches aim to combine diverse perspectives to
tackle the social complexity of problems and recognise
that different types of knowledge contribute alternative
and valuable perspectives to the problem discourse
[47, 59]. The involvement of decision-makers as participants in the model development and validation increases their sense of ownership and confidence that
the model is valid for their local context; they are
therefore more likely to draw on the model’s outputs
to inform decisions about priority interventions and
policies [68, 77, 78].

Box 1. Case study descriptions
Case Study 1. Model behaviour: A systems approach to reducing
alcohol-related harm
This project was implemented as a collaboration between The
Australian Prevention Partnership Centre, the New South Wales Ministry
of Health (NSW Health), and local and national alcohol researchers,
clinicians and programme planners to inform strategies for reducing
alcohol-related harms in NSW.
Alcohol misuse is a complex, systemic problem. Globally, alcohol has
been estimated to cause 3.3 million deaths each year, and the costs of
alcohol-related harms amount to more than 1% of gross national product in high-income countries. In Australia, alcohol accounts for approximately 3.2% of the total burden of disease and injury, and is estimated
to cost AU$15.3 billion each year [79, 80].
The design of effective responses to this problem has been
challenged by a lack of clarity on the mechanisms driving alcohol
misuse and its associated harms, differing views of stakeholders
regarding the most appropriate and effective intervention approaches, a
lack of evidence supporting commonly implemented and acceptable
intervention approaches, and strong evidence for less acceptable
interventions. As a consequence, political considerations, community
advocacy and industry lobbying contribute to a hotly contested debate
on what is the most appropriate course of action.
The developed model uniquely captures the heterogeneity of drinking
behaviours across the NSW population, the dynamics of those drinking
behaviours across the life course, the acute and chronic harms that arise
from those behaviours, and the differential effects of interventions across
subgroups in the population. Testing of the model demonstrated its ability
to reproduce a range of real world data patterns, which provides
confidence that the model can produce robust forecasts of the
comparative impacts of interventions into the future. The model is
currently being used to engage with broader policy stakeholders to
demonstrate the value of such models in informing effective and
acceptable strategies for reducing alcohol-related harms [38].
Case Study 2. Premier’s Priority Project – reducing childhood overweight
and obesity by 5%
In September 2015, the NSW Premier unveiled 30 State priorities to grow
the economy, deliver infrastructure, protect the vulnerable and improve
health, education and public services across NSW. Included in these areas of
focus were the 12 Premier’s Priorities, including an ambitious target to
reduce childhood overweight and obesity in children by 5% over 10 years.
Based on population projections and the anticipated impact of enhancing
the existing suite of interventions delivered by NSW Health, it was estimated
that additional strategies, or combinations of strategies, would be required
to achieve the Premier’s target. However, the complexity of the problem and
uncertainty about where best to target resources and efforts presented a
challenge to decision-makers. To address this, the Australian Prevention Partnership Centre in partnership with NSW Health undertook to co-develop a
system dynamics model of childhood overweight and obesity.
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(Continued)

(Continued)

The model development process engaged a broad range of
multidisciplinary stakeholders working in the area of childhood obesity
spanning the fields of academia, service delivery, policy, planning and
infrastructure. Through a series of participatory workshops the problem
was collaboratively mapped and interventions to be included in the
model prioritised. The map was conceptualised as a computational
model, quantified, tested and validated against historic data, and
iteratively refined through feedback sought during and between
workshops.

Project planning meetings were held to clearly define the aspects of
the problem to be modelled and its scope and boundaries, as well as to
identify key outputs of interest and intervention options to be included
and tested by the model.
Experts and key participants with an important ‘stake’ in the topic
were identified and invited to participate in the model development
group (participants). Group composition was purposefully considered
to ensure inclusion of a diverse range of views and identification of
participants who were considered reliable and reputable
representatives of broader stakeholder groups (stakeholders).
Background reading material regarding simulation modelling and
the topic of interest was sent to participants prior to the workshop
to provide a platform of common understanding.

The model is being used by NSW Health and their stakeholders
to test the likely impacts of a range of policies and programmes,
and to inform the combination of interventions that might achieve
the Premier’s target.

Model building and validation

Case Study 3. Simulation modelling for Diabetes in Pregnancy (DIP) in the
Australian Capital Territory (ACT)

Through a series of participatory workshops, the model building
group, informed by collated evidence and data, collaboratively
identified and mapped the key risk factors and likely causal
pathways leading to outcomes of interest for the focus topic of the
model.

This project was implemented as a collaboration between The
Australian Prevention Partnership Centre, ACT Health Directorate
(ACT Health), local and national researchers, clinicians and
policymakers. DIP is increasing both in the ACT and Australia, and
diabetes services are having difficulty meeting demand with existing
resources. The increase in DIP is associated with increasing
prevalence of risk factors such as overweight and obesity, older
maternal age and increasing numbers of women from high-risk
ethnic groups. Changes to diagnostic screening has resulted in
women being diagnosed with DIP earlier in their pregnancy and
therefore requiring services for a longer period of time. Women are
also more frequently presenting with a number of risk factors
resulting in more complex care needs.

The proposed model architecture was presented at the first
workshop, and then subsequent versions of the model were developed
to reflect participant language, input and feedback as well as providing
increased detail and maturity.
Participants were familiarised with the model infrastructure using
paper-based physical representations. For example, during one activity,
participants built a physical representation of the model, with model
components represented in card and tape. Participants worked
collaboratively to document factors that contribute to the problem
being modelled and mapped these directly onto the card and tape
representation (Fig. 2).

A dynamic simulation model focusing on DIP from an ACT
perspective was developed. The national context was considered in the
model development, with the model being considered a proof of
concept with the potential to expand more broadly.

Similar activities were conducted to involve participants in mapping the
mechanisms through which interventions would impact the model (Fig. 3).

The model considers the short, intermediate and long-term implications
of the increasing prevalence of risk factors for DIP. Prevention of risk factors
was prioritised in the model as small delays in the development of diabetes
will have large implications for the longer term burden of disease and costs
to the health system.

The interim conceptual map or model was tested and validated in
collaboration with the model building group during each workshop.
The workshop structure was flexible to account for differences in
group size and incorporated a range of activities with the whole
group or smaller sub-groups as appropriate to allow participants to
raise issues, negotiate perspectives and build consensus. For
activities where the group was split, the modelling team allocated
participants to ensure each sub-group included a range of
perspectives and areas of expertise, and to encourage productive
group dynamics.

Alternative models of care for DIP were considered in the model.
The rising prevalence of DIP is having a significant impact on health
service demand and resources, and the need to ‘do things
differently’ was identified by participants. The model informs the
investments for intervention in DIP, including both clinical and
population health interventions. Workload and resource use has
been incorporated into the model to enable it to act as a resource
allocation decision support tool. At the time of publication, this
model was being finalised.

Consensus building for policy actions
Final half-day workshops and follow-up webinars were conducted
where the model was presented back to the model building group for
verification, discussion, consensus, feedback of results and further input
on preferred visualisation of model outputs.
Outputs from modelled scenarios were presented to participants to
facilitate the development of new insights and knowledge about the
likely impact of interventions and discussion about potential policy
actions.

The participatory simulation modelling processes and
activities utilised in these case studies have been described
in detail elsewhere [38, 39]. However, a brief overview of
the process and examples of activities are provided in Box
2 to give context for the discussion below.

Examples of the user interface and model outputs are presented in
Figs. 4 and 5. These figures illustrate how model users create scenarios
to test and compare the outcomes for different combinations of
selected interventions. Figure 4 includes the user interfaces from the
Alcohol-related harm (top image) and the Premier’s Priority (bottom
image) case studies.

Box 2. Overview of the process and examples of activities
Project planning and engagement (Fig. 1)

The model outputs take the form of dynamic visualisations and
graphs that represent model outcomes for created scenarios, e.g.
for variations of intervention effectiveness and reach. These can be
compared against benchmark or ‘business as usual’ model outputs.
Figure 5 presents example outputs from the Alcohol-related harm
case study.

Early engagement with stakeholders for each case study was
undertaken to identify a priority problem, and determine and define policy
priorities requiring decision support methods. A domain expert, preferably
from the primary partner organisation (partner), was identified to be a lead
collaborator in the project (lead domain expert). This role included
supporting the engagement of stakeholders and co-facilitating workshops.
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Fig. 1 Participatory simulation modelling phases used in the case studies, from Atkinson et al., 2017 [40]

Key aspects of operationalising participatory
dynamic simulation modelling
In the remainder of this paper we draw on our
experience of operationalising participatory dynamic
simulation modelling to support chronic disease
prevention policy and practice in Australia. We consider
three key aspects of the process, (1) establishing
partnerships with stakeholders, (2) engaging participants
actively in the modelling process and (3) using coproduction methods to build trust in the model and its
outputs. We then discuss some of the lessons and implications for adopting these approaches in contemporary
knowledge mobilisation practice.

process with a view that they needed to do things
differently and were motivated to work on innovative
solutions.
Engagement
with
these
primary
partner
organisations (partners) continued throughout the
modelling process, from identifying relevant subject
matter experts to be involved (participants), to
soliciting input on relevant data and literature sources,
negotiating the model purpose, scope and structure,
and encouraging involvement in the facilitation of
modelling workshops.
Identifying and including a lead domain expert for
each case study, e.g. a public health practitioner or
clinician, who was well respected and associated with
the partner, increased engagement, solidified the

Establishing effective partnerships with stakeholders

In each of the case studies, the focus of the model was
proposed by Australian Capital Territory Health or New
South Wales Health as a priority area with current local
concern, complex causal risk factors and as issues where
previous policy responses had limited impact. The
health jurisdictions were therefore coming to the

Fig. 2 Causal factor mapping activity – Alcohol-related harm case
study workshop

Fig. 3 Intervention mapping to model architecture activity –
Diabetes in Pregnancy case study workshop
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Fig. 4 User interfaces from Alcohol-related harm (top image) and Premier’s Priority Project (bottom image) case studies demonstrating the facility
for participants to choose intervention combinations and vary parameters to generate unique scenarios

partnerships and built trust in the modelling process.
These lead domain experts acted as co-facilitators for
model development workshops, along with the project
leader from the modelling team. The combination of domain and modelling expertise allowed workshop cofacilitators to navigate interdisciplinary participation
through a process of developing a common language
and understanding to facilitate model development.

captured in the model. Significant learning occurred
through these deliberative dialogues, with participants
reporting that their ‘interaction was key’ to the modelling
process. The mapping activities provided an interactive
opportunity for participants to synthesise their collective
knowledge and expertise with quantitative evidence.
The practical hands-on mapping activities used during
workshops (Box 2) also familiarised participants with the
model architecture. The model architecture (the diagrammatic representation of the computer model) physically represented how the identified causal factors,
interventions and resulting outputs were incorporated
into the model. This allowed for two-way learning as increased familiarity and confidence in understanding the
model architecture enabled participants to critique and
provide feedback to modellers to ensure the model

Engaging participants actively in the modelling process

Facilitated workshop activities were designed to involve
participants actively in the modelling process (examples in
Box 2). These methods supported participant engagement
and investment in the model as they deliberated and
negotiated with each other to prioritise causal factors,
their interactions, and interventions and outcomes to be
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Fig. 5 Example model output from Alcohol-related harm case study demonstrating the output visualisations for participants generated scenarios
and comparison against baseline

Demonstrating the model conceptualisation to participants at each workshop and highlighting their contributions increased participants’ understanding of the model.
This transparency reinforced the value of their participation and their ownership of the model, and provided an
opportunity to establish the face validity of models against
expert and local knowledge.
Another important aspect to building trust in model
outputs was to encourage discussion about the
limitations and assumptions in the model design and
available data sources. Documentation of data sources
and assumptions built into the models was shared with
participants to critically evaluate and provide feedback.
Building participants’ trust in the model was necessary
for its acceptance by stakeholders/experts who were not
involved in its development (stakeholders). Involvement
of key opinion leaders in the model development groups
brought credibility to the models as participants acted as
ambassadors for the model within their broader
stakeholder groups. Diversity of expertise within the
participant group was also important so different
stakeholder groups felt their perspective had been
represented.
When some model outputs did not confirm long held
beliefs about likely effects of interventions and their
combinations, there was robust debate about the
implications and caution in using such results to inform
decision-making. In these situations, it was particularly

accurately represented their shared understanding.
Taking an iterative approach facilitated collective learning, and the demonstration of the evolving model at the
second and subsequent workshops further validated and
improved model design.
At times, the priorities of policy partners (in terms of
interventions and outputs to be included in the model)
differed from those of subject matter experts. The
participatory process of negotiation helped to build
consensus on what to prioritise in the model and enhanced
each participant group’s understanding of the others’
knowledge and research or policy. Expert facilitation skills
were necessary to draw out diverse contributions, maintain
engagement in the process and negotiate compromises
where necessary. Explicit processes, including voting, were
used to democratically resolve disagreements and to clarify
priorities in model development.

Co-production built trust in model outputs and facilitated
consensus for action

The strong partnerships and active engagement of
partners and participants throughout the iterative model
development were critical for building trust in model
outputs and providing the best opportunity for impact on
policy and programme decisions.
The use of co-production methods as described above
increased transparency in the model building process.
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interventions to address it. Differential participation did
occur in some of the workshops, e.g. participants sometimes deferred to those they perceived to have greater
authority or expertise for particular aspects of the content. However, the workshop facilitators promoted the
value of diverse perspectives in building a robust model
and regularly sought to draw out those who were less
vocal.
Consistent with other knowledge mobilisation
approaches, the participatory process was time consuming
and required ongoing efforts to maintain and coordinate
diverse engagements. However, the challenges were
outweighed by the positive outcomes of effective
collaborative networks, co-production of knowledge, and
capacity to integrate diverse evidence and expert opinion.
In our case study settings, many participants had limited
or no prior experience with dynamic simulation models or
the modelling process. An important dimension of the
knowledge mobilisation process was the translation that
occurred between disciplines, e.g. clinicians, computer scientists and population health professionals, to ensure that
everyone understood each other’s perspectives and were
working toward a common goal.
The processes of data gathering and synthesis
commonly highlighted gaps in local programme
outcome data, as well as in the published literature. For
example, locally available evaluation data was frequently
limited to process and participation measures, rather
than programme outcomes and effectiveness. Often, the
local contextually relevant data was utilised and
triangulated with other potentially more reliable but less
locally relevant sources to inform the models. Whilst
evidence gaps are an ongoing challenge in all settings,
the process of uncovering these gaps through the
participatory process, and prioritising data needs
through sensitivity testing in the model, provided
important information for prioritising future research
and guiding refinement of local programme evaluations
and routine data collection.
An important challenge of knowledge mobilisation
using this participatory modelling approach was the
building of trust in the model outputs. This was less of
an issue when the model outputs confirmed existing
preconceptions of underlying causal mechanisms, but
significantly more challenging when model outputs were
contrary to participants’ long held beliefs. This could be
particularly challenging for subject matter experts who
were required to reassess their prior expectations.
However, the dynamic, interactive nature of the models
as decision support tools facilitated ongoing dialogue
and negotiation with stakeholders and developed
understanding and trust.
Our analysis of participatory model building methods
is ongoing. Further activities in this programme of

useful to invite stakeholders to interact with the model,
challenge their assumptions, provide alternative data and
test their expectations against model outputs. Iterative,
open and non-defensive communication was critical to
facilitating these interactions, advancing understanding
of the complex problem and building trust in the decision support tool.
Model validation is an essential stage of all model
development, including models developed using
participatory approaches [77]. Demonstrating to partners,
participants and stakeholders that the models reproduced
historic data patterns across a range of indicators
confirmed their validity, and built confidence that the
models would produce robust forecasts into the future.
Collaborative processes were also used to maximise
the potential usability of the model. Participant
engagement with the model was encouraged to test and
refine the user interface. This user testing ensured that
the interface was intuitive and accessible for a diverse
range of users.

Conclusion
The participatory dynamic simulation modelling
processes utilised in these case studies built on
knowledge mobilisation best practice and produced
dynamic decision support tools that integrated diverse
forms of evidence, including research evidence, expert
knowledge and localised contextual information. The
participatory approach placed end-users at the centre of
the process and embedded deliberative methods and coproduction of knowledge. Policymakers, researchers, scientists, clinicians, consumers and modellers collaborated
and explored policy and health service scenarios for priority public health topics.
An important element of co-production in these case
studies was equal partnering with key stakeholders to
negotiate the priority issue to be modelled. These were
‘hot topics’ that were current, locally relevant, had complex causal mechanisms, and for which decision-makers
needed to decide between competing courses of action.
It was in these circumstances that participatory dynamic
modelling provided an opportunity for policy and
programme options and combinations to be tested
within a safe, simulated environment before being implemented in the real world. The case studies revealed valuable lessons for the participatory dynamic simulation
modelling process in health policy settings. The case
study topics were complex and multi-faceted, and the diverse representation of stakeholders in the modelling
groups was essential as no one individual could be an
expert on all aspects of the issue. An aspect of the
process was thus to emphasise the need for knowledge
sharing among stakeholders and to develop a common
understanding of the issue, and of the potential
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research involve evaluating the perceived value of the
participatory process; the commitment and confidence
of partners and participants to implement policy and
programme decisions identified through the modelling
process; and the impact of the process, i.e. how model
outputs will be used to inform policy and programme
decisions in the local public health settings.
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Chapter 5: Results part 2: Turning conceptual systems maps into
dynamic simulation models: revealing the analytical
deliberations and decisions of participatory dynamic simulation
modelling - an Australian health sector case study

The paper presented in this chapter is based on a qualitative, empirical analysis examining
the activities, processes and decisions involved in converting a qualitative system map into a
rigorously quantified, dynamic simulation model for diabetes in pregnancy. The analysis
uncovered the analytical work underlying the model development process and provides
unique insights to facilitate better understanding of participatory modelling and inform
future modelling projects.

Analyses of workshop and meeting recordings were triangulated with field notes and other
documentation to uncover the deliberative methods and decisions involved the
participatory model development process.

Paper 3:
Freebairn L, Atkinson J, Osgood N, Kelly P M, McDonnell G, and Rychetnik L. Turning
conceptual systems maps into dynamic simulation models: revealing the analytical
deliberations and decisions of participatory dynamic simulation modelling - an Australian
health sector case study. PloS one, 14(6), e0218875.
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0218875.
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Background
System science approaches are increasingly used to explore complex public health problems. Quantitative methods, such as participatory dynamic simulation modelling, can mobilise knowledge to inform health policy decisions. However, the analytic and practical steps
required to turn collaboratively developed, qualitative system maps into rigorous and policyrelevant quantified dynamic simulation models are not well described. This paper reports on
the processes, interactions and decisions that occurred at the interface between modellers
and end-user participants in an applied health sector case study focusing on diabetes in
pregnancy.
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An analysis was conducted using qualitative data from a participatory dynamic simulation
modelling case study in an Australian health policy setting. Recordings of participatory
model development workshops and subsequent meetings were analysed and triangulated
with field notes and other written records of discussions and decisions. Case study vignettes
were collated to illustrate the deliberations and decisions made throughout the model development process.

Data Availability Statement: The datasets
generated and analysed during the current study
are not publicly available as they contain
information that may identify individual
participants. The raw qualitative data are not
publicly available due to the ethical requirements of
protecting participant confidentiality. Requests for
regulated access may be directed to the Sax
Institute as the administering institution for this
research via their website https://www.saxinstitute.
org.au/contact-us/.

Results
The key analytic objectives and decision-making processes included: defining the model
scope; analysing and refining the model structure to maximise local relevance and utility;
reviewing and incorporating evidence to inform model parameters and assumptions; focusing the model on priority policy questions; communicating results and applying the models
to policy processes. These stages did not occur sequentially; the model development was
cyclical and iterative with decisions being re-visited and refined throughout the process.
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Storytelling was an effective strategy to both communicate and resolve concerns about
the model logic and structure, and to communicate the outputs of the model to a broader
audience.

Conclusion
The in-depth analysis reported here examined the application of participatory modelling
methods to move beyond qualitative conceptual mapping to the development of a rigorously
quantified and policy relevant, complex dynamic simulation model. The analytic objectives
and decision-making themes identified provide guidance for interpreting, understanding and
reporting future participatory modelling projects and methods.

Introduction
This paper contributes to the current knowledge gap about the development from qualitative
to quantitative modelling [1]. It examines the detailed implementation of the analytic processes and practical strategies used to convert the qualitative systems maps into a rigorous and
policy relevant dynamic simulation model. Dynamic simulation models are quantified, computer-based representations of complex systems that draw on best available evidence and provide a decision support tool to conduct policy experiments and forecast potential impacts. The
models enable working hypotheses of causal pathways to be explicitly and quantitatively operationalised to evaluate the effectiveness of potential interventions, or combinations of interventions, via computer simulation before they are implemented in the real world [2–6].
This paper provides a qualitative analysis of the stakeholder deliberations and decisions
that occurred within an Australian health sector participatory modelling case-study. This case
study applied the participatory approach to the development of a multi-method (or hybrid;
these terms are explained below) dynamic simulation model focusing on diabetes in pregnancy. We present the findings together with real-world examples of some of the core questions and decisions made, to inform health service researchers, policy makers and modellers
who may be considering undertaking participatory modelling projects. The findings detail
important aspects of project implementation, and the types of input from end-user participants. This includes the feedback, critiques, issues raised, and questions asked by stakeholders
as part of their engagement in the participatory modelling process; their analytical and material contributions to model development and peer-to-peer learning; and their role in the process of identifying and selecting different forms and sources of evidence. We also report on the
intellectual and practical challenges experienced by the core model building team—and strategies used to overcome them, as well as the overall challenges and significant opportunities arising from the participatory process itself.

Background
Knowledge created through application of the scientific method requires effort to translate
into action [7]. Knowledge mobilisation is defined as a dynamic and iterative process that
includes synthesis, dissemination, exchange and application of knowledge to improve health,
provide more effective health services and products and strengthen the health care system [8].
It is widely acknowledged that using research evidence for policy and practice is an emergent
and context dependent process, that relies on relationships, and can be time consuming and
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lack clear policy direction particularly in the face of complexity that characterises many of our
persistent health and social problems [9–13].
The many synergies of combining evidence-informed policy principles with systems science methods are increasingly recognised [14]. Systems science encompasses a range of
approaches that can be used to explore and understand public health problems as complex systems; in order to intervene more effectively and adapt to each particular context [15–19]. Key
elements of a systems science approach include synthesising diverse knowledge and evidence,
exploring the potential for non-linear relationships between contributing factors, and identification of unanticipated emergent behaviour of the complex systems (including policy resistance) [15, 19–22].
The collaborative exploration of a complex issue or problem using systems thinking can
generate a conceptual system map which reflects the qualitative, group understanding of the
complex issue [23, 24]. These qualitative maps and models can engender a high degree of
ownership and consensus about the nature of the problem, as they are based on the collective
expertise of the participants involved [25]. However, the practical application of these maps in
exploring and testing hypotheses about the impact of policy intervention options is limited
[25, 26]. Such hypothesis testing and comparison of the impacts of alternative scenarios relies
on subsequent rigorous quantification of the components, connections and relationships that
comprise the system using methods such as dynamic simulation modelling [25–27]. Simulation modelling allows experiments to be conducted to see how a system behaves under different conditions and scenarios [22, 28]. The postulated theory of causation is refined and shaped
through the participatory process of model building [6]. The process can enable health policy
and practice decisions makers to sharpen their understanding of the key components and
behaviour of a health-related issue as a complex system [6, 21, 22]. Once commissioned, these
models allow decisions makers to draw on and learn from this joint understanding to better
inform their policy and practice decisions [6, 9, 15, 21, 22, 28–30] and further model development and modification, post-commissioning, facilitates ongoing learning [6].
Participatory modelling approaches are an important feature of system dynamics modelling
and have been widely adopted in environmental modelling projects [1, 26, 27, 30–39]. Many
guidelines and principles for participatory modelling have been developed with varying
degrees of prescriptive detail [30, 32, 36, 40, 41]. The guidelines commonly emphasise the principles of: careful planning for stakeholder engagement; awareness and management of social
and group dynamics; flexibility and responsiveness to stakeholder input; iterating and refining,
being open and transparent; accepting uncertainty; and encouraging learning through theory
building and hypothesis testing [30, 32, 36–43]. The implementation of these principles of
participatory modelling processes are often not well described, or only reported in narrowly
defined discipline-specific forums (e.g. system dynamics projects reported in system dynamics
journals), thus limiting opportunities for interdisciplinary learning for public health policy
and practice [25, 44, 45].
Many participatory modelling projects have focussed efforts on qualitative mapping or
semi-quantitative modelling of systems using methods including fuzzy cognitive mapping,
rich picture diagrams, causal loop diagrams and systems structure diagrams [1, 23–26]. Understanding the process of transforming these representations into quantitative models is important, particularly for complex, quantitative models developed with an inter-disciplinary
participant group, such as the one described in this case study [1, 36, 41]. More detailed understanding is needed about the participatory modelling process and the impact of facilitators and
constraints [25]. Recent multi-method and systematic reviews of knowledge mobilisation and
participatory dynamic simulation modelling across health and other sectors also conclude that
more knowledge is needed about which approaches work best, in what settings, and how and
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why they are effective [42, 46, 47]. Effective learning about the future role of systems
approaches will come from natural experiments and case-studies, and the field of knowledge
mobilisation will benefit from empirical studies of participatory modelling in applied ‘realworld’ settings [46, 48, 49].
Three case studies, focusing on alcohol related harms, childhood overweight and diabetes
in pregnancy, utilising participatory dynamic simulation modelling methods have been implemented in Australian health policy settings [50–55]. Key aspects and activities of the novel participatory modelling methods used to collaboratively develop qualitative representations of the
complex systems being modelled; participant experiences of the modelling process; and the
model outputs and their application as decision support tools have been described elsewhere
[50, 51, 53, 56, 57]. This paper focuses on the diabetes in pregnancy case study. It reports the
findings of a qualitative analysis undertaken to examine the stakeholder deliberations, analytic
processes, and decisions involved in using a participatory process to transform qualitative conceptual maps of diabetes in pregnancy into a quantified dynamic simulation model.

Case study context
Diabetes in pregnancy (DIP) is a complication of pregnancy that is defined as carbohydrate
intolerance resulting in hyperglycaemia (abnormally high blood sugar). It includes women
for whom the first recognition or onset of the condition occurs during pregnancy, as well as
women with pre-existing type 1 and type 2 diabetes mellitus [58]. The prevalence of DIP is
increasing both in Australia and internationally [59], and increasing the burden on the health
care system. Approximately 16% of women who gave birth in the Australian Capital Territory
(the case study focus region) in 2016 were diagnosed with diabetes in pregnancy, increasing
from 6% in 2008 [60]. There are short- and long-term health risks for both mother and baby,
including increased risk of birth injury in the short term and development of diabetes later in
life [61–64]. The available evidence does not definitively guide health services on how best to
prevent and manage DIP. For example, questions regarding the timing and methods of prevention and screening, criteria for diagnosis, targets for treatment and differential effects of
treatment are all current challenges for DIP policy and treatment planning [65–68]. These
issues cross the spectrum from specialised clinical management to population health interventions and such policy and service decisions are likely to benefit from sophisticated analytical
tools, such as dynamic simulation modelling.

Methods
The qualitative study involved analysis of data methodically collected during the participatory
process for the development of a dynamic simulation model for diabetes in pregnancy (the
case study). The case study (Box 1) and the participatory modelling process (Box 2) are
described below to provide background contextual information. The data sources and qualitative analysis methods for this study are described below.

Data sources
Data sources for preparing this paper included recordings of participatory workshops (n = 3),
web-based meetings with participants (n = 3) and model development meetings (n = 3) with
the core modelling team. The face to face meetings were audio recorded and photographed
and the web-based meetings were audio-visually recorded. The core modelling group comprised of 11 people including computer scientists, computer science students, public health
practitioners and medical specialists. LF, JA, GM, NO and PK were members of the core
modelling group. Key meetings with members of the core model development group were
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Box 1: Case study description
Researchers partnered with an Australian jurisdictional health department, and a multidisciplinary group of stakeholders including clinicians, health economists, public health
practitioners, simulation modelling experts and health policy decision makers, to coproduce a sophisticated, multiscale dynamic simulation model to support health policy
and practice decisions for diabetes in pregnancy. The case study, participants, key project roles and participatory processes have been described in detail elsewhere [51, 54, 57].
The hybrid model was developed between 2016 and 2018 and integrates multiple modelling methods (agent-based, system dynamics and discrete event simulation modelling—
see the following references for more information about these modelling methods [32,
69–72]). The purpose of the model was to explore short- and long-term implications of
rising rates of diabetes in pregnancy and associated risk factors. The model simulates
alternative policy, program, and clinical intervention scenarios to inform prevention
and management decisions [51, 54].

audio recorded and one was professionally transcribed as a resource to facilitate the documentation of the model. Additional data included the written records and field notes from model
development meetings, including a key modelling team meeting held after the first workshop
where the qualitative conceptual map was synthesised. The field notes were based on observations of the participatory workshops, workshop debriefing discussions with research officers
(EO, NR, JD and CW, see Acknowledgements) and reflexive discussions regarding the model
development process between the authors. Email communications with participants were also
compiled for triangulation with the other data.

Data coding and analysis
The analysis presented in this paper builds on previous work focusing on the experiences and
perceptions of decision makers who engaged in the participatory modelling processes [57].
The previous analysis was conducted using grounded theory, whereas this data coding and
analysis used thematic analysis focusing on the research questions outlined below. It was
guided by the “theoretical” approach to thematic analysis described by Braun and Clarke [73]
with the focus being guided by the researcher’s analytic interest, and therefore more explicitly
researcher driven than inductive coding and analysis [73]. The thematic analysis focused on
the problem solving and decision-making processes underlying the explicit activities in which
stakeholders participated during the model development described in Fig 1. The analysis was
guided by the following research questions: What were the key elements and features of the
participatory approach that were required to successfully develop a policy relevant dynamic
simulation model from a qualitative systems map? What types of questions were asked by the
stakeholders, what concerns and issues were raised, and what was the feedback from participants during the process? What challenges and tensions arose in the process and how were
they managed?
The audio-visual recordings were viewed, coded and analysed by the lead investigator (LF).
Field notes, observations, records of reflexive discussions, email exchanges and recordings of
meetings / workshops were analysed progressively by LF and discussed regularly with JA, and
LR throughout the process. An iterative process of descriptive coding and analytical memos
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Box 2: Participatory modelling process
An overview of the approach used to build the dynamic simulation models using participatory methods has been described previously [51]. Broadly, this involves an iterative
process of convening expert stakeholders, conceptual problem mapping, synthesising
evidence, quantifying the key dynamic relationships within the system, presenting
model versions to participants and end users, refining the model, and applying the
model to support evidence-informed dialogues about policy options.
The end-user participants were central to the model development process. Contact was
initiated early and engagement was negotiated to ensure that the scope of the model
reflected key policy and planning questions, the interaction of key risk factors, and context specific intervention priorities [51]. The participatory process involved workshops,
web-based and face-to-face meetings and ongoing communication via email or telephone. Participants had differing levels of intensity and duration of involvement in the
project, ranging from those who contributed to group activities primarily as workshop
participants, to others who also contributed as workshop facilitators, attended the regular project team meetings, and facilitated subsequent communications about the application of the model.
An overview of the activities involved in the participatory process is presented in Fig 1.
Workshops were conducted where participants interacted and engaged in group activities to develop conceptual maps of the factors contributing to diabetes in pregnancy and
its potential outcomes. During the workshops, they also discussed the quality and availability of evidence to inform the model development, prioritised interventions and outcomes to be explored in the model, and provided feedback to refine the model. The
model development process was iterative at every stage, with the core model building
team gathering information from participants, integrating it with other evidence and
data sources to inform the model development process and receiving feedback from participants before proceeding to the next step (Fig 1). Interaction with participants also
occurred between workshops, and continued for some months after the final workshop.
In the later stages of model development, the iterative feedback process centred around
the presentation and discussion of the model results.

was used to develop themes and conceptual categories and explore their inter-relationships.
Themes and insights were triangulated across the different data types and sources. The progressive analysis was further revised as new data was incorporated. Analytic memos written
by LF were shared with JA and LR to facilitate the analysis review process. Vignettes based on
data from the case study were written to demonstrate practical examples of important decision
points and the processes used to develop model components.

Ethics and consent to participate
This study was reviewed and approved as low risk by the ACT Health Human Research Ethics
Committee (ACTHLR.15.150) and the University of Notre Dame Human Research Ethics
Committee (0151195).
All participants gave individual written consent, were assured of confidentiality, and were
free to withdraw from the study at any stage.
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Fig 1. Overview of activities involved in the participatory process.
https://doi.org/10.1371/journal.pone.0218875.g001

Results
The qualitative analysis uncovered the iterative cycles of engagement, analysis, negotiation and
refinement involved in the process of developing a dynamic simulation model as a quantified
decision support tool for diabetes in pregnancy. The core analytical objectives and decisionmaking themes involved in the participatory model development process are described below
and represented in Fig 2. In summary, the process of engaging with participants to develop a
quantitative model involved five distinct phases including: (i) defining and negotiating the
model scope; (ii) finding, critiquing and using evidence; (iii) analysing and refining the model;
(iv) ensuring that the model remained focused on priority policy questions; and (v) engaging
with, evaluating and communicating model outputs. Each of these phases are explained in
detail below. The schematic diagram in Fig 2 illustrates how each of these conceptually and
practically distinguishable aspects of model development involved interaction and engagement
with participants at the centre of the process. However, it is important to note that these phases
did not occur in any linear or chronological order. Instead interactions and discussions that
occurred later in the model development process, as the model was analysed and refined,
resulted in earlier phases being re-visited and refined or revised. The results section concludes
with a description of the overarching challenges that arose from the participatory process itself,
and the strategies used to overcome them, as well as the model application opportunities that
resulted from the participatory process. A glossary explaining modelling terms is provided in
the supplementary file: S1 Glossary.

Defining model scope
A primary aim of the first participant workshop was for the core model building team and
workshop participants to jointly conceptualise and qualitatively map the ‘system’ of Diabetes
in Pregnancy in the form of a ‘draft model structure’. In this instance, it was represented in the
form of ‘state charts’ as used in agent-based modelling methods [51, 54]. State chart elements
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Fig 2. Overview of the analytical objectives and decision-making processes involved in the participatory development of a dynamic
simulation model.
https://doi.org/10.1371/journal.pone.0218875.g002

relating to diabetes in pregnancy were derived from discussions with participants prior to the
first workshop and were pre-printed and presented as a draft model structure to facilitate the
activity. Participants were invited to add to and modify the draft model structure and encouraged to highlight and explain the interconnections between the components of the system, any
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Fig 3. Problem conceptualisation map from participant workshop 1 (detail).
https://doi.org/10.1371/journal.pone.0218875.g003

changes over time, feedback loops, and sources of inertia and delay. The problem conceptualisation for diabetes in pregnancy as it appeared at the end of Workshop 1 is shown in Fig 3.
The participants’ initial problem conceptualisation was a detailed, qualitative representation
of the interacting factors contributing to the development of diabetes in pregnancy, jointly
developed to incorporate the multiple perspectives of the expert participants. However, the
initial map developed in workshop 1 (Fig 3) required further synthesis and refinement of its
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Table 1. Factors influencing the development of diabetes in pregnancy prioritised from problem
conceptualisation.
Factor

Examples

Family history / genetic
factors

Family history of obesity or diabetes

Food environment / diet

Unhealthy diet, access to healthy foods, food security

Physical Activity

Level of physical activity or sedentary behaviour, physical environment

Health state

Diabetes in previous pregnancy, other obstetric risk factors, personal history high
birthweight

Health care system

Universal or selective screening, access to health care, government policy

Metabolic functioning

Glycemic regulation, insulin sensitivity, weight status, gestational weight gain

Non-modifiable factors

Maternal age, high risk ethnicity, migration

Psychosocial factors

Social network, education level, cultural norms, psychological factors

Events

Examples

Medical interventions

Screening, specialist services, diabetogenic medications, bariatric surgery

Model components

Examples

Agent types

Mothers, babies, health care workers

https://doi.org/10.1371/journal.pone.0218875.t001

conceptual representation before it could be operationalised as a computational model. To
achieve this, the core model development team, in subsequent consultation with the expert
stakeholders, used the map and voice recordings of the mapping exercise to identify important
themes, events and interconnections to be captured in the model. This involved systematically
reviewing the diagram to determine the priority factors that influenced the postulated causal
pathways, and the most important events and agents to be quantified in the model. These factors are presented in Table 1. For example, factors were prioritised for inclusion in the model
if they were identified in multiple places in the concept map, or emphasised by stakeholders as
influencing causal relationships between, and transitions within, the developed state charts.
The modelling methods used in the case study included system dynamics, agent-based and
discrete event modelling—a decision that was primarily made by the technical expert modellers, in consultation with the others in core modelling group. The current understanding of
the aetiology of diabetes in pregnancy (as described in Vignette 1 below) facilitated decision
making about the modelling methods. Advances in computer simulation tools have meant
that the multiple modelling methods mentioned above can be used in a single model, allowing
focused selection of the most appropriate method to articulate different components of the
model. This flexibility leveraged the advantages of each method without needing to constrain
the representation with the limitations of a single method. Aggregate model components, such
as with system dynamics, don’t allow for exploration into individual differences in predisposing factors, adherence to diet or medication, or other circumstances such as social determinants of an individual’s health. Therefore, agent-based modelling methods were chosen to
enable the exploration of individual differences in predisposition and risk exposures. Agentbased modelling methods were also used to capture individual trajectories through risk exposures, inherited risk due to maternal history and ethnicity and consequent development of disease. A system dynamics stock and flow ageing chain structure was initially chosen to initialise
and represent the population. Population members who met the definition for ‘high risk’, i.e.
according to the Australian Diabetes in Pregnancy (ADIPS) definition, ‘budded’ from the
aggregate stock and flow structure and became agents within the model. Agent-based modelling state charts were implemented to represent pregnancy transitions, weight transitions and
the development of diabetes. Discrete events simulation components were implemented to
represent agent use of health services.
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Fig 4. Simplified model structure presented in workshop 2.
https://doi.org/10.1371/journal.pone.0218875.g004

Analysing and refining the model to maximise relevance and utility
Versions of the model were presented back to participants at the second and third workshops
and other web-based meetings to demonstrate how the core modelling group had operationalised the qualitative conceptual map of diabetes in pregnancy. The participants’ analysis and
critique of the evolving model were an important contribution to improving the structure, and
refining the causal pathways, and their underlying logic and assumptions.
We include here an illustrative example of how the evolving draft model was presented to
participants in the second workshop using a simplified representation of the model elements
in Insightmaker™ (Fig 4). The examples of agent”life stories”, presented as clinical case histories, were used to talk participants through the model structure and logic.
For the expert participants, particularly those from clinical backgrounds, the presentation
of individual case histories, as “stories” from the model, was a familiar and well-understood
method of communication. It provided an opportunity for participants to become familiar
with a strategic view of the model, without becoming swamped by the detailed structures used
in modelling software. Participants asked questions of the core modelling team, clarified the
use of terminology, and helped to refine the model logic. They also provided feedback based
on their clinical and policy expertise that identified important gaps in the model; for example,
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the need to incorporate a representation of the complex heterogeneity of diabetes aetiology as
discussed in Vignette 1.
Vignette 1. Improving the representation of the development of diabetes in pregnancy
An issue raised frequently during workshops and meetings was the complex heterogeneity in
the development of diabetes in pregnancy. Participants emphasised that the causal mechanisms for development of the condition were complex, multifaceted and an area requiring
further knowledge development. For example, a baby may be born with diminished beta cell
mass and function due to genetic predisposition. The intrauterine environment also impacts
on risk; being exposed to dysglycemia (high blood sugars) in-utero can lead to short- and longterm effects on the baby including macrosomia, risk of high weight status in childhood and
adult life and increased risk of early development of diabetes. The causal mechanism for diabetes development in some individuals was through increased insulin resistance, however for
others, declining beta cell mass and function was the driving factor. A third group experience
a combination of both. These causal mechanisms were also influenced by non-modifiable factors, such as ageing, and modifiable factors, including weight status, diet, and physical activity
levels.
The definitions used in the model were aligned wherever possible with those used in
accepted clinical guidelines, and the collaborative process of deciding on the terms and definitions helped to facilitate shared understanding of these within the group. Participants also proposed credible assumptions to be used in the model e.g. all women from ethnic groups defined
by ADIPS as high risk should be defined as “high risk” in the model. Versions of the simplified
model were printed and used in small group activities in workshop 2 to map directly to the
model architecture the prioritised interventions, as identified by the group (Fig 5). This decision making process was aided by technological advancements in the user interface of the
selected modelling software, so that ‘state charts’, ‘action charts’, ‘stocks and flows’, and process
modelling components can be used to replace thousands of lines of code to clearly visualise
and communicate model logic and thereby facilitated transparency and enabled stakeholders
to meaningfully critique the model.
The repeated opportunities for stakeholder participants to actively interact with and discuss
the model allowed them to test the evolving model structure against their “real-life” professional experience of working in diabetes in pregnancy research, policy and practice. It also
allowed the modellers to test their own understanding of the issue (and how this knowledge
had guided their technical model development) against the knowledge of content experts
working in the field. The multi-disciplinary group of health sector participants brought to
modelling discussions a breadth and depth of knowledge and rich experience regarding the
issue that would be impossible to gain from reviewing the data / literature alone. Participants
were able to contextualise the logic and structure of the model, identify additional questions
and data to be investigated, and additional factors to consider for inclusion.

Finding and using the best available evidence
Over the duration of the model development process many published studies and other evidence sources were synthesised and used to inform assumptions and parameter values in the
model. Participants were motivated to understand and review the data and evidence utilised
and demonstrated their strong commitment to this process by continuing to engage and
respond to requests for evidence. The potential sources of data and evidence that could be
used to inform the model were, therefore, an important focus for discussion at workshops,
meetings and out of session communication. Participants drew on their extensive knowledge

PLOS ONE | https://doi.org/10.1371/journal.pone.0218875 June 27, 2019

131

12 / 27

Turning conceptual systems maps into dynamic simulation models using participatory methods

Fig 5. Intervention mapping to model architecture from workshop 2.
https://doi.org/10.1371/journal.pone.0218875.g005

of the literature, identified and explained the most relevant studies and their main findings,
and offered advice to the modelling team about local population characteristics, exposures,
and service variations that contextualised published study results. Importantly, participants
also identified limitations of the available evidence and data, such as quality concerns about
identification of diabetes in health service administrative datasets.
Agent-based models are valuable to explore individual differences in disease aetiology;
however, they can have substantial data needs, and complex models like the diabetes in pregnancy model require quantification of many parameters and relationships between model
components. Requests for evidence were circulated to the participant group for discussion as
they arose during the model development. There were many requests for evidence that were
identified by the core modelling team and discussed with participants during the model development process. Some examples include:
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1. What is the probability of adverse perinatal outcomes for women according to their level of
glycemic control during pregnancy (normal through to high levels of dysglycemia)?
2. Relating to the mechanism by which exercise affects insulin sensitivity—is it direct or moderated through weight status? Can physical activity have a positive impact on metabolic
function but no impact on weight status?
3. What is the effect of insulin during pregnancy and does it differ from pre- or postpregnancy?
These questions were framed with a brief contextual explanation of the model pathways
and structures that required the additional information. Where possible, participants answered
these questions by referring the core modelling group to quality published studies, including
randomised control trials and prospective longitudinal outcomes studies where available; providing health service administrative data; or providing expert advice based on their extensive
experience. The core modelling group also independently searched the literature for evidence
and conferred with the expert participants about the robustness and appropriateness of the evidence identified before and while it was used to inform model development.
The expert participants were also able to critique and identify limitations in the published
literature and health service data as well as knowledge gaps. For example, the health service
routinely collects perinatal statistics with respect to perinatal outcomes, such as birth weight
and admission to neonatal intensive care, however, only diagnosis of DIP is recorded and
not level of glycemic control during pregnancy. These data were therefore unable to directly
inform relationships between glycemic control and perinatal outcomes to answer question 1
above; and more detailed studies in the published literature were utilised instead. Where the
published evidence was relevant but not specific enough to apply to the local context, it was
often used to assist with calibration or validation rather than used as input parameters i.e. it
was used to evaluate the model behaviour rather than as evidence incorporated into the model
equations.
A common question that arose during the model development process was what to do
when there was insufficient local data or other published evidence to inform the model structure or parameterisation. Strategies such as calibration of key parameters using historic trends
for diabetes in pregnancy incidence and sensitivity analysis were utilised. These strategies are
established in modelling literature and practice as robust methods to address these common
modelling challenges but were unfamiliar to many participants. However, the mutual respect
that had developed between participants and the core modelling team and the recognised
value of dynamic modelling as a learning tool were helpful sources of confidence. The overall
framing of the process was that dynamic simulation modelling is a tool that allows contributors to articulate a hypothesis of complex causal pathways in the emergence and progression
of disease (including possible latent factors) by bringing together best available evidence and
data, and then testing and refining that hypothesis through computation, simulation and validation against real-world historic data patterns.
Sensitivity analysis was used to determine which uncertain parameter estimates were most
important to the outcomes of interest, which informed priorities for future research. This
identification of future research priorities was another function of the modelling process that
was highly valued by the participants.
Finally, the DIP model also utilised, as sources of evidence, the existing diabetes modelling
literature. For example, existing, peer-reviewed mathematical models of diabetes progression
were presented and explained to the clinical and policy expert participants for consideration
as evidence to help quantify parameter estimates and equations, such as those representing
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variations in the development of diabetes. These mathematical models enabled the modellers
to quantify and operationalise the latent variables and causal mechanisms underlying the heterogenous development of diabetes, an identified gap in clinical diabetes research. Grounding
the model in this established, and peer-reviewed, mathematical literature also enhanced the
rigour and reliability of the model outputs.

Focusing the model on priority policy and program questions
The model was primarily developed as a planning tool for exploring the resource implications
and service costs of alternative policy and program options. Participant feedback guided decisions about which components of the larger system model of DIP would be prioritised for
these health service decisions. They selected alternative health service options and service pathways as a priority for inclusion in the model.
The expertise of the participant group grounded the model in the real-world experience of
intervention effectiveness. For example, studies of interventions delivered during pregnancy
to prevent the development of diabetes have yielded disappointing results, and it was deemed
important for the model to be able to compare early intervention options. Pre-pregnancy
and inter-pregnancy interventions were prioritised for inclusion in the model; both at the
population level, and those targeting high risk women. The mechanisms for impact were
mapped to the printed model structure during the workshops and subsequent discussions.
Participants indicated the transitions, states, parameters and other structures that were likely
to be impacted by each intervention. For example, for interventions targeting weight loss, the
impact on the weight status state chart were discussed by the group, and then mapped to indicate how this could flow through to impact on other model structures. These discussions with
participants guided the core modelling group where to focus their efforts to ensure that the
necessary components were operationalised to allow the most important policy and program
questions to be explored (Vignette 2). Based on the detailed understanding of the expert participants, the structure of the model captured the impact of duration and level of exposure to
dysglycemia on beta cell function for individual agents, and thus enabled the testing of both
clinical and lifestyle intervention strategies targeted at different stages of the life course.
Vignette 2. Accurately capturing impact of prolonged exposure to dysglycemia on intervention
effectiveness
Participant input emphasised that the model needed to account for the length of exposure to
dysglycemia as this has a significant impact on intervention effectiveness. When a person is
exposed to dysglycemia for an extended period of time, they lose effective beta cell function,
and therefore, the ability to recover glycemic control even after engaging in an intervention. In
contrast, an individual who has just been newly diagnosed with impaired glucose regulation
or diabetes in pregnancy can recover glycemic control if they engage in physical activity or
dietary modifications that lower their blood sugar levels and reduce damage to their beta cell
function. Early interventions, for example, for a woman who experiences gestational diabetes
in her first pregnancy, may therefore have more effectiveness than interventions for people
with prolonged exposure to poor glycemic regulation.
These important policy and planning questions focused on the underlying physiological mechanisms impacting on intervention effectiveness. They motivated the development of more
detailed model mechanisms to capture the impact of actualised glycemic control on both
maternal and perinatal outcomes. A detailed articulation of glycemic control, rather than
simply considering the diagnostic status of an individual agent in broad terms, was required
for the model to robustly explore clinical intervention scenarios of interest to participants.
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Engaging with and communicating results and applying the model
Being open to and welcoming critique from diabetes experts was key to genuine co-design
of the model. It was also important to ‘socialise’ the results of the model; that is, to test them
against the knowledge and experience of the participant group. Viewing and discussing model
results / outputs was a critical phase of the model development process and was essential to
more fully elicit the expert knowledge of participants. Two types of knowledge were elicited
through discussion of model outputs, namely: tacit expert knowledge, i.e. the knowledge that
people generally won’t mention unless prompted; and explicitly considered expert knowledge
that couldn’t be applied to the model directly, i.e. knowledge that wasn’t reducible to any
one parameter or assumption and instead reflected the emergent behaviour of the system. In
both cases, the elicited knowledge served as key sources of evidence to challenge the working
dynamic hypothesis captured in the model. Simulation experiments enabled examination
of the logical implications of the hypothesis, represented in the model structure, logic and
assumptions, by exposing the performance of the model for outcomes of interest. For example,
increases or decreases in insulin sensitivity occurred for individual agents in association with
other physiological changes, such as pregnancy or weight gain or loss. This was consistent with
the elicited knowledge from participants and the empirical evidence.
Viewing and discussing the model results also ensured that the model had fidelity i.e. that
it produced results that were consistent with retrospective data and considered plausible by
experts working in the field. These discussions emphasised that the model was not a “crystal
ball” that would discern the future with pinpoint accuracy but could be used to make robust
forecasts and enhance understanding about the relative value of alternative policy and planning choices. Full transparency about how the model scope was defined, and the limitations of
the underlying data, also ensured that the participants were informed about its strengths and
limitations, and thus more confident to make decisions about its application and value.
Storytelling was an important communication tool used in the model building process, and
in discussing model outputs. The “life stories” of agents in the model were used throughout
the participatory process to communicate the model structure and its capacity to demonstrate
health outcomes at an individual level. Agents in the model were born with a risk profile based
on both their mother’s history and her glycemic control during pregnancy. The agents aged
during the model run time (80 years), gained and/or lost weight, underwent lifestyle and medical interventions, and experienced their own pregnancies. The model captured information
(outputs) for individual agent health outcomes that both influenced feedback loops within the
model and could also be used to report statistics from the model. This functionality offered
great power to support telling rich and compelling stories that illustrated the textured evolution of agents over time. The presentations of individual trajectories were an effective communication tool to improve participant understanding of the model structure and logic. The
communication of agent stories as “case histories” facilitated the ability of participants to relate
the model logic and assumptions to their real-world experience providing services to women
with diabetes in pregnancy. The process prompted questions and comments and facilitated
participants’ engagement in analysing, refining and informing the model.
Storytelling for individual agents was also viewed by the expert participants as a valuable
tool to communicate model results to a broader, less technical, audience. During discussions
about the model outputs, participants identified that presentation of the knowledge gained
from the model development process, as well as the results it produced, would be a critical
determinant of knowledge mobilisation and communication with a broader audience. But
they also reported that despite the improved transparency of the new software interfaces, the
sophisticated and highly technical nature of the model would be a barrier to developing clear
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and easy to understand policy messages. Thus, supplementing model outputs with storytelling
about individual patient journeys was viewed as a powerful tool to ensure that the results
were relatable and easily understood. A plain language fact sheet was developed for the
model incorporating both real-world and individual agent stories and is available at: https://
preventioncentre.org.au/wp-content/uploads/2018/08/080818_Diabetes_FactSheet.pdf and
a podcast was also made to communicate the project to a broader audience, available here:
https://preventioncentre.org.au/resources/tackling-the-pandemic-of-diabetes-in-pregnancy/.

Feedback and iteration
An important overarching theme derived from these findings was that of continual feedback
and iteration, in which decisions about model logic and structure were regularly re-visited as
new information became available. This is also represented in the configuration of Fig 2 in
which the processes of model development fit together as non-linear phases. For example, as
noted above, the process of participants viewing and discussing individual agent stories, and
engaging with results from the model, elicited additional information and developed new
forms of shared knowledge. This additional information and knowledge were then considered
for incorporation into the representation of causal pathways and other model components.
This led to further refinement of the model, and identified the need for additional evidence to
inform that refinement. The highly iterative nature of the participatory process resulted in
both challenges and opportunities that are discussed below.

Overcoming the challenges that arise from the participatory process
1. Tensions between model complexity and model simplicity
Desire for complexity and detailed representation—The expert participants had highly
evolved and detailed knowledge about many aspects of diabetes in pregnancy; including
disease aetiology, the technicalities of treatment and testing regimens, and complex health
service delivery. It was common for the conversations to go deeply into complex details,
for example, about service pathways, issues with diagnostic testing methods, and participation rates for screening. However, while such topics are important for real-world
service delivery, they were often too detailed to be captured in the model. Thus, an important challenge for the participatory model development process was to distinguish which
aspects of DIP were important to represent in detail, and which aspects could be left out
or represented in a more stylised, or simplified, way. It was important to address the
opportunity cost of including details and for the participants to prioritise only those
aspects that were essential for more detailed inclusion. These discussions considered the
extent to which the details would be needed to adequately represent intervention mechanisms, and their outcomes, and the likely pathways of impact for the prioritised policy
and practice questions. A road map analogy was an effective communication tool to facilitate these discussions, i.e. like a road map, the model needed to include essential landmarks to make it fit-for-purpose and did not need to include every tree or driveway along
the route. When particular details were considered important by some individuals but
could not be prioritised in the agreed scope of the model, they were recorded as opportunities for future model expansion in subsequent projects.
Desire for speed and simplicity—a contrasting challenge was the tension between developing a sophisticated and highly articulated model that could reliably and plausibly evaluate the interventions of interest to participants and their co-existing desire for a simpler,
faster model both in terms of development and running time. In these circumstances, the
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onus was on the core modelling group to balance this tension between complexity and
simplicity and determine the “minimal viable model”. The minimum viable model is the
simplest solution that has the requisite robustness, completeness and reliability to rigorously address the participant needs. These negotiations and decisions relied on the extensive knowledge and experience of the lead modeller to ensure that the model developed
was robust and rigorous considering these pressures.
2. Ensuring the model design and structure are appropriate
Decisions about how to represent prioritised factors in the model were challenging. An
early version of the model incorporated a simplified, statistical representation of the interaction between risk factors. For example, an individual’s probability of developing diabetes in pregnancy was programmed as increasing according to a linear correlation with
their count of risk factors. However, this representation was not dynamic, did not allow
for other important elements, such as the length of exposure to dysglycemia, lacked the
ability to robustly capture the effects of counter-factual interventions, and limited the use
of the model to explore the combination and interaction of intervention options in the
development of DIP. Later versions of the model used endogenous or latent variables to
represent the causal physiological mechanisms, thus allowing exploration of complex
interactions between risk factors, and the exploration of counterfactuals.
The use of endogenous or latent variables created challenges in the interpretation of model
outputs. For example, it was challenging on occasions when the model outputs didn’t produce
familiar or expected results, e.g. when the emergent outcomes were counterintuitive. This was
managed by identifying model outputs that could readily be checked against historic trends
and empirical evidence, which reassured the participants when the model reliably replicated
existing data. Unexpected results from the model also provided an opportunity to explore
the logic and assumptions of the model and make improvements. For example, model results
showed DIP incidence plateauing in contrast to the increasing rates observed in administrative
data, and this led to an investigation of possible explanations. The investigation explored
whether the plateau effect was due to the length of the ‘burn-in’ period used in the model and
different burn-in lengths were tested to assess their impact. The impact of the representation
of weight dynamics was also examined, leading to further changes as detailed in Vignette 3
below. Participant discussions regarding unexpected results also helped to identify quality
issues and anomalies affecting the administrative data used to determine historic trends. For
example, variations in the implementation of changes to the blood glucose standard used for
diagnosing diabetes in pregnancy and changes to diagnostic testing assays impacted historic
incidence rates leading to rapid increases. These artefactual increases resulted from process
changes rather than changes to the underlying population rate of diabetes in pregnancy and it
was important to consider this when assessing the model results against trends in administrative data.
Vignette 3: Challenges in representing weight dynamics
High weight status is an important and modifiable risk factor for the development of diabetes
in pregnancy. Weight status was identified in the initial problem conceptualisation and
included in model versions from the inception. The representation of weight status evolved significantly through the participatory model development process. Initially weight status was
represented as BMI categories in a state chart specifically characterising an individual as present in one of healthy weight, overweight and obese states. Each agent was assigned an initial
state based on an age and ethnicity specific distribution and transitions between states
occurred according to hazard rates. As the model evolved and interventions were prioritised,
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defined and quantified, it became evident that a more detailed representation of weight status
would be required.
The representation needed to capture:
• Intervention effects that resulted in weight loss for an agent but were insufficient to move
that agent from one BMI category to another i.e. a weight loss of five kilograms may reduce
an agents BMI by one or two units but may not move them from an obese to an overweight
state.
• Dynamics in weight status across the life course
• Population changes in weight distributions over time
• Impact of weight status on physiology underlying the development of diabetes in pregnancy,
particularly on insulin resistance, and distinct effects during and outside of pregnancy.
The representation of weight status was evolved to capture agent weight as a continuous variable
that changed dynamically with age and pregnancy events based on published evidence. An
agent’s weight status (BMI) impacts on their insulin sensitivity with increasing weight leading
to decreasing insulin sensitivity.
3. Deciding when the model is ready
Dynamic simulation models can always be further refined and improved. Another important challenge arising from the participatory process was achieving consensus on when
the results were “good enough” to inform decision making. This decision was primarily
informed by the following considerations:
1. Reliability—How reliably the model results matched historic data trends across a range
of indicators, including diabetes in pregnancy incidence overall and for important subgroups; population weight status categories over time; and general demographics such as
age structure.
2. Completeness—How satisfied the core modelling team were that they had captured the
most salient aspects of the issue in enough detail to robustly explore policy questions.
3. Experimentation—did the model produce plausible results during scenario testing of
interventions, i.e. did the simulated intervention scenarios producing results that had
face validity among participants who had extensive professional expertise in diabetes in
pregnancy and sound knowledge of relevant research?
4. Timing—having the model results ready in time to be used in policy dialogues.
5. Acceptability—Was there sufficient acceptance of the fidelity and plausibility of results
produced by the model among the expert participants? Were significant concerns raised
and adequately addressed?
4. Being transparent about uncertainty
It was also important to be transparent with participants about model uncertainty, for
example, differentiating parameters based on quality, comprehensive evidence and
those where the evidence was less certain. Sensitivity analyses determined how influential the parameters were on the model results. This information was shared with participants and discussions focused on either identifying new studies that could be utilised or
confirming that the evidence gaps still existed and were therefore a priority for future
research.
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Opportunities arising from the participatory process
The participants in this case study were nationally and internationally acknowledged experts
and included health professionals who were embedded in local service provision and policy
decision making. The participatory model development process included drawing on the participants’ networks to socialise the model to other decision makers, who had not been involved
in the process. The participants also identified opportunities for the model to be presented and
applied as a decision support tool for policy and programs. Through their professional networks, the participant group facilitated new relationships and useful leads for additional expertise and evidence to improve the model. Participants continued their engagement with the
model after the formal activities of the process were finalised and advocated for the model to
be used in policy decision making.
In summary, the participatory process resulted in a robust, highly transparent model with
an agile, responsive design. The multiple modes of engagement and interaction with participants provided a built-in peer review-like process to ensure that the model was valid and fit for
purpose. The network of participants involved in the project also facilitated the identification
of new priorities and opportunities for research and further model development.

Discussion
The primary goal of participatory dynamic simulation modelling is to provide decision support and facilitation in planning and policy contexts. The initial exploration of diabetes in
pregnancy conducted at the commencement of the model development process resulted in a
qualitative conceptual map that was complex, not yet well-defined, and of limited value for
guiding policy. Through a deliberative participatory process that included synthesis and
exchange of data and information, and iterative cycles of negotiation and refinement, a quantified decision support tool was developed. To fully understand and evaluate the rationale and
logic of an participatory modelling process, both the interaction among the model building
group, and the relationship between the participatory process and the decision context needs
to be described [25]. The key elements of an interdisciplinary, participatory approach to
develop a dynamic simulation model for diabetes in pregnancy included: determining the
focus topic; defining the model scope; iteratively refining the model structure and logic;
reviewing and using evidence; ensuring that the model was focused on priority policy questions; communicating results; and applying the model to inform health policy decision. The
decisions required were highly interactive; with participants engaged via multiple forums e.g.
workshops, web meetings, emails, and small group meetings. Participants identified important
sources of evidence to inform model parameters and assumptions. The professional networks
available through the participant groups ensured that the model was focused on current, priority policy questions and initiated opportunities for it to be applied in practice. Storytelling was
an effective strategy for facilitating participant understanding of the structure and logic of this
complex model and to communicate model results to a wider policy audience.
A new framework for reporting participatory modelling projects has been proposed within
the environmental modelling field as a tool to facilitate sharing of knowledge about the participatory process and stimulate innovation [25]. The 4Ps framework has highlighted the need to
describe “how” participants are involved in model development: firstly, to contribute to the
interpretation of models developed using participatory methods; and secondly, to facilitate
learning about participatory modelling tools and strategies [1, 25]. The 4Ps framework identifies purpose, process, partnerships and products as key dimensions of participatory modelling
projects and practices: (1) the Purpose for selecting a PM approach (the why); (2) the Process
by which the participants were involved in model building (the how); (3) the Partnerships that
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formed around different parts of the process (the who); and (4) the Products resulting from
these efforts (the what) [25]. Our analysis from the DIP case study falls within the Process
component of the 4 Ps framework in that it explored how the participants were involved in
the model building process. Three questions are raised in this component: What were the
characteristics of the interaction between the participants and the model? What was the level
of participation? What was the relationship between the participatory modelling and decisionmaking processes? [25]. We consider these questions below in relation to the DIP case study
and other modelling literature.

Contribution of expertise to develop and refine the model
Participant interactions contributed significant expertise and local context knowledge to the
development and refinement of the model. Advances in modelling software are improving the
visual representation of model components, making them easier to use, and more transparent
to stakeholders not trained in modelling [6, 42]. This facilitates a participatory process by
which the significant combined knowledge of expert groups can be applied to model development [6]. By repeatedly exposing and explaining the underlying model components in workshops and meetings, the participants in this case study were able to understand, analyse and
refine the overall logic and structure of the model. They were able to identify areas where more
detail was required or where assumptions could be improved. However, their involvement in
decision making about the type of modelling methods used was limited e.g. which factors to
represent using system dynamics vs agent-based modelling components. As health stakeholders become more experienced with dynamic simulation modelling, the potential will increase
for them to contribute to technical decision-making regarding modelling methods. The experience and knowledge developed by participants’ in this case study may enable them to even
more confidently and effectively contribute to future modelling projects.
Incorporating participatory processes in simulation modelling also facilitates learning by
building shared a understanding of the problem and potential solutions, and which is refined
with data and evidence through group interactions [36, 41, 74]. Through the exchange of
information, knowledge is shared, and new knowledge is created, leading to changes in understanding [25, 36]. The interdisciplinary dialogue facilitates the sharing of different types of
knowledge on critical issues from a range of perspectives [36, 44, 52].
The model developed in this case study utilised and integrated diverse evidence sources to
quantitatively operationalise a theory of the causal mechanisms of intergenerational, social,
cultural, economic and environmental factors that influenced behaviour and development of
diabetes in pregnancy based on the qualitative map developed interactively with participants.
Model assumptions and parameter values were derived through a process of evaluating and
critiquing the many sources of evidence, including those considered both at the top e.g. systematic reviews and meta-analyses, and the bottom, e.g. case reports, of traditional evidence
hierarchies [52, 75]. Integration and triangulation of evidence from systematic reviews, local
analytic studies, conceptual models, and expert and local knowledge was required to map and
quantify a broad range of complex public health issues [19, 52]. The model simulations allowed
robust examination of the logical and quantified consequences of the postulated dynamic
causal hypotheses and to test the impact of policy and planning decisions and counterfactuals
using experimentation.

Participants were highly engaged in the co-production process
Stakeholder input and acceptance are important factors in increasing the usefulness and application of models [25, 36, 42]. The degree of success of a participatory process can be discerned
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from stakeholders’ trust in modelers’ expertise and the amount and quality of information
they give, as well as whether they intend to use the model and will participate in future collaborations [36]. Most participants in the case study reported here remained highly engaged
throughout the project. They continued to contribute to discussions, attended meetings and
were responsive to email communications. The level of interest in the model and associated
communication products was high. Participants contributed advice on how to ensure the
model could be applied to high priority policy questions and identified opportunities to facilitate its use in this context.
Models cannot comprehensively reflect the real world as details need to be omitted and
boundaries defined around what is to be modelled [42, 71]. Highly-detailed models often
require more data than is available; take longer to develop; can be difficult to calibrate and
validate; and most importantly, they can be hard to understand [1, 42]. Both stakeholders and
modellers can struggle with determining the level of detail to include and get drawn into trying
to model reality instead of the decision essentials [42]. This challenge was evident throughout
this case study. The model scope and level of abstraction was frequently re-visited and needed
careful negotiation throughout the participatory process.

Participatory modelling facilitated the use of the model for decision
making
Finding effective strategies to communicate about both the model and the model results were
an important challenge in this project. Modelling to inform policy relies on clearly explaining
results, and their limitations, building confidence in the modelling process and outputs, and
ensuring that the outputs are appropriately used [42, 57]. Active collaboration builds confidence in the model and enlists local champions for its application [42, 57]. The participatory
process facilitated the identification of opportunities for making the model accessible to policy
audiences, and strategies to address likely communication challenges. Opportunities to use the
model to identify the policy options that were likely to have the greatest impact in local service
planning were proposed. Participants were also interested in using the model to test whether
highly advocated, but contested, interventions would be effective and or scalable to the population level.
Additional opportunities and potential applications of the model beyond the primary purpose of policy analysis were identified through the participatory interactions. For example,
participants proposed that the model could be used to inform health education messaging by
primary practitioners, such as demonstrating the risk of developing diabetes based on weight
status, and the positive impact of engaging in lifestyle modification. This messaging was
viewed as potentially leveraging women’s motivations to protect the health of their baby to
encourage them to reduce their own risk profile pre-pregnancy and maintain good glucose
control during pregnancy.

Conclusion
The model developed in this case study moved beyond qualitative system mapping to a sophisticated, rigorously quantified, multi-method dynamic simulation model which represents the
complex interrelationships underlying the development of diabetes in pregnancy. The challenges of the participatory process were outweighed by the benefits. The process allowed for
the contribution of participants’ extensive and rich understanding of the issues, which was
combined with the expertise of the modelling team to inform, analyse and refine the model
logic and structure. The core analytical objectives and decision-making themes reported in
this paper provide valuable insights for understanding and elucidating the process components
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of the 4Ps framework. Our analysis makes explicit the deep analytical work that occurs within
the workshops, interactions and meetings of the participatory process. Like the workings
underlying a clock face, the underpinning analytic processes are fundamental to participatory
model development, but not readily observed without ‘lifting the lid’ through systematic data
collection and analysis. In detailing the core analytical objectives and negotiations underpinning the participatory process, our findings provide unique insights for the planning and
reporting of future participatory modelling projects.
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Chapter 6: Results part 3: Decision makers’ experience of
participatory dynamic simulation modelling methods for public
health policy

The published manuscript presented in this chapter reports on the experiences of end-user
decision makers who engaged in the participatory DSM processes and their perceptions of
the feasibility and value of this approach.
The paper focuses on the experience of participating in the interactive model building
activities, the perceived benefits and challenges of the approach and how the DSMs were
being used to inform policy and program decisions from the perspective of these decision
makers. Participants from the DIP case study were interviewed before and after the
participatory modelling process, and the participants from the two additional case studies
were interviewed after their participatory process to gain their perspectives on the efficacy
and value of the approach to inform decision making.

Paper 4:
Freebairn L, Atkinson J, Kelly P M, McDonnell G, and Rychetnik L. Decision makers’
experience of participatory dynamic simulation modelling methods for public health policy.
BMC Health Informatics and Decision Making 2018; 18(1):131. doi: 10.1186/s12911-0180707-6

The interview schedule was published as supplementary material for this manuscript and is
included in Appendix 8 of this thesis.
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Background
Evidence informed decisions are essential to ensure that
health policies provide cost effective and high-quality
programs and services. However, barriers to the use of
evidence to inform decision making remain [1]. Policy
and program decision making processes are frequently
non-linear and iterative. They are influenced by a range
of factors, that compete with research evidence, such as
the political environment, budget and resource constraints, and public perceptions of the value of policy options being considered, [1–6]. Evidence provided to
policy makers needs to be in a form that is useful and
relevant in this context [4, 7, 8]. Policy makers require
synthesised and contextualised evidence that establishes
the need for a policy response, compares and prioritises
policy options, and demonstrates cost-effectiveness of
interventions [4, 9].
Research evidence for the prevention of chronic disease often points to a large range of contributing risk
factors, including broader social determinants of health
[10, 11]. Without tools to make sense of this complex
array of evidence it is difficult to understand the dynamic interactions of risk factors and interventions [12],
potentially leading to the adoption of approaches that
may seem intuitive but fail to deliver reductions in disease burden at the population level or lead to unintended consequences [12, 13].
Systems science methods are well suited to public
health and disease prevention questions because the approach takes into account the complexity, context, dynamic nature, and system-wide behaviour associated
with public health issues [14]. Dynamic simulation
models recreate complex systems and human behaviours
as computer simulations. They can be used to synthesise
evidence, answer hypothetical questions about the potential outcomes of policy and intervention options, and
inform decision making [13, 15].
Incorporating a participatory process into the development of dynamic simulation models can facilitate the exploration of how multiple environmental factors,
individual risk profiles and interventions interact [16,
17]. It can be used to enhance knowledge about the
focus issue from the perspective of different disciplines,
explore conflicting views, test potential solutions to
complex issues and even to develop a shared language
about the issue which can support ongoing communication [18–21]. The participatory model development
process involves an in-depth, interdisciplinary deliberation and co-production process to initially map the
causal pathways for the focus issue, and the mechanisms
by which interventions have an effect on outcomes [19].
A range of evidence is synthesised, including empirical
evidence, expert and practice based knowledge, and theory, to develop, quantify and test a simulation model of
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the issue [13, 18, 19, 22, 23]. The resulting dynamic
simulation model can be used as a decision support tool
to explore complex problems such as the prevention of
chronic disease and simulate proposed policy and practice scenarios [13, 23].
Advances in technology have led to increased adoption
of tools and methods aimed at integrating diverse evidence sources to inform decision making [13, 17]. However, rigorous assessment of the value and utility of
these methods and tools is required if their adoption to
support evidence informed policy and planning in the
health sector is to be achieved. The uptake of dynamic
simulation modelling in health has lagged behind other
sectors, such as the environmental sciences and business
industry [24], and it has been argued that this has, at
least in part, been due to limited engagement with stakeholders and involvement of end-users in health-related
simulation model development [13, 21, 24, 25]. This has
also impacted on the implementation of model findings
[24, 26] and led to a reluctance among “non-researchers”
to use models as decision support tools [21, 24]. Where
policy makers have been included in the simulation
modelling process there has been limited examination of
their experience; e.g. perspectives on the utility of the
model, learning relating to the development and use of
the model, or commitment to implement the model
findings [13, 27, 28].
This paper reports on the experience of end-user decision makers, including senior policy makers and health
service providers, who participated in three participatory
simulation modelling case studies in Australian health
policy settings. We report on their perceptions of the
value and efficacy of this method as a tool for evidence
synthesis and decision support in applied health sector
policy and service planning contexts.

Methods
Context

The Australian Prevention Partnership Centre (http://
preventioncentre.org.au/), in collaboration with jurisdictional governments have pioneered the co-production of
sophisticated, multiscale dynamic simulation models to
support health policy and practice decisions [29–33]. In
developing these models, researchers partnered with
health departments, clinicians and regional planners in
collaboration with a multidisciplinary group of stakeholders using a participatory process [32, 33]. This research is based on three of these case studies described
briefly below (Table 1). The case studies and participatory processes are described more fully elsewhere [34].
Procedure

The evaluation of the participatory modelling process was
informed by the Challenge and Reconstruct Learning
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Table 1 Description of dynamic simulation modelling case studies and context
Topic area

Type of model

Model
development
period

Context

Application to decision making

Reduction of
alcohol-related
harms (Alcohol)

Agent based model

2015–2016

Alcohol misuse is an important public health issue
for which there are complex causal mechanisms
and contested intervention options. This model
was developed to inform jurisdictional government
strategies for reducing alcohol-related harms.

The model represents the heterogeneity of alcohol
use across the population, how the dynamics of
drinking behaviours vary across the life course, the
harms, both short and long term, that arise from
alcohol use, and the differential effects of
interventions across subgroups in the population.

Reduction of
childhood
overweight and
obesity (Obesity)

System dynamics model

2016

In 2015, an Australian State Premier set an
ambitious target to reduce childhood overweight
and obesity in children by 5 % over 10 years. It was
predicted that additional strategies, or
combinations of strategies, would be required to
achieve the Premier’s target. Decision makers were
presented with the challenge of determining
where best to focus resources and efforts.

The model explores the complex issue of child
overweight and obesity, incorporates existing
programs and tests the likely impacts of a range of
policies and programs. It forecasts the combination
of interventions required to achieve the Premier’s
target.

Prevention and
management of
Diabetes in
Pregnancy (DIP)

Hybrid model (system
dynamics, agent based
modelling and discrete
event simulation)

2016–2017

. Diabetes in pregnancy is increasing in Australia
and internationally and exploration of new
strategies to prevent and manage the condition is
needed. The model considers the short, and longterm implications of the increasing prevalence of
both DIP and associated risk factors.

The model focuses on the development of
Diabetes in Pregnancy (DIP) from the perspective
of the individual. Prevention interventions were
prioritised in the model as delays in the
development of diabetes will potentially result in
reduction in the longer-term burden of disease
and costs to the health system. However, the
model can also explore clinical interventions.
Health service utilisation has been captured in the
model enabling it to explore the resource impact
of model of care scenarios.

(CHARL) Framework proposed by Smajgl and Ward [35].
The CHaRL framework involves assessing formalised and
facilitated learning among decision makers and decision
influencers at varied policy levels in deliberative processes.
The key component of the CHaRL framework is the
change in perception or belief about assumed causality
within the system. The change in perceptions or beliefs
can be measured using individual value and attitude/belief
orientations recorded by participants before and after the
modelling process [35].
The three modelling case studies were chosen to allow
for data to be collected at all stages of the participatory
process. The model development process had been finalised in two of the case studies, and data were also collected on the use of models to inform decision making.
Data collections are described below.
For data triangulation, key informant interviews and
participant observation during workshops (field notes
kept by lead author LF) were used to collect information
across the three case studies as outlined below.

Participants and sampling

Purposive sampling was used for each case study to recruit participants with a range of expertise, including
providing or planning health services, undertaking research or developing policy for the issue in focus.
Pre-process interviews in the DIP case study occurred
with six participants that included senior clinical and
public health policy decision makers.
Sampling for the post workshop interviews (n = 7) ensured representation across the three case studies to include perspectives from case studies with models at
different stages of development and project roles, (e.g.
facilitator or participant), or policy making roles, (e.g.
clinical, policy, or public health executive). Some interviewees had participated in more than one case study.
Focus for selection in the post-process interviews was
on the setting where policy change decisions would
occur i.e. interviews were with participants who were
employed within government agencies with jurisdiction
over the relevant policy decisions. Recruitment of interviewees continued until saturation was reached for the
main themes and categories.

1. Pre-workshop interviews (Diabetes in Pregnancy
project n = 5)
2. Post workshop interviews (all case studies n = 7)
3. Workshop observations (all case studies, total
workshops n = 9)

Data collection

Participant experiences and perspectives across all three
case studies were collected in semi-structured interviews
with key informants focusing on their personal response to
the participatory modelling process and perceptions of the:

Qualitative analysis was conducted for the transcripts
from the semi-structured interviews, and the observation
field notes. The data collection and analysis methods are
described in detail below.

○ value of simulation modelling as policy decision
support tool
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○ strengths and limitations of the method and
intention to use simulation modelling in the future
○ perceived enablers and barriers to the use of
simulation modelling
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importance of evidence-informed decision making however, they identified challenges relating to the availability,
applicability, persuasiveness, timeliness and accessibility
of evidence to inform decision making.
Lack of evidence was described as the “biggest challenge” in circumstances where no policy relevant evidence existed, or the available evidence was not
sufficiently robust to inform health policy or service decisions. In situations where rigorous studies like randomised controlled trials were not likely to be conducted
due to ethical, practical, or funding constraints, there
was a clear view that an ongoing lack of evidence was
unlikely to be resolved using traditional methods of research. Further, when evidence was available, it was not
necessarily applicable to local health service or population context, making it difficult to use for local policy
decisions.
Evidence was reported to be only one of many competing factors involved in decision making and respondents described other factors as more powerful decision
influencers. Evidence needed to be convincing to compete with these other influences, including the input of
advocacy groups, incentives and restrictions built into
funding models and internal (organisational) and external (political and community) competition for resources.
It was also reported that the use of evidence in policy
decision making continued to be limited by poor accessibility. Thus, research needed to be communicated in
more accessible ways to policy makers who vary in their
level of expertise in interpreting and applying research
findings. Policy makers and program planners often
prioritised government reports and statistics, and
non-government organisation reports to inform decisions as they used more accessible language and were
free to access. Some policy makers were unable to access
journal articles behind a “pay wall”. It was widely reported that there was little time in policy settings to explore evidence in detail or to conduct research. In this
context, respondents consistently identified that there
was significant room for improvement in the way evidence was translated and used to inform policy and
practice decisions. As a result, respondents were

Interviews were conducted face to face where possible
(n = 5), however telephone and web conferencing interviews (n = 8) were also used to allow interviews with participants in distant locations. Interviews across formats
were of comparable length (ranging from 30 to 60 min)
and depth of exploration of the issues discussed. Interviews were conducted by the lead author and a research
officer (EO - two pre-workshop interviews, see acknowledgements). Indicative questions for pre- and post- interviews are presented in Additional file 1. Field notes were
based on observations of the participatory workshops and
debriefing discussions between the authors and research
officers (EO, NR and CW, see acknowledgements).
Data coding and analysis

Interviews were audio recorded and transcribed using a
professional transcription company, checked for quality
and de-identified. The transcriptions were coded and
analysed by LF. The analysis was guided by grounded
theory principles [36, 37]. An iterative process of descriptive coding and analytical memos was used to develop themes and conceptual categories, explore their
inter-relationships, and to triangulate insights from the
interview and field note data. The progressive analysis
was iteratively reviewed by JA and LR and further revised as new data was incorporated. Analytic memos
written by LF were also shared with JA and LR to facilitate the analysis review process.

Results
Table 2 provides an indication of the data analysed for
each results section.
Pre-modelling perceptions of evidence use in decision
making

Prior to the commencement of the participatory modelling process, respondents consistently emphasised the
Table 2 Overview of data analysed for each results section
Results section

Analysis based on:
Pre-modelling interviews

Post-modelling interviews

DIP

DIP

Alcohol

Childhood Obesity

Experiences of participatory modelling

X

X

X

Learning through participation

X

X

X

X

X

Pre-modelling perceptions of evidence use in decision making

X

Experience of using dynamic simulation modelling to inform decision making

DIP - Dynamic simulation modelling to inform the prevention and management of diabetes in pregnancy
Alcohol - Dynamic simulation modelling to inform reductions of alcohol related harms
Childhood Obesity - Dynamic simulation modelling to inform how best to reach the Premiers target for reducing childhood overweight and obesity
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the decision to participate. Most interviewees embarked
on the project with little or no experience of dynamic
simulation modelling, however they had trust in the
modelling team or domain expert who initially
approached them, and this facilitated their decision to
participate.

motivated to explore new methods, such as participatory
dynamic simulation modelling, to see how they could
improve and increase the use of evidence in their applied
settings.
Experiences of the participatory simulation modelling
process

“It's having known [facilitator] for a long time through
the [work area], and our work with the [topic X].
[Facilitator] knowing that part of my research was
based about [topic X] disease, and various other
things I've been looking at.” (Senior clinician)

As identified in Table 2, this section is based on
post-modelling interviews across the Diabetes in Pregnancy, Alcohol and Childhood overweight and obesity
case studies.
Motivations for participating

An interest in learning new methods to facilitate evidence informed decisions in public health was commonly identified as a reason to participate in the case
studies.

Due to the significant time investment involved in participatory dynamic simulation model development, the
opportunity costs and likely outcomes from the modelling projects were significant factors in policy makers’
decision to participate in the process. Targeted and tailored engagement, facilitated by a trusted domain expert,
with key participants in the planning phase of the project was important to justify the benefits of participating
and ensure that from the policy makers’ perspective, the
topic was high priority, of professional interest, complex
and had contested options for intervening. Across the
modelling case studies, many interviewees reported that
they explicitly considered the opportunity cost of participating in the dynamic simulation modelling project before deciding to become involved. They went through a
process of weighing up whether the likely outcomes
from the modelling projects would be worthwhile given
the significant time commitment required.
Commonly reported reasons for agreeing to participate
included: the person’s professional involvement and expertise in the topic being modelled, the trusted relationship with either the modelling team or the lead domain
expert involved in the project, curiosity about dynamic
simulation modelling and participatory methods, and aspirations to improve the use of evidence in decision
making. These are explored further below. A few participants were directed to participate by their organisation.
The choice of focus topic to be modelled was a key
criterion for agreeing to join the participatory dynamic
simulation modelling project. The topic needed to be an
important local priority of current professional and or
organisational concern with complex causal risk factors
and need for policy or programme response. In order to
justify the commitment to participate the topic needed
to be complex with different perspectives of which
causal factors and exposures were important, different
intervention options to decide between, contested views
about what works and what doesn’t, and where the combined impact of interventions was unknown.
Trust in and familiarity with the project team were
commonly identified as important factors influencing

“I was interested in processes for better being able to
inform and educate the policy making process”
(Public health executive)
“it’s an incredibly useful policy tool if it's done
appropriately with the right people asking the right
questions. It's a very powerful tool.” (Public health
executive)
Goals for participating in the case studies included
learning about the process of developing a simulation
model and how it can be used to inform decision making. The participatory approach was highly valued by
most interviewees as it provided an opportunity to combine their expertise with the expertise of the modelling
team to produce an innovative decision support tool.
Engaging in the participatory activities

Workshop participants engaged in a range of large and
small group activities to collaboratively develop a conceptual map of the problem, prioritise and map the impact of interventions to model architecture and identify
data and evidence to incorporate into (or parameterise)
the models. These activities have been described in detail
elsewhere [34].
Collaboration and co-production

Collaboration and co-production were identified by participants in these case studies as the unique and highly
valued aspect of the participatory dynamic simulation
model development. The participatory approach facilitated the contribution and synthesis of a significant
knowledge base and was critical to eliciting and negotiating priority causal factors, exposures and interventions
to be represented in the model. The process of contributing expertise and then explicitly seeing how it was
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in some circumstances e.g. when the discussion is focused on highly specialised biological causal mechanisms
of disease development and progression.
Some respondents reported that they initially perceived the workshop activities to support active participation as less rigorous or evidence-based than they had
expected. For example, that some participants were relying on their opinion rather than evidence, were advocating for causes or had a priori preferences for particular
actions and thus a potentially biased view of the evidence. A couple of participants noted that they observed
differential engagement by other participants with the
activities and “people not taking it as seriously as perhaps they should have”. However, most of these respondents also noted that as the model development process
progressed they were reassured by the use of good data
and evidence to inform the model and to test hypotheses
that came from expert opinion.

used in the model were important factors in facilitating
engagement and a sense of ownership in the model.
“The session with lots of string and sticky notes and
things on the board, it looked a mess and going away
thinking, “How are they going to use all that?” But I
actually was surprised, pleasantly surprised, at how
that was actually used to inform the development of
the model, and it really was.” (Senior clinician)
The contribution of considerable knowledge and diverse expertise of participants was consistently identified
as important. Many respondents commented that they
were surprised at the willingness of participants to contribute their experience, ideas and knowledge to educate
the modelling team about the issue and guide the model
development.
“I think the participatory approach, you're having
people in the room that have accumulated knowledge,
expertise in the area over quite a number of years,
actually brings a lot of knowledge into that room, and
it's not possible for one or three or five people to do
the literature searches and understand all the
information” (Senior clinician)

“I was a bit sceptical of that process, and in terms of
input given that it's meant to be evidence-based inputs through that conceptual mapping of the bits of
paper and string, and plaster, ... I expected it to be
more rigorous, but I learned by doing it, that really it
was more about informing the modelling team in
terms of logic, structure and models, and then they
went away and found the evidence, if you like, to support the link of this, and of course all pathways, and
the association pathways.” (Public health executive)

Respondents also noted that people “put their egos
aside” during the workshops as the interdisciplinary and
co-production approach meant that participants were
learning from each other. The content expert participants learned about dynamic simulation modelling and
the modellers learned about the priority public health
issue being modelled.
While being time consuming and personally challenging for some respondents to engage in; the interactive
activities and group discussions were viewed as critical
to eliciting and negotiating priority causal factors, exposures and interventions to be represented in the model.
Many respondents noted that the same outcome could
not be achieved through one on one discussions as the
inclusion of a diverse range of participant perspectives
was important to guide the model development.

Contributing expertise and then explicitly seeing how
it was used in the model were important workshop activities. The process of unfurling the model by describing
the logic and architecture and relating it to discussions
at previous workshops was highly regarded by participants. The model was viewed as “the fruits of their
labour” and a sense of innovation and excitement was
expressed by many respondents.
Two key roles were identified as facilitating engagement in these case studies. The first was having a
trusted domain expert for each project who was a
well-respected authority on the focus issue and played
a lead role in the project planning and workshop facilitation. The domain expert facilitated the approaches to key stakeholders, increasing the likelihood
of their agreement to participate, and was a known
colleague to promote engagement in the participatory
process. The second “translator” role was identified
by respondents who were more closely involved in facilitating workshops and working with participants.
This role involved both explaining the policy context,
e.g. current policy priorities and interventions, and
contextualising the data, e.g. explaining data collection methods, representativeness and limitations, for

“By having everybody in the same room, you got to
really be able to relate to everybody's little piece of the
puzzle. I think if you had just done that with
individuals, you wouldn't have got the model that
you've developed.” (Senior clinician)
The lack of consumer involvement in the modelling
case studies described in this paper was identified as a
gap in representation. However, respondents also noted
that finding consumer representatives and strategies to
realise the benefits of consumer input can be challenging
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outcomes and how they can be used to facilitate policy
conversations are discussed in more detail below.

the modelling team and conversely translating the
model requirements and development process to the
workshop participants.
Having an embedded policy officer, who along with
the lead domain expert, played the role of translator
working within the modelling team ensured that the
model was policy relevant, well understood and used. A
key aspect of this was being able to run model scenarios
independently of the modelling team to provide timely
responses to policy questions (e.g. switching interventions on and off and/or modifying parameters such as
reach and effectiveness and producing results).

“That's I think what the benefit of the model will be,
is that it can show to people if you change one thing
here, what's it going to change for everything else.”
(Senior clinician).

How dynamic simulation models facilitate the use of
evidence to inform decision making

The following analysis is primarily based on responses
regarding the two simulation models that were finalised
at the time of writing (Alcohol and Childhood obesity).
The exception to this is the discussion regarding the
identification of evidence gaps which includes responses
from all case studies.

Participant learning through group model building

Respondents reported that the participatory process
worked well in facilitating interactions and contributing
expertise. The process also provided an opportunity for
the expert participants to be exposed to multiple perspectives and frameworks for viewing the problem but was not
identified as resulting in individual learning about the
focus issue. A commonly cited reason for this was the selection of participants who were experts in the focus issue,
many of whom had dedicated their career to working on
it. They came to the process with a good understanding of
the different perspectives and complex causal relationships e.g. costs, drivers, and evidence-based strategies.

Participatory approach and trust in the model as a decision
support tool

The participatory approach used in the model development engaged respondents actively in the process and
increased their familiarity and trust in the model outputs. Respondents reported an increased sense of ownership and interest with these models compared with
other modelling projects that had not used a participatory approach.

“I think it gave people a broad picture and they
recognised where everybody's different areas fit. But
whether it actually changed how they link things
together, I don't know.” (Senior clinician)

“…there were times where I'm thinking, “Really? We
know all this stuff, and do we have to spend all this
time?” But you realise that that's the nature of it, that
if we didn't go through those processes there wouldn't
be the same trustworthiness, or people wouldn't trust
it as much, they'd be questioning it.” (Public health
executive)

However, all respondents reported that they learned
about the potential of dynamic simulation modelling to
support decision making and the process of developing
simulation models through the participatory process.
“What we learned is the potential value of developing
a simulation model. Talking to the others, everyone
was quite impressed by where it's got to, so the
exchange and knowledge between the different
discipline areas, I guess, was the most positive. ... I
don't think you've changed our views very much on
[topic X]. ” (Senior clinician)

Respondents valued that the model was transparent
about “what’s under the hood”. They noted that they
understood the logic of the model and the evidence used
to inform it and this increased their trust and willingness
to use the model to facilitate policy and program planning conversations.
Model outputs were described as involving a bit of
“science and magic” or “computer magic” that was engaging and useful, however concern was expressed that
model outputs could be interpreted by people not involved in the participatory process as reality rather than
as a decision support tool to compare alternative strategies. Respondents emphasised their awareness of the
limitations of the models, the need to ensure that model
outputs were interpreted appropriately and for end-users
to be aware of the assumptions and limitations of the
evidence used in the models.

Interviewees identified that the participatory modelling
process and model outputs allowed participants to develop insights into the interrelationships between causal
factors and emergent behaviour of the system i.e. “If you
change your practice how does that impact on other
parts of the system”; explore the combined impact and
interaction between interventions; and explore new and
untested interventions in the model prior to them being
implemented in the real world. These important learning
154

Freebairn et al. BMC Medical Informatics and Decision Making

(2018) 18:131

Page 8 of 14

derived from dynamic simulation modelling. This dynamic interaction facilitated policy discussions for local
health program planning and engagement with other
agencies. The model outputs were used to explore which
interventions with which target groups would yield bigger benefits in the long term.
Many respondents noted that the interaction with and
communication of model insights were areas requiring
further development. The development of communication tools, such as interactive user interface tools and
presentations that could be easily adapted to different
audiences, were viewed as critical to facilitate the use of
the models in policy and program discussions to inform
decision making.
Due to delays in model development, the intended
presentation of one of the models to a broader range of
stakeholders was unable to occur within the anticipated
project timeline. A small number of respondents identified this as an important missed opportunity from a
co-production and participatory research perspective
that undermined the application of the model findings
to policy decisions.

Many respondents discussed the importance of ensuring that the participant group included representatives
for the policy and intervention options being considered
in the models. For example, if regulatory interventions
were being considered then stakeholders who have regulatory oversight for the issue should be included in the
participatory process to increase trust and reduce the
risk of resistance from these stakeholders to using the
model to support decision making.
Using the model to synthesise and facilitate use of evidence
in policy conversations

The models were valued as communication tools. They
were viewed as giving credibility to the argument for
prevention interventions. The ability to manipulate policy levers to switch interventions on and off or to modify
the reach and effectiveness of interventions and then observe the impact on outcomes of interest were frequently identified as providing an important evidence
base to support policy and planning conversations. For
example, model outputs were used to demonstrate the
impact of current programs and reinforce with local service providers the importance of maximising reach and
effectiveness of their current programs and to inform
planning decisions by forecasting the impact of local interventions if scaled up to the population level.

Model maturing process

The dynamic simulation models were commonly viewed
as tools that would mature over time. The maturing
process was described in terms of continuously refining
the inputs, assumptions and parameters used in the
model as new knowledge and evidence became available;
building on the model when new policy questions arose
and maturing the methods used to communicate model
outputs such as user interfaces and presentation of results. The allocation of sufficient time to familiarise participants with the use of the model, train “super users”
and socialise the models with broader stakeholder
groups were identified as important elements to support
the communication of model outputs and increase their
use in decision making.
Identifying and prioritising gaps in the existing evidence base was an important component of the model
maturation process. The interactive discussions regarding the causal factors and impact of interventions for
each focus topic facilitated the identification, clarification and prioritisation of gaps in current knowledge and
evidence and could be used to guide future research.

“Well, it's a neat graphical tool that assists the
presentation of data on effectiveness of programmes.
It's quite neat the way you can say, “Well, if we do
programme X, this is the result we're going to achieve
on this variable” It’s nice to be able to present a
dynamic model like that. In that sense, people engage
with it.” (Public health executive)
Dynamic simulation modelling was viewed by most respondents as offering unique benefits, including the ability
to investigate the impact of intervention combinations and
interactions on outcomes, forecasting delays in intervention
effects and therefore informing expectations for performance monitoring of program implementation and providing
a tool to test the potential impact of new ‘bold’ innovative
interventions before they were rolled out in the real world.
“I think it's the learning, and the benefits of the
modelling, and the things it can do that we can't do
from normal longitudinal studies or trials, qualitative
work, it is impossible to do what the model does, but
that's the point of benefit.”(Public health executive)

Discussion
The aim of this research was to explore the experience
of end-user decision makers who participated in participatory simulation modelling projects and the perceived
value and efficacy of this method as an evidence synthesis and decision support method in an applied health
sector context from their perspective. Overall, the participatory approach used to develop the dynamic

The ability to dynamically interact with the model to
develop insights into which programs needed to be enhanced, which gaps needed to be filled and which target
groups to focus on were identified as important benefits
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in dynamic simulation modelling as a new method for
evidence synthesis and exploring “what if” scenarios for
policy analysis, particularly with a familiar and trusted
team.

simulation models was valued by these participants, including both senior clinical experts and public health executives, and was an essential process for building trust
in the model as a decision support tool. The collaborative, co-production principles used to develop the simulation models facilitated participant understanding of the
logic and evidence used in the models and increased
their sense of ownership and willingness to use the
models for decision making. The models were broadly
viewed as useful and convincing communication tools to
facilitate policy discussions. The unique benefits of the
models included the ability to explore the interaction of
risk factors and causal mechanisms; the interaction and
combination of public health interventions; the impact
of scaling up the reach and effectiveness of existing programs and the impact of new and untested interventions
in simulation before they were implemented in the real
world. The participatory process was time consuming,
changeable and resource intensive. Therefore, complex issues with contested options for intervening were more
likely to be viewed as worthwhile for the significant time
investment required for participatory model development.

Collaboration and co-production were key elements
valued in the participatory approach

Relationships and collaborations are frequently identified
as critical factors in systems approaches [41, 42]. Participatory dynamic modelling provides a structured process
to facilitate inter-disciplinary dialogues and co-production
methods involving a range of participants, including
end-user decision makers. Participatory modelling approaches aim to combine diverse perspectives to tackle
the social complexity of problems and recognise that different types of knowledge contribute alternative and valuable perspectives to the problem discourse [18, 21, 23, 43].
Participants in the case studies reported in this paper
viewed the participatory process as a valuable
co-production approach to understand the focus issue
from a system perspective, for example, enabling the consideration of how decisions made in one part of the health
service, or indeed by other government departments,
could impact on programs and services in another. The
ability to combine the significant knowledge from multiple
experts to guide the model development as a decision support tool was viewed as a unique benefit of the participatory process.
Participatory model development and validation has
been shown to increase confidence that the model results
were both valid and useful for the participants’ local context [19, 27, 44, 45]. Decision maker involvement in model
development resulted in them being more likely to draw
on the model’s outputs to inform decisions about priority
interventions and policies [27, 43, 46]. The involvement of
key stakeholders and decision makers in these case studies
was identified as critical to developing trust in the use of
the model to support decision making. Participants also
noted the importance of ensuring that representatives of
important stakeholder groups, such as consumers and
relevant policy agencies, were included in model development process.
The domain expert and translator roles were identified
in these case studies as important to facilitate engagement in the participatory process and use of the model
to inform decision making. Similar roles have been identified in community based environmental modelling
contexts [16, 45] as playing an important role liaising between the modelling team and stakeholders. The key elements for the translator role include being a member of
the stakeholder community who can both identify with
the needs and articulate them within a group model
building session and has credibility in translating and
conveying insights from the modelling process [16]. In

Motivations for participating

Participating in research activities, including participatory modelling, requires significant time investment for
stakeholders and it is important to consider the factors
that motivate their participation when planning research
[38]. Studies focusing on stakeholder inclusion in health
research, have often been from the perspective of the researchers. Factors such as the difficulty of finding stakeholders with the right skills and knowledge who are
interested and available to participate or the difficulty of
dedicating time to stakeholder engagement in a context
where it isn’t measured and may not be valued [39, 40],
have been the focus rather than the perspective of the
stakeholders and their motivations for becoming involved. The case studies reported here provide insight
into the motivations from the stakeholder perspective.
Targeted recruitment of stakeholders with a professional
involvement and expertise in the topic being modelled,
facilitated by a trusted relationship with either the modelling team or a lead domain expert involved in the project were found in these case studies to be important
and successful strategies to motivate policy makers to invest their time.
Motivations for community groups to engage in participatory modelling have been found to be highest when
the problem needs to be solved with some urgency and
existing approaches have already been tried and failed or
known to be unsuitable for the problem at hand [16]. In
the complex and contested context of the priority focus
issues for the case studies reported here, policy makers
and health service providers were motivated to engage
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the health setting case studies reported here, it was important that the “translator” was embedded within the
stakeholder organisation and facilitated the acceptance
and use of the model to support policy discussions.
Thompson et al. (2010) described the beneficial relationship between the translator and the modellers as the
translators driving the modellers to integrate the participants’ requests and insights into the model, and the
modellers driving the translators to introduce complex
science and dynamic interrelationships to the stakeholders [45].

modelling that people learn how to model better, and
with better modelling comes better insights to improving
the system [16]. To increase the sophistication and effectiveness of participatory modelling facilitation
methods, better understanding about how different
stakeholder groups evolve the knowledge and skills to
work with decision support tools like simulation models
to plan policy and programs will be an important area of
future research.

Participant learning

Stakeholders are more likely to trust a model if they
have been involved in informing and grounding the understanding captured in the model, they understand it
and they feel ownership [18, 48, 49]. The participatory
approach used in these case studies engaged policy decision makers actively in the model development process
which fostered their interest and trust in the model outputs. Making the model understandable and accessible
to stakeholders has been identified as an important
principle of participatory modelling [49] and was a key
benefit commonly identified across these case studies.
Participants understood the logic of the model and the
evidence used to inform it and this transparency increased their trust and willingness to use the model to
facilitate policy and program planning conversations.
Ensuring stakeholder representation for the policy and
intervention options being considered in the models was
identified as a key consideration for project planning to
realise the benefits of the participatory process. Participatory modelling has been shown to successfully facilitate productive problem solving across agency
boundaries by providing a neutral platform for discussion and scenario testing to explore a broad range of options and solutions [16, 18, 48, 50]. The participatory
process can bring key stakeholders from different agencies responsible for implementing policy and programs
together to explore and test “what if” policy scenarios
and explore which interventions represent the most effective leverage points in the local context and therefore
align and mobilise prevention efforts of community
stakeholders [51].
The finalised models in the case studies reported on
here are being used as credible, communication tools to
synthesise and facilitate use of evidence in policy conversations regarding prevention interventions. The models
capture the complexity of real-world policy questions
and provide a dynamic analytic tool that can overcome
the limitations of traditional analysis methods [52, 53].
The ability to manipulate policy levers to determine impact of interventions on health outcomes (including the
ability to test alternative reach, adoption, and effect scenarios) provided an important evidence base to support

Intentions to use dynamic simulation modelling to inform
decision making

Simulation modelling aims to enhance knowledge of
participants from the perspective of different disciplines
and more thorough exploration of focus problems using
systems science [21, 38]. The evaluation framework used
to guide the design of this research focused on changes
in perceptions about the assumed causality pathways in
the system to assess participant learning [35]. Interviewees reported that the participatory process provided
opportunity to be exposed to multiple perspectives,
interact and contribute expertise, however they did not
identify that they had learned about the causal pathways
for the focus issue. Participants in the case studies reported here were long term experts in the focus issue,
many of whom had dedicated their career to working on
the issue, therefore they came to the process with a good
understanding of the different perspectives and complex
causal relationships and therefore may not have gained
new knowledge through the participatory process. However, this finding is consistent with Rouwette et al. who
found that participants in group model development
processes experienced difficulty identifying their learning
from these processes without specific prompting [19].
Participatory modelling processes can be characterised
as social learning exercises [27], and the shifts in perceptions and learning that result can play out differently at
the individual and group levels [47]. Participatory modelling involves the sharing of knowledge through group
discussion, interactive activities and interactions with the
model [27, 47]. Recent participatory modelling research
in the environmental sciences has found measures of individual cognitive change to be informative, but unable
to reflect how the group evolves in their capacity to
make decisions informed by the model [47].
All respondents in these case studies reported that
they learned about the potential of dynamic simulation
modelling to explore complex interrelationships for the
focus issue and emergent behaviour of the system to
support decision making and the process of developing
simulation models through the participatory process.
This was identified as an important learning outcome
and is consistent with the key benefit of participatory
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health policy and planning conversations and develop
realistic insights into the impact of enhancing or
expanding existing interventions and identify priority
gaps and areas of need.
The unique benefits offered by participatory dynamic
simulation modelling have previously been identified
from the perspective of modelling teams. For example,
helping stakeholders understand how multiple variables,
factors, and interventions interact, being able to test the
potential impact of programs and policies in the “safety”
of a virtual environment before they are implemented,
saving time, effort, costs and resources, guiding and
prioritising data collection and facilitating discussions
among stakeholders [49]. The importance of these benefits to end-user decision makers was confirmed by these
case studies with participants identifying that the ability
to dynamically investigate the impact of intervention
combinations and interactions on outcomes, forecast delays in intervention effects and test the potential impact
of new innovative interventions before they were rolled
out in the real world were valued and utilised in policy
and program decision making discussions. The benefits
of participatory dynamic simulation modelling methods
identified by the policy makers are summarised below.
These are benefits that dynamic modelling provides over
other forms of knowledge mobilisation [34, 23] from the
perspective of end-users of these models as decision
support tools.

policy advice. For these case studies, the intended presentation of one of the finished models to a broader
range of stakeholders did not occur due to timing and
resource constraints. This was as an important missed
opportunity from a co-production and participatory research perspective that undermined the application of
the model findings to policy decisions.
The refinement of communication tools, such as interactive user interface tools and presentations that could
be easily adapted to different audiences, will be critical
to facilitate the use of the models in policy and program
discussions to inform decision making.
Supporting good understanding of the model development process, for example, how decisions are made regarding the methods used to represent causal
mechanisms dynamically, where to add complexity,
where to simplify the model and how to deal with and
communicate uncertainty in the models are important
ongoing challenges. These are the subject of future work
in this program of research on participatory modelling.
The dynamic simulation models are tools that mature
over time with the inputs, assumptions and parameters
being continuously refined and updated as new knowledge and evidence become available. The identification
and prioritisation of gaps in the existing evidence base
was facilitated by the interactive discussions regarding
the causal factors and impact of interventions for each
focus topic and used to guide future research priorities.
Key implementation strategies are summarised below.
The strategies cover practical aspects of the workshop
facilitation and important aspects of communication and
engagement with participants before, during and after
the model development workshops. It is important to
acknowledge that these strategies are not intended to be
prescriptive. Each modelling has project has unique requirements, stakeholders and policy context, and therefore being flexible and responsive to project needs and
stakeholder feedback is critical.

Summary - unique benefits of participatory dynamic
simulation modelling identified by policy makers
 Increasing familiarity and trust in the model by use

of participatory, co-production methods.
 Synthesising diverse evidence in an interactive and
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dynamic decision support tool that facilitates the
exploration of “what if ” scenarios and policy
options.
Exploring the combination and interaction of
interventions to develop insights into which
interventions to enhance, which gaps to fill and
which target groups to focus on
Exploring the impact of new and untested
interventions prior to implementation in real world
Forecasting delays in intervention effects to guide
implementation monitoring
Identifying and prioritising evidence gaps

Summary of implementation strategies for project phases
Key project roles

Domain expert – well-respected authority on the focus
issue who can play a lead role in the project planning
and workshop facilitation.
Translator – person who can contextualise the policy
environment and data for the modelling team and translate the model requirements and development process
to the participants.
Expert participants – people with a range of expertise, including providing or planning health services,
undertaking research or developing policy for the issue
in focus.

Implementation challenges and future work

The co-production and participatory approaches to
model development were time consuming, unpredictable
and messy, making them more suitable for longer term
planning in the first instance. However, once the models
were developed they could be used for short-turnaround
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Dynamic simulation modeller – person with computer
programming and data analysis expertise in developing
dynamic simulation models.
Super-user – person who learns to use the model
interface and apply it to explore policy scenarios
“in-house”. They are usually employed by the jurisdictional health department in analytic roles.
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Communication outside workshops

1. Maintain frequent communication with participants
providing progress reports, answering questions,
requesting advice and evidence.
2. Provide opportunities for direct interaction between
key participants and the modelling team to refine
the model scope and direction.
3. Identify where key issues remain for participants
and work together to try and resolve them e.g.
refining the definitions of categories or parameters
used in the model.

Planning phase

1. Use a domain expert to facilitate engagement and
trust.
2. Engage a broad range of participants to provide
diverse and representative perspectives. Important
to include “domain expert”, “translator”, “clinical
experts”, “modeler”, “policymakers”, “super users”
3. Provide background briefing material about the
participatory process prior to the workshops to
enable participants to prepare and do “pre-thinking”
4. Increase motivation to participate by engaging with
key stakeholders from lead agencies in the planning
phase to ensure the focus topic is high priority and
of professional interest. Complex issues with
contested options for intervening are more likely to
be viewed as worthwhile for the significant time
investment required for participatory model
development.
5. Wherever possible, book workshops and meetings
well in advance to provide the best opportunity for
a broad range of stakeholders to be able to attend.

Using the model to inform decision making

1. Be transparent about the logic, assumptions and
parameters used in the model.
2. Use “translators” to facilitate ongoing interaction
with the model and communication of model
outputs to stakeholders.
3. Ensure that time is provided to socialise the model
with a broader stakeholder group who were not
involved in the participatory process.
4. Develop simple, clear and concise key messages
about insights from the model
5. Develop associated tools to facilitate
communication e.g. an intuitive and interactive user
interface and adaptable presentations to suit a
variety of audiences.
Limitations

Two of the three models developed in these case studies
were finalised at the time of the interviews. The participant perspectives of the utility of participatory dynamic
simulation to inform decision making was thus limited
to these two case studies. The perspectives included this
analysis were limited to participants employed by government agencies with jurisdiction over many of the policy and program decisions relevant to the focus topics
being modelled in these case studies. Their perspectives
may vary from those of other participants in the case
studies, for example academic researchers or representatives from non-government agencies. Decision maker’s
views of different methods of dynamic simulation modelling, e.g. system dynamics vs agent based modelling,
will be an important issue to explore in future research
as decision makers develop and broaden their experience
of different forms of modelling.
The lack of consumer representation in these case
studies is a limitation. The development of strategies to
realise the benefits of consumer involvement in participatory dynamic simulation modelling to inform health
policy decisions is an important area for future focus.

Participatory model development phase

1. Use “translators” to facilitate the communication of
technical concepts between the content experts and
the modelling team.
2. Use intuitive and engaging activities and ensure that
these are sufficiently prepared in advance. The
activities used in these modelling case studies are
described elsewhere [34].
3. Prioritise opportunities for participants to actively
engage and interact with each other and hands-on
model development activities over less interactive
update sessions. Provide opportunities to have fulsome discussions about priority issues.
4. Have a clear agenda and keep to time, as much as
possible, while maintaining flexibility to allow
important discussions to continue or to move on
from activities that are completed.
5. Use small group work where possible to increase
active participation.
6. Choose venues with sufficient physical space and
technical capacity.
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Conclusion
The case studies reported here have provided new insights into the experience of engaging in participatory
dynamic simulation modelling from the perspectives of
the end-user policy makers and senior clinicians with
decision making roles in Australian jurisdictional health
departments. The participatory, co-production process
was viewed as an essential approach to ensure the dynamic simulation models incorporated the best available
knowledge and evidence for the focus issue and that the
models were well understood or “transparent” to build
trust in the model as a decision support tool for policy
discussions. The unique benefits of the dynamic simulation models included being able to synthesise diverse
evidence; explore the combination and interaction of
risk factors and interventions; explore the impact of new
and untested interventions in silico; and identify evidence gaps to prioritise for future research. Given the
commitment of time and resources to the participatory
model development process, it was important to ensure
that the topic justified the investment i.e. It was a high
local priority, complex and had contested options for
intervening. Engaging domain experts and people to
work as “translators” from within the stakeholder organisation were important to facilitate engagement in the
process and use of the models as policy decision support
tools. Participatory modelling processes are more suitable for longer term planning in the first instance (prior
to the model being developed), however are responsive
to short-turnaround policy advice once developed as a
decision support tool. The ongoing refinement of model
development workshop activities and communication
tools to support the application of model findings to policy decisions will be important foci for future research
on these methods.
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Chapter 7: Results Part 4: ‘Turning the tide’ on diabetes in
pregnancy: Insights from advanced dynamic simulation
modelling
This chapter presents the model developed for the primary case study focusing on diabetes
in pregnancy (DIP) and reports on the model findings. These results are presented using
three methods of communication: an academic manuscript for publication as a journal
article, communication products that I developed and used to disseminate insights arising
from the model to decision makers within the ACT Health service, and some technical
supplementary information about the model itself.

Section 7.1 includes the journal manuscript describing the model development, structure
and logic, and reporting on the insights from scenario testing (model findings) to inform
decision making. The manuscript included in this chapter is currently undergoing external
clinical review prior to journal submission. The communication products aimed at
disseminating knowledge about both the project and the policy insights to a non-technical,
policy audience are included in Section 7.2 and Appendix 9. These communication products
included a plain language fact sheet about the project, an interactive dashboard and a
podcast interview. The detailed documentation of the model structure and associated
parameters, functions and data sources are included in Appendix 10. Some of this material
was included in a technical paper on which I am a contributing co-author (as listed in the
front of this thesis) that was led by the computer science members of the modelling team.
The model documentation will also be published as supplementary material to the
manuscript included in Section 7.1.
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Abstract
Introduction: Diabetes in pregnancy is rapidly increasing, with both short- and long-term
risks to the health of women and their babies. Strategies to manage and prevent this
condition are contested. Dynamic simulation models (DSM), developed using participatory
methods, can be used to explore and test policy and program scenarios before they are
implemented in the real world. This paper reports on the development and use of an
advanced DSM to explore the impact of interventions on maternal weight status and
incidence of diabetes in pregnancy (DIP, including gestational diabetes and pre-existing
type 1 and type 2 diabetes).
Method: A consortium of experts worked collaboratively to develop a hybrid dynamic
simulation model of diabetes in pregnancy comprising of integrated system dynamics,
agent-based and discrete event model components. The structure and parameterisation of
the model drew on a range of data sources. A series of scenarios comparing the impact of
population-level and individually targeted prevention interventions were investigated to
identify the combination of interventions that would deliver the greatest impacts.
Results: Population interventions promoting weight loss in early adulthood were found to
be more effective (17.6% reduction in incidence by 2030) than targeted pre-pregnancy
(5.2% reduction) and post-pregnancy (4.2% reduction) interventions in reducing the
population incidence of DIP. Combining targeted interventions for high risk groups with
population interventions promoting healthy weight in early adulthood was most effective
for reducing DIP incidence (28.8% reduction by 2030). Scenarios exploring the impact of
scaling up or scaling back interventions promoting healthy weight in childhood
demonstrated significant changes in the selected outcome measure for glycemic
regulation, insulin sensitivity, in the short term and diabetes in pregnancy in the long term.
Discussion: Population-level weight reduction interventions will be necessary to “turn the
tide” on DIP. Weight reduction interventions targeting individuals identified as high risk,
while beneficial for those individuals, did not significantly impact forecasted diabetes in
pregnancy incidence rates. The importance of maintaining interventions promoting healthy
weight in childhood was also demonstrated.
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Research in context
Evidence before this study: The rising prevalence of diabetes in pregnancy (DIP) is having a
significant impact on health service demand and resources, yet the strategies for screening,
diagnosing, preventing and managing DIP remain contested. Exploration of effective
decision support tools is needed to guide evidence-informed policy and programs for this
complex problem. We searched PubMed and Medline (OVID) databases from inception up
to August 24, 2018 using the search terms: “dynamic simulation” “agent-based model”
“system dynamics” with a combination of “diabetes” and “pregnancy” and “gestational
diabetes”, without language restrictions. We identified only one Canadian study, by
members of this modelling consortium, reporting on a dynamic simulation model exploring
the intergenerational effects of DIP on the development of type 2 diabetes in an Indigenous
population.

Added value of this study: This study brought together local, national and international
researchers, clinicians and policy makers to collaboratively develop a multi-scale DSM for
DIP capable of exploring the likely impact of policy and health service scenarios to prevent
and manage DIP before they are implemented in the real world. The DSM incorporated the
complex and interrelated causal factors that contribute to the development of DIP and
explored intervention options and combinations, spanning the spectrum from clinical to
population health interventions. For the first time, this study brings together the best
available evidence and data with integrated DSM approaches to deliver insights for the
challenging problem of DIP. Additionally, the unique tripartite structure of the model
incorporates multiple integrated dynamic modelling methods. This represents unparalleled
sophistication and allows representation of the problem of DIP at multiple integrated levels
of abstraction (biological dynamics, individual-level behavioural dynamics and service
dynamics) which accommodates a complex systems perspective, while also optimising
model performance.

165

Implications of all the available evidence: The scenario testing capacity enabled by this
multi-scale DSM advanced the findings from previous studies and provided guidance for
decision making for the prevention of DIP. The scenarios reported in this paper confirmed
the importance of public health interventions to maintain healthy weight status in
childhood and support women to achieve healthy weight prior to pregnancy. These
interventions were shown to improve insulin sensitivity and reduce the incidence of DIP in
the modelled population.
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Introduction
Diabetes in pregnancy (DIP), including gestational and pre-existing type 1 and 2 diabetes, is
increasing both in Australia and internationally [1-3], challenging the capacity of health care
services. The increase in DIP is directly associated with the increasing prevalence of risk
factors including overweight, obesity, older maternal age and shifts in population
demographics and ethnicities [2-4]. With increasing prevalence of risk factors, service
providers report that women are more frequently presenting with more complex diabetes
and obstetric care needs [5]. Additionally, diabetes during pregnancy increases risk for later
chronic disease for the woman [3] and early onset of type 2 diabetes for her children [2, 6].

The available evidence for DIP policy and treatment planning is not definitive [1] and
current challenges include: determining the timing and methods of screening, criteria for
diagnosis, targets for treatment, resource allocation, identification and management of
pre-existing diabetes during pregnancy, risk stratification, timing and type of prevention
activities and individual differential effects of treatment [1, 7-9]. To address the increasing
incidence of DIP, there have been increasing calls for upstream prevention activities to
focus on lifestyle risk factors pre-conception rather than during or post-pregnancy [10-12].
These contested intervention options cross the spectrum from primary prevention
approaches to highly specialised clinical management, which can be implemented
independently or in combination and may be phased or implemented simultaneously.
Sophisticated analytical tools are required to synthesise diverse evidence types across
disciplines and support decision making.

Systems science methods provide decision makers with insights into how multiple causal
pathways interact to generate the patterns of disease we see in the real world and how
interventions modify those pathways [13, 14]. Dynamic simulation modelling (DSM) is a
method that recreates complex systems and human behaviours as a computer, or
mathematical, model. The models can answer ‘what if’ questions, via computer simulation,
about the likely impacts over time of different policy and intervention options and their
combinations [15, 16]. This is important for prevention policy and practice, where decision
support tools must steer a course through the complexity of interactions that give rise to
real-world public health problems, such as the rapid increase in DIP [15-17]. They are also
useful for conditions with slow and variable development, like diabetes mellitus, that
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involves underlying dynamics between physiological factors, such as the non-linear
interrelationships between weight status, pregnancy, insulin sensitivity, insulin production
and glycemic regulation [18-20]. These physiological variables interact and some are
difficult to measure empirically, meaning that conditions like diabetes present significant
challenges for traditional experimental methods [18, 21]. Analytic methods like dynamic
modelling and simulation play an important role in improving understanding of the
dynamics of disease progression [18, 22, 23]. The multi-scale, hybrid model reported in this
paper builds on current understanding of glycemic regulation dynamics related to weight
status and pregnancy [19, 20], leveraging existing peer-reviewed mathematical models of
diabetes [18, 22, 23] and explores the dynamics of glycemic regulation, weight status and
pregnancy on the development of DIP [24].

Recent advances in modelling software have increased model transparency, making them
more accessible to non-modellers. This has facilitated expert stakeholder participation in
the model development process, increasing the opportunities for interdisciplinary learning
about complex health problems and building trust in the model outputs [25-29]. The aim
of this study was to develop a DIP decision support tool for policy and program decision
makers, using participatory DSM [30]. The model development process, and discussions of
the model outputs enable key stakeholders to explore the likely impacts of both clinical and
population level intervention options for DIP, via simulation, before they are implemented
in the real world. The process has been reported elsewhere [25, 29-31]. The aim of this
paper is to explore the impact of prevention interventions targeting weight status on DIP
incidence and insulin sensitivity. Insulin sensitivity, while not being a commonly utilised
clinical measure, was selected as an outcome measure of glycemic regulation for these
scenarios as it reflects metabolic dynamics both during pregnancy and with changing
weight status and is potentially responsive to lifestyle interventions [19, 20]. Intervention
scenarios were tested to explore the impact of timing, subgroup targeting, and adherence
to lifestyle changes on the incidence of DIP and insulin sensitivity.
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Methods
Box 1: Study context

The model explored DIP in Australian Capital Territory (ACT) and was built in partnership with
the ACT Government Health Directorate (ACT Health). Approximately 16% of ACT resident
women who gave birth in the ACT in 2016 were diagnosed with DIP (increasing from 6% in
2008) [32]. ACT Health services provide government funded health services for the
population of the ACT (approximately 410,000) and are the major health referral centre for
the Greater Southern Region of New South Wales. The total catchment area population is
over 600,000 people. The number of women giving birth in the ACT is over 6,000 per year.
Approximately 15% of these women are non-ACT residents who access services in the ACT
for high risk pregnancy complications (i.e. those requiring tertiary level care). Models of
antenatal maternity care provided in the ACT include hospital based out-patient care,
tertiary level care, private midwifery care, and shared care (that is, integrated with primary
health care providers). A specialist gestational diabetes service operating from one public
hospital with satellite clinics in community health centres works with generalist maternity
services to provide education and health services for women with DIP.

Model development
The model development process drew on best practice guidelines for computational
modelling and included the grounding of assumptions in theory and evidence, sensitivity
testing and calibration [33, 34]. The model was built using a participatory approach that
engaged a consortium of academics, clinicians, public health policy makers, program
planners, modellers and health economists in the process. This approach has been
described in detail elsewhere [25, 30, 31]; and a diagrammatical overview of the process is
depicted in Figure 1.

169

Figure 1: Overview of the participatory model development process

The hybrid model was constructed using AnyLogic simulation software
(http://www.anylogic.com/). Detailed information is available in the supplementary
resources, including the model documentation and technical paper.

Model inputs and data sources
The structure and parameterisation of the model drew on a range of data sources,
including census and population data, systematic reviews, meta-analyses, accepted
formulas and conceptual models, survey data, policy/programme effectiveness data,
economic data and the expert knowledge of the multidisciplinary stakeholders who
participated in model development. Local data was prioritised where this was available.
Expert opinion was utilised when other evidence options were exhausted or for
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triangulation of multiple data sources when parameters were uncertain. The data included
statistics relating to demographic characteristics and trends, the incidence of DIP and
associated risk factors, and the underlying physiology determining individual glycemic
control including beta cell mass and function based on previous mathematical models of
diabetes progression [18, 22, 23]. Census, population and health system data were sourced
from the Australian Bureau of Statistics and ACT Health administrative data collections.
Model input parameter values, their sources and the data used for model calibration are
provided in the supplementary resource. The model was calibrated to the incidence of DIP
in ACT Health maternal and perinatal statistics from 2008 to 2016.

Model structure
The tripartite model incorporates system dynamics (SD), agent based modelling (ABM) and
discrete event simulation (DES) components with construction and analysis implemented in
AnyLogic® version 7.3.6 Professional (http://www.anylogic.com/). The model structure has
been described elsewhere [24] and is described in detail in the supplementary resource. A
summary is provided here of the following representations:

A.
B.
C.
D.
E.
F.

Pregnancy
Dysglycemia classification
Glycemic regulation including beta cell mass and function
Population structure
Weight status
Clinical service

The overall model structure is depicted in Figure 2 which is intended to depict a high level
overview of model components rather than full details. The model population is initialised
using demographic characteristics e.g., age and country of birth, of the female population of
the Australian Capital Territory (ACT) from the 2011 Australian Census [35]. The model is
initialised in 1948 with time units in years. The model then undergoes a burn-in period of 60
years to 2008. Model outputs from 2008 to 2016 have been calibrated against retrospective
data [24].
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Figure 2: Overview of model components and structure
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The model incorporates a dynamic representation of the underlying physiological
regulation associated with an individual’s glycemic status that is based on previous
mathematical models of diabetes progression [18, 22, 23]. The mechanism for glycemic
regulation included in the model is referred to as an endogenous dynamic mechanism. This
means that the model represents, over time, the evolution of specific, latent factors related
to the level of dysglycemia and metabolic load that a woman experiences. Glycemic
regulatory capacity is represented as a stock (an accumulation), allowing the level of an
individual’s regulatory capacity to increase and decrease over time. Therefore, the factors
that influence glycemic regulatory capacity such as increased metabolic load due to
pregnancy, changes to diet and physical activity and pharmacological interventions can be
modified within the model and the impact measured over time and between generations.
Glycemic regulatory capacity is a function of two factors in the model. Firstly, it is a function
of biologic regulatory capacity; that is, the changes in insulin sensitivity and insulin
production associated with underlying physiology [18, 20, 22, 23]. Secondly, there is a
component of external regulation by the individual, that is, their conscious regulation
through adherence to blood testing, medication regimens and lifestyle interventions
including diet and physical activity. The model mechanism allows for changes in an
individual’s adherence to medical and lifestyle interventions over time. The model also
incorporates the impact of beta cell decline associated with exposure to dysglycemia based
on modelling carried out by De Gaetano et al. [18, 22, 23]. Exposure to dysglycemia results
in a decline of beta cell function over time and this eventually limits the individual’s
regulatory capacity. Reduced beta cell function decreases the effectiveness of lifestyle
interventions on glucose regulation, meaning that, even if an individual with reduced beta
cell function makes significant changes to their diet and activity levels, the impact on the
blood glucose regulation will be minimal.

Pregnancy occurs according to the ACT age and ethnicity specific fertility rate. The model
tracks relevant risk factor information for the occurrence of dysglycemia in the current
pregnancy, for example, Body Mass Index (BMI), age, history of diabetes, and family history
of diabetes. Insulin sensitivity decreases significantly during pregnancy for both
normoglycemic and dysglycemic women, based on findings of studies by Catalano [19, 20].
When a woman gives birth, there is a birth event in which a baby is introduced into the
model. The baby inherits characteristics, including the mother’s DIP status and history of
diabetes, maternal weight status and ethnicity. Outcomes, including birthweight, type of
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birth e.g., caesarean section, neonatal intensive care admission and Apgar scores, are
recorded at birth. The model incorporates the glycemic changes occurring during pregnancy
[36]; it is notable that such changes can impart physiological impact for mother and child
(e.g., on beta cell mass and function) that persists beyond that pregnancy. Responsive to
the focus on DIP, the model includes only female agents. Births for male babies occur in the
model, however these agents are deleted from the population. Model outputs reflect the
impact of interventions on females in the population.
High weight status is an important risk factor for declining insulin sensitivity and the
development of diabetes. Weight is represented in the model as a continuous variable that
changes dynamically with age [37] and pregnancy [38]. An individual’s weight status (BMI)
impacts on their insulin sensitivity [18-20], with increasing weight leading to decreasing
insulin sensitivity. This paper reports on weight reduction intervention scenarios tested in
the model as described below.
Simplifying assumptions about individual behaviour were made to ensure the model is
parsimonious, while allowing it to approximate real-world behaviour over time. A summary
of the key assumptions is presented below:
1. Age specific fertility rates were calculated using birth rates from 2013. The model
assumes that age specific fertility rates will remain stable over the period of the
simulation.
2. The model assumes that 60% of pregnancies were intended, providing
opportunities for intervention during pregnancy planning [10]. The assumption was
applied uniformly across age groups.
3. Adherence to healthy lifestyle behaviours was assumed to increase after exposure
to intervention and then decline over the subsequent two years.
4. Individuals, who were eligible, had an equal chance of receiving interventions.

Underlying the model structure and assumptions described above are simple mathematical
relationships designed to capture the concept they represent. For instance, the decline in
intervention adherence was assumed to follow a curve whose coefficients cause adherence
to the weight management intervention to increase immediately following an intervention
and decline over the subsequent two-year period.
Health services are captured in the model, with the current service model being
represented as a DES component. Future planned work for the model will explore the
impact of alternative service models on resources and outcomes.
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Scenarios tested in this analysis
The scenarios tested in this analysis focused on the impact of targeted and population-level
weight reduction strategies. Many of the risk factors for DIP are not modifiable, however
weight status is an important modifiable risk factor for both DIP and type 2 diabetes
mellitus. The scenarios prioritised for this analysis are described below.

1. Impact of population vs targeted weight management interventions

These scenarios compared the impact of weight management interventions delivered
across the population of females aged 20 to 35 years with targeted interventions delivered
to females who were at high risk according to the Australian Diabetes in Pregnancy criteria
[1] either before or after their pregnancies. The interventions are described below.

Scenario

Description

1.

Population intervention

This intervention targets all women aged 20 to 35 years
through a public health intervention. The goal of the
intervention is to support women to maintain or achieve a
healthier weight status.

2.

Targeted pre-pregnancy
intervention

This intervention targets women who have one or more risk
factor for DIP. It is available to all women who are considering
pregnancy (60% of pregnancies [10]). The intervention aims to
achieve a healthy weight via adherence to diet and physical
activity recommendations and.

3.

Targeted post-pregnancy

This post pregnancy intervention targets women who have
had diabetes in a previous pregnancy. The intervention aims to
increase adherence to diet and physical activity
recommendations and to achieve a healthy weight before the
next pregnancy.

4.

Combined

This scenario combines all the above interventions
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The effectiveness of each intervention in reducing weight is a model parameter that can be
varied. For simplicity, the interventions in these scenario runs were assumed to result in
weight reductions that were normally distributed with a mean weight reduction of 1.3
kg/m2 (SD = 1.7 kg/m2). The distribution was based on an Australian study of mobile phone
based public health intervention aimed at preventing weight gain in young adults [39] and
an Australian study of post pregnancy lifestyle change supported by motivational
interviewing [40]. Weight loss results for individuals who received the interventions were
drawn from this distribution. It was assumed that all eligible individuals received the
intervention and that the intervention effectiveness degraded over time, with adherence
diminishing over a two-year period.

2. Impact of childhood weight interventions

These interventions explored the impact of childhood weight interventions. As childhood
weight dynamics had not yet been fully articulated in the model, these hypothetical
scenarios were simulated by modifying the weight distribution of the population on entry
to adulthood. Increasing population-wide interventions to reduce childhood overweight
and obesity was simulated by shifting the weight distribution of the population to the
“left”, so that more individuals entered adulthood within the healthy weight range (normal
distribution with mean BMI = 22). Scaling back population-wide interventions addressing
childhood overweight and obesity was also simulated. The scaling back intervention shifted
the population weight distribution to the “right” so that more individuals entered
adulthood either overweight or obese (normal distribution with mean BMI = 30). The
interventions were implemented for individuals born from 2018 and the simulations were
run for 42 additional years (2060) to allow individuals to age and enter their reproductive
years.

Model outputs and data analysis
For the scenario testing, key outcome indicators against which the impacts of scenarios
were compared to the baseline were: (1) incidence of DIP (%) and (2) insulin sensitivity
(KxgI). Diabetes in pregnancy incidence was calculated as a percentage based on the
proportion of all women giving birth in each year who were diagnosed with DIP. KxgI was
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used as a mathematical index of insulin sensitivity representing insulin dependent glucose
tissue reuptake [22].

To estimate latent or poorly measured parameters and to support the projection of status
quo future incidence of DIP using model outputs, we calibrated a baseline model without
interventions against the following historical data: the incidence of DIP for sub-populations
in ACT from 2008-2016 according to ADIPS risk profiles[1]; the prevalence of macrosomia
by DIP status in the ACT from 2010-2016 [24].

Outputs from the model were summarised using the R statistical package to obtain means,
standard errors and 95% confidence intervals; summary data was tabulated and graphed in
Microsoft Excel. Given that runs of the model were computationally expensive, 36 runs
were deemed sufficient to account for stochasticity and provide stable predictions of
scenario performance and of the variance in performance. The comparison of simulation
results between baseline and intervention scenarios was expressed as a percent difference
in reported outcomes. 95 % confidence intervals about the means were reported as
estimates of the variation between simulation runs and to test statistical significance.

Results
Results for scenario testing simulations are presented below.

Scenario testing results
1. Impact of population vs. targeted weight management interventions
Diabetes in pregnancy incidence for the baseline and scenario simulation are presented as a
percentage, based on the proportion of all women giving birth in each year who were
diagnosed with DIP, in Table 1 and Figure 3. The baseline incidence of DIP was 15.9%
(95%CI 15.5 to 16.3) in 2020; 16.1% (95% CI 15.8 to 16.4) in 2030 and 17.3% (95% CI 16.9 to
17.7) in 2040. The population weight loss intervention in early adulthood resulted in a
non-significant 3.0% reduction in DIP incidence by 2020 (15.5%; 95% CI 15.1 to 15.9),
however by 2030 the 17.6% reduction in DIP incidence (13.3%; 95% CI 13.0 to 13.6) was
statistically significant. In comparison, the impact of targeted pre- and post-pregnancy
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interventions on population level DIP incidence ranged from a non-significant reduction of
just over 2% in 2020, a small but statistically significant reduction of 4-5% in 2030 and 4-6%
in 2040, respectively. Incidence rates with confidence intervals for these scenarios are
presented in Table 1. Combining targeted interventions for high risk groups with population
weight loss interventions was the most effective scenario for reducing DIP incidence, with a
reduction of 14.4% by 2020 to 13.6% (95% CI 13.2 to 14.0), two years after the simulated
interventions were implemented, 28.8% by 2030 (11.5%; 95% CI 11.2 to 11.8) and 32.1% by
2040 (11.8%; 95% CI 11.5 to 12.1).
Figure 3: Comparative impact of scenarios on DIP incidence simulated from 2018 to 2040

20.0
18.0
16.0
14.0

Percentage

12.0
10.0

Baseline

8.0

1. Population intervention

6.0

2. Targeted pre-pregnancy intervention

4.0

3. Targeted post-pregnancy intervention

2.0

4. Combined - population and targeted pre and post
pregnancy interventions

0.0
2019

2020

2025
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2030

2035

2040

Table 1: Summary DIP incidence statistics for baseline and scenarios simulated from 2018 to 2040
2020

2030

2040

%

95% CI
(±)

%
reduction
from
baseline

Baseline

15.9

0.4

-

16.1

0.3

-

17.3

0.4

-

1. Population intervention

15.5

0.4

-3.0

13.3

0.3

-17.6

13.8

0.3

-20.5

2. Targeted pre-pregnancy

15.5

0.3

-2.8

15.3

0.3

-5.2

16.2

0.4

-6.2

3. Targeted post-pregnancy reduction
4. Combined - population and targeted pre and post
pregnancy

15.6

0.3

-2.1

15.5

0.3

-4.2

16.7

0.4

-3.8

13.6

0.4

-14.4

11.5

0.3

-28.8

11.8

0.3

-32.1

%

95% CI
(±)

%
reduction
from
baseline

%

95% CI
(±)

%
reduction
from
baseline

Table 2: Summary insulin sensitivity (KxgI) statistics for baseline and scenario simulations simulated from 2018 to 2040
2020

KxgI

95% CI (±)

Baseline

50.3

0.02

1. Population intervention

52.2

0.03

2. Targeted pre-pregnancy

50.5

0.02

3. Targeted post-pregnancy reduction
4. Combined - population and targeted pre and post
pregnancy

50.5
55.7

2030
% increase
from
baseline

KxgI

95% CI (±)

48.4

0.02

3.8

56.5

0.03

0.3

49.3

0.03

0.02

0.4

51.5

0.02

10.6

67.9

KxgI - an index of insulin sensitivity representing insulin dependent glucose tissue reuptake
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2040
% increase
from
baseline

% increase
from
baseline

KxgI

95% CI (±)

46.4

0.03

16.7

58.0

0.03

25.2

1.8

47.7

0.03

2.8

0.06

6.3

50.1

0.07

8.1

0.11

40.3

70.7

0.13

52.4

Insulin sensitivity results for the baseline and intervention simulations are presented in
Table 2. Baseline projections of insulin sensitivity (KxgI) were 50.3 (95% CI 50.1 to 50.5) in
2020; 48.4 (95% CI 48.2 to 48.6) in 2030 and 46.4 (95% CI 46.1 to 46.7) in 2040 The
population intervention targeting weight loss in early adulthood resulted in a nonsignificant 3.8% increase in insulin sensitivity by 2020 and a significant 25.2% increase by
2040 (KxgI = 58.0; 95% CI 57.7 to 58.3). Smaller increases in population level insulin
sensitivity were found for the targeted pre- and post-pregnancy interventions, with
targeted pre-pregnancy weight loss interventions resulting in an increase in insulin
sensitivity of 2.3% in 2040 (KxgI = 47.7; 95% CI 47.4 to 50.0). The targeted post-pregnancy
interventions had a significantly higher impact by 2040 with an increase in insulin
sensitivity of 8.1% (KxgI = 50.1; 95% CI 49.4 to 50.8). Combining targeted weight loss
interventions for high risk groups with population-level weight loss interventions was the
most effective scenario for increasing insulin sensitivity across the population, with an
increase of 10.6% two years after the simulated interventions were implemented (2020)
(KxgI = 55.7; 95% CI 55.5 to 55.9) increasing to 52.4% in 2040 (KxgI = 70.7; 95% CI 57.7 to
58.3).

2. Impact of childhood weight status on entry to adulthood
The interventions were implemented for female agents born from 2018 and were
simulated to 2060 to allow time for individuals to age into adulthood and their
reproductive years. Minimal impact of the interventions was observed on DIP incidence
until 2060 (Figure 5), when the scenario with all females entering adulthood at a healthy
weight resulted in a 21.2% decrease in the percentage of women diagnosed with DIP from
baseline (Table 4) (2060 Baseline 17.0%, 95% CI 16.7 to 17.3; Scenario 13.4%, 95% CI 13.1
to 13.7).
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Figure 4: Comparative impact of childhood weight scenarios on DIP incidence simulated from 2018 to
2060

19.0
17.0

Percentage

15.0
13.0
11.0
9.0
7.0
5.0
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2030
All normal weight

2040

2050

2060

More overweight or obese

Changes in insulin sensitivity (KxgI) were observed earlier in the simulation, from 2030, for
the childhood weight interventions (Figure 5). The scaling up simulation -- with all
individuals entering adulthood at a healthy weight -- increased insulin sensitivity, as
measured by KxgI, for the population by 8.5% from the baseline simulation by 2030,
increasing to 47.3% by 2060 (Table 4). The scaling back simulation shifted the weight
distribution for the population further toward overweight and obesity as they entered
adulthood. This resulted in a decrease in insulin sensitivity for the population of 31% from
baseline by 2060 (Table 4).
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Figure 5: Impact of scaling up and scaling back childhood weight interventions on population insulin
sensitivity (KxgI)

80.00
70.00
60.00

Kxgi

50.00
40.00
30.00
20.00
10.00
2018

2020
Baseline

2030
All normal weight

2040

More overweight or obese

KxgI - an index of insulin sensitivity representing insulin dependent glucose tissue reuptake
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2050

2060

Table 3: Summary DIP (percentage) incidence statistics for baseline and child weight status interventions scenarios simulated from 2018 to 2060
2020
95% CI
(±)
Per cent

%
change
from
baseline

2030
Per
cent

95% CI
(±)

%
change
from
baseline

2040
95% CI
(±)
Per cent

%
change
from
baseline

2050
95% CI
(±)
Per cent

%
change
from
baseline

2060
95% CI
(±)
Per cent

%
change
from
baseline

Baseline

15.6

0.28

15.8

0.31

16.9

0.31

17.2

0.3

17.0

0.3

All normal weight

15.9

0.26

1.8

15.9

0.31

0.8

17.1

0.31

1.4

17.0

0.3

-0.9

13.4

0.3

-21.2

More overweight or obese

15.7

0.27

0.4

15.7

0.30

-0.6

17.1

0.27

1.3

17.3

0.3

0.4

17.6

0.3

3.8

Table 4: Summary population insulin sensitivity (KxgI) statistics for baseline and scaling up and scaling back scenarios simulated from 2018 to 2060
2020
95% CI
(±)
mean

Baseline

50.3

0.02

All normal weight

50.9

0.02

More overweight or obese

49.7

0.02

2030
% change
from
baseline

95% CI
(±)
mean

48.4

0.02

1.2

52.5

0.02

-1.2

44.6

0.02

2040

%
change
from
baseline

95% CI
(±)
mean

46.4

0.03

8.5

54.2

0.03

-7.8

39.3

0.02

KxgI - an index of insulin sensitivity representing insulin dependent glucose tissue reuptake
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%
change
from
baseline

2050
95% CI
(±)
mean

45.7

0.02

16.9

60.0

0.03

-15.4

34.7

0.02

%
change
from
baseline

2060
95% CI
(±)
mean

%
change
from
baseline

45.6

0.02

31.2

67.1

0.04

47.3

-24.1

31.5

0.02

-30.9

Discussion
The simulations reported here prioritised scenario testing of several lifestyle prevention
interventions promoting healthy weight status. Population-level interventions promoting
weight loss in early adulthood were found to be more effective than targeted pre- and
post-pregnancy interventions in reducing the population incidence of DIP. Combining
targeted interventions for high risk groups with population health promotion supports was
shown to be the most effective scenario for reducing DIP incidence, especially in the longer
term. Scaling up childhood health weight interventions, resulting in all female children
entering adulthood at a healthy weight, achieved a significant improvement in insulin
sensitivity in the short term and decreased DIP in the long term. Scenarios testing the
impact of scaling back childhood healthy weight interventions, i.e., having more children
entering adulthood overweight or obese, resulted in declines in insulin sensitivity across the
population and, therefore increasing risk of early development of diabetes mellitus.

The study presented in this paper is unique in that dynamic simulation modelling was used
to explore the metabolic dynamics underlying the development of DIP and compare the
likely impact of population level interventions with interventions targeting high risk
individuals. This simulation study builds on other research assessing the effectiveness of
targeted lifestyle prevention programs to prevent DIP incidence [10, 12, 41]. Given the
substantial time needed to achieve weight reduction, it has been argued that early
intervention at a population level will be necessary to reduce obesity-related outcomes in
pregnancy [10], and this was confirmed by the modelling. The scenarios presented in this
paper demonstrated that population level interventions will be needed to make an impact
on DIP incidence across the population. Targeted interventions, both pre- and postpregnancy, did not substantially impact on population DIP incidence.

Over half of pregnancies are planned [10], and this was reflected in the model, with only
individuals who were planning to become pregnant being eligible to receive the targeted
pre-conception intervention. Therefore, the small proportion of the total population
receiving the intervention and individual variations in adherence, included in the model to
reflect reality, impacted on intervention effectiveness. The targeted interventions resulted
in only a modest impact on population incidence rates for DIP. This result should not
devalue the role of targeted interventions, as these are important and beneficial for
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individuals and their offspring [11]. However, the results emphasise the need for
population interventions to support healthy lifestyle behaviours for all individuals, whether
they actively plan their pregnancy or not [10].

A recent review of research into antenatal lifestyle programs for high risk women found
that they did not successfully prevent DIP [12]. Further examination of the individual and
intervention characteristics that facilitated adoption and adherence to interventions has
been identified as a priority [12]. The DIP model presented here incorporated
representations of the non-linear dynamics and feedback loops that impact intervention
effectiveness e.g., the impact of age and pregnancy related weight changes across the life
course and the impact of individual adherence to diet and physical activity
recommendations on both DIP incidence and insulin sensitivity. The reduction in DIP
incidence was only achieved when individuals remained adherent to the lifestyle changes
associated with the intervention.

Scenario testing provides an important tool for exploring hypothetical policy options,
including “do nothing” alternatives that forecast the impact of ceasing current
interventions [14, 33, 42]. In these scenarios, the DIP model hypothetically tested the
impact of scaling back interventions promoting healthy weight for children in school
settings. This scenario forecasted the impact of more children entering adulthood at a
higher weight status on insulin sensitivity, placing them at risk of early development of
diabetes mellitus. These results signify the potential importance of the current global focus
and efforts to reduce childhood overweight and obesity.

Diverse local perspectives and interests can provide decision makers with conflicting advice
regarding the best course of action [16]. Data limitations, insufficient local analytic capacity
and inadequate tools to support longer term planning in a context of changing local needs,
contribute to the persistence of a trial and error approach to program planning that may
delay or prevent the realisation of significant impacts on important public health issues like
DIP [15, 42]. The DSM approach described in the present study is one way to address these
challenges and can also contribute to prioritising data gaps for future research and data
collection, and infrastructure to better support interventions to prevent and manage DIP.
The participatory approach facilitated opportunities for interdisciplinary dialogue and
combining diverse perspectives in the consideration of policy options. The developed
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partnerships and relationships were critical to the model development and to its likely
subsequent use to inform health service and policy decisions.

Future applications of the model include further exploration of the: intergenerational
impacts resulting from exposure to DIP; factors that influence childhood weight gain e.g.
breastfeeding and other aspects of diet, school-based health promotion interventions, and
physical activity etc.; impact of model of care alternatives; and impact of prevention
interventions on health service utilisation. Health economic considerations will also be
added to future iterations of the model.

Limitations
There are limitations to consider when interpreting the findings of this paper. There is
potential measurement bias in the range of secondary data used to parameterise the
model. Where possible, routinely collected local health service information was obtained to
estimate population-based estimates of DIP, birth outcomes, weight status, and fertility
rates. There were also some parameters relating to the heterogeneity of aetiology of DIP
and the dynamics of glycemic regulation where data were not available, and these are
identified as priorities for future research. The model acknowledges these potential sources
of measurement bias, and commonly used strategies were employed to address them,
including the triangulation of multiple data sources, calibration to refine parameter
estimates and the engagement of stakeholders with detailed knowledge of the limitations
and likely direction and size of potential measurement biases in key data sources. In
addition, sensitivity analysis was undertaken to estimate the impact of uncertainty on
primary outcome indicators and guide priorities for new data collection and quality
improvement of existing data collection.

Conclusion
Population health interventions will be necessary to “turn the tide” on DIP. Interventions
targeting high risk individuals, while beneficial for those individuals, delivered small
reductions in DIP incidence rates. The importance of maintaining interventions promoting
healthy weight in childhood was demonstrated. Scenarios simulating the impact of scaling
back these interventions showed that insulin sensitivity decreased significantly, increasing
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the risk for early development of diabetes mellitus. DSMs are learning support tools that
can mature over time as new evidence becomes available and methods are advanced to
facilitate further development. This decision support tool for DIP was developed as a
working model and is being published for transparency and to invite input. A key priority for
future research is improved knowledge about the dynamics and heterogeneity in the
aetiology of glycemic dysregulation and diabetes mellitus development, and the impact of
glycemic control during pregnancy on perinatal outcomes.
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7.2

Communication products developed to facilitate model use and

knowledge dissemination
Three key products were developed to support communication about this technical
modelling project to a non-technical policy audience. The products were a plain language
fact sheet, an interactive dashboard and a podcast. The fact sheet and interactive
dashboard communication products are described in this section and the podcast transcript
is included in Appendix 9.

Project fact sheet
I led the development of plain language fact sheet (below) to facilitate communication
about the modelling project. The factsheet was developed with Ms Helen Signy and Ms
Ainsley Burgess, communication officers with The Australian Prevention Partnership
Centre, and was aimed at Ministerial advisors and a wider health policy audience.

The fact sheet provided background information about diabetes in pregnancy as a priority
issue impacting on health services in the ACT, information about the model development
process and preliminary results from the model. A local Canberra woman with diabetes in
pregnancy was interviewed by Ms Signy and her story was included to illustrate the local
impact of diabetes in pregnancy and the importance of prevention interventions.
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Preventing diabetes in pregnancy
Diabetes in pregnancy is putting more and more strain on
the ACT’s health system. We need to do things differently
Diabetes in pregnancy, including gestational diabetes, is
increasing both in the ACT and Australia. This is due to the rise
in risk factors such as overweight and obesity, older mothers
and more women from high-risk ethnic groups.

Percentage of women diagnosed with diabetes in
pregnancy who gave birth in the ACT,* 2008–2016

Gestational diabetes occurs when high levels of blood glucose
are detected during pregnancy that, if untreated, increase
the risk of poor pregnancy outcomes. It also predicts a future
higher risk of permanent diabetes in mothers and obesity and
diabetes in children.

18
14
10

6%
6

Pregnancy is a time when public health interventions can have a
big impact. Women are more motivated to make changes, and
these can also positively affect the health of future generations.

Percentage of women (%)

16%

2
2008

2010

2012

2014

2016

Year

Achieving even small delays in the development of diabetes
will have significant implications for the longer-term burden
of disease and costs to the health system.

*Includes ACT residents only.
Source: ACT Maternal Perinatal Data Collection.

CASE STUDY
Pip is 37, she is about to have her first baby – and has gestational diabetes

“

Both Pip and her new daughter will be at
increased risk of type 2 diabetes in future.
Pip is one of about 800 women diagnosed
every year in the ACT with gestational
diabetes. She joins an ever increasing number
of women whose future health and that of her
children is at risk.
Before I conceived, no-one ever suggested to
me my history of polycystic ovary syndrome,
diet, weight or age put me at risk of
gestational diabetes. If I had known,
I could have made changes before I became
pregnant to try and reduce my risk.
Sometimes I feel like I’m doing this alone.
Better support before and during my
pregnancy would make a big difference, and
would mean a better outlook for both me
and the baby.

“
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What did we do?
We brought together diabetes in pregnancy experts including leading
academics, policy makers and clinicians from across Australia. Their insights
were combined with research and data to develop a dynamic simulation model
of diabetes in pregnancy in the ACT.
“With the collaborative modelling approach, the people in the room have
accumulated knowledge and expertise in the area over many years. To have that
wealth and depth of knowledge involved is incredibly valuable.”
Professor Christopher Nolan, Director of Endocrinology and Diabetes, ACT Health

A dynamic simulation model is a sophisticated computer ‘what if’ tool that can
test the likely impact of a range of possible solutions over time. It considers the
short, intermediate, and long-term implications of the increasing prevalence of
risk factors for diabetes in pregnancy and looks at alternative models of care.
Based on real data, the model can be used to test out different solutions to see
which will be most effective and cost effective. The expert group identified,
clarified and prioritised gaps in current knowledge and evidence which can be
used to guide future research and, in turn, further improve the model.
BUILDING AND USING A DYNAMIC SIMULATION MODEL
WITH STAKEHOLDERS

BUILD

Build a conceptual
map of the problem
collaboratively

3

VALIDATE

t

Research evidence

2
t

EVIDENCE
SOURCE

1

Does the model
reproduce historic
data trends?

Expert knowledge

Convert to a
computer model

t

t

Health service and
survey data
Refine the model

Compare
Model
output

Local practice
experience

t
t

A. Pre-pregnancy intervention
to lose weight

OFF

B. Family–centred programs
to reduce weight

Run ‘what if’ scenarios through the model

t

hypoglycaemia.

Children of mothers who had
gestational diabetes have
a 2–4 fold increased risk of
being overweight/obese and
having long-term impaired
glucose tolerance.

diet and physical activity.

Baseline

Compare predicted impact over time

Intervention A

Intervention B

2010

t

Babies of mothers who
have gestational diabetes
are at short-term risk
of high birthweight,
birth complications and

?
Impact

2015

Facilitate discussion to help drive policy action

2 THE AUSTRALIAN PREVENTION PARTNERSHIP CENTRE

mothers almost ten fold.

Both gestational diabetes
and type 2 diabetes are
associated with modifiable
lifestyle risk factors such as

Switch on different intervention combinations. For example:

ON

Gestational diabetes,
increases the subsequent
risk of type 2 diabetes in

Real
data

APPLY

4

x10
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2020

2025

2030

There are also strong
genetic and family related
risk factors which are
not modifiable.

What did we find?
Early findings from the model reinforce the long-term benefits for women and their children of preventing
diabetes in pregnancy:

•

Women with obesity experience a sharper decline in insulin sensitivity compared with normal weight women
(see image below)

•

Interventions delivered between pregnancies or after pregnancy for women who have experienced diabetes
in pregnancy could reduce their risk of progressing to Type 2 diabetes

•
•

Pregnancy and pre-conception is a time when interventions can improve health outcomes for whole families
It is possible to significantly reduce the number of women with diabetes in pregnancy by focusing on risk
factors like diet, physical activity and weight

•

These lifestyle interventions should target women in early adulthood, before pregnancy, to reduce the
incidence of diabetes in pregnancy.

What happens to insulin sensitivity during pregnancy?

•
•

High insulin-sensitivity helps keep blood glucose levels in the normal range
Low insulin-sensitivity, or insulin resistance, is associated with type 2 diabetes.
Ability to process blood sugar
sharply falls with pregnancy but
returns after the baby is born

60

Healthy
weight

Ability to process
blood sugar naturally
goes down with age

40
P = Pregnant

20

P

P

Age (years)

10

Unhealthy
weight

P = Pregnant

20

30

50

40

50

60

70

Ability to process blood
sugar is already very low
in her late twenties

40

After pregnancy,
ability to process
blood sugar is in
the dangerous level,
putting her at risk
of lifelong diabetes

It briefly improves during
pregnancy as the body
tries to compensate

30
20

P

P

Age (years)

10

80

20

30

40

50

60

70

80

Source: Early results from the diabetes in pregnancy dynamic simulation model.
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FACT SHEET 3

Next steps
This project has demonstrated that participatory dynamic simulation modelling is an effective way of informing
program and policy decision-making for diabetes in pregnancy in the ACT. Dynamic simulation models mature over
time and can be continuously refined as new knowledge and evidence becomes available.
One of the main benefits of the modelling process was that it brought together a large group of stakeholders,
including key decision makers, to discuss the causes of diabetes in pregnancy and impacts of interventions. Building
these networks is a crucial step in driving a multi-sector approach that can lead to practical changes on the ground.

What interventions could be modelled in the future?

•
•
•
•

Pre-pregnancy population level interventions, for example app-based support for women and couples to
make lifestyle changes
Targeted pre-pregnancy interventions for women with multiple risk factors
Post-pregnancy interventions to support families to maintain a healthy lifestyle
Different models of care for women with diabetes in pregnancy.

About this project
This project was implemented as a collaboration between the Prevention Centre and Australian Capital Territory
Government Health Directorate (ACT Health).
The model harnesses advances in technology incorporating multiple methods including agent-based modelling,
system dynamics and discrete event simulation into a logically consistent decision support tool for health policy
and program decision making.
The model incorporates best available evidence, data and expert opinion. We collaboratively developed the model
structure with recognised experts in providing care, planning services, undertaking research and developing
policy for the diagnosis and management of diabetes. We used an iterative process of model development where
we presented the model back to participants at meetings and workshops to continually incorporate their feedback
and refine the structure. The model was built by systems modelling experts based in Canada.
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Freebairn L, Atkinson J, Kelly PM, McDonnell G, Rychetnik L. Decision maker’s experience of participatory dynamic simulation
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Freebairn L and Kelly P. Harnessing new technologies to inform health decision making: Dynamic simulation modelling as a decision
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Interactive dashboard
I led the development of an interactive dashboard designed for use by a policy audience.
The dashboard was programmed by Mr Luke Penza and Dr Ante Prodan, computer
scientists employed by The Australian Prevention Partnership Centre, in Tableau© using
model output data.

The dashboard was designed to be presented to the ACT Minister for Health and
Wellbeing; therefore, priority was given to displaying the results in a simplified and clear
format. This was intended to facilitate the communication of key messages about the
insights derived from the simulated scenarios. To achieve this purpose, it was decided to
remove measures of model output variation and uncertainty, such as 95% confidence
intervals from the dashboard. These measures of uncertainty were included in papers
prepared for publication.

The dashboard allowed policy makers to engage with model outputs dynamically to test
“What if” scenarios relating to the impact of population health and targeted interventions.
Contextual information about the model and its development were provided on the first
tabs viewed by the user. The scenario testing tabs allowed users to select interventions and
compare their effect on outcome measures, including insulin sensitivity and diabetes in
pregnancy incidence, against the baseline. Being able to forecast the number of women
receiving services is important for resource allocation and service planning decisions.
Therefore, the dashboard included forecasted estimates of the number of women receiving
the selected interventions and the number diagnosed with diabetes in pregnancy for each
year. Screen shots from the dashboard are displayed and explained below.
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1. Home tab. This screen provided an overview of the model development process. It
displayed photographs depicting modelling participants engaging in activities to
map the causal factors contributing to the development of diabetes in pregnancy.
The conceptual maps developed in the activities shown in the photographs were
used to inform the model structure and logic.
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2. Model structure tab. This screen provided a strategic overview of the model
structure and showed the relationships between model components. The model
structure presented on this tab shows that individual characteristics, weight status
and pregnancy status all contribute to an individual’s internal dynamics of glucose
regulation e.g. their blood glucose levels and insulin sensitivity. Glucose regulation
in turn effects an individual agent’s risk of developing and being diagnosed with
diabetes in pregnancy and impacts on their use of health services. The background
photograph shows a Canberra woman who was receiving diabetes in pregnancy
care. She is depicted in a distinctive local setting to illustrate the local focus for the
model.
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1. Scenario testing screen 1. On this screen, users could choose up to five
interventions to compare against the baseline scenario over time. A description of
each scenario was displayed when users hovered their cursor over the drop-down
arrow. Users selected to display either insulin sensitivity (shown) or diabetes in
pregnancy incidence as the outcome presented in the graph at the top left. The
percentage difference from baseline for each scenario was displayed in the graphs
in the bottom right of the screen. Impact on BMI categories for the agent
population for each scenario are displayed in the graphs in the bottom left of the
screen.
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2. Scenario testing screen 2. On this screen users could choose up to four
interventions to compare against the baseline scenario in the graph at top left.
Users selected to display either insulin sensitivity (shown) or diabetes in pregnancy
incidence as the outcome. The percentage difference from baseline for each
scenario is displayed in the graphs in the bottom right of the screen. Impact on
BMI categories for the agent population for each scenario are displayed in the
graphs in the bottom left of the screen.
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3. Model outputs compared with retrospective data. The ability to replicate
historical trends is commonly used to assess model performance. The validation of
this model was demonstrated by its ability to closely replicate the percentage of
women diagnosed with diabetes in pregnancy from the ACT maternal and perinatal
data collection. The retrospective data is shown in black below and the model
results are shown in orange.

204

4. Forecasted number of women diagnosed with diabetes in pregnancy. This tab
presented the forecasted number of women diagnosed with diabetes in pregnancy
for each scenario. The graphs displayed on this tab updated dynamically with the
intervention selected on previous tabs or could be manipulated manually by the
user on this tab.
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5. Forecasted number of women receiving interventions. The forecasted number of
women receiving interventions was displayed along with more detailed
descriptions for each intervention. A grid of graphs was utilised for this
presentation to accommodate the significant difference in numbers receiving
interventions. For example, the forecasted number of women receiving the
population intervention each year settled at around 15,000 after the initial
implementation period, whereas the targeted interventions were delivered to
significantly smaller numbers of women.
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Chapter 8: Discussion and conclusions
This thesis presents an in-depth exploration of the implementation, feasibility and value of a
participatory approach to the development of dynamic simulation models (DSMs) that
address real-world health policy questions. The participatory process utilised in these
projects was novel both in terms of the methods and activities utilised to mobilise knowledge
and engage participants actively (Chapters 3 to 5) and in terms of the complexity of the policy
questions addressed and the sophistication of the DSMs developed (Chapters 5 to 7). The
thesis research examined the participatory model development processes, and analytic
objectives and decision-making involved in developing a DSM to inform policy and planning
for diabetes in pregnancy in the ACT (Chapters 4, 5 and 7). It also explored the experiences
and perceptions of end-user decision makers involved in participatory processes for three
DSM case-studies (Chapter 6).

Each manuscript presented in the results of this thesis (Chapters 4-7) includes a discussion of
findings and conclusions. Chapter 4 revealed how participatory DSM builds on best practice
elements of knowledge mobilisation practice by embedding co-production principles and
actively engaging key stakeholders, including end-users, as participants in the model
development process. Chapter 5 revealed the iterative cycles of engagement, analysis,
negotiation and refinement involved in the process of developing a DSM as a quantified
decision support tool for diabetes in pregnancy. The key analytic elements of the
interdisciplinary, participatory approach to develop a DSM for diabetes in pregnancy
included: negotiating a focus topic that was a current priority for participants; defining the
model scope; iteratively refining the model structure and logic; reviewing and synthesising
evidence to quantify the main dynamic relationships within the system; ensuring that the
model was focused on priority policy questions; engaging with and communicating model
results; and applying the model to support evidence-informed dialogues about policy
options. Chapter 6 provided new insights about the participatory process from the
perspective of end-user decision makers in three case-studies. The participatory aspects
were highly valued by both senior clinical and public health decision makers and were viewed
as essential for ensuring that the models utilised the best available evidence and focused on
priority policy questions that were locally relevant. The participatory process was also critical
to building trust in the model as a decision support tool. The diabetes in pregnancy model
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(Chapter 7) developed in the primary case study demonstrated a greater need for population
level (over targeted) interventions focused on weight loss in order to “turn the tide” on
diabetes in pregnancy. These findings from the individual papers will not be discussed again
in detail in this Chapter. Instead, the main findings of the thesis are synthesised from across
the included papers and discussed below as a body of work. The following sections also
present the challenges and limitations of this “real-world” participatory action research
study, and recommendations for future research.

Applying a participatory dynamic simulation modelling approach to public
health issues
As researchers and public health professionals navigate complex health policy environments,
there is growing need to engage in interdisciplinary problem solving, including creating and
using a wide range of evidence and other information [1-7]. DSM is a rapidly advancing
approach to decision support that can move beyond the limitations of traditional static,
statistical methods to facilitate greater understanding about challenging public health issues
[4, 8-10]. However, adoption of complex DSMs requires a conceptual shift for epidemiology
and public health professionals [4, 11, 12]. Dynamic simulation modelling requires a shift in
thinking away from statistical association models focused on effect estimates to simulations
which can test scenarios under different conditions. It also relies on a synthesis of diverse
evidence rather than focus on observed associations within finite and specific datasets [11,
12]. Complex DSMs do still require observational and experimental epidemiological data [11,
12]. However, these data need to be used differently, and in combination with new types of
data collected and generated using innovative technologies, such as mobile device
technology and machine learning. Prior research demonstrated that data from disparate
sources can be synthesised and collated in order to create simulation models that enable the
exploration of the key public health questions of interest [4-6, 9, 11, 12].

The technology required for modelling complex domains is readily available and increasingly
accessible to use [13]. However, for the full potential of policy-relevant modelling to be
achieved, attention needs to be paid to the processes of model development and to the
inhibitors and facilitators of model use [4, 13]. In the modelling case studies examined in this
thesis, the models were developed in partnership with Australian jurisdictional health
departments who were the primary stakeholders with key decision-making responsibilities
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for the complex, public health issues being examined. Participatory modelling processes
provided an opportunity for the stakeholders from a range of disciplines, including the enduser decision makers, to work collaboratively on complex and contested problems [5, 9, 13,
14]. The participatory processes adopted in the case studies facilitated the incorporation into
the modelling process of participants’ extensive and rich knowledge about the focus issues.
Their contributions were used by the modelling teams to inform, analyse and refine the logic
and structure for the models. According to the typology of stakeholder involvement
proposed by De Gooyert et. al., the role of stakeholders in our research included balancing
(identifying alternative decision options and associated trade-offs), structuring (increasing
knowledge about the focus issue) and involving (providing multiple viewpoints of the
problem issue and potential solutions) [15]. The involvement of these primary stakeholders
as partners ensured that the models targeted priority policy and program questions,
increased interest and confidence in the use of the models for decision support and
increased the likelihood of them being applied in practice (Chapters 4, 5 and 6).

Using co-production to convert qualitative conceptual maps into quantified simulation
models

Relationships and co-production of knowledge are key elements of knowledge mobilisation
and are critical to ensure that research findings are policy-relevant and can be utilised to
inform decision making [16-19]. The participatory approach provided a structured process to
facilitate interdisciplinary dialogue and combine diverse perspectives. This research
confirmed how the developed partnerships and relationships were critical to the model
development and to its likely subsequent use to inform health service and policy decisions. It
was important to ensure that partners were engaged early in the project and that they were
involved in deciding the priority topic to focus on. The end-user participants actively engaged
in modelling decisions; they were interested in ensuring that the model was grounded in
rigorous evidence and focused on their priority policy questions. This co-production was a
key element for maintaining the partnership relationships throughout the process.
Engagement activities and modelling team-participant interactions also occurred both within
and outside of formal workshops and meetings to facilitate participants’ contribution of
knowledge and their understanding of the model. Interactive activities were designed and
implemented to draw out participant knowledge and expertise and to familiarise them with
the model. The professional networks available through the participant groups identified and
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facilitated future opportunities for the model to be applied in practice. The end-user
participants all emphasised the importance of collaboration and valued the opportunity to
interact with colleagues to discuss the focus issue from a range of perspectives.

Recent reviews of knowledge mobilisation and participatory DSM across health and other
sectors identified the need for more knowledge about the implementation of participatory
approaches to model development [13, 20, 21]. Despite acknowledgement of the importance
of including end-user stakeholders in model development [13, 22-24] most participatory
modelling projects have not explicitly reflected on the participatory process component of
the project [23, 25]. Those that have reflected on the participatory process have
concentrated on health service and facility design [26, 27] rather than population health
policy development. This thesis is the first empirical research specifically focused on
understanding and elaborating the participatory method in applied population health policy
settings. The in-depth, empirical examination also exposed and reported the joint analytic
processes involved in converting the collaborative, conceptual system map developed with
participants into a rigorous quantified DSM (Chapter 5). The decision-making processes
involved in the model development were highly interactive, as participants identified,
reviewed and critiqued important sources of evidence to inform model parameters and
assumptions, and deliberated among themselves to ensure that the model was focused on
current, priority policy questions. Communication challenges commonly arise during
complex modelling projects [13] and were identified in the primary case study in this thesis.
For example, finding strategies to communicate a strategic view of the model logic and
assumptions without swamping participants in a detailed view of the structures used in the
modelling software was important. In my research of the participatory modelling process,
storytelling was identified as an effective strategy to overcome these challenges and
facilitate participant understanding of the structure and logic of the complex DIP model.
Storytelling was also effective to communicate model results to a wider policy audience
(Chapters 5 and 7). In the primary case study, the use of “case history” stories derived for
individual agents in the model were a familiar method to facilitate communication with
participants.
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Using participatory modelling to mobilise knowledge and inform health policy decision
making

Natural experiments and case-studies have been identified as important methods to
facilitate learning about the future role of systems approaches to knowledge mobilisation,
particularly, empirical studies of participatory modelling in applied ‘real-world’ settings [20,
28, 29]. The participatory DSM approach implemented in these case studies, and empirically
analysed in this thesis, built on elements of knowledge mobilisation best practice by
integrating and synthesising diverse forms of evidence into dynamic decision support tools;
embedding deliberative methods that placed end-users at the centre of the process and
emphasising stakeholder participation to co-produce knowledge. The perspectives of endusers on the unique benefits that participatory DSM provided over other forms of knowledge
mobilisation were also identified. These unique benefits are described in Chapters 4 to 6 and
included:



increasing familiarity and trust in the model through the use of participatory, coproduction methods;



the synthesis of diverse evidence into an interactive and dynamic decision support
tool;



the facility to explore “what if” scenarios and policy options;



exploring combinations and interactions of interventions to consider which
interventions to enhance, which gaps to fill and which target groups to focus on;



exploring the impact of new and untested interventions prior to implementing in the
real world;



and being able to forecast delays in intervention effects to modify expectations,
guide implementation monitoring, and identifying and prioritising evidence gaps.

As new technologies enable greater model transparency, increasingly participatory processes
can combine the significant knowledge of domain experts with the expertise of modellers to
develop complex, dynamic decision support tools [9]. Participants in the case studies
examined in this thesis reported that it was especially valuable to learn how decisions in one
part of the system impact on other parts i.e. to understand the focus issue from a systems
perspective. However, the participatory approach was resource intensive and required a
structured and rigorous process to ensure it added value to the modelling process and built
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trust in the modelling outputs (Chapters 4 to 6). Being involved in the participatory modelling
projects involved a significant time investment for participants. The policy makers who
engaged in the projects reported that they had carefully weighed the benefits and costs
before agreeing to participate. A significant factor contributing to their decision to
participate was that the focus topic was a current, local priority for which effective policy and
intervention options were unclear or contested (Chapter 4 and 6). In this context,
participants were motivated to explore both the issue in depth and new methods for
supporting decision making because the models were developed specifically to address their
local priorities and decision needs.

Interrogation of the model logic and model results is important to facilitate refinement of the
model and understand the implications for policy [13, 30]. Engaging with and discussing the
model findings was a critical phase in the participatory model development process in the
primary case study. Participants were encouraged to challenge and question the model and
critically review the data used to inform it. Unexpected results generated from the three case
study models provided opportunities to explore and challenge both the model assumptions
and the assumptions held by the participants in relation to the focus issues (Chapter 5 and 6).
Reviewing and discussing model results also provided an important opportunity to elicit
further participant knowledge prompted in this context.

Managing Uncertainty

Quantitative modelling methods including scenario analysis, system dynamics, agent based
modelling and discrete events simulation are useful to both identify and manage uncertainty
[25]. Management of uncertainty is an important element of good practice in model
development [31]. The types of uncertainty that are of particular importance for simulation
modelling in the health domain include: stochastic uncertainty - the random variability in
health outcomes between identical patients; parameter uncertainty - the uncertainty in
estimation of the parameter of interest; heterogeneity – the variability between patients that
can be attributed to characteristics of those patients; and structural uncertainty - the
assumptions inherent in the decision model [32]. The participatory modelling process
facilitated transparency of and robust discussion about the uncertainties inherent in the
models. The participants comprehensively reviewed and refined the evidence used to inform
model parameters and, through this process, identified key parameters that had higher levels
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of uncertainty as priorities for future research (Chapters 5 and 6). As described in Vignette 1,
Chapter 5, heterogeneity of both disease aetiology and outcomes for different population
groups was an important source of uncertainty that was acknowledged and explored at
length in the DIP model case study. Through the participatory process, knowledge about
individual characteristics that were likely to contribute to differential risk of disease or
effectiveness of interventions was elicited and shared between domain experts and the
modelling team. These discussions were viewed as providing important information to guide
which individual characteristics were represented in the model logic and structure (Chapter
5). Close involvement of participants in the model development process provided
opportunity for structural model assumptions to be made transparent and tested against
expert domain knowledge to ensure the assumptions were valid and robust. Statistical
methods, including drawing parameter values from known probability distributions and
calibrating parameters against retrospective data, were used in these case studies for
parameter estimation and to reflect stochastic uncertainty about individual differences in
health outcomes [9, 32]. Multiple simulations were used to assess variation in model
outputs between runs and the variation was measured and reported using 95% confidence
intervals for scenarios.

Embedding decision makers in the model development process, and making this process as
transparent as possible, facilitated their knowledge about the uncertainty associated with
the models. Participants emphasised that this increased their awareness of the limitations of
the models, the need to ensure that model outputs were interpreted appropriately, and for
non-participant end-users to be aware of the assumptions and limitations of the model
(Chapter 6). Issues relating to uncertainty are discussed throughout the thesis, however the
term “uncertainty” was not frequently used in the published papers. The audience for
published papers included health professionals and policy makers who were less likely to be
familiar with this modelling terminology. Therefore, the concepts were mainly discussed
using more accessible language such as when describing the tensions inherent in identifying
and negotiating quality evidence and prioritising evidence gaps, evaluating outputs and
deciding when the model was “fit” for use (Chapters 5 and 6).
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Summary of implications for future participatory modelling projects

There were a range of implications and suggested implementation strategies for future
modelling projects arising from this thesis: including strategies to facilitate the recruitment
and ongoing engagement of policy makers; ensure that the participatory process activities
were efficient and engaging and ensure that the models remained policy relevant and
focused. These have been outlined in detail in Chapters 4 to 6, however key implementation
strategies drawn from across the thesis are summarised in this section. In summary, the
engagement of senior clinicians and policy makers in the participatory approach provided
many benefits which justified the time and resources required for implementation. The sense
of ownership of the models and commitment from policy makers to use what they came to
view as ‘their’ model was an important outcome of the participatory process that facilitated
the use of the models to inform decision making. It was evident that senior policy makers
were selective about their involvement in research activities and would only engage and
participate if there was flexibility in the project to set focus questions based on their current
priority policy needs, and to revise the questions as needed. Having a known colleague
already involved in the project was also a useful strategy to encourage engagement.

The active engagement of stakeholders helped to parameterise and provided face validity
checks for the models. The collaboration facilitated the dynamic and continuous integration
of significant knowledge and a rigorous evidence base into the models. Through
collaboration, the modellers were informed about the complexities of the system they were
aiming to represent, and equally, the participants were educated about the capabilities and
limitations of the model that they were helping to develop. The participants perceived and
valued their role as knowledge contributors to the process and it is important that this is
emphasised in the participatory activities. When planning participatory workshops, emphasis
should be placed on structuring activities, such as those described in this thesis, that engage
participants actively to contribute their expertise. Translation of information between
disciplines emerged as an important challenge in these case studies and it is recommended
that ‘translator’ roles be implemented, preferably embedded within the policy environment,
to facilitate communication between participants, particularly between the primary policy
partners and the technical modelling team.
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The development of knowledge translation products was also identified as an important
phase of participatory modelling research projects. The participants in the primary case study
facilitated communication opportunities and identified key messages of interest to a broader
policy audience. It is recommended that knowledge dissemination be considered part of the
participatory process to elicit and leverage participant expertise. The DSMs developed in
these case studies provided an opportunity to explore priority public health issues from a
quantified and rigorous, systems perspective. This facilitated the mobilisation of knowledge
and generation of policy insights that would not have been possible using more traditional
statistical techniques.

Building on the 4 p’s framework for reporting participatory modelling projects
in an applied health setting
The detailed examination of the participatory process reported in this thesis has added
significant value and new understanding to a recently proposed framework [33] for reporting
participatory modelling projects. This framework was developed in the environmental
science modelling domain; and provides a useful template to facilitate reporting and
communication by structuring the description of participatory modelling projects [33]. The
manuscript in Chapter 5 demonstrated how the ‘Process’ component of Gray et al’s
framework is relevant to health modelling projects, and can be applied to foster learning
across sectors. The Process component explores how participants were involved in the model
development, describes the level of participation, and the relationship between the process
and decision making.

However the Gray framework also identifies ‘Purpose’, ‘Partnerships’ and ‘Products’ as key
components of participatory modelling projects and practices [33]. The Purpose component
defines the issue being modelled, describes the justification for building the model and for
using a participatory process (the why). The Partnerships component describes the
stakeholder partnerships that formed around different parts of the process (the who),
defines the owner of the process and the criteria for including participants. The Product
component describes the outputs resulting from these efforts (the what) including the policy
insights. I have applied these four components to the primary case study, the DIP model, in
Table 1 to provide an overview of all of the case-study findings, and to demonstrate how the
framework can be used as an interdisciplinary method to report on and facilitate learning
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from participatory modelling projects across sectors. On reviewing this application of the 4P
categories to the findings in my thesis, I have proposed that two additional components be
added to the 4 P’s framework: i.e. consideration of research ‘imPact’, and ‘Prioritising’ future
research. These potential new components have also been added to Table 1 and are
explained and discussed below.

Considering imPact

The first additional component arising from this thesis is imPact. There are increasing
demands to demonstrate the beneficial impact of research in terms of the social, economic
and domain specific outcomes e.g. health outcomes [34-38]. Research impact can be direct
or indirect and short or long term [36] and it is acknowledged that it can be difficult to
measure and demonstrate, particularly when reporting in short term policy and grant
application cycles [35, 36, 38]. However, it is important to consider and report examples of
the impact of simulation models beyond the generation of policy insights, where possible, to
both provide practical demonstration of their value and promote their ongoing use for policy
discourse. Research impact has been defined as the intended positive impact of a research
activity or an intervention [38, 39]. A systematic review conducted in 2017 identified 26
research impact frameworks for health care research [37]. The authors synthesised the
research impacts that were common across the frameworks into short, mid and long term
impact outcomes in five domains including primary research related outcomes (short term),
influence on policy making, health service impact (mid term), health and societal and
economic impact (long term) [37]. Impact reporting frameworks need to be flexible, not
impose onerous reporting requirements and able to be tailored to fit the diverse range of
research projects conducted [37]. The following question is proposed to be included in the
reporting framework - “What was the imPact of the modelling process?”. Three sub-domains
are proposed for this component; process impact, forecast impact and policy impact. These
are explained below and are applied to the primary case study in Table 1:

1. Process impact: Describe the outcomes arising from the co-production, participatory
process and the model, such as capacity building and knowledge exchange, that
increase the likelihood of impact. Provide examples of products used to
communicate insights from the model.
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2. Forecast impact: Describe how the model outputs can be used to forecast the impact
of policy or program interventions. For example, the DIP model outputs forecast the
need for population level weight reduction interventions over interventions targeted
at high risk groups to impact on the incidence of DIP.
3. Policy impact: Describe how model outputs are being used to inform decision
making. For example, the DIP model is being applied to inform the development of a
diabetes plan for the ACT.

Prioritising future research

The second additional component is Prioritisation. Identifying and Prioritising gaps in the
existing evidence base is an important component of the model development and
maturation process (Chapter 6) [4]. Lack of data should not preclude the use of modelling,
particularly when the model development applies an iterative, participative approach that
allows data needs to be identified and ways of addressing these to be developed [13]. The
participatory process in these case studies mapped the causal factors and explored the
impact of interventions for each focus topic in these case studies which facilitated the
identification, clarification and prioritisation of gaps in current knowledge and evidence
which can be used to guide future research. A core factor in policy makers’ motivation for
participating in the projects was that the case studies focused on priority topics which had
aspects that were not currently well understood and had contested policy alternatives that
could be explored using the simulation models. The knowledge gaps identified and prioritised
as an important focus for future research in the primary case study included understanding
the individual heterogeneity of aetiology of diabetes in pregnancy and the impact of differing
levels of glycemic control during pregnancy on maternal and perinatal outcomes (Table
1).The negotiation and prioritisation of evidence gaps was a highly valued benefit of the
participatory process for end-user and researcher participants (Chapter 6) and is important
to communicate to the broader research community when reporting on participatory
modelling projects.
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Table 1: Extended 4 P's framework for reporting participatory modelling projects applied to the primary case study

Component

Questions / Dimensions

Application to DIP model

Purpose

Why model? And Why
participatory?

The decision rationale for modelling Diabetes in pregnancy (DIP) for ACT Health
was as follows. DIP is a complication of pregnancy that is defined as
carbohydrate intolerance resulting in hyperglycaemia (abnormally high blood
sugar). It includes women for whom the first recognition or onset of the
condition occurs during pregnancy, as well as women with pre-existing type 1
and type 2 diabetes mellitus [40]. There has been a dramatic increase in the
prevalence of DIP both in Australia and internationally [41] alongside increases
in identified risk factors including high maternal body weight, physical inactivity,
increasing maternal age, increasing parity and ethnicity [42-44]. There are shortand long-term health risks for both mother and baby, including increased risk of
birth injury in the short term and development of diabetes later in life [45-48].
The available evidence does not definitively guide health services on how best to
prevent and manage DIP with policy and program questions crossing the
spectrum from population health interventions to complex clinical management
issues [49-52]. Sophisticated analytical tools, developed using an
interdisciplinary approach, such as participatory DSM, are needed to inform
policy and health service planning decisions.
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Component

Questions / Dimensions

Application to DIP model

Process

How were stakeholders involved
in the model development?

The participatory process centred around three face- to face- workshops where
participants interacted to collaboratively map a qualitative conceptualisation of
the focus issue; prioritised and mapped interventions to be tested in the model;
prioritised and defined the outcomes to be measured; and reviewed and refined
iterations of the model. Multiple additional forums e.g. web meetings, emails,
and small group meetings, were used to engage participants throughout the
process. A diagrammatic overview of the activities involved in the participatory
process was included in Chapter 5. The activities were fully described in Chapters
3, 4 and 5. The model was developed to test policy intervention scenarios.

Partnerships

Who participated and why?

A diverse range of domain experts, including clinicians, public health specialists,
researchers, and computer scientists engaged in the participatory process to
collaboratively conceptualise the complex issues relating to diabetes in
pregnancy and to co-produce a DSM to support decision making. The members
of the participatory modelling consortium were listed in Chapter 7.

Products

What was produced by the
modelling process?

The core product was a multi-scale DSM of diabetes in pregnancy in the ACT that
can explore policy and health service scenarios to prevent and manage DIP. The
model incorporated the complex and interrelated causal factors that contribute
to the development of DIP and explored intervention options and combinations,
spanning the spectrum from clinical to population health interventions. The
model brought together the best available evidence and data with integrated
complex systems modelling approaches to inform policy decision making for
diabetes in pregnancy and is described in Chapter 7. Associated products were
developed to facilitate communication of model results to a broader nontechnical audience. These included a plain language factsheet about the model,
a podcast and an interactive results dashboard (Chapter 7).
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Component

Questions / Dimensions

Application to DIP model

ImPact

What was the impact of the
modelling process?

Process impact: Capacity building and knowledge exchange was a key impact of
the participatory modelling. The process enabled significant knowledge about
both dynamic simulation modelling and diabetes in pregnancy to be combined
to develop a decision support tool for policy and practice decision making.
Professional academic, clinical and information sharing networks were
established through the process. The model and the participatory process have
been presented in multiple clinical, simulation modelling and knowledge
mobilisation forums.
Forecast impact: High weight status is an important and modifiable risk factor for
DIP, and the impact of prevention interventions targeting weight were
prioritised for first testing in the model. Model results forecasted that
population level interventions would be necessary to make an impact on DIP
incidence in the ACT. Targeted interventions for high risk women delivered
either pre- or post-pregnancy were simulated to have a positive impact for
individuals but would not substantially impact on population DIP incidence. The
model also demonstrated that prevention interventions need to overcome BMI
increases associated with increasing maternal age and parity.
Policy impact: These findings are currently being used to support and inform a
diabetes prevention and management plan for the ACT. The model findings have
been used to emphasise the importance of including diabetes in pregnancy as a
central focus for the service plan.

Prioritising

What future research priorities
arose from the process and/or
the model?

Two research priorities that arose from the process included firstly, improving
knowledge about the dynamics and heterogeneity in the aetiology of glycemic
dysregulation and diabetes mellitus development and secondly, understanding
the impact of glycemic control during pregnancy for women diagnosed with DIP
on maternal and perinatal outcomes.
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Research in a real-world context – reflections on the challenges, strengths and
limitations of this participatory action research
In this section I will reflect on the participatory action research (PAR) approach employed as
a conceptual framework to investigate the research objectives, and discuss the associated
challenges, strengths and limitations. PAR differs from conventional research in three ways
[53]. Firstly, the focus of PAR is to both study and enable action. As described in the Chapter
1, the action is decided through a reflective cycle, whereby participants collect and analyse
data, then determine what action should follow. The resulting action is then further
researched, and an iterative reflective cycle perpetuates data collection, reflection, and
further action [53]. Secondly, participants become partners in the research process: including
selecting the research topic, data collection, and analysis and deciding what action should
happen as a result of the research findings [53, 54]. Thirdly, PAR contrasts with less dynamic
approaches that separate data and information from their contexts, PAR is embedded within
the research context [53]. The PAR framework of action orientation, collaboration, reflection,
iteration and involvement of researchers as participants was applied on two levels in this
thesis. Firstly, within the core research cycle investigating the development of the DSMs for
diabetes in pregnancy; and secondly, as part of the reflective research cycle examining the
participatory approach to model development in both the primary and the two additional
case studies.

Researcher position is critical to consider in participatory action research as the action
researcher impacts on the process being examined and exerts influence on the study [53,
55]. My position in the participatory action research was as a participant observer; I both
enabled and examined the process of developing the DIP dynamic simulation model using
participatory methods and studied the value and utility of the participatory modelling
process as perceived by end-user decision makers. As outlined in Chapter 3, my role in the
primary case study (DIP model) was highly visible as the project lead, core modelling team
coordinator, and primary conduit between the technical modellers and the stakeholder
participants. My central role as both project enabler and PhD candidate / researcher was an
important consideration when interviewing the end-user decision makers to elicit their
perceptions of the value and utility of participatory modelling for decision support. Firstly, I
was explicit about seeking participants true perceptions of the process and invited them to
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genuinely reflect on both pros and cons. Secondly, the participants were all senior research,
policy and practice professionals who were also aware of my status as a PhD candidate and
less likely to feel the pressure of providing a socially desirable response than perhaps less
experienced study participants may have been. Finally, the potential for interviewees to limit
the disclosure about negative aspects of the process was further mitigated in the research
design with the inclusion of two additional case studies. This allowed me to collect data from
projects where I had not played a visible role in facilitating workshops and developing the
model. The additional interviews provided opportunity to compare across interviews to
examine whether there was some caution among participants from the primary case study to
fully disclose their views on the value of the process. The level of interviewee openness was
found to be similar across all case studies. The senior policy makers and clinicians
interviewed were comfortable to openly discuss both the negative and positive aspects of
their experience with the participatory model development process and the benefits and
limitations of using the models to inform decision making (Chapter 6).

A core characteristic of participatory action research is that it is embedded in a real-world
context [53]. As described above and in Chapters 4 to 6, this can strengthen the research by
providing opportunities for it to be directly applied to addressing real issues. However, realworld policy making can also result in challenging and unexpected circumstances that delay
or impact on the implementation of the research [55]. This thesis examined the in-depth
collaboration of senior clinicians, policy makers and researchers from multiple Australian
jurisdictions that addressed priority public health issues. Engaging the very senior and highly
busy participants in the model development processes provided access to a significant
knowledge base, and opened doors to opportunities for the models to be applied in practice.
However, these senior domain experts also had many competing commitments and a
significant challenge of implementation was ensuring that interactions with them were
focused and efficient, met their expectations, minimised the risk of overburdening them and
therefore facilitated their ongoing engagement in the process. An additional, practical
challenge was finding suitable times to bring all the participants together. For the DIP case
study for example, it became apparent as the project progressed that long lead times would
be essential when booking workshops and meetings to ensure that as many key participants
as possible were able to attend. It was therefore necessary to estimate when each
development stage of the model would be ready for presentation to participants well in
advance. Most times, these estimations were reasonably accurate, and meetings went ahead
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as scheduled, however sometimes unexpected delays occurred and some meetings had to be
postponed resulting in further, lengthy negotiations regarding scheduling.

The core modelling team for the primary case study also had other priorities to balance
during the study period. For example, the head of the technical modelling team based in
Canada, Professor Nathaniel Osgood, a highly skilled and experienced modeller with
substantial teaching and research commitments, relied on much of the detailed
programming being completed by his post-graduate students, working under his supervision.
All these modellers needed to balance their time on the DIP model development with other
commitments. There were also two personnel changes among the student modellers as each
person primarily responsible for model development moved on in their own studies. The DIP
model is a highly sophisticated and complex model and each new modeller required time to
become familiar with it and learn the next steps for its development under the guidance of
Professor Osgood. The development of an Australian-based programming workforce who
specialise in health sector modelling has been an ongoing challenge and priority for The
Australian Prevention Partnership Centre and other agencies who aim to expand the usage of
these technologies for policy decision support.

Finally, it is important to reflect on my own position as an employee within ACT Health –
which I believe was invaluable in enabling and facilitating the implementation of this
collaborative project. While undertaking this research I also continued to work part-time as a
Manager within the Epidemiology Section in ACT Health. In this capacity I was embedded
within the health service, which provided invaluable opportunities to use my established
professional relationships to establish the project within ACT Health, and to engage
participants in the model development process. My work context also enabled me to
subsequently apply the findings of the research to inform ACT Health policy development for
diabetes in pregnancy. Fortuitously, the completion of the DIP model coincided with the
timing of the ACT Health Minister’s interest in diabetes, and diabetes in pregnancy in
particular, as an important health issue. To facilitate communication of the model and
engagement with the Minister and her advisers, a suite of knowledge translation products
was developed, including a fact sheet, an interactive dashboard and a podcast (Chapter 7).
However, just prior to the date scheduled for the model to be presented to the Minister,
other priorities subsumed her attention. These included a major organisational restructure in
which ACT Health was a split into two agencies, and intense, negative local media interest in
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her portfolio (for example https://www.canberratimes.com.au/canberra-news/health-splitnot-a-fix-but-good-step-forward-fitzharris-20181002-p5079a.html). These issues resulted in
the postponement of the presentation to, and engagement with, the Minister. However, at
the time of writing she remains interested in the model as a new analytical method for
informing policy and it is intended that the meeting will proceed – although after the
submission of this thesis. It is important to note that whilst these matters were specific to
the context of the ACT at the time of this thesis, similar fast moving events are the norm in
the modern political context. They need to be considered when embarking on complex
modelling projects and to guide realistic expectations about the timing and likelihood of
successful impact.

Recommendations and next steps:
Recommendation 1: Develop strategies to share knowledge and support
interdisciplinary modelling collaborations

One of the most important determinants of the successful policy modelling projects
examined in this thesis was the collaboration and communication among those involved: the
modellers themselves, the participants and stakeholders and the end-users of the model
outputs. This cross-disciplinary collaboration was essential to yield useful policy models that
were actually used by decision makers [13, 56]. However, because of the diversity of
professional backgrounds among those involved, it was challenging to navigate the
differences in terminology, methodological approaches and domain understanding for each
discipline [7, 56, 57]. In all of the case studies included in this thesis, “translators” played a
pivotal role in working between the disciplines to facilitate communication and
understanding [56]. Further development of strategies and methods to support
interdisciplinary modelling collaborations, and communication forums to share knowledge
across disciplines (e.g. [7]) is recommended to facilitate ongoing advances in crossdisciplinary participatory modelling research.
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Recommendation 2: Incorporate strategies derived from this participatory action
research in the implementation of future participatory modelling projects

There were also many challenges associated with the practical implementation of the
participatory aspects of the modelling. It was time consuming, intellectually demanding and
required effective and patient coordination and facilitation skills. However, the benefits
outweighed the challenges, providing opportunity to develop useful, policy-relevant models
that were truly grounded in rigorous evidence and the significant knowledge base of the
participants. Participant interest and engagement remained high across the three case
studies and opportunities to utilise the models to inform decision were facilitated through
their professional network. Detailed recommendations and procedural guidance for the
implementation of participatory DSM were reported in Chapters 4 to 6. The key
recommendations are summarised below:

Emphasise co-production – co-production of knowledge was reported by all participants as a
highly valued outcome. It is recommended that a diverse group of expert participants be
engaged as equal partners in all phases of the project from negotiating a focus topic, to
engaging in the model development activities, actively contributing expert knowledge,
refining the models, reviewing the model results and identifying and facilitating opportunities
to communicate policy and program insights. Ensuring that the participant group includes
representation of groups who have an important stake in the focus topic is recommended to
facilitate the acceptance and use of the model.

Focus on a current priority topic – Participatory modelling processes are time consuming and
resource intensive. Therefore, it is recommended that future modelling projects include a
planning phase in which the focus topic is considered and negotiated with policy partners
prior to commencement.

Recruit key project roles – It is recommended that the two key project roles that facilitated
effective engagement of expert participants in these case studies be utilised in future
modelling projects. These are the Domain expert, a well-respected authority on the focus
issue and who can play a lead role in the project planning and workshop facilitation; and the
Translator, a person who can translate the characteristics of the policy environment and data
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for the modelling team and the model requirements and development process for the
participants.

Encourage openness and transparency in the process – The participatory process provides a
valuable opportunity to leverage significant knowledge in the development of policy decision
support models. A challenging, but rewarding, aspect of the process was openly engaging
with participants to iteratively critique, refine and ultimately improve the model. It is
recommended that openness and transparency in the process be encouraged in future
modelling projects to increase trust with participants and achieve policy relevant and useful
DSMs.

Communicate – Communication was critical in all phases of the modelling project. It is
recommended that background briefing material about the participatory process is
developed prior to the commencement of the participatory process to enable participants to
prepare. It is recommended that frequent concise and targeted communication and project
updates be provided to participants to facilitate their ongoing engagement without
overburdening them. Simple, clear and concise key messages about insights from the model
should be derived and tools developed to facilitate communication to a variety of audiences.

Recommendation 3: Build dynamic simulation modelling capacity among public health
professionals and expand research into the application and comparison of modelling
methods for health policy questions

Many of the participants who engaged in the modelling projects had limited experience with
DSM methods at the outset [56]. They were therefore unable, for example, to contribute to
decisions about the methods used to represent causal pathways, or strategies to overcome
gaps in the evidence base. As participant experience with and knowledge of DSM methods
increases, further research into end-user or policy makers’ views about different systems
science methods will be possible and is highly recommended. For example, the perceived
value of agent-based modelling compared with system dynamics modelling in terms of
conceptual design, model structure and usefulness for decision making would be of value to
explore, along with the preferences for one modelling method over another for different
policy questions. These insights would help inform future modelling projects and target areas
requiring development. Incorporating DSM concepts and their application to public health
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issues into public health professional, biostatistics and epidemiologist training programs is
also recommended to increase awareness and adoption of these methods in the health
sector.

Recommendation 4: Develop and test methods to facilitate interdisciplinary
communication

A key challenge identified in this thesis was the design of communication methods that were
effective across disciplines. Methods were required, firstly, to communicate model structure
and logic in a way that was transparent and understandable for participants, and secondly, to
communicate the model results to a broader policy audience. The lack of effective,
transdisciplinary communication methods is a barrier to the uptake of modelling for public
health [4] and the challenge will increase as more complex and sophisticated policy models
are developed. Storytelling was one strategy utilised in this research to both communicate
the model structure (Chapter 5) and the model findings (Chapter 7), however further
research will be required to explore the effectiveness of this communication approach in
other settings and whether other strategies are equally or more effective. Observational and
experimental study designs could be utilised to investigate this issue drawing on participatory
action research, communications, psychology and organisational behaviour research.

Recommendation 5: Test the novel participatory methods utilised in these case
studies in other settings

The case studies investigated in this thesis were based in Australian jurisdictional health
departments. Further exploration is necessary to determine if the novel collaborative
methods used in these case studies would be as effective in other international settings.
However, the in-depth analysis identified themes that were generalisable across the three
case studies and can be utilised by multiple disciplines, including researchers, modellers,
health service planners and policy makers, to inform future participatory modelling projects.
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Next steps for the diabetes in pregnancy model
Dynamic simulation models mature over time. Further model development and modification
can occur post-commissioning as new knowledge and evidence becomes available or new
policy questions arise (Chapter 6) [9]. Further development work is planned for the DIP
model developed in the primary case study to leverage its ability to explore intergenerational
effects of diabetes in pregnancy on health outcomes. The use of agent-based modelling
methods allows for individual agents to “inherit” a maternal history of diabetes in pregnancy.
The effect of this on the individual agent’s risk of developing childhood overweight or
obesity, diabetes in pregnancy, or early onset type 2 diabetes mellitus will be incorporated
into the next version of the model.

Conclusion
This thesis explored the use of participatory DSM to inform health policy discourses, and it is
the first empirical research specifically focused on understanding and elaborating the
participatory method in applied health policy settings. This aim was achieved through the
application and study of a novel participatory modelling approach in one primary and two
secondary case studies. The in-depth analysis demonstrated that participatory DSM is
feasible, useful and valuable to apply to priority public health issues with global significance
[58]. The novel participatory activities utilised in these case studies successfully elicited and
mobilised detailed and comprehensive knowledge and evidence about the focus issues which
was synthesised and incorporated into the models. The process utilised in the primary case
study was examined in detail to uncover the core analytic processes, activities and decisions
involved in developing a DSM for diabetes in pregnancy using participatory methods. The
analysis identified the common motivators for participation, the highly valued co-production
elements and the unique benefits of DSM from the perspective of senior end-user policy
makers who engaged in the case studies. The DSMs developed in these case studies are
being used to provide policy insights and to inform decision making in Australian health
services. The systematic data collection and analysis in this thesis identified key elements
required for successful implementation of participatory DSM projects and provided valuable
insights and practical guidance for implementing future projects in applied health settings.
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Population Health Bulletin. Volume 6, Issue 2, May 2017, p, 31-32
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Case Study
Harnessing new technologies to inform health decision making:
Dynamic simulation modelling as a decision support tool for diabetes in pregnancy
Louise Freebairn, Epidemiology Section and Dr Paul Kelly, Chief Health Officer & Deputy Director General, Population Health Protection & Prevention Division, ACT Health
There is mainstream acceptance that decision making for health programs and policies should be evidence-based; however this can be difficult to achieve. The concept of “evidence informed decisions” is particularly challenging in population health policy and practice, where
many of the current “big questions” are complex and not easy to address. These problems have multiple interacting causal factors with
competing possible courses of action for decision makers to choose between, each course of action potentially resulting in complex and
unintended consequences.1,2 Many factors, including availability and diversity of information, opinion and experience, timing, the political
cycle, local norms, the influence of external players, and the availability of funds all influence decision-making.3,4
Research methods in prevention science have traditionally taken a reductionist approach focusing in detail on components of a system.5,6
For example, many studies have looked at the effectiveness of specific interventions on specific target groups. These studies have contributed, and will continue to contribute significantly to our knowledge, however, these methods have difficulty accounting for the complexity
of population health where there are delays between cause and effect and unanticipated consequences of interventions.7 New approaches,
such as dynamic simulation modelling, provide insights into broader system behaviour in population health and enhance the evidence
available for decision making.

Dynamic simulation modelling

Dynamic simulation modelling is a systems science method that recreates complex systems and human behaviours as a computer, or
mathematical, model. These models can answer ‘what if’ questions about the likely impacts over time of different policy and intervention
options and combinations so that they can then be considered more broadly before implementation in the real world.1,8 Dynamic simulation modelling has been used to map health system components and their interactions, bring together evidence, examine and compare the
potential outcomes of interventions, and guide more efficient investment and conscientious disinvestment of resources.8 This is important
for preventive health policy and practice where decision support tools must have the capacity to steer a course through the complexity of
interactions that give rise to real-world public health problems such as the global epidemic of chronic disease.1,8,9
Advances in technology have made modelling methods more user-friendly and allow for greater participation in model development.
Participatory model development engages multidisciplinary stakeholders in a group model building process where participants share their
knowledge about the causal pathways for the focus issue and where and how interventions have an impact on outcomes. Through a series
of participatory workshops, the model building group, informed by evidence and data, collaboratively identify and map the key risk factors and likely causal pathways leading to outcomes of interest. The map is then used to construct, quantify and test a computer modelled
representation of the causal pathways and intervention effects for the focus issue.1,8,10-12
The Population Health Protection & Prevention, ACT Health, in partnership with The Australian Prevention Partnership Centre, has
brought together local, national and international researchers, clinicians and policy makers (see modelling participant group description
below) to collaboratively develop a dynamic simulation model for Diabetes in Pregnancy in the ACT.13 More information about this
process is available here: http://preventioncentre.org.au/our-work/research-projects/gestational-diabetes-through-a-systems-science-lens/.

Diabetes in Pregnancy in the ACT

Diabetes in pregnancy (DIP) is increasing both in the ACT and Australia,14,15 and this is challenging the capacity of diabetes services. The
increase in DIP is associated with an increasing prevalence of risk factors such as overweight and obesity, older maternal age and increasing numbers of women from high-risk ethnic groups.14 Diagnostic screening guidelines were modified in 2015 to address the changing
characteristics of women becoming pregnant and the increasing prevalence of type 2 diabetes mellitus.16 The new guidelines recommend
that women who are high risk for developing diabetes in pregnancy should be screened in the first trimester of pregnancy.16 Consequently,
these women are diagnosed with DIP earlier in their pregnancy and require services for a longer period of time. With increasing prevalence
of risk factors, service providers report that women are more frequently presenting with a combination of risk factors resulting in more
complex diabetes care needs.
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Case Study
Harnessing new technologies to inform health decision making:
Dynamic simulation modelling as a decision support tool for diabetes in pregnancy
The rising prevalence of DIP is having a significant impact on health service demand and resources, and the need to “do things differently”
was identified by participants. The model can inform investments for intervention in DIP, spanning the spectrum from clinical to population health interventions. Workload and resource use have been incorporated into the model to enable it to act as a resource allocation
decision support tool. Prevention of risk factors was also prioritised in the model as small delays in the development of diabetes will have
large implications for the longer-term burden of disease and costs to the health system. The model considers the short, intermediate, and
long term implications of the increasing prevalence of risk factors for DIP. At the time of publication, this model was being finalised.
What if?
Dynamic simulation modelling is a decision support tool allowing for policy and practice scenarios to be simulated and explored.
This “what if” capacity can be used to compare interventions alone or in combination before they are implemented. Examples of
“what if” questions that can be explored in the ACT Diabetes in Pregnancy model include: What if we implemented population
health interventions to reduce modifiable risk factors for diabetes in pregnancy? What if we targeted particular sub-groups with these
interventions? How should the intervention be delivered? What if we modified the model of care for diabetes in pregnancy services?
What is the likely impact on resource use?

Diabetes in Pregnancy ACT Modelling Group Participants

The Diabetes in Pregnancy Modelling group participants included policy and program officers, endocrinologists, a neonatologist, a general
practitioner, diabetes educator, public health professionals, medical and population health researchers and dynamic simulation modelling
experts. Participants included local, national and international experts in the field travelling from South Australia, Northern Territory, New
South Wales and Saskatchewan, Canada to participate in the workshops.

Conclusion

Participatory dynamic simulation modelling provides opportunity for diverse health stakeholders to collaborate and explore policy and
health service scenarios for priority public health topics and support decision making. Technological advances in modelling software combined with participatory modelling methods place the decision maker at the centre of the process in the development of dynamic decision
support tools. Research into the impact of these methods on decision making is ongoing.
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Appendix 2: Ethics approval letters

Ethics approval letters from:


ACT Health Human Research Ethics Committee; and



University of Notre Dame Australia Human Research Ethics Committee.
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Appendix 3: Participant information and consent forms

Participant information form and consent forms are included for: firstly, the model
development group who participated in the diabetes in pregnancy case study and secondly,
the end-user participants from the additional case studies who were interviewed.
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Appendix 4: Summary report – Gestational diabetes modelling workshop one

The following report was provided to participants from the model development group for
the diabetes in pregnancy case study following workshop one.
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Summary of Gestational Diabetes
Modelling Workshop One
5 May 2016
Background
The purpose of The Australian Prevention Partnership Centre (TAPPC) is to develop
and use systems thinking and systematic ways of preventing lifestyle related chronic
disease. People from a range of disciplines, backgrounds and countries have
gathered together to come up with practical ways to support decision making and
research translation to address these issues
This project will develop a dynamic simulation model that will look at gestational
diabetes mellitus (GDM) from an ACT perspective and will be using ACT data.
However, the national context will be considered in the model development and
the model will be a proof of concept with the potential to expand much more
broadly.
The model will consider the short, middle and long-term implications of the current
food culture, overweight and obesity and GDM and Type 2 diabetes mellitus. Small
delays in the development of diabetes will have large implications for the longerterm burden of disease and costs to the health system. This long-term vision is
important as the model is built collaboratively.
Increasing demand for health services due to the rising prevalence of GDM is having
a significant impact on resources and the need to “do things differently” was
identified by several workshop participants. Workload and resource use will be
incorporated into model to enable it act as a resource allocation decision support
tool.
This workshop brings together practitioners, policy makers and researchers and
allows for greater accessibility of data and expertise. This partnership also allows for
research to be translated into policy and program decisions more readily.

MODELLING FOR GETATIONAL DIABETES WORKSHOP 1 | SAX INSTITUTE
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Model purpose
The following purposes for the model were synthesised from the key modelling
questions contributed by participants at the workshop. Full responses are included
in Appendix A.


Determine the best investments for intervention in GDM. E.g. “I’m here to
see if modelling can help determine the right interventions, at the right
times, by the right people, in the most efficient and effective way (to make a
difference).” Interventions in the model to include both clinical and
population health interventions.



Examine GDM within a context or system e.g. Food environment, personal
environment such as stress and coping.

Determining model structure: interventions and outcomes
Participants were divided into two groups to identify priority interventions and
outcomes. Interventions and outcomes will be the focus of workshop 2, however it
is important to understand the types of interventions and outcomes that will be
incorporated into the model when commencing the model build. Workshop 2 will
focus on identifying the causal mechanisms for the interventions and outcomes.
Each group identified interventions and outcomes and then all participants voted on
those interventions and outcomes they considered to be most important for
inclusion in the model (see images below).

Interventions:
This group discussed interventions based on a life course (from pre-pregnancy right
through to college, Image A below). It was discussed that the biggest benefit at the
population level is achieved when targeting people going from normal weight to
overweight.
Most of the interventions that were mentioned were around education and primary
prevention around physical activity and healthy eating.
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Image A: Interventions identified across the life course

Top 5 prioritised interventions:

1.

Weight and height measurement pre pregnancy - having ongoing education
about what is a healthy BMI, for pre pregnancy in particular. This would be a
combination of awareness and education and measurement. Include a
feedback mechanism.

2.

Targeted preconception programs for high risk - women who are considered
v high risk for GDM, come to program that works on getting them into the
right shape before they conceive. (Subset of the first program)

3.

Inter pregnancy - lifestyle change targeted at this stage of a woman's life
course. Trying to reduce women who have had GDM gain for overweight
and obese

4.

Early screening at booking for the pregnancy. (Clinically based intervention).
Not just for when they come to the hospital, but also when they come to GP
- and what that would involve.

5.

Incentives for lifestyle change.
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Outcomes:
This group identified outcomes for the mother and outcomes for the baby
separately and divided them into short term, medium term and long term outcomes
(see Images B and C below).

Top 5 prioritised outcomes:

1.
2.
3.
4.
5.

Incidence of GDM
Maternal diabetes
Childhood obesity
Early onset diabetes
Diabetes complications

Image B: Outcomes for Mother identified by participants
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Image C: Outcomes for baby identified by participants

Mapping causal factors to the model infrastructure
Image D: Participants mapping factors to the agent based modelling infrastructure
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A “strawman” model infrastructure for three agent state charts was laid out on a
large table.
The three state charts were as follows:
Pregnancy state chart: States = not pregnant, 1st pregnancy, subsequent pregnancy
GDM state chart: States = Low risk for GDM, high risk for GDM, GDM diagnosed
(with sub states indicating that the GDM was well controlled or not)
Weight state chart: States = normal/underweight, overweight, obese
Participants were asked to identify factors that contribute to people moving
between the states in each state chart.
Image E: Detail of mapped factors

Refining the priority causal factors for inclusion in the model
A sub-group of participants met subsequent to the workshop to refine and
synthesise the factors identified. A process of grouping the factors identified the
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following themes (listed in no particular order) which will be represented in the
model.
1. Family history/genetic factors
a. Family history of diabetes
b. Family history of obesity
c. Epigenetics
d. Genes
2. Food
a. Unhealthy diet
b. Food security
c. Food environment
3. Physical Activity
a. Level of physical activity
b. Level of sedentary behaviour
c. Physical environment
4. Health state
a. Previous pregnancy with GDM
b. Multiple pregnancy
c. Previous still birth
d. Previous macrosomic baby
e. Previous pregnancy with fetal growth restriction
f. Personal history of macrosomia
5. Health care system
a. Type of screening test
b. Universal or selective screening
c. Access to health care – rurality/remoteness
d. Health bureaucracy
e. Government policy
f. Infrastructure/environment
g. Market/trade
6. Metabolic functioning
a. Weight status
b. Gestational weight gain
7. Non-modifiable factors
a. Age
b. High risk ethnic group
c. Migration
d. Polycystic Ovary Syndrome (PCOS)
8. Psychosocial
a. Education level

MODELLING FOR GETATIONAL DIABETES WORKSHOP 1 | SAX INSTITUTE

263

b.
c.
d.
e.
f.
g.

Social network
Cultural norms
Occupation
Inequality
Psychological factors
Poverty

Next steps:


Workshop 2 will focus on interventions and outcomes. Participants will
identify the causal mechanisms for interventions and pathways for
measuring outcomes.



Participants have been invited to be involved in model development
meetings and discussions between workshops.



Workshop 2 – 19 August 2016.

MODELLING FOR GETATIONAL DIABETES WORKSHOP 1 | SAX INSTITUTE

264

Appendix A Key questions identified by participants














I’m interested in the food environment and the impact this has on the
problem of GDM. How can we link the acute management of GDM with
population level management? How do we measure outcomes that occur at
the systems level?
How do we manage GDM, particularly in the second half of pregnancy?
How does GDM fit into the broader problem of diabetes and obesity
prevention?
I’m concerned with the continuum of pre-pregnancy, during pregnancy and
after pregnancy. Here to see if modelling can help determine the right
interventions, at the right times, by the right people, in the most efficient
and effective way (to make a difference).
Consideration of personal and contextual factors that contribute to stress.
Better ways to assess models of care for managing GDM.
Interested in looking at different approaches before and after prevention,
and how the model can help decide where to invest for intervention.
Different models of care provision and testing better ways to prevent GDM.
The risk for the next generation and prevention as early as possible for the
next generation.
What is the best bang for buck for population interventions and clinical
management interventions? Also, long term considerations in terms of
health services costs and burden of disease.
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Appendix 5: News article – Workshop unpicks causes of gestational diabetes as part
of simulation modelling project.

This news article was written for publication on the Australian Prevention Partnership
Centre website: Workshop unpicks causes of gestational diabetes as part of simulation
modelling project. http://preventioncentre.org.au/news-and-events/prevention-centrenews/workshop-unpicks-causes-of-gestational-diabetes-as-part-of-simulation-modellingproject/
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Appendix 6: Summary report – Gestational diabetes modelling workshop two

The following report was provided to participants from the model development group for
the diabetes in pregnancy case study following workshop two.
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Summary of Gestational Diabetes
Modelling Workshop Two
19 August 2016
Background
The purpose of The Australian Prevention Partnership Centre (TAPPC) is to develop
and use systems thinking and systematic ways of preventing lifestyle related chronic
disease. People from a range of disciplines, backgrounds and countries have
gathered together to come up with practical ways to support decision making and
research translation to address these issues
This project will develop a dynamic simulation model that will look at gestational
diabetes mellitus (GDM) from an ACT perspective and will be using ACT data.
However, the national context will be considered in the model development and
the model will be a proof of concept with the potential to expand much more
broadly.
The model will consider the short, middle and long term implications of the current
food culture, overweight and obesity and GDM and Type 2 diabetes mellitus. Small
delays in the development of diabetes will have large implications for the longer
term burden of disease and costs to the health system. This long term vision is
important as the model is built collaboratively.
Increasing demand for health services due to the rising prevalence of GDM is having
a significant impact on resources and the need to “do things differently” was
identified by a number of workshop participants. Workload and resource use will be
incorporated into model to enable it act as a resource allocation decision support
tool.
This workshop series brings together clinicians, policy makers and researchers and
allows for greater accessibility of data and expertise. This partnership also allows for
research to be translated into policy and program decisions more readily.
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Model purpose
The following purposes for the model were synthesised from the key modelling
questions contributed by participants at the workshop. Full responses are included
in Appendix A.


Determine the best investments for intervention in GDM. E.g. “I’m here to
see if modelling can help determine the right interventions, at the right
times, by the right people, in the most efficient and effective way (to make a
difference).” Interventions in the model to include both clinical and
population health interventions.



Examine GDM within a context or system e.g. Food environment, personal
environment such as stress and coping.

Reporting back and presenting the current version of the model
An overview of the model architecture was presented showing the three model
levels as follows:
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A simplified model conceptualisation was presented, as shown below and case
examples were used to demonstrate how people would “move through” the model
levels.
Image A: Gestational Diabetes Mellitus model conceptualisation

Participants were shown screenshots of the model in the AnyLogic software
and the model running.

Intervention mapping
The top 5 prioritised interventions from Workshop 1 (see below) were reviewed and
discussed.
Top 5 prioritised interventions:

1.

Weight and height measurement pre pregnancy - having ongoing
education about what is a healthy BMI, for pre pregnancy in particular. This
would be a combination of awareness and education and measurement.
Include a feedback mechanism.

2.

Targeted preconception programs for high risk - women who are
considered v high risk for GDM, come to program that works on getting
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them into the right shape before they conceive. (Subset of the first
program)
3.

Inter pregnancy - lifestyle change targeted at this stage of a woman's life
course. Trying to reduce women who have had GDM gain for overweight
and obese

4.

Early screening at booking for the pregnancy. (Clinically based
intervention). Not just for when they come to the hospital, but also when
they come to GP - and what that would involve.

5.

Incentives for lifestyle change.

Other potential interventions suggested for inclusion in the model were:


Interventions targeting prevention of people transitioning into higher weight
categories.



GP screening for type 2 diabetes opportunistically or pre-pregnancy



Transgenerational interventions from birth – evidence base is limited



App based intervention – providing service information, risk calculators for
GDM, information about timing of visits to health services etc

The following four interventions were agreed on to be the focus during this
workshop.


Weight and height measurement pre-pregnancy,



Targeted pre-conception lifestyle program for high risk women,



Changing models of care for women with diagnosed GDM,
Inter-pregnancy lifestyle change.

Participants were “walked through” an example of intervention mapping using early
screening for GDM as an example intervention as shown below.
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Image B: Gestational Diabetes Mellitus model conceptualisation with example intervention
“Early screening” mapped

MODELLING FOR GETATIONAL DIABETES WORKSHOP 2 | SAX INSTITUTE

275

INTERVENTION MAPPING ACTIVITY:

Participants worked in two groups, each group working on two interventions.

Intervention 1: Transgenerational intervention - Monitoring peoples’ weight
across their life course.

This intervention targets “everybody” from a “whole of life” perspective. People
have their BMI measure to identify those who are overweight and obese. These
people can then be referred to services.

Delivery:





Awareness campaign plus GP standard practice – also in schools?
(height and weight could be done in vaccination program). Though
potential stigma from mass weighing. Discussion of potential opt-out for
height and weight as part of immunisation consent.
Need to coach GPs in this to make it routine, like taking BP.
Getting men involved- possibly at football. Discussion of interventions
at barbers (US model).

Target risk factor:


It targets risk factors of diet and PA, therefore weight states.

Effectiveness


Little evidence available

Differential effects:




Differential effects: It would affect the ‘worried well’ differentially, it is
easier to target children, cultural perceptions of weight, geographic
location.
Delivery mechanism would have an effect on the effectiveness, e.g. if it
was conducted in a school hall (overweight kids would not go to school
that day).
Providing varied settings for different ethnic groups, need to approach
through AMSs for Indigenous people.
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Slow cultural shifts (e.g. with smoking), however legislative change is
necessary as well for large societal change.

Unintended consequences:




stigma, and also potential for encouraging eating disorders (though
eating disorders are less of a risk than Overweight and obesity).
Similar to smoking being made socially unacceptable, it could be
similarly unacceptable to make poor food choices (including fast food,
restaurants, supermarkets etc).
Acceptability of running the school based program.

Resources:


Resources used include GPs, dieticians, practice nurses.

Image C: Transgenerational intervention mapped to model conceptualisation
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Intervention 2: Inter-pregnancy lifestyle change
GDM makes you higher risk for diabetes and getting GDM again therefore there is
an opportunity between pregnancies to intervene with women to reduce their risk.
This intervention aims to change their weight status to reduce diabetes risk. noting
that not everyone who has had GDM is considered pre-diabetic.
Risk factors targeted:





weight status,
diet,
history of GDM

Delivery:






Barriers:




Target is at the individual level.
Counselling: If a woman has had GDM, had lifestyle interventions, in
between they will need postnatal testing, discuss results and what they
mean with the woman and impact on lifestyle. General
recommendation is if test result is normal, should be re-tested in 1-2
years (normally 5 years if you aren’t planning on becoming pregnant
again). If you have pre-diabetes, then it’s yearly test recommendation.
NDSS reminder system will include letter for this. Follow up rates vary
across Australia.
App based delivery may be appropriate particularly for young adults research shows differential effect by age.

There is no Medicare number for diet and lifestyle intervention targeted
at obstetrics, GDM wouldn’t be considered a chronic condition.
People may not attend GP. It might be better to make interventions
available through mothers’ groups or Maternal and Child Health clinics
Maternal guilt – another responsibility for mothers (to keep fit)

Differential effects:




Age, SES, Indigenous status would be relevant for this.
SES and geographic location – effects ability to afford a healthy diet, so
dietary advice may need to be targeted according to this.
Exercise advice – targeted to individual preferences.
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Is obesity individual or societal responsibility?

Image C: Interpregnancy intervention mapped to model conceptualisation
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Intervention 3: Targeted pre-conception lifestyle program for women
The intervention discussed was an app based intervention supported by a social
media campaign. The app would include:


Information for localised pregnancy services and resources e.g. GP
recommendations, include GIS location information, information about
shared care GP program, location of obstetricians, scan reminders for
genetic conditions etc.



Embedded risk calculators (for GDM and other high risk pregnancy
conditions). If a high score is calculated – advised to see GP



Simple lifestyle messages



Goal setting



Prompts based guidelines – e.g. Are you taking folic acid? Have you seen
your GP (based on predetermined visit schedule)?

Pre-pregnancy GP visit:


Immunisation



Folic acid



Risk identification



Pre-pregnancy glucose tolerance



BMI



Blood pressure



Advice re: lifestyle



Contraception advice

Target group:

This intervention targets the population of reproductive age people. It is primarily
targeted at women.
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Risk Factors targeted:


Lifestyle behaviours e.g. Physical activity and diet



Providing information about risk

Impact

Effectiveness estimates from app implemention studies could be used in the model
e.g. Canadian app, behavioural intervention apps.

Increased demand for GP services

Differential effects:


Uptake may vary by SES, literacy, ethnicity, geographic location.



People with a family history of diabetes may be more motivated to access
information



Unplanned pregnancies – women who have unplanned pregnancies are
unlikely to be impacted by this intervention

Unintended consequences:


Shifting health spending to pre-conception care.



Undernutrition to avoid high glucose levels.
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Image D: Pre-conception intervention mapped to model conceptualisation
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Intervention 4: Comparing different models of care.
This group discussed step up and step down models of care. In step up model,
women receive usual antenatal care, and don’t see the endocrinologist unless
required. In step down models women see the full multidisciplinary team and then
services are reduced if their diabetes is being managed. The traditional model is for
women to see the multidisciplinary team for every visit.
Intervention:
Compare models of care. E.g. Provide training to midwives, GP’s, and obstetricians
so they can provide GDM care in usual antenatal pathways instead of immediately
referring to endocrinologist. Guidelines to be developed to outline the criteria for
escalation of care. Therefore, only a small proportion would need to go to
multidisciplinary clinics freeing up endocrinology services for people with Type 1
and Type 2 diabetes.
Effectiveness:
Outcome studies if available.
Cost analysis of different models
Barriers
Health professionals reluctant to change practice.
Unintended consequences
Some providers who get paid per episode of care may not refer to a
multidisciplinary clinic because they wouldn't get end of care payments, leading to
perverse incentives. We need to be aware of what each provider will gain or lose.
This intervention assumes that there will be no loss of funding due to the changed
model of care.
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Image E: Models of care comparison intervention mapped to model conceptualisation
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INTERVENTION MAPPING ACTIVITY REPORTING BACK:

All four intervention maps were transferred onto a large diagram of the model
architecture to promote group discussion and feedback.
Image C: Four interventions mapped to large model conceptualisation
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OUTCOMES:
Top 5 prioritised outcomes:

The following outcomes were prioritised at workshop 1:

1.
2.
3.
4.
5.

Incidence of GDM
Maternal diabetes
Childhood obesity
Early onset diabetes
Diabetes complications

The group agreed that the following outcomes should be added to the model:


Premature births should be added (though extreme prematurity is rare with
GDM), so we will count it as pre-37 weeks.



Large for gestational age – birthweight to be added as an outcome



NICU admission



Type of birth – caesarean section, normal birth, instrumental birth



Health economics – Cost of the outcomes considered in the model, including
cost of birth (e.g. emergency Caesarean)



Short term outcomes: quality of life for mother – literature shows QoL
weights for different types of birth. And quality of life weights for infants
with low birthweight etc. A challenge identified for using this outcome is
how long do you apply these- i.e. If someone has caesarean birth how long
does it affect them? Quality of life can fluctuate, however mortality and
morbidity can be combined as quality adjusted life years (QALY) which can
provide a standard measure



Some women who change their lifestyle after GDM, although many will
revert to previous lifestyle after pregnancy. The influence of the partner will
impact on women’s ability to maintain lifestyle changes – women cook two
meals during pregnancy then change back after pregnancy to just cooking
unhealthy food.
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NEXT STEPS:


The model architecture will be finalised



Data will be sourced and used to populate the model



Validation and verification of the model against historic data



Workshop 3 will be held in November 2016 to allow the group to interact
with and critique the functioning model.
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Appendix 7: News article – Project expanded to tackle all forms of diabetes in
pregnancy

The Australian Prevention Partnership Centre news article: Project expanded to tackle all
forms of diabetes in pregnancy. http://preventioncentre.org.au/news-andevents/prevention-centre-news/project-expanded-to-tackle-all-forms-of-diabetes-inpregnancy/
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Appendix 8: Indicative questions for semi-structured interviews
The following interview schedule was published as supplementary material for the
manuscript included in Chapter 6.

Freebairn L, Atkinson J, Kelly P M, McDonnell G, and Rychetnik L. Decision maker’s
experience of participatory dynamic simulation modelling methods for public health policy.
BMC Health Informatics and Decision Making 2018; 18(1):131.
https://doi.org/10.1186/s12911-018-0707-6
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Indicative questions for pre-modelling workshop interviews

Introduction

Thank you very much for agreeing to be interviewed for this project. I am going to ask you
some questions about challenges that gestational diabetes health services are facing, about
your experience of evidence based decision and making and your experience with simulation
modelling processes.

GESTATIONAL DIABETES SERVICES
1.

Based on your experience, what are the current challenges that GDM services are
facing?

2.

What do you think is driving these challenges?

3.

What changes do you think GDM services need to make to cope with these
challenges?

4.

Which interventions would you prioritise to prevent and manage GDM?

EVIDENCE BASED DECISION MAKING

The next questions are about evidence-based decision making.
1.

Could you talk a little about your thoughts on evidence-based decision making in
the health policy context?

2.

What factors have you found to be useful to support its use? What are the main
challenges?

3.

Have you had experience using results of evidence synthesis methods such as
systematic reviews, meta analyses? Did they meet your needs for evidence to
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inform your decision making? From your experience, what are the strengths and
limitations of these methods?
4.

What other forms of evidence do you use in decision making?

SIMULATION MODELING

The following questions are about any experience you have had with simulation modeling
processes
1.

Have you participated in any form of dynamic simulation modeling process before?
(Only continue if reply yes)

2.

Could you tell me about the modelling process and your experience of it?

3.

In your opinion what are the benefits and limitations of simulation modelling as an
evidence synthesis tool?

FINAL QUESTION

Finally, we are interested in your goals for participating in the project.

What do you hope to get out of participating in this modeling process?

Thank you very much for agreeing to be interviewed. Just before we finish, do you have any
questions that you would like to ask about this project?
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Indicative questions for post modelling semi-structured interviews.

Introduction:

·

I am interested in hearing about your experience of participating in the XX dynamic
simulation modelling project.

·

We have several projects that have used similar methodology and are at different stages
of maturity. I would like to talk to you about your experiences with the XX modelling
projects so we can collect information on impact in different settings and at different
stages of maturity

·

1.

I am keen to hear your honest appraisal of the pros and cons of this method

How did you come to be involved in the project? When you were first approached,
what were your thoughts? Why did you agree? What were your expectations at the
beginning of the modelling project? Were those expectations met?

2.

Were there aspects of the workshops that you found useful? [Prompt as needed What were these and why?]

3.

I’d like to ask you a bit about some of the different aspects of the participatory
process. Could you tell me about your experience of:

a.

The activities at the workshops

b.

The interactions with professionals from a range of disciplines
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c.

The model outputs

(prompt as needed – what do you feel you gained from these)

4.

We are interested in exploring the value of using a participatory approach to develop
the model. In your view, what were the benefits of using this approach? And what
were the challenges?

5.

One key aspect of group model building is to bring together a diverse group of experts
to discuss and compare their “mental models” (by that I mean their individual
understanding of an issue and its context). The aim of this is to enable the modellers
to learn about the issue from a range of perspectives, and for the expert participants
to compare their own perspectives to that of others in the group. What are your
thoughts about this aspect of the workshops? In your opinion, how successful were the
workshops in enabling this to occur?

6.

Having been through the experience of the workshops, what are your thoughts now on
how dynamic modelling can facilitate evidence being used to inform decision making?

7.

Have you been able to apply any insights gained from the modelling process to your
work? If so, could you talk about some examples? In your opinion, were your insights
based on your involvement in the workshops or from the results generated by the
model?

8.

Could you talk a bit about the purpose for which the model was developed and the
broader context? I’m interested to hear whether this has had any influence on its
subsequent use.
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9.

Since you participated in the modelling process, have you been able to use the model
outcomes or insights you gained from the process to build an argument for prevention
programs?

10.

Would you like to see this work developing into the future? Would you be interested
in being involved?
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Appendix 9 Prevention Works podcast

I was invited to speak about the DIP modelling project for the Prevention Works podcast
series commissioned by The Australian Prevention Partnership Centre. The Prevention
Works podcast presents a series of interviews with policy makers, practitioners and
researchers discussing the work of Prevention Centre to find new approaches to the
prevention of lifestyle-related chronic disease. The transcript of the interview with
Professor Chris Nolan and myself is included below and the interview is available on the
Prevention Centre website: https://preventioncentre.org.au/resources/tackling-thepandemic-of-diabetes-in-pregnancy/
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Appendix 10 Model documentation
The detailed documentation of the model structure and associated parameters, functions
and data sources are included in this section. I was the primary author of this document with
input from Ms Yang Qin and Professor Nathaniel Osgood, from the University of
Saskatchewan. Ms Qin and Professor Osgood provided information about the model
components and structure, parameter values and equation functions used in the model. As
noted at this start of this chapter, the computer science members of the modelling team are
leading a technical paper, on which I am a contributing co-author, in which some of the
material in this section will also be included. That paper will describe the validation,
calibration and sensitivity analyses conducted during the model development. At the time of
submission, the technical manuscript was in draft format and is not presented here as it is
not core to my thesis.

.
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Executive summary
Purpose of this guide: This document describes the dynamic simulation model developed to explore
prevention and clinical management options for diabetes in pregnancy in the ACT.

The challenge: Diabetes in pregnancy (DIP) is increasing in the ACT, in Australia and internationally and
diabetes services are having difficulty meeting demand with existing resources. The increase in DIP in the
ACT is associated with increasing prevalence of risk factors such as overweight and obesity, older
maternal age and increasing numbers of women from high-risk ethnic groups. Changes to diagnostic
screening have resulted in women being diagnosed with DIP earlier in their pregnancy and therefore
requiring services for a longer time. Women are also more frequently presenting with multiple risk factors
resulting in more complex care needs.

A systems approach: The Australian Prevention Partnership Centre, in partnership with ACT Health and
the University of Saskatchewan, adopted a participatory dynamic simulation modelling approach to
explore how best to prevent and manage diabetes in pregnancy. The process of model development
included mapping the complex problem, model conceptualisation, quantification, testing and validation
and drew on existing systematic reviews, meta analyses, research evidence, available data, and the expert
knowledge of a broad range of multidisciplinary stakeholders working in the area of diabetes in
pregnancy in the ACT, in other states and territories and internationally.

The model: is a logically consistent framework that integrates disparate data sources. It can be used as a
‘what if’ tool to test the likely impacts over time of a range of policies and programs to see what
combination of interventions are likely to be effective for the prevention and management of diabetes in
pregnancy.

Structure of this document: This document describes the process of model development, provides
detail on the components of the model, and the data and evidence sources used to inform its design and
parameterisation. The model can be updated over time to ensure it remains current and continues to
produce outputs that are consistent with observed data. The model can also be used as an interactive
tool to inform policy and program decisions relating to diabetes in pregnancy.
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Acronyms used
BMI
DIP
EI
GDM
GP
IGR
LT
NICU
Ow
Ob
OGTT
OwO
PA
T1DM
T2DM
TAPPC

Body mass index
Diabetes in Pregnancy
Early intervention
Gestational Diabetes Mellitus
General practitioner
Impaired Glucose Regulation
Less than (this phrase has been used within age ranges)
Neonatal Intensive Care Unit
Overweight
Obese
Oral Glucose Tolerance Test
Overweight or obese
Physical activity
Type 1 Diabetes Mellitus
Type 2 Diabetes Mellitus
The Australian Prevention Partnership Centre
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Background and rationale
The challenge of diabetes in pregnancy
Diabetes in pregnancy (DIP) is increasing in the ACT, in Australia and internationally. The increase in DIP in
the ACT is associated with increasing prevalence of risk factors such as overweight and obesity, older
maternal age and increasing numbers of women from high-risk ethnic groups. Changes to diagnostic
screening has resulted in women being diagnosed with DIP earlier in their pregnancy and therefore
requiring services for a longer time. Women are also more frequently presenting with multiple risk factors
resulting in more complex care needs.
The model considers the short, middle and long-term implications of impaired glucose regulation and the
increasing prevalence of risk factors for DIP. Prevention of risk factors was prioritised in the model as small
delays in the development of diabetes will have large implications for the longer-term burden of disease
and costs to the health system.
Alternative models of care for DIP were also considered in the model. The rising prevalence of DIP is having
a significant impact on health service demand and resources, and the need to “do things differently” was
identified by participants. The model informs the investments for intervention in DIP, including both clinical
and population health interventions. Workload and resource use has been incorporated into the model to
enable it to act as a resource allocation decision support tool.

The value of dynamic simulation modelling
Dynamic simulation modelling is a term given to quantitative systems science modelling methods,
including:


System dynamics, which captures feedbacks delays and accumulations at an aggregate level,



Agent-based modelling, which represents individual heterogeneity and social network influences



Discrete event simulation, which captures service delivery and implementation processes and can
be used to explore optimal resource distribution.

These methods have long been used successfully in the engineering, business and industry sectors, but
more recently are being used to support the design of efficient and effective responses to complex
population health and health care problems [1-5]. These tools represent a significant advance in
traditional epidemiological methods and are particularly valuable for exploring the complexity of multiple
interacting risk factors and the dynamics of populations and their behaviours over time [6, 7]. They can
also be used to explore the potential impact of interventions, individually or in combination, over time for
populations or specific target groups.
System dynamics represents complex problems at an aggregate / macro level using three core
components: 1) stocks (key variables, like population BMI, that increase or decrease over time); 2) flows
(rates of change in a stock); and 3) feedback loops (which can connect stocks and flows over time).
System dynamics is underpinned by well-established mathematical theory of nonlinear dynamics [8-10].
Further information regarding the mathematics behind system dynamics can be found at:
https://www.wpi.edu/Pubs/E-project/Available/E-project-052812144829/unrestricted/MathematicsBehindSystemDynamics.pdf.
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Agent based modelling (ABM) methods have been enhanced more recently and allow for representation
of individuals or agents within the system. The model can be built from the ground up by defining
agents, their behaviours and their interactions [11, 12]. ABM is a computational method used to examine
the actions of agents (e.g., individuals) situated in an environment (e.g., neighbourhood). ABMs specify
decision rules controlling dynamics, such as If-Then statements and mechanistic interactions among
agents. When the program is run, agents interact with one another and their environment often resulting
in counterintuitive insights about behaviour of agents and the system [13]. Incorporating ABM
components allows flexibility to incorporate the dynamics of people making decisions affecting
population health outcomes, and thus efficient planning of health care interventions [14].
Discrete event simulation (DES) methods represent processes, that is, as a sequence of operations or
events performed across entities [12]. For example, discrete event methods are frequently used to
represent and improve efficiency of health services, for example, emergency departments. This modelling
method represents complex systems at a low level of abstraction. The core concepts in DES are events,
entities, attributes, and resources. An event happens at a certain time point in the environment and can
affect resources and/or entities. Entities have attributes and consume resources while experiencing
events, but consumption is not affected by individual-level behaviour. Attributes are features or
characteristics unique to an entity. They can change over time or not. Resources are objects that provide
a service to an entity. Queues are another important concept in DES and occur when several entities
compete for a specific resource for which there is a constraint [14]. DES modelling is useful to analyse
resource utilisation, throughput of services and the impact of varying policy decisions [14].
Advances in modelling software technology now enable multiple modelling methods to be integrated
[12]. This allows for modellers to represent the many interacting components of a system and the
complex interplay between individual behaviour and social connections across populations [11]. All three
modelling methods have been utilised in this tripartite DIP model.

Project aim
The overall aim of the project was to develop a dynamic simulation model to inform the best
investments for intervention in diabetes in pregnancy, including both clinical and population health
interventions. This project includes:


Synthesis of diverse evidence sources into a “what if” tool to be used to inform policy and
program decision making,



Analysis and forecasting of the likely impacts of intervention options in the short and long term
for mother and baby,



Extending dynamic simulation methodologies to successfully integrate agent based, system
dynamics and discrete event simulation methods into a logically consistent representation of
diabetes in pregnancy, and



Facilitating focused and constructive stakeholder participation in model building and strategy
dialogues.
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Scope
To develop a dynamic simulation model to inform the best investments for intervention in diabetes in
pregnancy for the ACT, including both clinical and population health interventions.
This dynamic simulation model focuses on diabetes in pregnancy (DIP) from an ACT perspective. However,
the national context was also considered in the model development with the model being considered a
proof of concept with potential to be applied in different contexts.
It is noted that interventions may have differential effects on various socio-economic, geographic or
cultural groups. However, due to the lack of available data at this stage, stratification of effects on
subgroups (other than age) has not been incorporated into this model.

Models as repositories for best evidence, data and local knowledge
The following perspective is attributed to Professor Nate Osgood, Department of Computer Science, University of
Saskatchewan
Models are far from static tools used to support strategic decisions at a given point in time. Instead, they can
be updated, refined and expanded as new questions arise and as resources are available to delve deeper into
particular components of a model. Models capture our best understanding about a complex problem and
improve as our knowledge deepens. As new evidence comes to light and as new interventions are tested and
evaluated, the results can be integrated into an existing model to help us derive actionable policy and practice
recommendations. As such, simulation models allow us to further leverage investment in research, the
collation of big data, the evaluation of policies and programs, and in infrastructure improvements for
reporting of administrative data. Furthermore, dynamic simulation models are moving away from being
technocratic artefacts built in back rooms and are increasingly being used as tools for improving
communication, stakeholder engagement, consensus building, teaching and learning, and for elucidating
research priorities.
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Method
Model development process
The dynamic simulation model was developed using a participatory and transparent evidence synthesis
process. A multi-disciplinary group of domain experts from academia, policy, public health and clinical
practice, as well as health economists and national and international leaders in dynamic simulation
modelling were invited to contribute to this work as part of the expert model building group (see
Appendix A).
Three participatory workshops were held (on 5 May and 19 August 2016 and 9 March 2017), during
which facilitated sessions were conducted. The expert group collaboratively mapped the key risk factors
and pathways for developing diabetes in pregnancy, and the mechanisms by which selected
interventions have their effect. This has been described in detail elsewhere [15, 16].
A causal map of the problem produced by the expert group in the first workshop was developed into a
computational simulation model through an iterative process of model conceptualisation, quantification
of parameters and representation of the mathematical relationships among the components of the
logical structure. Iterative consultation and validation took place, to ensure the final model would be
detailed where required for the application of interventions, but sufficiently streamlined to keep the
model manageable. The conversion to a computational model drew on published conceptual
understandings of the problem, available data sources, published research and expert guidance to arrive
at a plausible and testable representation. The behaviour of the system over time is displayed
graphically by the computer modelling software (AnyLogic®). The model was progressively refined over
multiple iterations with domain and policy experts (through subsequent workshops and stakeholder
meetings) and investigation of differences between the predicted and observed historical behaviours.
The model was calibrated and validated against historical data. The product of this process is an
interactive dynamic simulation model capable of forecasting the likely impact of interventions over time,
either individually or in different combinations.
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Overview of the model
Overview of model components
The hybrid model incorporates system dynamics, agent based and discrete event representations using
AnyLogic® software (http://www.anylogic.com/), and consists of the following components:
A. Pregnancy representation
B.

Dysglycemia classification representation

C. Glycemic regulation representation
D. Population structure
E.

Weight status representation

F.

Service representation

G. Interventions for scenario testing

Figure 1: Overview of model components

Each of these components is shown in Figure 1: Overview of model componentsFigure 1 and is described
below.
The model is initialised on 1 January 2010 and model time units are in years. This retrospective feature
contributes to validation of the model, through comparing model outputs from 2010 to 2015 with real
world data.
Please refer to Appendix C for an explanation of the model symbols used in the subsequent figures.
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A. Pregnancy representation
Pregnancy is represented using a statechart indicating the individual agent’s pregnancy status. Women
initially enter the model in a not-pregnant state and men to the not-possible state. Pregnancy occurs
according to an age specific fertility rate. Pregnant women are divided two categories: planning
pregnancy and not planning pregnancy. The women who do not plan their pregnancy will enter pregnant
state directly. Alternatively, women who planned their pregnancy will stay in the planningPregnancy state
for six months, then enter the pregnant state, as shown in Figure 2. After entering the pregnant state, the
women will transition between a set of states representing the trimesters of pregnancy. While duration of
pregnancy is indicated using the trimester states, the model also collects the precise duration of
pregnancy in continuous time. The pregnancy statechart is shown in Figure 2.
The model includes a set of parameters associated with the pregnancy, for example parity, BMI, age,
history of diabetes, and family history of diabetes, that are relevant as risk factors for the occurrence of
dysglycemia in the current pregnancy. These parameters are described in
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Table 1.
When a woman gives birth, there is a birth event in which a baby is introduced into the model. This birth
event is associated with a variety of types of outcomes, information that is passed on to the new child for
example, the mother’s DIP status and history of diabetes, weight status and ethnicity is passed onto the
baby. Outcomes including birthweight, type of birth e.g. Caesarean section, NICU admission and Apgar
scores are recorded at birth.

Figure 2: Pregnancy statechart structure
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Table 1: Parameters in pregnancy state chart
Parameter

Type

Description

Source

getFertilityRate(currentAge(),ethnicity) getFertilityRate(currentAge(),ethnicity) /
1000

function return
double

age and ethnicity specific fertility rate of age 15 50

ACT Maternal
Perinatal Data
Collection and
ABS Census
2011

planningPregnancy

0.4

boolean

Rate of planned pregnancies

[17]

probOfBF

0.75

double

randomTrue(), used in condition determine who is
NOT in breastFeeding

Assumption

dipTestTime

Uniform(8, 12) or Uniform (26, 28)

double

= Service.assignDiPTestTime(agent: Person)
normally test time is 26 - 28 week of pregnancy.
For high risk group (e.g. obese, age > 35) they will
have the test at 8 - 12 weeks

Clinical

mothersDiabetesStatus_atBirth

Value

NormoglycemicDiabetesStatus /
GestationalDiabetes / Type1DM /
Type2DM

DiabetesStatus

getDiabetesStatus()

mothersWeight_atBirth

Not_Overweight_or_Obese /
Overweight / Obese

Weight

mother’s weight status at delivery

mother

this

Person

Reference to mother

maternalPreviousLiveBirths

parity

int

How many children did the mother give birth to

mother’s glycemia status at delivery

before this delivery?
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guidelines

Parameter

Value

Type

Description

maternalAgeAtBirth

currentAge()

double

Current age of the mother

timeUntilNaturallyFertile

max (0.0, normal(0.15,0.15));

double

time unit is year,
this is the time that agent is in postpartum state
(either in breastfeeding or in not breastfeeding
state)

Source

Table 2: Functions in pregnancy state chart
function name

parameters

probilityVarCalculation

(p_normalGlocuse: double,
oddRatio: double,
normalGlycemia: double,
g_average: double)

description

[1,2]
earlyLatePregnancyInsulinSensitivityByWeight

(weight:Weight)

At the beginning of pregnancy, calculate KxgI-EarlyPreg and KxgI-LatePreg of this agent according to
their weight status, for linear interpolation in function
linearInterpInPregnancy(timeDuringPregnancy)
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B. Dysglycemia classification representation

The dysglycemia classification representation relates to the underlying glycemic regulation of the
individual as shown in Figure 1
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Figure 3.
Awareness of their glycemic status and/or being diagnosed with a dysglycemia condition are important
factors influencing an individual’s access to lifestyle and pharmacological interventions. The dysglycemia
classification statechart separates the underlying glycemic status from the diagnosis of T2DM and GDM,
as the point of diagnosis is dependent on clinical service and screening regimens.
There are four states in the dysglycemia classification statechart representing the range of possible
categories for an individual's glycemic status. These are: normoglycemic and impaired glucose regulation
(IGR), Type 1 diabetes mellitus (T1DM), Gestational diabetes mellitus (GDM), and Type 2 diabetes mellitus
(T2DM). Individuals transition between the classification states depending on whether their underlying
glycemic level exceeds the criteria for each state as indicated in Table 3.
Case example: An individual may start in a normoglycemic state and then develop, without her
awareness, an impaired glucose regulation state, as her glycemia level increases. The increases may be
caused by ageing or weight increase. For simplicity of the representation of underlying glycemia status,
we use one state to represent normoglycemic state and IGR state.
Both normoglycemic and IGR agents, at the time of a pregnancy, may transition to a GDM state. Post
pregnancy, depending on the agent's degree of glycemic control, there are two possible transitions
(Figure 3). If the agent adheres to lifestyle intervention changes and maintains a degree of control over
her dysglycemia, she may return to the IGR and normoglycemic state. In the absence of effective
glycemic control and further decline of her condition, she might proceed to T2DM immediately.
There are currently no transitions from diagnosed T2DM to normoglycemic and IGR. These transitions are
possible; however, it is rare for people to move between states in this direction and often this only occurs
with bariatric surgery, which is not a priority intervention for inclusion in this model.
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Figure 3: Dysglycemia classification representation structure

Table 3: Parameters in dysglycemia classification state chart
parameter

value

description

source

hazardOfT1DMAmongstThoseSuscep
tible

0.04

Among susceptible people,
there are 4% chance to
develop into T2DM

Clinical
estimate

isGeneticallyPredisposedToT1DM

(self.ethnicity ==
Australian_Born) &&
randomTrue(prevalen
ceType1DM_Australia
nBorn)

Among Australian born
people, there are 1%
chance to be T1DM
susceptible people

prevalenceType1DM_AustralianBorn

0.01

used to give value for
isGeneticallyPredisposedTo
T1DM

fastingBloodGlucoseThreshold_befor
e2015

5.504

the glycemia standard
before 2015

calibrated

thresholdCoefficientToT2DM

1.636

used to calculate the
standard of T2DM,
the T2DM standard after
2015 = 1.636*5.504

calibrated

coeffRatesToGDM

0.642

used to calculate the
standard of GDM state,
the GDM standard after
2015 = 1.636*5.504*0.642

calibrated
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C. Glycemic regulation representation

The model incorporates a representation of the underlying physiological regulation associated with an
individual’s glycemic status based on mathematical models of diabetes progression by De Gaetano, Hardy and
colleagues [18-20]. The mechanism for glycemic regulation included in the model is referred to as an
endogenous dynamic mechanism. This means that the model represents over time the evolution in certain
factors related to the level of dysglycemia and metabolic load a woman experiences in pregnancy. Glycemic
regulatory capacity is represented as a stock, allowing the level of an individual’s regulatory capacity to
increase and decrease over time. Therefore, the factors that influence glycemic regulatory capacity such as
increased metabolic load due to pregnancy, changes to diet and physical activity and pharmacological
interventions can be modified within the model and the impact measured over time and between generations.
Glycemic regulatory capacity is a function of two factors in the model. Firstly, it is a function of biologic
regulatory capacity, that is, the internal regulatory capacity associated with underlying physiology. Secondly,
there is a component of external regulatory ability of the individual, that is, their conscious regulation through
adherence to blood testing, medication regimens and lifestyle interventions including diet and physical
activity. The model mechanism allows for changes in an individual’s adherence over time.
As glucose levels rise, a well-regulated person's physiology absorbs the blood glucose levels. However, in the
event of insulin resistance, as caused by pregnancy, high weight or other factors [21], the body’s direct
regulatory mechanisms for lowing that glucose are impaired (i.e., lower insulin sensitivity). The body normally
responds to this by increasing the replication rate of beta cells, thereby producing more beta cells (β) to
output more insulin and lower the blood glucose level. The increase in the replication rate of beta cells (here,
), depends on a reasonably high pancreatic reserve (here, represented by ). Over time, the pancreatic
reserve is drained faster with high glucose levels, meaning that the ability to replicate beta-cells quickly is
impaired. As a result, the body may be unable to further increase beta cells in response to high glucose levels
thereby further lowering the pancreatic reserve . Eventually the cycle of beta cell loss (with <0), results in
further high levels of glucose, causing in turn more damage in terms of loss of beta cells. In short, with high
glucose levels, the body can initially respond through normal mechanisms. When those mechanisms fail, it
turns to expanding beta cell levels. However, if that is insufficient to bring down the blood glucose levels to
safe levels, the ability to further expand beta cell levels is impaired because of a drained and insufficient
pancreatic reserve. As a result, the blood glucose becomes even higher, eventually causing beta cells to
decrease, and further worsening blood glucose levels.
The model incorporates the impact of beta cell decline associated with exposure to dysglycemia. Exposure to
dysglycemia results in a decline of beta cell function over time and this eventually limits the individual’s
regulatory capacity. Reduced beta cell function decreases the effectiveness of lifestyle interventions on
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glucose regulation meaning that, even if an individual with reduced beta cell function makes significant
changes to their diet and activity levels, the impact on the blood glucose regulation will be minimised. As well
as capturing the duration of time that an individual is exposed to dysglycemia, the model also captures
episodes of diabetes in pregnancy with poorly controlled blood glucose levels that have exposed a baby to
dysglycemia prenatally. The glycemic regulation representation is shown in Figure 4.
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Figure 4: Glycemic regulation representation
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Table 4: Parameters from the diabetes progression models by De Gaetano, Hardy et al.
Parameter name

Notation

Description

Value

Source

Unit

Beta0_initialBetaPara
meter

B0

initial β-cell mass

1000

Table 2 in
[18]

Mc in [19]
1 in the
table of
[20]

I0_initialInsulinemia

I0

insulinemia at age t0, t0 is
18 yr in the model, but in
here is age 0

50

[18]

pM

G0_initialGlycemia

G0

glycemia at age t0, t0 is 18
yr in the model, but in here
is age 0

GDistributi
on()

Glambda_glycemiaOf
MaximalSensitivity

Gλ

glycemia of maximal
sensitivity of regulation of β
cells
G0
in model, right now we use
5, should change to G0,
assuming the subjects to be
in a perfect state of health
at t0.

5

Tgl_LiverGlucoseOutpu
tVariable

Tgl

liver glucose output,
represents the net difference
of zero-order liver
production and zero- order
brain uptake of glucose).

see
equations

Kxg_1stOrderInsulinInd
ependentGlucoseTissue
UpdateRate

Kxg

1st order insulin
independent glucose tissue
uptake rate,
“glucose effectiveness”,

9.504*12

Table 2 in
[18]

min-1

KxiStart_BaseLine1stOr
derInsulinEliminationR
ate

KxiStart

1st order elimination rate for
insulin at baseline (e.g. at 18
yr)

0.05 * 60
*24*365
due to
model unit

Table 2 in
[18]

min-1

KxiEnd_EndOflife1stOr
derInsulinEliminationR
ate

KxiEnd

1st order elimination rate for
insulin at the end of life (e.g.
at 90 yr)

0.035 * 60
*24*365
due to
model unit

Table 2 in
[18]

min-1
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Parameter name

Notation

Description

Value

Source

Unit

KxgI0

KxgI0

value of KxgI at t0

4.32*12 in
the model
due to
model unit

Table 2 in
[18]

min−1 /pM

tI

tI

Elapsed time after
adulthood (t0) of midpoint
KxgI (0.5 × KxgI ) decrease

120

Table 2 in
[18]

mo in [4]
[5],
nothing in
[3]

vI_HillDecement

νI

steepness of hill-function
decrement in insulin
sensitivity

18

Table 2 in
[18]

1

LambdaMinParameter

λmin

minimum value of λ (β cell
replication rate), the
maximum net apoptosis rate

-0.02*12

Table 2 in
[18]

mo-1

eta0_InitialPancreaticR
eservationParameter

η0

value of η(baseline
pancreatic re- serve at t0
(determined)

0.04*12

Table 2 in
[18]

mo-1

K_ethaG_ConstantRate
OfpancreaticGlucoseTo
xicity

Kηg

pancreatic glucose toxicity
coefficient, expressing the
effect of (hyper)glycemia on
the pancreatic reserve. This
parameter embodies an
operational definition of
glucose toxicity as the
relationship between
(prevailing) glucose
concentration and

0.02*12

Table 2 in
[18]

mo−1
(mM)−1

Gh_glucoseConcentrati
oinForHillShapedGlyce
maiEffectOnPancreaticI
nsulinRelease

Gh

centering glucose
concentration for Hillshaped glycemia effect on
pancreatic insulin release

9

Table 2 in
[18]

mM

vh_PowerCoeffecientFo
rHillShapedGlycemiaEff
ect

νh

power coefficient for Hillshaped glycemia effect on
pancreatic insulin release

4

Table 2 in
[18]

1

A0_initialGlycosylated
Haemoglobin

A0

A(t0), initial condition on
glycosylated
Haemoglobin(HbA1c)

5

Parameter name

Notation

Description

Value

Source

Unit

Kxa_eliminationRateOf
GlycosylatedHaemoglo
bin

Kxa

the spontaneous elimination
rate of (glycosylated)
Haemoglobin(Hb A1c),
The elimination rate of Hb
A1c is assumed to reflect the
elimination of red blood
cells.

0.238*12

E1467 [20]

mo-1
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Parameter name

Notation

Description

Value

Source

Unit

tMax

tmax

Maximum age for aging in
insulin first-order eliminate
rate in a person

90

E1467 [20]

mo

x0

x0

Initial value of x

1

1

Table 5: Parameters sourced from other papers
Parameter name

Notation

Description

Value

Source

Unit

BetaMaxParameter

Bmax

maximal β − cell popula on

4000

Table 2 in
[18, 20]

Mc

t0

t0

Starting age, with system at
equilibrium, in month

18yr

p E1465
in [20]

dt

time interval for events

1
=
dtPregnanc
y
=
dtNonPreg
nancy

dtPregnancy

time interval for
equationSolverEvent during
pregnancy

0.05

dtNonPregnancy

time interval for
equationSolverEvent during
NOT pregnancy

1

InsulinSensitivityFractio
nEarlyPregnancyNorm
al

in
earlyLatePregnancyInsulinSe
nsitivityByWeight(weight),
calculate KxgI-EarlyPregfor
normal weight person

0.95

[21]

InsulinSensitivityFractio
nEarlyPregnancyObese

in
earlyLatePregnancyInsulinSe
nsitivityByWeight(weight),
calculate KxgI-EarlyPreg for
obese person

1.27

[21]

InsulinSensitivityFractio
nEarlyPregnancyOver
Weight

in
earlyLatePregnancyInsulinSe
nsitivityByWeight(weight),
calculate KxgI-EarlyPreg for
overweight person

0.89

[21]
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Parameter name

Notation

Description

Value

Source

in
earlyLatePregnancyInsulinSe
nsitivityByWeight(weight),
calculate KxgI-LatePreg for
normal weight person

0.54

[21]

Description

Value

Source

InsulinSensitivityFractio
nLatePregnancyObese

in
earlyLatePregnancyInsulinSe
nsitivityByWeight(weight),
calculate KxgI-LatePreg for
obese person

0.77

[21]

InsulinSensitivityFractio
nLatePregnancyOverW
eight

in
earlyLatePregnancyInsulinSe
nsitivityByWeight(weight),
calculate KxgI-LatePreg for
overweight person

0.43

[21]

NewtonRaphsonEpsilon

Newton–Raphson method

0.1

tau_CompleteRecovery
Time

used in creating event
recentlyDeliveredBaby_Dyn
amicEvent,
set isRecentlyPregnant
false.

6.0/12

tau_RecoveryTime

the time that agent in
postpartum period,
used in
InsulinSensitivityInPostPartu
m() for the calculation of
KxgI in postpatum

3.0/12

tI

tI for normal weight,
used in
InsulinSensitivityFromDegae
tano() to calculate KxgI
trajectory

120

InsulinSensitivityFractio
nLatePregnancyNormal

Parameter name

Notation
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Parameter name

Description

Value

Source

tI_Obese

tI for obese,
used in
InsulinSensitivityFromDegae
tano() to calculate KxgI
trajectory

25.5

Derived from
[18-20]

tI_overWeight

tI for overweight,
used in
InsulinSensitivityFromDegae
tano() to calculate KxgI
trajectory

29

Derived from
[18-20]

insulinDose

used when insulin treatment
is applied

offspringKxgIGlycemiaCo
efficient

calibrated value

6.649

alphahVariable

used in
rootOfNumericalSolution_N
wRph
() to calculate G

Ghvh

isNormalPancreaticReco
veryT_eta

parameter decide if η is
declining or not

false

t_etha_End

Notation

ηend

maternalInsulinSensitivit
yCoefficient

preGravidInsulinSensitivi
ty

KxgI-PreGravid

η value at the end of the
period of observation

calibrated

represent impaired insulin
sensitivity for offspring
whose mother is in DIP.
we assume the value of first
generation is 1

first
generation
and
offspring
whose
mother has
not had DIP
is 1,
otherwise is
insulinSensi
tivityCoeffic
ientForOffs
pring(Glyce
miaReadin
gs after 26
weeks)

KxgIvalue at the beginning of
pregnancy

KxgI(t)
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Parameter name

Notation

Description

Value

earlyPregnancyInsulinSensiti
vity

KxgI-EarlyPreg

KxgIvalue at the early
pregnancy

normal
weight:
InsulinSensi
tivityFractio
nEarlyPreg
nancyNorm
al * KxgI-

Source

Unit

PreGravid

overweight:
InsulinSensi
tivityFractio
nEarlyPreg
nancyOver
Weight *
KxgI-PreGravid
obese:
InsulinSensi
tivityFractio
nEarlyPreg
nancyObes
e*
KxgI-PreGravid
latePregnancyInsulinSensitiv
ity

KxgI-LatePreg

KxgIvalue at the late
pregnancy

normal
weight:
InsulinSensi
tivityFractio
nLatePregn
ancyNorma
l * KxgIPreGravid

overweight:
InsulinSensi
tivityFractio
nLatePregn
ancyOverW
eight *
KxgI-PreGravid
obese:
InsulinSensi
tivityFractio
nLatePregn
ancyObese
*
KxgI-PreGravid
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Table 6: Model states and dynamic variables
Parameter name

Notation

Description

Ro_ratioOf1stOrderTo2ndOrderRateConstant
ForTissueGlucoseUptakeFromPlasmaParamet
erVariable

Ratio of 1st- to 2nd-order (insulin-dependent)
rate constants for tissue glucose uptake from
plasma

gamma_InsulinResistanceAsNoOfmMGlucose
AtWhichGlycemiaStabilizesPerpMInsulinemia
Variable

Resistance to insulin as the number of mM
glucose at which glycemia stabilises for a single
pM of insulinemia, is the converse of glucose
effectiveness [insulin sensitivity (KxgI)] and
expresses resistance to insulin as the concentration at which glucose stabilises for each
picomolar of insulin concentration.

I_fastingSerumInsulinConcentrationVariable

I

fasting serum insulin concentration

ImaxB_InsulinAttainableLevelVariable

ImaxB

insulin-attainable levels expressed as the
maximal contribution of 1 million -cells to
fasting insulin plasma concentration.
Its value is determined by the maximal insulin
secretion rate per million -cells TigB and by the
actual first-order apparent rate of elimination
of insulin from plasma (Kxi), which is considered
here to decrease with age.

betaVariable

β

initial value is 1000, -cell mass as millions of
active -cells

EthaPancreaticReplicationReserveVariable

the current ability of the pancreas to increase
its -cell proliferation rate if sufficiently
stimulated by the ambient glucose
concentration, depending on the current state
of pancreatic health.

T_ethaSpontaneousRecoveryRateOfPancreas
Variable

spontaneous recovery rate of the pancreas,
an impairment in cell replicating reserve has
been simulated by forcing a decline in the term
reflecting cell recovery from injury,
.
For the case of normal replicating ability, this
parameter is kept fixed throughout life;
otherwise the parameter is made to decrease
linearly from a normal initial value to a
somewhat decreased value at the end of the
period of observation.

G_fastingPlasmaGlucoseConcentrationVariabl
e

G

fasting plasma glucose concentration
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Parameter name

Notation

Description

A_glycoseylatedHaemoglobinHbA1cVariable

A

just calculate in the model, not used by other
function
glycosylated haemoglobin, with increase
determined by prevailing glycemias and by the
concentration of native Hb A0 and decrease
linearly determined by the continuous
destruction of red blood cells.

Kag_productionRateOfGlycosylatedHaemoglo
binFromCirculatingGlucoseVariable

Kag

the rate of production of Hb A1c from
circulating glucose.

h_glucoseEffectOnPancreasVariable

h

Glucose effect on pancreas.
In the model, h is calculated, but not used
anywhere.

Kxi_1stOrderInsulinEliminationRateVariable

Kxi

First-order elimination rate constant for insulin
and reflects clearance from the plasma, occurs
when glycemia exceeds the renal threshold, in
which case glucose is eliminated with urine in a
linear, plasma concentration-dependent
fashion. When glycemia is below the renal
threshold, as occurs in most normal or treated
subjects, there is difficulty identifying a
physiological process to which a linear term for
glucose elimination may correspond.

hG0_initialGlucoseEffectOnPancreasVariable

h(G0)

Value of the h(G) function at t0 (determined)

TigB_maximumPancreaticInsulinSecretionPer
MillionBetaVariable

TigB

maximal insulin secretion rate,

ImaxB_InsulinAttainableLevelVariable

ImaxB

maximal insulin secretory capacity, (ImaxB) has
been defined as the ratio of maximal insulin
secretion per million -cells per litre of
distribution space [maximal insulin
secretion(TigB)] and Kxi. In other words, we
make a distinction between secretion rate
(TigB) and the effect, in terms of concentration,
that this maximal secretion rate attains
(ImaxB). The distinction is relevant when (like
for the present simulations) the apparent firstorder elimination rate(Kxi) for insulin is made to
decline with age.

LambdaMaxVariable

λmax

Maximum (positive) value of ,
maximum replication rate of -cell, assuming no
apoptosis

xGlucoseVariable

x

Replaces glucose variations with variations of a
scale-free pure number
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Parameter name

Notation

Description

LambdaVariable

λ

Net rate constant for -cell growth (or decay)
resulting from the difference between
production (replication) rate and mortality
(apoptosis) rate.

KxgI_SecondOrderInsulinDependentGlucoseTis KxgI
sueUptakeRate

This coefficient represents the second-order
insulin-dependent glucose uptake rate constant
per unit of insulin and therefore reflects insulin
sensitivity (KxgI) of peripheral tissues.

MetforminInterventionPart1Variable

= getInterventionVariable(currTime,
tMetforminPart1, MetfDosePart1,
betaMetfPart1, alphaMetfPart1);

MetforminInterventionPart2Variable

=
getInterventionVariable(currTime, tMetforminP
art2, MetfDosePart2, betaMetfPart2,
alphaMetfPart2);

LifeStyleInterventionVariable

= getInterventionVariable(currTime, tLifeStyle,
adherence() * LiStDose, betaLifeStyle,
alphaLifeStyle);
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Table 7: Equations used in glycemic regulation representation
Equations

isUnderInsulinTreatment ? ρ = ρ + insulinDose *
adherence() / Kxi

Unit of
state /
variable

Description

Source

Mc

Initially beta cell mass is 1000, then beta cell is either increasing or
decreasing, which is determined by net rate constant for -cell growth
(or decay) resulting from the difference between production
(replication) rate and mortality (apoptosis) rate (lambda variable). If
beta cell is increasing due to compensation to G increase, the
maximum increase is 4000.

[18, 19]

mo-1

moving from some starting value (0) and then changing [potentially
[18-20]
increasing to a maximum (max) or decreasing toward zero] depending
on the prevailing glycemia levels. sustained hyperglycemia will lead to
a decrease of η.

%

To link observable glycated haemoglobin dynamics with the glucose
dynamics, a simple linear model of the kinetics of HbA1c has been
hypothesised
When insulin treatment is applied,
the impact of treatment with insulin on insulin sensitivity has been
considered by adding an additional term to the equation describing I in
the slow model of DeGaetano and find G and I based on this extra
term. The impact of treatment with insulin has been calculated in the
body of the function "updateGfastingGlucoseAndIFastinInsulin".
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[18-20]

Equations

Unit of state

Description

Source

Equation used to calculate glycemia value

[18-20]

Glucose effect on pancreas.
In the model, h is calculated, but not used anywhere.

[18-20]

/ variable

min-1

[18-20]

min-1

[18-20]

pM/min/Mc

[18-20]
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Equations

Unit of state / variable

Description

Source

pM/Mc

[18-20]

mo-1

[18-20]
[18-20]

mo-1

λ depends on prevailing glucose concentrations in the sense that it
varies from a minimum negative value

[18-20]

(λmin) to a maximum value that is dependent on both the prevailing
pancreatic reserve described here (λmax=λmin+η) and glucose level
according to a sigmoidal third-degree Hill function, with λ=λmin when
G=0 and λ tending to λmax as G tends to infinity.

Equations

pM

It has been assumed that the insulin-independent glucose tissue uptake [18-20]
rate constant Kxg is small (within the range of considered glycemias)
compared with insulin-dependent glucose uptake (50) and that,
consequently, the ρ is also approximately zero.

Unit of state / variable

Description

Source

mM/min

[20]

mM × pM

[18-20]
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Equations

Unit of state /
variable

Description

Source

%/mo/mM

[18-20]

min−1 /pM

this equation is in the function
InsulinSensitivityFromDegaetano(double tI)
different tI is used for different weight category
tI for normal weight, tI_Obese for obese, tI_Overweight for
overweights

[20]

mo-2

This equation reflects the case of normal replicating ability, this
parameter is kept fixed throughout life.

[20]
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Table 8: Functions used in glycemic regulation representation
function name

parameters

description

insulinSensitivityCoefficientForOffspring

GValueList:
ArrayList<Double>

averageGlycemia= after 26 weeks of pregnancy, the average value of the
difference between the glycemia values which are higher than GDM
standard, and GDM standard
e-offspringKxgIGlycemiaCoefficientaverageGlycemia

adherence

Beta (2, 5, 0, 1)

slopeOfDeclineInInsulinSensitivityDueToImpairment

if Tη is impaired, we assume it decreases linearly from a normal initial value
to a decreased value at the end of the period of observation. The slope of
the linear equation is calculated using the following equation.

getT_ethaSpontaneousRecoveryRateOfPancreasVariable

calculate T
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function name

parameters

description

insulinSensitivityBasedWeight

(weight: Weight,
kxgIOffspringCoefficient:
double
)
from[18-20], assume KxgI trajectory based on different weight status
(represented by tI), without weight change during the observation.

insulinSensitivityBasedWeight() calculates kxgI for changing weight status. if
weight change to overweight or obese, tI here will use tI_overweight or
tI_obese, respectively.

linearInterpInPregnancy

(timeDuringPregnancy:double)

assumption: kxgI will decrease during pregnancy, after postpartum will back to
normal.
there using LinearInterpolator from org.apache.commons.math3.
[] x = {timeOfPregnancy, timeOfPregnancy+3*month(),
timeOfPregnancy+9.3*month()};
[] y = {KxgI-PreGravid, KxgI-EarlyPreg, KxgI-LatePreg};
f = interpolate(x,y)
f(timeDuringPregnancy)
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function name

parameters

description

InsulinSensitivityInPostPartum

(KxgI_coefficient:double)

calculateInsulinSensitivityFunction

KxgI is being calculated during pregnancy, postpartum, non-pregnancy, lifestyle interventions and metformin treatment.
One very important issue that should be reconsidered is the dose of metformin
and insulin. The impact of metformin and lifestyle treatment is based on the
work of DeGaetano et al [18, 19].
during pregnancy: KxgI = maternalInsulinSensitivityCoefficient *
linearInterpInPregnancy(t)
postPartum: KxgI = maternalInsulinSensitivityCoefficient*
InsulinSensitivityInPostPartum()
non-pregnant: KxgI = insulinSensitivityBasedWeight()
lifestyle treatment && metformin treatment: KxgI = KxgI + KxgI *
(LifeStyleInterventionVariable + MetforminInterventionPart1Variable +
MetforminInterventionPart2Variable)
lifestyle treatment: KxgI = KxgI + KxgI * LifeStyleInterventionVariable
metformin treatment: KxgI = KxgI + KxgI *
(MetforminInterventionPart1Variable + MetforminInterventionPart2Variable)
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function name

parameters

description

equationSolverFunction

This function finds the integration of all flows using Euler method, replacing the
integration process in Anylogic.
Β, η and A is updated here

updateGfastingGlucoseAndIFastinInsulin

This function finds and updates the values for Glucose and Insulin based on
Newton–Raphson method. The other import functionality of this function is
updating all the components of System-Dynamics including "States" and
"Dynamic variables".
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D. Population representation
The model starts with an index population, these are people who start in the model at different ages and
are initialised in different states. The index population is based on ACT demographic information taken
from the 2011 Australian Census and National Health Survey data. At the birth transition in the
pregnancy state chart, individuals are born into the model, and the sex of descendants is determined by a
distribution. For simplicity, male descendants are deleted after they transit to the
descendantPopulation_Male state. Initial and descendant female population leave the population
according to the death rate from the Australian Bureau of Statistics
(http://stat.data.abs.gov.au/Index.aspx?DataSetCode=DEATHS_AGESPECIFIC_OCCURENCEYEAR) . Age is
initialised and collected in continuous model time and can be calculated at any point in the model. This
allows statistics to be aggregated by any relevant age groupings eg. 1-year, 5-year or, 10-year age
groups etc. In this way, the model supports flexible characterisation. The population statechart
representation is shown in
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Figure 5.

Babies born into the model inherit their mother's status at time of birth, allowing the model to collect
family history information about those children and their descendants. The information available for the
descendent population is therefore richer than the initial population. For example, the mother's glycemia
status affects the insulin sensitivity of children. The initial population has imposed assumptions onto the
model, for example, for initial population, their insulin sensitivity is assumed not affected by their
mother's status, however for the descendent population this information is generated by the model.
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Figure 5: Population representation structure
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Table 9: Parameters used in population representation
Parameter

Value

initialAgeCategory

Type

Description

AgeGroup

assign age
group when
enter
population
state chart

agentIndexNumber

Determined when agent is created in the model.

int

agent index
in the
population

motherIndexNumber Determined when agent is created in the model.

int

for
descendant,
its mother's
index in the
population

gender

Female/Male

Gender

agent's
gender.

ethnicity

ADiPS/ATSI/Australian_Born/Other

Ethnicity

agent's
ethnicity

descendant

True / false

boolean

the agent is
born during
model
running or
not

ageCreatedinModel

Determined when agent is created in the model. For First

double

Agent age

generation of the model, the value is draw from a

at start of

distribution

the model

(https://www.populationpyramid.net/australia/1978/),

run

for all descendent, the value is 0.
isImmigrant

True / false

boolean

the agent is
immigrant
or not
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E. Weight status representation
BMI categories have been used in this model to categorise an individual’s weight status. The categories
used in the statechart are: not overweight/obese; overweight, obese and NA (not applied). However,
underlying the statechart, weight status is characterised as a continuous variable based on z score and
age specific BMI distributions [22]. Upon entry to adulthood, agents are allocated a z-score representing
their position within the population weight distribution. Their position within the distribution is assumed
to stay the same as they age. Hayes et al reported that the population weight distributions move toward
higher BMI through the life course i.e. people gain weight as they age, therefore an agent with a z score
of 1 on entry to adulthood may be healthy weight, however if they maintain the same z score into their
40’s the movement of the population weight distribution may position them within the overweight
category. Individuals can transition between weight states as they lose or gain weight. If an agent loses
weight due to an intervention a new lowered z-score is assigned and if they gain weight, for example due
to pregnancy [23], they are assigned a new higher z-score. The weight status representation is shown in

.

When an agent is introduced into the model, the BMI of the agent is initialised based on the BMI
distribution of the age group that this agent belongs to. The corresponding Z-score is calculated from
the BMI value and mean of the BMI distribution. As the agent ages they will transfer from current age
group to next age group (e.g. 25 -> 35). The BMI distribution also changes from the distribution of
current age group to the distribution of next age group. By applying the Z-score to the BMI distribution
of the next age group, the BMI will be calculated. The BMI value of the next age group for an agent will
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be calculated in an event with cyclic timeout of 10 years. A second event with cyclic timeout of 1 year was
used to move the BMI of current age group towards the BMI of next age group gradually.

With this Z-score-BMI mechanism, we also capture the BMI change after pregnancy. After pregnancy,
based on a distribution, four types of BMI change can occur. These include decreasing more than 1 BMI
unit, no change of BMI, increasing more than three BMI unit and increasing 1 BMI unit. After the BMI
value has changed after pregnancy, the new BMI and BMI distribution of current age group of the agent
are used to recalculate the agent’s Z-score.
Figure 6: Weight status statechart

Table 10: Parameters used in weight dynamics
Parameter

Value

Type

Description

BMI

assignInitialBMI(age)

double

BMI value of the
agent

Z-score

getZscore(age, BMI)

double

Representing the
position of the
BMI value in BMI
distribution.
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weight

Weight

overweightBMILowerBound

25

int

overweightBMIUpperBound

30

int

Weight category
of the agent

Table 11: Functions used in weight dynamics
Function name

parameters

description

getZscore

(age: double, BMI: double)

Calculate the Z-score of an agent
based on age and BMI

getBMI

(age: double, Z-score:
double)

Calculate the Z-score of an agent
based on age and Z-score

getWeightCategory

(BMI: double)

Calculate weight category of an
agent

assignInitialBMI

(age: double)

When model introduced into model,
assign initial BMI to the agent based
on their age.

BMIChangeBetweenPregnancy

Based on BMI change type after
pregnancy, assign new BMI and Zscore after pregnancy
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F. Service representation
Services during pregnancy are represented using discrete events simulation components. Regular
primary care is represented in a statechart in Person reflecting that a woman is receiving usual health
care services through a general practitioner (Figure 7 (1)). For non-pregnant agents, they are in
InPrimaryCare state and receive risk factor check every two years. Agents leave InPrimaryCare state when
they become pregnant, when they enter the NotInPrimaryCare state. While in the NotInPrimaryCare state,
agents move through the clinical service pathway as follows.
Clinical pathway 1 is shown in Figure 7 below. A pregnant female agent enters the service at the
beginning of her pregnancy. She receives an early pregnancy assessment in the earlyPregnancyTest
service block (usually performed by her GP). She then waits at delayBeforeTest block for her Diabetes in
Pregnancy (DIP) test in dipAssessment block. The DIP test time varies with individuals. In this model,
agents who are not categorised as high risk receive the DIP test at 26 - 28 weeks gestation. However,
high-risk agents, including obese agents, high risk ethnicities or whose age is over 35 years, have the DIP
test at 8 - 12 weeks gestation. At this dipAssessment block, if the woman’s blood glucose level is above
the diagnostic threshold (see Table 3) a message transition is triggered in the diagnosis statechart and
the agent transitions to a diagnosed state.
The agents whose DIP test result is negative will be referred to standard antenatal care and remain there
until delivery. At antenatal care service, resource sets of administrative officers, nurses and physicians are
allocated to the queueing agents.
If the DIP test result is positive, meaning the agent has T1DM, T2DM or GDM, the agent first moves to
the DIPEducation service block. This service has a resource set of diabeteNurseEducators and delay time
of 5 hours. At this time, the agent will start lifestyle intervention. The agent will have lifestyle intervention
for 1 week at the delay block underLifestyleAfterEducation. After this delay, agents are referred to the
dietitian for a review at dieticianReview service and have their glycemic levels reviewed.
At this point, if the glycemic level does not exceed the GDM criteria, meaning the lifestyle intervention in
DIPEducation session is working, the agent continues lifestyle intervention in dietControl delay for 1
week. After dietControl, the agent’s glycemic control is monitored every week until delivery. During this
time, if the glycemia result in any week is higher than the GDM criteria in this model, the agent is referred
to select-output lifestyleOrInsulinTreatment. If the test results are all negative, the agent will go to
delayBeforePostpartumFollowUp delay for postpartum check.
Agents who have high glycemic levels at the dieticianReview service are referred to select-output
lifestyleOrInsulinTreatment. Here the agent will be assessed to continue lifestyle intervention or start
insulin treatment. The model assumes that if an agent's glucose level is higher than the criteria of T2DM,
the agent will start insulin treatment and continue the insulin treatment until delivery, otherwise she will
go back to diet control with continuing lifestyle intervention and ongoing monitoring until delivery.
After delivery, all agents will wait six weeks until they receive postpartum follow-up dip assessment. There
are three different conditions in this test. First, if glucose level is higher than GDM criteria but not yet
developed into T2DM, the agent will continue lifestyle intervention and leave this service pathway.
Second, if the agent is T2DM or T1DM, the agent will start all three treatments: lifestyle intervention,
insulin treatment, metformin treatment. Then they also leave this service pathway. Third, if the glucose
level of the agent is lower than GDM criteria, the agent will stop lifestyle intervention then leave service
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pathway. After leaving ACT health service pathway, the agents will transition back to InPrimaryCare state
in PrimaryCare_Statechart in Person. This representation allows the model to capture resource use and
costs associated with service provision to individual agents, and intervention in primary care. Different
models of clinical care can be represented and compared in this section of the model.

Figure 7: Service representation

Table 12: Functions used in service representation
Function

Return

Description

type
gdmStandard()

double

get model's criteria for gdm

T2DMStandard()

double

get model's criteria for T2DM

assignDiPTestTime(Person)

double

when enter ACT health service, assign dip test time for different agent,
normally test time is 26 - 28. For high risk group (e.g. obese, age > 35)
they will start test at 8 - 12 weeks
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G. Interventions for scenario testing

Four types of population level interventions are implemented into the model and described as follows.
A. Public health messaging and mobile app support
The intervention is target on the women aged 20-35 years. As a pre-pregnancy intervention, it is applied
in InPrimaryCareState of PrimaryCare_Statechart every year. The targeted women will have certain
probability to take this intervention, as well as retake the intervention. The intervention achieves healthier
pre-pregnancy BMI and optional lifestyle change, by reducing BMI for overweight or obese agent
whereas no BMI reduce for healthy weight agent. The lifestyle change resulting from the intervention
improves the insulin sensitivity in glycemia regulation representation of the model.

B.

Targeted pre-pregnancy support

This intervention takes place at the planning pregnancy state before pregnancy, and works on women
with risk factors, including BMI greater than 28, age greater than 30 years and high-risk ethnicity
according to the ADIPS criteria [24]. Similarly, with the mechanism of public health message and mobile
app support intervention, health professional support also targets weight reduction and optional lifestyle
change.

C. Targeted post-pregnancy support
The intervention targets on women how had DIP in previous pregnancy, take places between pregnancy
and include both weight reduction and lifestyle change. In this intervention, the target group is the
women who were diagnosed with DIP in a previous pregnancy. The lifestyle change intervention with
strong adherence allows the intervention to have a stronger effect on insulin sensitivity.
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Table 13: Parameters used in interventions
Parameter name

Description

Value

Source

alphaLifeStyle

used in getInterventionVariable()
as parameter alphaPart for
calculation of
LifeStyleInterventionVariable

0.08

[17]

alphaMetfPart1

used in getInterventionVariable()
as parameter alphaPart for
calculation of
MetforminInterventionPart1Vari
able

0.015

[17]

alphaMetfPart2

used in getInterventionVariable()
as parameter alphaPart for
calculation of
MetforminInterventionPart2Vari
able

0.1

[17]

betaLifeStyle

used in getInterventionVariable()
as parameter betaPart for
calculation of
LifeStyleInterventionVariable

0.026

[17]

betaMetfPart1

used in getInterventionVariable()
as parameter betaPart for
calculation of
MetforminInterventionPart1Vari
able

0.008

[17]

betaMetfPart2

used in getInterventionVariable()
as parameter betaPart for
calculation of
MetforminInterventionPart2Vari
able

0.03

[17]

LiStDose

used in getInterventionVariable()
as parameter dose for
calculation of
LifeStyleInterventionVariable

main.lifeStyleInterventionDos
eParameter,

[17]

= 3.754
can be changed

tLifeStyle

time starts lifestyle intervention

isUnderLifeStyleIntervention

default false, change to true
when intervention starts

tMetforminPart1

time starts metformin treatment
part 1
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Parameter name

Description

Value

Source

MetfDosePart1

used in getInterventionVariable()
as parameter dose for
calculation of
MetforminInterventionPart1Vari
able

main.MetforminIntervention
DoseParameter1

[17]

=0.357

isUnderMetforminTreatment

default false, change to true
when intervention starts

tMetforminPart2

time starts metformin treatment
part 2

time()

MetfDosePart2

used in getInterventionVariable()
as parameter dose for
calculation of
MetforminInterventionPart2Vari
able

main.MetforminIntervention
DoseParameter2

professionSupportRiskFactorB
MI

Risk factor to determine whether
an agent is eligible to take
professional support
intervention

28

professionSupportRiskFactorAg
e

Risk factor to determine whether
an agent is eligible to take
professional support
intervention

30

professionSupportRiskFactorEt
hnicity

Risk factor to determine whether
an agent eligible to take
professional support
intervention

ADiPS

MetforminInterventionPart1Varia
ble

Works on improving insulin
sensitivity after agent leave
service pathway with T2DM

=
getInterventionVariable(currTi
me,
tMetforminPart1, MetfDosePar
t1,
betaMetfPart1, alphaMetfPart1
);

MetforminInterventionPart2Varia
ble

Works on improving insulin
sensitivity after agent leave
service pathway with T2DM

=
getInterventionVariable(currTi
me, tMetforminPart2,
MetfDosePart2, betaMetfPart2
, alphaMetfPart2);

LifeStyleInterventionVariable

Works on improving insulin
sensitivity when lifestyle change
is enabled in the interventions

=
getInterventionVariable(currTi
me, tLifeStyle,
adherence() * LiStDose,
betaLifeStyle, alphaLifeStyle);
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Table 14: Functions used in interventions
Function

Return
type

getInterventionVariab
le

(curTime:
double

Description

t_interv:
double
dose:
double
betaPart:
double
alphaPart:
double)
Peak

(alpha:
double
beta:
double)
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Appendices

Appendix A: Members of the Diabetes in Pregnancy Modelling Consortium
Name

Position

Organisation

Jo-An Atkinson

Lead – Decision Analytics

Tracey Baker

General Practitioner

Sax Institute and The Australian
Prevention Partnership Centre
Chapman Medical Practice

Lynelle Boisseau

Diabetes Educator

ACT Health Diabetes Service

Jacqui Davison

Project Officer

Roland Dyck

Professor of Medicine

The Australian Prevention
Partnership Centre
University of Saskatchewan, Canada

Jeff Flack

Associate Professor,
Endocrinology and Medical
Informatics
Manager, Epidemiology Section
and PhD Candidate

Louise Freebairn

Alison Hayes
Paul Kelly

Alison Kent
Louise Maple-Brown

Geoff McDonnell

Associate Professor, Health
Economics
Chief Health Officer and Deputy
Director, General, Population
Health Prevention and Protection
Professor and Senior Staff
Specialist, Neonatology
Associate Professor,
Endocrinologist – Diabetes,
Kidney and Aboriginal Health
Adviser, Simulation Modelling

Allen McLean

PhD Candidate, Simulation
Modelling

Chris Nolan

Professor of Endocrinology,
Director of Diabetes Services
ACT
Project Officer

Eloise O’Donnell
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Liverpool Hospital, University of
New South Wales
ACT
Health,
The
Australian
Prevention Partnership Centre and
University of Notre Dame Australia
School of Public Health, University
of Sydney, and CRE
ACT Health

Australian National University and
ACT Health
Menzies School of Health Research,
Royal Darwin Hospital.
The Australian Prevention
Partnership Centre
University of Saskatchewan,
Canada, The Australian Prevention
Partnership Centre
Australian National University, ACT
Health
The Australian Prevention
Partnership Centre
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Name

Position

Organisation

Nate Osgood

Professor of Computational Science,
Simulation Modeller

Michael Peek

Professor of Obstetrics and
Gynaecology, Maternal Fetal Medicine
Specialist,
Computer scientist

University of Saskatchewan,
Canada, The Australian
Prevention Partnership Centre
Australian National University,
ACT Health

Luke Penza

Ante Prodan

Senior Lecturer, Computational
Epidemiology

Nick Roberts

Project Officer

Lucie Rychetnik

Professor, Deputy Director – Research

Anahita Safarishahrbijari

Computational Science, Simulation
Modeller,

David Simmons

Professor of Medicine, Endocrinology

Jana Sisnowski

Research Officer

Christine Whittall

Policy Officer
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University of Western Sydney
and The Australian Prevention
Partnership Centre
University of Western Sydney
and The Australian Prevention
Partnership Centre
The Australian Prevention
Partnership Centre, NSW
Ministry of Health
The Australian Prevention
Partnership Centre, University
of Sydney, University of Notre
Dame, Australia
Department of Computer
Science, University of
Saskatchewan, Canada
Western Sydney University,
Western Sydney Area Health
Service
University of Adelaide, Country
SA Primary Health Network
Office for Health and Medical
Research, NSW Ministry of
Health
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Appendix B: Symbols used in modelling diagrams
System dynamics modelling
Stella / iThink symbols

System Dynamics Symbols
Level

Rate

Auxiliary variable

Source/sink
Flow
Cause-effect
connector

Level:





Rate/flow:
also called stock, accumulation, or state
variable
a quantity that accumulates over time
change its value by accumulating or
integrating rates
change continuously over time even
when the rates are changing
discontinuously

Auxiliary:





also called flow, activity, movement
change the values of levels
value of a rate is
o Not dependent on previous values
of that rate
o But dependent on the levels in a
system along with exogenous
influences

Source and sink:



arise when the formulation of a level’s
influence on a rate involves one or more
intermediate calculations



source represents systems of levels
and rates outside the boundary of the
model



often useful in formulating complex rate
equations



sink is where flows terminate outside
the system



used for ease of communication and
clarity



value changes immediately in response
to changes in levels or exogenous
influences.
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Source: adapted by G McDonnell from https://www.cise.ufl.edu/~fishwick/cap4800/sd2.ppt

Agent-based modelling
Statechart
(description and image from Anylogic 7 in 3 days available at: http://www.anylogic.com/free-simulation-book-and-modeling-tutorials )

Statecharts have states and transitions. The states are “alternative” meaning that objects can only be in one
state at a time. A transition execution may lead to a state change that makes a new set of transitions active.
The statechart’s states may be hierarchical – a state may contain other states and transitions.
One agent may have several statecharts that describe independent parts of the agent’s behaviour.

Source:

Anylogic 7 in 3 days available at: http://www.anylogic.com/free-simulation-book-and-modeling-tutorials

MODEL OVERVIEW: PREVENTION AND MANAGEMENT OF
DIABETES IN PREGNANCY IN THE ACT

53

368

References
1.

2.

3.

4.

5.

6.

7.
8.
9.
10.
11.
12.
13.

14.

15.

16.

17.

18.

19.

Combined DES/SD simulation model of breast cancer screening for older women: An overview.
Proceedings of the 2013 Winter Simulation Conference
[http://ieeexplore.ieee.org.ezproxy2.library.usyd.edu.au/xpl/conhome.jsp?punumber=1000674]
Prospective healthcare decision-making by combined system dynamics, discrete-event and agentbased simulation. Paper presented at: Proceedings of the 2013 Winter Simulation Conference
[http://ieeexplore.ieee.org.ezproxy2.library.usyd.edu.au/xpl/conhome.jsp?punumber=10006742013]
Sadsad R, McDonnell G, Viana J, al E: In: Brailsford S, Churilov L, Dangerfield B, eds. Discrete-Event
Simulation and System Dynamics for Management Decision Making, First Edition. . Chichester, UK:
John Wiley & Sons; 2014.
Discrete choice, agent based and system dynamics simulation of health profession career paths
Paper presented at: Proceedings of the 2014 Winter Simulation Conference
[http://ieeexplore.ieee.org.ezproxy2.library.usyd.edu.au/xpl/conhome.jsp?punumber=10006742014]
Atkinson J, Page A, Wells R, Milat A, Wilson A: A modelling tool for policy analysis to support the
design of efficient and effective policy responses for complex public health problems.
Implementation Science 2015, 10(26):doi:10.1186/s13012-13015-10221-13015.
Page A, Atkinson J-A, Heffernan M, McDonnell G, Prodan A, Osgood N, Hickie I: Static metrics of impact
for a dynamic problem: The need for smarter tools to guide suicide prevention planning and
investment. Aust N Z J Psychiatry 2018:1410470838.
Auchincloss AH, Roux AV: A New Tool for Epidemiology: The Usefulness of Dynamic-Agent Models
in Understanding Place Effects on Health. Am J Epidemiol 2008, 168(1):1-8.
Homer J, Hirsch G: System dynamics modeling for public health: background and opportunities. Am
J Public Health 2006, 96(3):452-458.
Lin Y, Duan X, Zhao C, Xu L: Systems science: methodological approaches. Florida: CRC Press: Taylor &
Francis Group; 2013.
Matthies M, Malchow H, Kriz J: Integrative systems approaches to natural and social dynamics.
Germany: Springer; 2001.
Luke DA, Stamatakis KA: Systems science methods in public health: dynamics, networks, and agents.
Annu Rev Public Health 2012, 33:357-376.
Borshchev A: The Big Book of Simulation Modeling: Multimethod Modeling with AnyLogic 6.
Chicago: AnyLogic North America; 2013.
Burke JG, Hassmiller Lich K, Neal JW, Meissner HI: Enhancing dissemination and implementation
research using systems science methods. International Journal of Behavioral Medicine 2015, 22(3):283291.
Marshall DA, Burgos-Liz L, Ijzerman MJ, Osgood ND, Padula WV, Higashi MK, Wong PK, Pasupathy KS,
Crown W: Applying dynamic simulation modeling methods in health care delivery research-the
SIMULATE checklist: report of the ISPOR simulation modeling emerging good practices task force.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
2015, 18(1):5-16.
Freebairn L, Rychetnik L, Atkinson J-A, Kelly P, McDonnell G, Roberts N, Whittall C, Redman S:
Knowledge mobilisation for policy development: implementing systems approaches through
participatory dynamic simulation modelling. Health research policy and systems 2017, 15(1):83.
Freebairn L, Atkinson J, Kelly P, McDonnell G, Rychetnik L: Simulation modelling as a tool for
knowledge mobilisation in health policy settings: a case study protocol. Health Research Policy and
Systems 2016, 14(1):71.
Stephenson J, Heslehurst N, Hall J, Schoenaker DAJM, Hutchinson J, Cade JE, Poston L, Barrett G, Crozier
SR, Barker M et al: Before the beginning: nutrition and lifestyle in the preconception period and its
importance for future health. The Lancet 2018.
Hardy T, Abu-Raddad E, Porksen N, De Gaetano A: Evaluation of a mathematical model of diabetes
progression against observations in the Diabetes Prevention Program. American Journal of
Physiology - Endocrinology and Metabolism 2012, 303(2).
De Gaetano A, Panunzi S, Palumbo P, Gaz C, Hardy T: Data-driven Modeling for Diabetes. Data-driven
Modeling for Diabetes 2014:165-186.

MODEL OVERVIEW: PREVENTION AND MANAGEMENT OF
DIABETES IN PREGNANCY IN THE ACT

54

369

20.

21.
22.

23.

24.

De Gaetano A, Hardy T, Beck B, Abu-Raddad E, Palumbo P, Bue-Valleskey J, Pørksen N: Mathematical
models of diabetes progression. American Journal of Physiology-Endocrinology and Metabolism 2008,
295(6):E1462-E1479.
Catalano PM: Trying to understand gestational diabetes. Diabet Med 2014, 31(3):273-281.
Hayes A, Gearon E, Backholer K, Bauman A, Peeters A: Age-specific changes in BMI and BMI
distribution among Australian adults using cross-sectional surveys from 1980 to 2008. Int J Obes
2015, 39(8):1209-1216.
Knight-Agarwal CR, Williams LT, Davis D, Davey R, Cochrane T, Zhang H, Rickwood P: Association of BMI
and interpregnancy BMI change with birth outcomes in an Australian obstetric population: a
retrospective cohort study. BMJ Open 2016, 6(5).
Nankervis A, McIntyre H, Moses R, Ross G, Callaway L, Porter C, Jeffries W: ADIPS consensus guidelines
for the testing and diagnosis of gestational diabetes mellitus in Australia. Modified June 2014.

MODEL OVERVIEW: PREVENTION AND MANAGEMENT OF
DIABETES IN PREGNANCY IN THE ACT

55

370

371

